61869-08-7 | Paroxetine

Packsize	Purity	Availability	Price	Discounted Price
100mg	96%	in stock	$35.00	$24.00
250mg	96%	in stock	$50.00	$35.00
1g	96%	in stock	$131.00	$92.00
5g	96%	in stock	$415.00	$290.00
10g	96%	in stock	$733.00	$513.00
25g	96%	in stock	$1,332.00	$932.00

Description

• Catalog Number: AI53775
• Chemical Name: Paroxetine
• CAS Number: 61869-08-7
• Molecular Formula: C19H20FNO3
• Molecular Weight: 329.3654
• MDL Number: MFCD00869588
• SMILES: Fc1ccc(cc1)[C@@H]1CCNC[C@H]1COc1ccc2c(c1)OCO2

Computed Properties

• Complexity: 402
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 2
• Heavy Atom Count: 24
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 4
• XLogP3: 3.5

Literature

• Impact of selective serotonin reuptake inhibitors on neural crest stem cell formation.

  Toxicology letters 20171105

• Editor's Highlight: Therapeutic Concentrations of Antidepressants Inhibit Pancreatic Beta-Cell Function via Mitochondrial Complex Inhibition.

  Toxicological sciences : an official journal of the Society of Toxicology 20170801

• Medicinal chemistry of adenosine, P2Y and P2X receptors.

  Neuropharmacology 20160501

• X-ray structures and mechanism of the human serotonin transporter.

  Nature 20160421

• Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class.

  Toxicology letters 20160122

• Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay.

  Toxicology in vitro : an international journal published in association with BIBRA 20151001

• Crystal Structure of G Protein-coupled Receptor Kinase 5 in Complex with a Rationally Designed Inhibitor.

  The Journal of biological chemistry 20150821

• Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs.

  Toxicological sciences : an official journal of the Society of Toxicology 20150601

• Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.

  Chemical research in toxicology 20150518

• Bioactivation of sitaxentan in liver microsomes, hepatocytes, and expressed human P450s with characterization of the glutathione conjugate by liquid chromatography tandem mass spectrometry.

  Chemical research in toxicology 20130617

• P2X receptors as drug targets.

  Molecular pharmacology 20130401

• Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions.

  Journal of applied toxicology : JAT 20130201

• Differential responses to distinct psychotropic agents of selectively bred dominant and submissive animals.

  Behavioural brain research 20130101

• Involvement of the sigma1 receptor in the antidepressant-like effects of fluvoxamine in the forced swimming test in comparison with the effects elicited by paroxetine.

  European journal of pharmacology 20121205

• Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20121203

• Astrocytic 5-HT(2B) receptor as in vitro and in vivo target of SSRIs.

  Recent patents on CNS drug discovery 20121201

• N-substituted phenoxazine and acridone derivatives: structure-activity relationships of potent P2X4 receptor antagonists.

  Journal of medicinal chemistry 20121126

• Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels.

  The Biochemical journal 20121115

• Determination of selected pharmaceutical residues in wastewater using an automated open bed solid phase microextraction system.

  Journal of chromatography. A 20121102

• A fully validated method for the simultaneous determination of 11 antidepressant drugs in whole blood by gas chromatography-mass spectrometry.

  Journal of pharmaceutical and biomedical analysis 20121101

• Fluoxetine and sertraline may be associated with lower risk of suicide death than paroxetine in adults with depression.

  Evidence-based mental health 20121101

• Distribution of antidepressant residues in wastewater and biosolids following different treatment processes by municipal wastewater treatment plants in Canada.

  Water research 20121101

• Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors.

  Journal of psychiatric research 20121101

• A novel spirocyclic tropanyl-Δ²-isoxazoline derivative enhances citalopram and paroxetine binding to serotonin transporters as well as serotonin uptake.

  Bioorganic & medicinal chemistry 20121101

• Antidepressant switching patterns in the treatment of major depressive disorder: a General Practice Research Database (GPRD) Study.

  International journal of clinical practice 20121101

• Optimization of solid phase microextraction for non-lethal in vivo determination of selected pharmaceuticals in fish muscle using liquid chromatography-mass spectrometry.

  Journal of chromatography. A 20121026

• Liquid chromatography-tandem mass spectrometry method for determination of five antidepressants and four atypical antipsychotics and their main metabolites in human serum.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20121015

• Validation of visualized transgenic zebrafish as a high throughput model to assay bradycardia related cardio toxicity risk candidates.

  Journal of applied toxicology : JAT 20121001

• Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: a trial from the University of Rochester Cancer Center Community Clinical Oncology Program.

  Sleep medicine 20121001

• DRD3, but not BDNF, genotype affects treatment response to paroxetine in major depressive disorder: a preliminary study.

  Journal of clinical psychopharmacology 20121001

• Parasomnias: an updated review.

  Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20121001

• Efficacy of Yiqiyangxin Chinese medicine compound combined with cognitive therapy in the treatment of generalized anxiety disorders.

  Asian Pacific journal of tropical medicine 20121001

• Convergent animal and human evidence suggests the activin/inhibin pathway to be involved in antidepressant response.

  Translational psychiatry 20121001

• How to use an article reporting a multiple treatment comparison meta-analysis.

  JAMA 20120926

• Antidepressants for patients with tinnitus.

  The Cochrane database of systematic reviews 20120912

• Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

  Purinergic signalling 20120901

• The CRF₁ receptor antagonist SSR125543 attenuates long-term cognitive deficit induced by acute inescapable stress in mice, independently from the hypothalamic pituitary adrenal axis.

  Pharmacology, biochemistry, and behavior 20120901

• Comparison of two extraction methods for the determination of selective serotonin reuptake inhibitors in sewage sludge by hollow fiber liquid-phase microextraction.

  Journal of separation science 20120901

• Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats.

  The European journal of neuroscience 20120901

• 4-aminopyridine toxicity: a case report and review of the literature.

  Journal of medical toxicology : official journal of the American College of Medical Toxicology 20120901

• Efficacy and safety of tramadol for premature ejaculation: a systematic review and meta-analysis.

  Urology 20120901

• Methods for retrospective detection of drug safety signals and adverse events in electronic general practice records.

  Drug safety 20120901

• The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review.

  The Journal of rheumatology. Supplement 20120901

• Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine.

  Progress in neuro-psychopharmacology & biological psychiatry 20120807

• Modulation of antipsychotic-induced extrapyramidal side effects by medications for mood disorders.

  Progress in neuro-psychopharmacology & biological psychiatry 20120807

• Ketamine-enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophrenia.

  Progress in neuro-psychopharmacology & biological psychiatry 20120807

• A link between oxytocin and serotonin in humans: supporting evidence from peripheral markers.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120801

• Antidepressant use during pregnancy and the risk of pregnancy-induced hypertension.

  British journal of clinical pharmacology 20120801

• Effects of diphenyl diselenide on depressive-like behavior in ovariectomized mice submitted to subchronic stress: involvement of the serotonergic system.

  Psychopharmacology 20120801

• Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120801

• Anaerobic treatment of sewage sludge containing selective serotonin reuptake inhibitors.

  Bioresource technology 20120801

• Ask the doctor. I have been taking an SSRI (paroxetine HCI) for many years for chronic anxiety and, at times, panic attacks. What are the side effects of the long-term use of SSRIs?

  Harvard health letter 20120801

• Effect of paroxetine and bupropion on human resting brain perfusion: an arterial spin labeling study.

  NeuroImage 20120716

• Psychotropic medication during endocrine treatment for breast cancer.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120701

• The SSRI citalopram affects fetal thalamic axon responsiveness to netrin-1 in vitro independently of SERT antagonism.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120701

• Pilot and pivotal study to evaluate the bioequivalence of two paroxetine 40 mg tablet formulations in healthy Chinese subjects.

  International journal of clinical pharmacology and therapeutics 20120701

• Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers.

  Pharmacogenomics 20120701

• Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians.

  Postgraduate medicine 20120701

• Paroxetine use during pregnancy and perinatal outcomes including types of cardiac malformations in Quebec and France: a short communication.

  Current drug safety 20120701

• Meta-analysis of the clinical effectiveness of traditional Chinese medicine formula Chaihu-Shugan-San in depression.

  Journal of ethnopharmacology 20120601

• Pharmacological treatment of unipolar depression during pregnancy and breast-feeding--a clinical overview.

  Nordic journal of psychiatry 20120601

• Do drug warnings and market withdrawals have an impact on the number of calls to teratogen information services?

  Pharmacopsychiatry 20120601

• Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study.

  Progress in neuro-psychopharmacology & biological psychiatry 20120601

• Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience.

  The journal of headache and pain 20120601

• Conditioned fear stress combined with single-prolonged stress: a new PTSD mouse model.

  Neuroscience research 20120601

• Citalopram is a more potent platelet function inhibitor than paroxetine in a case-control study.

  Journal of thrombosis and haemostasis : JTH 20120601

• New agents promote neuroprotection in Parkinson's disease models.

  CNS & neurological disorders drug targets 20120601

• Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children.

  Clinical toxicology (Philadelphia, Pa.) 20120601

• Antidepressant agents and suicide death among US Department of Veterans Affairs patients in depression treatment.

  Journal of clinical psychopharmacology 20120601

• Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review.

  Depression and anxiety 20120601

• The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters.

  The Journal of biological chemistry 20120525

• Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.

  Journal of medicinal chemistry 20120524

• Promoter polymorphisms of SERPINE1 are associated with the antidepressant response to depression in Alzheimer's disease.

  Neuroscience letters 20120516

• Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials.

  Journal of psychopharmacology (Oxford, England) 20120501

• Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains.

  Psychopharmacology 20120501

• Social fear conditioning: a novel and specific animal model to study social anxiety disorder.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120501

• Chronic fluoxetine selectively upregulates dopamine D₁-like receptors in the hippocampus.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120501

• Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment.

  International clinical psychopharmacology 20120501

• Clinically relevant drug interactions in anxiety disorders.

  Human psychopharmacology 20120501

• Differential effects of diazepam, tandospirone, and paroxetine on plasma brain-derived neurotrophic factor level under mental stress.

  Human psychopharmacology 20120501

• Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120501

• Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin.

  Journal of molecular and cellular cardiology 20120501

• Can Minnesota Multiphasic Personality Inventory-2 predict response to selective serotonin reuptake inhibitors in depressed outpatients?

  International clinical psychopharmacology 20120501

• K(+) efflux through two-pore domain K(+) channels is required for mouse embryonic development.

  Reproduction (Cambridge, England) 20120501

• An increase in spinal cord noradrenaline is a major contributor to the antihyperalgesic effect of antidepressants after peripheral nerve injury in the rat.

  Pain 20120501

• A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation.

  Drug safety 20120501

• Early steps in the development of a claims-based targeted healthcare safety monitoring system and application to three empirical examples.

  Drug safety 20120501

• A case of serotonin syndrome precipitated by fentanyl and ondansetron in a patient receiving paroxetine, duloxetine, and bupropion.

  Journal of clinical anesthesia 20120501

• Italian guidelines for primary headaches: 2012 revised version.

  The journal of headache and pain 20120501

• Modulation of the platelet serotonin transporter by thermal balneotherapy: a study in healthy subjects.

  European review for medical and pharmacological sciences 20120501

• Glad about SAD (PD).

  Neurology 20120417

• A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.

  Neurology 20120417

• Paroxetine use should be avoided during pregnancy.

  American family physician 20120415

• Pyrazolo[4,3-c][1,2]benzothiazines 5,5-dioxide: a promising new class of Staphylococcus aureus NorA efflux pump inhibitors.

  Journal of medicinal chemistry 20120412

• Target screening and confirmation of 35 licit and illicit drugs and metabolites in hair by LC-MSMS.

  Forensic science international 20120410

• Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study.

  The Journal of clinical psychiatry 20120401

• Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19.

  European journal of clinical pharmacology 20120401

• Cost-effectiveness analysis of burning mouth syndrome therapy.

  Community dentistry and oral epidemiology 20120401

• Evaluation of organic cation transporter 3 (SLC22A3) inhibition as a potential mechanism of antidepressant action.

  Pharmacological research 20120401

• Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers.

  Journal of clinical psychopharmacology 20120401

• Effects of paroxetine on plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia.

  Therapeutic drug monitoring 20120401

• High venlafaxine serum levels after prior fluoxetine medication.

  Journal of clinical psychopharmacology 20120401

• The declining use of reboxetine in years 2000 to 2006: a pharmacoepidemiological comparative study.

  Journal of clinical psychopharmacology 20120401

• Depressive state due to isolated adrenocorticotropic hormone deficiency underlies school refusal.

  Psychiatry and clinical neurosciences 20120401

• [Management of hot flushes for breast cancer survivors].

  Gynecologie, obstetrique & fertilite 20120401

• Interaction of morphine and selective serotonin receptor inhibitors in rats experiencing inflammatory pain.

  Journal of Korean medical science 20120401

• A population-based study of the use of selective serotonin reuptake inhibitors before and after introduction of generic equivalents.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20120401

• Endophenotypes and serotonergic polymorphisms associated with treatment response in obsessive-compulsive disorder.

  Clinics (Sao Paulo, Brazil) 20120401

• Diffusion of counterfeit drugs in developing countries and stability of galenics stored for months under different conditions of temperature and relative humidity.

  Croatian medical journal 20120401

• A simple HPLC method for the simultaneous determination of two selective serotonin reuptake inhibitors and two serotonin-norepinephrine reuptake inhibitors in hair, nail clippings, and cerebrospinal fluid.

  Journal of separation science 20120401

• Inter-relationship between different platelet measures of 5-HT and their relationship to aggression in human subjects.

  Progress in neuro-psychopharmacology & biological psychiatry 20120330

• Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: evidence for the involvement of the serotonergic system.

  European journal of pharmacology 20120315

• Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): double blind, randomised, parallel group, placebo controlled trial.

  BMJ (Clinical research ed.) 20120309

• Paroxetine-induced reduction of sexual incentive motivation in female rats is not modified by 5-HT1B or 5-HT2C antagonists.

  Psychopharmacology 20120301

• Paroxetine reduces crying in young women watching emotional movies.

  Psychopharmacology 20120301

• Application of microextraction by packed sorbent to isolation of psychotropic drugs from human serum.

  Analytical and bioanalytical chemistry 20120301

• Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120301

• Systematic review: the treatment of noncardiac chest pain with antidepressants.

  Alimentary pharmacology & therapeutics 20120301

• A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia.

  Brain, behavior, and immunity 20120301

• Randomized open-label drug-drug interaction trial of dextromethorphan/quinidine and paroxetine in healthy volunteers.

  Clinical drug investigation 20120301

• Evidence-based somatic treatment of depression in adults.

  The Psychiatric clinics of North America 20120301

• Molecular analysis and modeling of inactivation of human CYP2D6 by four mechanism based inactivators.

  Drug metabolism letters 20120301

• Comparison of treatment adherence between selective serotonin reuptake inhibitors and moclobemide in patients with social anxiety disorder.

  Psychiatry investigation 20120301

• Positive result in the early passive phase of the tilt-table test: a predictor of neurocardiogenic syncope in young men.

  The Korean journal of internal medicine 20120301

• A case of serial nightmares and oneiroid state under paroxetine for senile depression.

  Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society 20120301

• Antidepressants and advertising: psychopharmaceuticals in crisis.

  The Yale journal of biology and medicine 20120301

• Hypotensive bradycardic events during shoulder arthroscopic surgery under interscalene brachial plexus blocks.

  Korean journal of anesthesiology 20120301

• Simultaneous quantification of selective serotonin reuptake inhibitors and metabolites in human plasma by liquid chromatography-electrospray mass spectrometry for therapeutic drug monitoring.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120215

• Emotional memory impairments in a genetic rat model of depression: involvement of 5-HT/MEK/Arc signaling in restoration.

  Molecular psychiatry 20120201

• Slow versus standard up-titration of paroxetine for the treatment of depression in cancer patients: a pilot study.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120201

• Predictors of outcome of pharmacological and psychological treatment of late-life panic disorder with agoraphobia.

  International journal of geriatric psychiatry 20120201

• A rapid LC-MS/MS method for quantitation of eszopiclone in human plasma: application to a human pharmacokinetic study.

  Biomedical chromatography : BMC 20120201

• Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study.

  British journal of clinical pharmacology 20120201

• In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions.

  Pharmaceutical research 20120201

• Pilot randomized clinical trial of an SSRI vs bupropion: effects on suicidal behavior, ideation, and mood in major depression.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120201

• Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer.

  Gut 20120201

• Childhood maltreatment and social anxiety disorder: implications for symptom severity and response to pharmacotherapy.

  Depression and anxiety 20120201

• Sub-chronic dietary tryptophan depletion--an animal model of depression with improved face and good construct validity.

  Journal of psychiatric research 20120201

• The association between sunshine duration and paroxetine response time in patients with major depressive disorder.

  Journal of affective disorders 20120201

• A randomized, naturalistic, parallel-group study for the long-term treatment of panic disorder with clonazepam or paroxetine.

  Journal of clinical psychopharmacology 20120201

• Quantitative method validation for the analysis of 27 antidepressants and metabolites in plasma with ultraperformance liquid chromatography-tandem mass spectrometry.

  Therapeutic drug monitoring 20120201

• Granuloma annulare photoinduced by paroxetine.

  Photodermatology, photoimmunology & photomedicine 20120201

• Angular cheilitis after paroxetine treatment.

  Journal of clinical psychopharmacology 20120201

• Adjunctive sleep medications and depression outcome in the treatment of serotonin-selective reuptake inhibitor resistant depression in adolescents study.

  Journal of child and adolescent psychopharmacology 20120201

• Paroxetine for the treatment of depression: a critical update.

  Expert opinion on pharmacotherapy 20120201

• Paroxetine-induced severe sleep bruxism successfully treated with buspirone.

  Clinics (Sao Paulo, Brazil) 20120201

• [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].

  L'Encephale 20120201

• Modulation of frontostriatal interaction aligns with reduced primary reward processing under serotonergic drugs.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20120125

• Risk factors for obesity in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120120

• Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.

  BMJ (Clinical research ed.) 20120112

• Therapeutic effect of paroxetine on stress-induced gastric lesions in mice.

  Progress in neuro-psychopharmacology & biological psychiatry 20120110

• Shock priming enhances the efficacy of SSRIs in the foot shock-induced ultrasonic vocalization test.

  Progress in neuro-psychopharmacology & biological psychiatry 20120110

• Exhaustive electromembrane extraction of some basic drugs from human plasma followed by liquid chromatography-mass spectrometry.

  Journal of pharmaceutical and biomedical analysis 20120105

• Probing binding pocket of serotonin transporter by single molecular force spectroscopy on living cells.

  The Journal of biological chemistry 20120102

• Unifying concept of serotonin transporter-associated currents.

  The Journal of biological chemistry 20120102

• Efficacy of antidepressants as analgesics: a review.

  Journal of clinical pharmacology 20120101

• Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study.

  European journal of clinical pharmacology 20120101

• The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine.

  European journal of clinical pharmacology 20120101

• Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment.

  Neuropharmacology 20120101

• Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: Testing the hypotheses.

  British journal of clinical pharmacology 20120101

• Chinese herbal formula xiao yao san for treatment of depression: a systematic review of randomized controlled trials.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial.

  The American journal of psychiatry 20120101

• Testosterone treatment fails to accelerate disease in a transgenic mouse model of spinal and bulbar muscular atrophy.

  Disease models & mechanisms 20120101

• Mass-spectrometric studies of new 6-nitroquipazines-serotonin transporter inhibitors.

  Analytical and bioanalytical chemistry 20120101

• A chinese herbal formula to improve general psychological status in posttraumatic stress disorder: a randomized placebo-controlled trial on sichuan earthquake survivors.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Acupuncture as treatment of hot flashes and the possible role of calcitonin gene-related Peptide.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Dysfunctional neurotransmitter systems in fibromyalgia, their role in central stress circuitry and pharmacological actions on these systems.

  Pain research and treatment 20120101

• Selective serotonin reuptake inhibitors and risk for major congenital anomalies.

  Obstetrics and gynecology 20120101

• The problem of confounding in studies of the effect of maternal drug use on pregnancy outcome.

  Obstetrics and gynecology international 20120101

• Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat?

  Obstetrics and gynecology international 20120101

• Impact of anxiety on quality of life in Parkinson's disease.

  Parkinson's disease 20120101

• Development of a novel 96-microwell assay with high throughput for determination of olmesartan medoxomil in its tablets.

  Chemistry Central journal 20120101

• Silicosis caused by chronic inhalation of snail shell powder.

  Journal of Korean medical science 20120101

• The Link between Thyroid Function and Depression.

  Journal of thyroid research 20120101

• Chronic fluoxetine treatment in middle-aged rats induces changes in the expression of plasticity-related molecules and in neurogenesis.

  BMC neuroscience 20120101

• The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial.

  BMJ open 20120101

• Paroxetine-associated hypereosinophilia may clinically resemble a panic attack.

  Clinical neuropharmacology 20120101

• Psychopharmacological enhancement: a conceptual framework.

  Philosophy, ethics, and humanities in medicine : PEHM 20120101

• The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease.

  Parkinson's disease 20120101

• Validation of key behaviourally based mental health diagnoses in administrative data: suicide attempt, alcohol abuse, illicit drug abuse and tobacco use.

  BMC health services research 20120101

• A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence.

  Patient preference and adherence 20120101

• Fluoxetine counteracts the cognitive and cellular effects of 5-fluorouracil in the rat hippocampus by a mechanism of prevention rather than recovery.

  PloS one 20120101

• Topiramate and the vision: a systematic review.

  Clinical ophthalmology (Auckland, N.Z.) 20120101

• Psychopathological dimensions of tinnitus and psychopharmacologic approaches in its treatment.

  General hospital psychiatry 20120101

• Managing atrial fibrillation in the elderly: critical appraisal of dronedarone.

  Clinical interventions in aging 20120101

• Challenging medical ghostwriting in US courts.

  PLoS medicine 20120101

• When too much is not enough: obsessive-compulsive disorder as a pathology of stopping, rather than starting.

  PloS one 20120101

• Glutamate may be an efferent transmitter that elicits inhibition in mouse taste buds.

  PloS one 20120101

• [Cardioprotective effect of fluvoxamine, sigma-1 receptor high affinity agonist].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20120101

• Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the spanish society of clinical pharmacology.

  Frontiers in pharmacology 20120101

• Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review.

  Cost effectiveness and resource allocation : C/E 20120101

• Novel spectrophotometric method for determination of cinacalcet hydrochloride in its tablets via derivatization with 1,2-naphthoquinone-4-sulphonate.

  Chemistry Central journal 20120101

• Obsessive compulsive disorder.

  BMJ clinical evidence 20120101

• Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation.

  Core evidence 20120101

• Antidepressant treatment for acute bipolar depression: an update.

  Depression research and treatment 20120101

• Neuroimmune endocrine effects of antidepressants.

  Neuropsychiatric disease and treatment 20120101

• Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trial.

  BMJ open 20120101

• [Effect of treatment with selective serotonin reuptake inhibitors on lipid profile: state of the art].

  La Clinica terapeutica 20120101

• Selective serotonin reuptake inhibitor use is associated with right ventricular structure and function: the MESA-right ventricle study.

  PloS one 20120101

• Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression.

  Frontiers in psychiatry 20120101

• Role of 5-hydroxytryptamine2C receptors in marble-burying behavior in mice.

  Biological & pharmaceutical bulletin 20120101

• Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression: a randomized trial.

  PloS one 20120101

• Affect Expression and Self-Regulation Capacities of Infants Exposed in utero to Psychotropics.

  Frontiers in psychiatry 20120101

• Effects of arterial cannulation stress on regional cerebral blood flow in major depressive disorder.

  Scientific reports 20120101

• Restless leg syndrome, periodic limb movements, febrile seizures and Attention deficit hyperactivity disorder in an Indian family.

  Annals of Indian Academy of Neurology 20120101

• Reduced serotonin reuptake transporter (SERT) function causes insulin resistance and hepatic steatosis independent of food intake.

  PloS one 20120101

• [Psychopharmacological treatment of patients complicated with cardiovascular disease].

  Nihon rinsho. Japanese journal of clinical medicine 20120101

• [Application of antidepressant to treat patients in the department of otolaryngology].

  Nihon rinsho. Japanese journal of clinical medicine 20120101

• Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.

  Current medicinal chemistry 20120101

• Lower gastrointestinal bleeding and paroxetine use: two case reports.

  Psychosomatics 20120101

• Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in The Health Improvement Network (THIN).

  PloS one 20120101

• Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan.

  Substance abuse treatment, prevention, and policy 20120101

• Successful treatment of olfactory reference syndrome with paroxetine.

  The Journal of neuropsychiatry and clinical neurosciences 20120101

• Current and future options for the management of phantom-limb pain.

  Journal of pain research 20120101

• Interplaying factors that effect multiple sclerosis causation and sustenance.

  ISRN neurology 20120101

• Changes in prefrontal-limbic function in major depression after 15 months of long-term psychotherapy.

  PloS one 20120101

• Inhibitory action of antidepressants on mouse Betaine/GABA transporter (BGT1) heterologously expressed in cell cultures.

  International journal of molecular sciences 20120101

• Polysaccharides from wolfberry prevents corticosterone-induced inhibition of sexual behavior and increases neurogenesis.

  PloS one 20120101

• Psychiatric patient and anaesthesia.

  Indian journal of anaesthesia 20120101

• Efficacy and safety of add on low-dose mirtazapine in depression.

  Indian journal of pharmacology 20120101

• Unusual effects of nicotine as a psychostimulant on ambulatory activity in mice.

  ISRN pharmacology 20120101

• GABA metabolism and transport: effects on synaptic efficacy.

  Neural plasticity 20120101

• Antidepressants and menstruation disorders in women: a cross-sectional study in three centers.

  General hospital psychiatry 20120101

• Clinical utility of vilazodone for the treatment of adults with major depressive disorder and theoretical implications for future clinical use.

  Neuropsychiatric disease and treatment 20120101

• Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good.

  Frontiers in psychology 20120101

• Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials.

  PloS one 20120101

• The role of neurokinin-1 receptor in the microenvironment of inflammation and cancer.

  TheScientificWorldJournal 20120101

• Effect of a New Prokinetic Agent DA-9701 Formulated with Corydalis Tuber and Pharbitidis Semen on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Efficacy and Safety of Duloxetine in Patients with Chronic Low Back Pain Who Used versus Did Not Use Concomitant Nonsteroidal Anti-Inflammatory Drugs or Acetaminophen: A Post Hoc Pooled Analysis of 2 Randomized, Placebo-Controlled Trials.

  Pain research and treatment 20120101

• An overview of the evidence and mechanisms of herb-drug interactions.

  Frontiers in pharmacology 20120101

• Abnormalities of white matter microstructure in unmedicated obsessive-compulsive disorder and changes after medication.

  PloS one 20120101

• Imiglucerase in the treatment of Gaucher disease: a history and perspective.

  Drug design, development and therapy 20120101

• GluA1 phosphorylation alters evoked firing pattern in vivo.

  Neural plasticity 20120101

• Phelan-McDermid syndrome in two adult brothers: atypical bipolar disorder as its psychopathological phenotype?

  Neuropsychiatric disease and treatment 20120101

• The role of paliperidone extended release for the treatment of bipolar disorder.

  Neuropsychiatric disease and treatment 20120101

• The association of C3435T single-nucleotide polymorphism, Pgp-glycoprotein gene expression levels and carbamazepine maintenance dose in patients with epilepsy.

  Neuropsychiatric disease and treatment 20120101

• Duloxetine inhibits effects of MDMA ('ecstasy') in vitro and in humans in a randomized placebo-controlled laboratory study.

  PloS one 20120101

• 5-HTTLPR polymorphism impacts task-evoked and resting-state activities of the amygdala in Han Chinese.

  PloS one 20120101

• Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson's disease.

  Mediators of inflammation 20120101

• Sudden death of cardiac origin and psychotropic drugs.

  Frontiers in pharmacology 20120101

• Downbeat nystagmus induced by sedation in LASIK.

  Case reports in ophthalmological medicine 20120101

• Orbital aspergillosis: voriconazole - the new standard treatment?

  Case reports in ophthalmology 20120101

• A Pilot Study of Mifepristone in Combat-Related PTSD.

  Depression research and treatment 20120101

• Herbal medicines for Parkinson's disease: a systematic review of randomized controlled trials.

  PloS one 20120101

• Treatment-resistant depression: therapeutic trends, challenges, and future directions.

  Patient preference and adherence 20120101

• Optimal treatment of social phobia: systematic review and meta-analysis.

  Neuropsychiatric disease and treatment 20120101

• [Efficacy of adepress (paroxetine) in the treatment of depression in patients with chronic cerebral ischemia in the late recovery phase of ischemic stroke with the estimation of the velocity of passive transmembrane ion transport].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20120101

• Combination of valproate and paroxetine in mice exposed to picrotoxin.

  International journal of nanomedicine 20120101

• Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder.

  Oxidative medicine and cellular longevity 20120101

• An audit of first prescription of new patients attending a psychiatry walk-in-clinic in north India.

  Indian journal of pharmacology 20120101

• Drug Eruptions: An 8-year Study Including 106 Inpatients at a Dermatology Clinic in Turkey.

  Indian journal of dermatology 20120101

• Parent report of antidepressant, anxiolytic, and antipsychotic medication use in individuals with Williams syndrome: effectiveness and adverse effects.

  Research in developmental disabilities 20120101

• Citalopram versus other anti-depressive agents for depression.

  The Cochrane database of systematic reviews 20120101

• Treatment of panic in chest pain patients from emergency departments: efficacy of different interventions focusing on panic management.

  General hospital psychiatry 20120101

• A new approach to determining pharmacologic adulteration of herbal weight loss products.

  Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 20120101

• Stuttering treated with olanzapine: a case report.

  Actas espanolas de psiquiatria 20120101

• Effectiveness and cost-effectiveness of antidepressants in primary care: a multiple treatment comparison meta-analysis and cost-effectiveness model.

  PloS one 20120101

• Effects of interventions on depression in heart failure: a systematic review.

  Heart & lung : the journal of critical care 20120101

• Iatrogenic Cushing's syndrome with inhaled steroid plus antidepressant drugs.

  Multidisciplinary respiratory medicine 20120101

• A 10-year analysis of the effects of media coverage of regulatory warnings on antidepressant use in The Netherlands and UK.

  PloS one 20120101

• Warfarin: pharmacological profile and drug interactions with antidepressants.

  Einstein (Sao Paulo, Brazil) 20120101

• Clinical studies on treatment of earthquake-caused posttraumatic stress disorder using electroacupuncture.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Duloxetine versus other anti-depressive agents for depression.

  The Cochrane database of systematic reviews 20120101

• Neural response to eye contact and paroxetine treatment in generalized social anxiety disorder.

  Psychiatry research 20111230

• The involvement of the neurosteroid allopregnanolone in the antihyperalgesic effect of paroxetine in a rat model of neuropathic pain.

  Neuroreport 20111221

• Differences between mice strains in response to paroxetine in the forced swimming test: involvement of serotonergic or noradrenergic systems.

  European journal of pharmacology 20111215

• Interventions for treating anxiety after stroke.

  The Cochrane database of systematic reviews 20111207

• Effects of GABAB ligands alone and in combination with paroxetine on hippocampal BDNF gene expression.

  European journal of pharmacology 20111205

• Switching from brand-name to generic psychotropic medications: a literature review.

  CNS neuroscience & therapeutics 20111201

• An eight component decision-making model for problem gambling: a systems approach to stimulate integrative research.

  Journal of gambling studies 20111201

• Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database.

  British journal of clinical pharmacology 20111201

• Determinants of pharmacodynamic trajectory of the therapeutic response to paroxetine in Japanese patients with panic disorder.

  European journal of clinical pharmacology 20111201

• Venlafaxine in somatopsychic and autopsychic depersonalization.

  Progress in neuro-psychopharmacology & biological psychiatry 20111201

• The influence of personality factors on paroxetine response time in patients with major depression.

  Journal of affective disorders 20111201

• Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trial.

  Progress in neuro-psychopharmacology & biological psychiatry 20111201

• Paroxetine controlled-release formulation in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled study in Japan and Korea.

  Psychiatry and clinical neurosciences 20111201

• Paroxetine-induced dysarthria in a 42-year-old man with pathologic laughing.

  The Australian and New Zealand journal of psychiatry 20111201

• Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorder.

  Journal of clinical psychopharmacology 20111201

• Medication use and functional status decline in older adults: a narrative review.

  The American journal of geriatric pharmacotherapy 20111201

• The MMPI-2 neurotic triad subscales and depression levels after pharmacological treatment in patients with depressive disorders - clinical study.

  Psychiatria Danubina 20111201

• Serotonin reuptake inhibitors and hyperprolactinaemia: a case/non-case study in the French pharmacovigilance database.

  Drug safety 20111201

• Potentially harmful drug-drug interactions in the elderly: a review.

  The American journal of geriatric pharmacotherapy 20111201

• The effects of agomelatine on sexual function in depressed patients and healthy volunteers.

  Human psychopharmacology 20111201

• Inverse correlation between clinical response to paroxetine and plasma drug concentration in patients with major depressive disorders.

  Human psychopharmacology 20111201

• Selective serotonin reuptake inhibitors and risk for major congenital anomalies.

  Obstetrics and gynecology 20111201

• Time to discontinuation among the three second-generation antidepressants in a naturalistic outpatient setting of depression.

  Psychiatry and clinical neurosciences 20111201

• [Strontium-89 therapy and subarachnoid phenol block successfully eliminated intractable pain of metastasis in the patient with advanced urachal carcinoma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111201

• Paruresis and parcopresis in social phobia: a case report.

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20111201

• Antidepressants in pregnancy: a review of commonly prescribed medications.

  Obstetrical & gynecological survey 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Use of Lorazepam in drug-assisted interviews: two cases of dissociative amnesia.

  Psychiatry investigation 20111201

• Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.

  The Journal of clinical psychiatry 20111201

• A lifespan view of anxiety disorders.

  Dialogues in clinical neuroscience 20111201

• A review of obsessive-compulsive disorder in children and adolescents.

  Dialogues in clinical neuroscience 20111201

• Pharmacotherapy of anxiety disorders: a critical review.

  Dialogues in clinical neuroscience 20111201

• Pharmacotherapy for anxiety disorders in children and adolescents.

  Dialogues in clinical neuroscience 20111201

• Experimental panic provocation in healthy man-a translational role in anti-panic drug development?

  Dialogues in clinical neuroscience 20111201

• Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors.

  International journal of environmental research and public health 20111201

• Metabolite profiling of antidepressant drug action reveals novel drug targets beyond monoamine elevation.

  Translational psychiatry 20111201

• Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study.

  PLoS currents 20111113

• A fluorescence displacement assay for antidepressant drug discovery based on ligand-conjugated quantum dots.

  Journal of the American Chemical Society 20111109

• Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20111108

• [Dynamic level observation of brain-derived neurotrophic factor in patients with first-episode generalized anxiety disorder].

  Zhonghua yi xue za zhi 20111108

• Efficacy of 2 interventions for panic disorder in patients presenting to the ED with chest pain.

  The American journal of emergency medicine 20111101

• Deaths involving contraindicated and inappropriate combinations of serotonergic drugs.

  International journal of legal medicine 20111101

• Ameliorating effect of Yokukansan on the development of atopic dermatitis-like lesions and scratching behavior in socially isolated NC/Nga mice.

  Archives of dermatological research 20111101

• Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.

  The Journal of clinical psychiatry 20111101

• Investigating outcomes following the use of selective serotonin reuptake inhibitors for treating depression in pregnancy: a focus on methodological issues.

  Drug safety 20111101

• Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder.

  Advances in therapy 20111101

• Quetiapine. A me-too neuroleptic; no panacea.

  Prescrire international 20111101

• A case series of aripiprazole augmentation of selective serotonin reuptake inhibitors in treatment-refractory obsessive compulsive disorder.

  International journal of psychiatry in clinical practice 20111101

• Odd odds.

  The Journal of clinical psychiatry 20111101

• [Pregnant opioid addicted patients and additional drug intake. Part II: Comorbidity and their therapy].

  Medizinische Monatsschrift fur Pharmazeuten 20111101

• Selective serotonin reuptake inhibitors in pregnancy and infant outcomes.

  Paediatrics & child health 20111101

• Paroxetine-induced Ca2+ movement and death in OC2 human oral cancer cells.

  The Chinese journal of physiology 20111031

• Depression in children and adolescents.

  BMJ clinical evidence 20111021

• An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's Disease.

  PLoS currents 20111011

• Treatment with paroxetine, but not amitriptyline, lowers levels of lipoprotein(a) in patients with major depression.

  Journal of psychopharmacology (Oxford, England) 20111001

• A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.

  The Journal of clinical psychiatry 20111001

• Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20111001

• The contribution of low-affinity transport mechanisms to serotonin clearance in synaptosomes.

  Synapse (New York, N.Y.) 20111001

• Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomized/castrated mice via both 5-HT reuptake inhibition and σ(1) receptor activation.

  Psychopharmacology 20111001

• Association between tryptophan hydroxylase-2 genotype and the antidepressant effect of citalopram and paroxetine on immobility time in the forced swim test in mice.

  Pharmacology, biochemistry, and behavior 20111001

• Serotonin transporter occupancy in rats exposed to serotonin reuptake inhibitors in utero or via breast milk.

  The Journal of pharmacology and experimental therapeutics 20111001

• New approaches to combining pharmacotherapy and psychotherapy for posttraumatic stress disorder.

  Expert opinion on pharmacotherapy 20111001

• A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression.

  Journal of clinical psychopharmacology 20111001

• Selective serotonin reuptake inhibitors and risk for major congenital anomalies.

  Obstetrics and gynecology 20111001

• Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study.

  Croatian medical journal 20111001

• The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.

  Movement disorders : official journal of the Movement Disorder Society 20111001

• Medical therapy for premature ejaculation.

  Therapeutic advances in urology 20111001

• [Oral paroxetine for premature ejaculation: a randomized controlled study].

  Zhonghua nan ke xue = National journal of andrology 20111001

• QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes.

  Deutsches Arzteblatt international 20111001

• Effect of serotonin reuptake inhibitors on pulmonary hemodynamics in humans.

  Journal of clinical medicine research 20111001

• Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter.

  Journal of medicinal chemistry 20110922

• [Interactions between metoprolol and antidepressants].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20110920

• Psychological and pharmacological interventions for depression in patients with coronary artery disease.

  The Cochrane database of systematic reviews 20110907

• Characterization of 5-HT(1A/1B)-/- mice: an animal model sensitive to anxiolytic treatments.

  Neuropharmacology 20110901

• Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population.

  Journal of affective disorders 20110901

• Re: Didem Sunay, Melih Sunay, Yasin Aydoğmuş, et al. Acupuncture versus paroxetine for the treatment of premature ejaculation: a randomized, placebo-controlled clinical trial. Eur Urol 2011;59:765-71.

  European urology 20110901

• Aggravation by paroxetine, a selective serotonin reuptake inhibitor, of antral lesions generated by nonsteroidal anti-inflammatory drugs in rats.

  The Journal of pharmacology and experimental therapeutics 20110901

• Gepirone-ER treatment of low sexual desire associated with depression in women as measured by the DeRogatis Inventory of Sexual Function (DISF) fantasy/cognition (desire) domain--a post hoc analysis.

  The journal of sexual medicine 20110901

• Antidepressants and the risk of sudden cardiac death and ventricular arrhythmia.

  Pharmacoepidemiology and drug safety 20110901

• Agomelatine: a narrative review.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20110901

• A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.

  The Australian and New Zealand journal of psychiatry 20110901

• Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study.

  Cell death & disease 20110901

• A rare case of male hysteria - hemiparesis successfully treated with amitriptyline.

  Psychiatria Danubina 20110901

• Antidepressant prescribing patterns in Korea: results from the clinical research center for depression study.

  Psychiatry investigation 20110901

• The effects of antidepressants and pilocarpine on rat parotid glands: an immunohistochemical study.

  Clinics (Sao Paulo, Brazil) 20110901

• Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI Exposure.

  Current neuropharmacology 20110901

• Raphe-Hippocampal Serotonin Neurotransmission In The Sex Related Differences of Adaptation to Stress: Focus on Serotonin-1A Receptor.

  Current neuropharmacology 20110901

• Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump.

  Journal of medicinal chemistry 20110825

• Dextromethorphan as a phenotyping test to predict endoxifen exposure in patients on tamoxifen treatment.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110820

• Paroxetine is associated with malformation during pregnancy.

  BMJ (Clinical research ed.) 20110810

• Psychosocial interventions for premature ejaculation.

  The Cochrane database of systematic reviews 20110810

• Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine.

  The Journal of clinical psychiatry 20110801

• Pain management in patients with cancer: focus on opioid analgesics.

  Current pain and headache reports 20110801

• Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosin.

  British journal of clinical pharmacology 20110801

• Neural correlates of antidepressant-related sexual dysfunction: a placebo-controlled fMRI study on healthy males under subchronic paroxetine and bupropion.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110801

• Norepinephrine transporter (NET) knock-out upregulates dopamine and serotonin transporters in the mouse brain.

  Neurochemistry international 20110801

• Antidepressant use and cognitive functioning in older medical patients with major or minor depression: a prospective cohort study with database linkage.

  Journal of clinical psychopharmacology 20110801

• Erythema multiforme photoinduced by paroxetine and herpes simplex virus.

  Photodermatology, photoimmunology & photomedicine 20110801

• The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation.

  Journal of psychosomatic research 20110801

• Sedative, anxiolytic and antidepressant activities of Citrus limon (Burn) essential oil in mice.

  Die Pharmazie 20110801

• Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.

  Journal of medicinal chemistry 20110714

• Data mining approach shows promise in detecting unexpected drug interactions.

  JAMA 20110713

• Professor files complaint of scientific misconduct over allegation of ghostwriting.

  BMJ (Clinical research ed.) 20110713

• Paxil study under fire.

  Nature 20110712

• Specificity profile of paroxetine in major depressive disorder: meta-regression of double-blind, randomized clinical trials.

  Journal of affective disorders 20110701

• Sleep disturbance associated with an enhanced orexinergic system induced by chronic treatment with paroxetine and milnacipran.

  Synapse (New York, N.Y.) 20110701

• Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes.

  Psychopharmacology 20110701

• Metabolic drug interactions between antidepressants and anticancer drugs: focus on selective serotonin reuptake inhibitors and hypericum extract.

  Current drug metabolism 20110701

• The selective serotonin reuptake inhibitor paroxetine does not alter consummatory concentration-dependent licking of prototypical taste stimuli by rats.

  Chemical senses 20110701

• A systematic review of treatments for refractory depression in older people.

  The American journal of psychiatry 20110701

• Species independence in brain tissue binding using brain homogenates.

  Drug metabolism and disposition: the biological fate of chemicals 20110701

• Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels.

  Clinical pharmacology and therapeutics 20110701

• Selective serotonin reuptake inhibitors and risk for major congenital anomalies.

  Obstetrics and gynecology 20110701

• A randomized, controlled study comparing the effects of vestipitant or vestipitant and paroxetine combination in subjects with tinnitus.

  Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20110701

• Assessing risks and benefits of nonhormonal treatments for vasomotor symptoms in perimenopausal and postmenopausal women.

  Journal of women's health (2002) 20110701

• Effects of paroxetine on the pharmacokinetics and pharmacodynamics of immediate-release and extended-release metoprolol.

  Pharmacotherapy 20110701

• Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults.

  The Cochrane database of systematic reviews 20110615

• Base-catalyzed reactions of environmentally relevant N-chloro-piperidines. A quantum-chemical study.

  Organic & biomolecular chemistry 20110607

• Effects of tryptophan depletion and tryptophan loading on the affective response to high-dose CO2 challenge in healthy volunteers.

  Psychopharmacology 20110601

• The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients.

  Progress in neuro-psychopharmacology & biological psychiatry 20110601

• Species differences in intestinal metabolic activities of cytochrome P450 isoforms between cynomolgus monkeys and humans.

  Drug metabolism and pharmacokinetics 20110601

• Glucose dysregulation associated with antidepressant agents: an analysis of 17 published case reports.

  International journal of clinical pharmacy 20110601

• Hallucination induced by paroxetine discontinuation in patients with major depressive disorders.

  Psychiatry and clinical neurosciences 20110601

• Baseline lipid levels and acute treatment response to paroxetine and tianeptine in depressed women.

  Journal of clinical psychopharmacology 20110601

• A case of thalamic pain successfully treated with Kampo medicine.

  Journal of alternative and complementary medicine (New York, N.Y.) 20110601

• Efficacy of prophylactic treatment with selective serotonin reuptake inhibitors for depression after open-heart surgery.

  Surgery today 20110601

• Economic impact of nonpersistence with antidepressant treatment in the adult population of Quebec: a comparative cost-effectiveness approach.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20110601

• Possible role of BDNF-induced microglial intracellular Ca(2+) elevation in the pathophysiology of neuropsychiatric disorders.

  Mini reviews in medicinal chemistry 20110601

• Clinical Characteristics of Microscopic Colitis in Korea: Prospective Multicenter Study by KASID.

  Gut and liver 20110601

• Biomarkers in development of psychotropic drugs.

  Dialogues in clinical neuroscience 20110601

• Do defense styles of ego relate to volumes of orbito-frontal cortex in patients with obsessive-compulsive disorder?

  Psychiatry investigation 20110601

• The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders.

  Current neuropharmacology 20110601

• Defense style in panic disorder before and after pharmacological treatment.

  Psychiatry research 20110530

• 3,4-methylenedioxymethamphetamine (MDMA) interacts with therapeutic drugs on CYP3A by inhibition of pregnane X receptor (PXR) activation and catalytic enzyme inhibition.

  Toxicology letters 20110530

• Antidepressant use during pregnancy. FPIN’s clinical inquiries.

  American family physician 20110515

• Serotonin-1A receptors in the dorsal periaqueductal gray matter mediate the panicolytic-like effect of pindolol and paroxetine combination in the elevated T-maze.

  Neuroscience letters 20110509

• The serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C.

  The Journal of biological chemistry 20110506

• Effect of corticosterone and paroxetine on masculine mating behavior: possible involvement of neurogenesis.

  The journal of sexual medicine 20110501

• Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients.

  European journal of clinical pharmacology 20110501

• Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy.

  Psychopharmacology 20110501

• Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype.

  Psychopharmacology 20110501

• Acupuncture versus paroxetine for the treatment of premature ejaculation: a randomized, placebo-controlled clinical trial.

  European urology 20110501

• Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation.

  Gastroenterology 20110501

• Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women.

  The journal of sexual medicine 20110501

• Differential behavioural and neurochemical outcomes from chronic paroxetine treatment in adolescent and adult rats: a model of adverse antidepressant effects in human adolescents?

  The international journal of neuropsychopharmacology 20110501

• Contribution of acupuncture to Western medical knowledge of premature ejaculation: an intriguing new development.

  European urology 20110501

• Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia, a literature review of evidence.

  American journal of Alzheimer's disease and other dementias 20110501

• Altered brain activation in ventral frontal-striatal regions following a 16-week pharmacotherapy in unmedicated obsessive-compulsive disorder.

  Journal of Korean medical science 20110501

• Tamoxifen-SSRIs interaction: clinical manifestations of inhibition and lack of inhibition of CYP2D6.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20110501

• Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature.

  PLoS medicine 20110501

• The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.

  Journal of psychopharmacology (Oxford, England) 20110401

• A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.

  Journal of affective disorders 20110401

• Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data.

  The international journal of neuropsychopharmacology 20110401

• A structural mean model to allow for noncompliance in a randomized trial comparing 2 active treatments.

  Biostatistics (Oxford, England) 20110401

• Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes.

  Breast (Edinburgh, Scotland) 20110401

• Chronic paroxetine treatment does not affect sexual behavior in hormonally sub-primed female rats despite 5-HT₁(A) receptor desensitization.

  The journal of sexual medicine 20110401

• Changes in brain protein expression are linked to magnesium restriction-induced depression-like behavior.

  Amino acids 20110401

• Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20110401

• Meta-regression analysis of paroxetine clinical trial data: does reporting scale matter?

  Journal of clinical psychopharmacology 20110401

• Randomized, open naturalistic, acute treatment of panic disorder with clonazepam or paroxetine.

  Journal of clinical psychopharmacology 20110401

• From trial and error to trial simulation III: a framework for interim analysis in efficacy trials with antidepressant drugs.

  Clinical pharmacology and therapeutics 20110401

• Balance control improves following replacement of paroxetine with venlafaxine and levodopa in a case of microvascular dementia.

  The American journal of geriatric pharmacotherapy 20110401

• Pharmacogenetics of drug-induced birth defects: what is known so far?

  Pharmacogenomics 20110401

• Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials.

  The Journal of clinical psychiatry 20110401

• IFN-α-2a (Interferon) and ribavirin induced suicidal attempt in a patient of chronic HCV: A rare case report.

  Indian journal of pharmacology 20110401

• Influence of GIRK channel inhibition on alcohol abstinence and relapse risk in Japanese alcohol-dependent outpatients.

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20110401

• Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorder.

  Human psychopharmacology 20110401

• Platelet [³H] paroxetine binding in female patients with borderline personality disorder and their sisters.

  Psychiatry research 20110330

• Increased neural response to trauma scripts in posttraumatic stress disorder following paroxetine treatment: A pilot study.

  Neuroscience letters 20110324

• Vogel conflict test: sex differences and pharmacological validation of the model.

  Behavioural brain research 20110317

• Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis.

  BMJ (Clinical research ed.) 20110311

• Influence of metoprolol dosage release formulation on the pharmacokinetic drug interaction with paroxetine.

  Journal of clinical pharmacology 20110301

• Depression in Parkinson's disease: symptom improvement and residual symptoms after acute pharmacologic management.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20110301

• Monitoring of circadian rhythms of heart rate, locomotor activity, and temperature for diagnosis and evaluation of response to treatment in an animal model of depression.

  Journal of molecular neuroscience : MN 20110301

• Which medication do I need to manage dizzy patients?

  Acta oto-laryngologica 20110301

• Synthesis, molecular docking and binding studies of selective serotonin transporter inhibitors.

  European journal of medicinal chemistry 20110301

• Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.

  International journal of clinical practice 20110301

• Effects of anticholinergic drugs on verbal episodic memory function in the elderly: a retrospective, cross-sectional study.

  Drugs & aging 20110301

• Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy.

  Birth defects research. Part A, Clinical and molecular teratology 20110301

• Using time-series intervention analysis to understand U.S. Medicaid expenditures on antidepressant agents.

  Research in social & administrative pharmacy : RSAP 20110301

• Functional magnetic resonance imaging study on the effects of acute single administration of paroxetine on motivation-related brain activity.

  Psychiatry and clinical neurosciences 20110301

• Treatment strategy in schizophrenia combined with eating disorder.

  Psychiatria Danubina 20110301

• Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample.

  Pharmacogenomics 20110301

• Antidepressants in acute bipolar depression: an inconclusive meta-analysis.

  The Journal of clinical psychiatry 20110301

• Clinical correlates of oppositional defiant disorder and attention-deficit/hyperactivity disorder in adults.

  Postgraduate medicine 20110301

• [Hemiparkinsonism due to a solitary infarction of the right external segment of the globus pallidus: a case report].

  Rinsho shinkeigaku = Clinical neurology 20110301

• Inflammation in depression: is adiposity a cause?

  Dialogues in clinical neuroscience 20110301

• Pharmacogenomics of antidepressant treatment effects.

  Dialogues in clinical neuroscience 20110301

• New insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum.

  Dialogues in clinical neuroscience 20110301

• Hormone treatment of depression.

  Dialogues in clinical neuroscience 20110301

• Mirtazapine augmentation for selective serotonin reuptake inhibitor-induced sexual dysfunction: a retropective investigation.

  Psychiatry investigation 20110301

• Uncontrolled self-medication with venlafaxine in a patient with major depressive disorder.

  Psychiatry investigation 20110301

• The Selective Serotonin Reuptake Inhibitor Paroxetine, but not Fluvoxamine, Decreases Methamphetamine Conditioned Place Preference in Mice.

  Current neuropharmacology 20110301

• MOP Reduction During Long-Term Methamphetamine Withdrawal was Restored by Chronic Post-Treatment with Fluoxetine.

  Current neuropharmacology 20110301

• Pharmacologic treatment of depression in multiple sclerosis.

  The Cochrane database of systematic reviews 20110216

• On the three-arm non-inferiority trial including a placebo with a prespecified margin.

  Statistics in medicine 20110210

• Update in women's health for the general internist.

  Journal of general internal medicine 20110201

• Anxiolytic effects of a semipurified constituent of guaraná seeds on rats in the elevated T-maze test.

  Planta medica 20110201

• Characterization of 5-HT transporter and receptor system in HeLaS3 cells by [(3)H]8-OH-DPAT and other serotonergic ligands.

  Archives of biochemistry and biophysics 20110201

• Burning mouth syndrome and secondary oral burning.

  Otolaryngologic clinics of North America 20110201

• Impact of treatment success on health service use and cost in depression: longitudinal database analysis.

  PharmacoEconomics 20110201

• The relationship between adverse events during selective serotonin reuptake inhibitor treatment for major depressive disorder and nonremission in the suicide assessment methodology study.

  Journal of clinical psychopharmacology 20110201

• Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) study.

  Journal of clinical psychopharmacology 20110201

• Pulmonary instillation of activated charcoal: early findings on computed tomography.

  The Annals of thoracic surgery 20110201

• Improvement in sexual functioning in patients with type 2 diabetes and depression treated with bupropion.

  Diabetes care 20110201

• SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and Adolescents.

  Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent 20110201

• Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.

  Bipolar disorders 20110201

• Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarker.

  Pharmacogenomics 20110201

• [Paroxetine, hypothyroidism and, despite everything, inadequate antidiuretic hormone secretion].

  Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20110201

• Should CYP2D6 inhibitors be administered in conjunction with tamoxifen?

  Expert review of anticancer therapy 20110201

• [The delayed sensitization of CRH response developed after chronic variable stress on the acoustic startle reflex].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20110201

• Adverse drug reaction monitoring in psychiatry out-patient department of an Indian teaching hospital.

  Indian journal of pharmacology 20110201

• Re: adverse effect of paroxetine on sperm.

  The Journal of urology 20110201

• Discovery of novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.

  Journal of medicinal chemistry 20110113

• [Pharmacovigilance update].

  Revue medicale suisse 20110112

• Antidepressant use and colorectal cancer risk: a Danish population-based case-control study.

  British journal of cancer 20110104

• Temperament and character profiles of sasang typology in an adult clinical sample.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Spectrofluorimetric determination of paroxetine HCl in pharmaceuticals via derivatization with 4-chloro-7- nitrobenzo-2-oxa-1,3-diazole (NBD-Cl).

  Journal of fluorescence 20110101

• A systematic review on the effectiveness of pharmacological interventions for chronic non-specific low-back pain.

  European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 20110101

• Neurometabolic correlates of depression and disability in episodic cluster headache.

  Journal of neurology 20110101

• A new female rat animal model for hypoactive sexual desire disorder; behavioral and pharmacological evidence.

  The journal of sexual medicine 20110101

• Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone.

  European journal of clinical pharmacology 20110101

• Pharmacoepidemiological characterization of psychotropic drugs consumption using a latent class analysis.

  International clinical psychopharmacology 20110101

• Randomized Controlled Trials of Acupuncture (1997-2007): An Assessment of Reporting Quality with a CONSORT- and STRICTA-Based Instrument.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Cleanup strategies and advantages in the determination of several therapeutic classes of pharmaceuticals in wastewater samples by SPE-LC-MS/MS.

  Analytical and bioanalytical chemistry 20110101

• Comparative neurochemical profile of 3,4-methylenedioxymethamphetamine and its metabolite alpha-methyldopamine on key targets of MDMA neurotoxicity.

  Neurochemistry international 20110101

• Attributes of response in depressed patients switched to treatment with duloxetine.

  International journal of clinical practice 20110101

• Drug treatment for mood disorders in pregnancy.

  Current opinion in psychiatry 20110101

• Use of dried plasma spots in the determination of pharmacokinetics in clinical studies: validation of a quantitative bioanalytical method.

  Analytical chemistry 20110101

• Pharmacokinetic interactions between etravirine and non-antiretroviral drugs.

  Clinical pharmacokinetics 20110101

• Effect of inhibition of cytochrome P450 enzymes 2D6 and 3A4 on the pharmacokinetics of intravenous oxycodone: a randomized, three-phase, crossover, placebo-controlled study.

  Clinical drug investigation 20110101

• Update on treatments for premature ejaculation.

  International journal of clinical practice 20110101

• Paroxetine rapidly modulates the expression of brain-derived neurotrophic factor mRNA and protein in a human glioblastoma-astrocytoma cell line.

  Pharmacology 20110101

• Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis.

  The British journal of psychiatry : the journal of mental science 20110101

• International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.

  Trials 20110101

• Preventing hospital admissions by reviewing medication (PHARM) in primary care: design of the cluster randomised, controlled, multi-centre PHARM-study.

  BMC health services research 20110101

• Autoscopic phenomena: case report and review of literature.

  Behavioral and brain functions : BBF 20110101

• Fear and avoidance of eye contact in social anxiety disorder.

  Comprehensive psychiatry 20110101

• Are old-old patients with major depression more likely to relapse than young-old patients during continuation treatment with escitalopram?

  BMC geriatrics 20110101

• Secretion of beta-human chorionic gonadotropin by non-small cell lung cancer: a case report.

  Journal of medical case reports 20110101

• Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency.

  PloS one 20110101

• Does treatment of subsyndromal depression improve depression and diabetes related outcomes: protocol for a randomised controlled comparison of psycho-education, physical exercise and treatment as usual.

  Trials 20110101

• Antidepressants modulate intracellular amyloid peptide species in N2a neuroblastoma cells.

  Journal of Alzheimer's disease : JAD 20110101

• Influence of enriched environment on viral encephalitis outcomes: behavioral and neuropathological changes in albino Swiss mice.

  PloS one 20110101

• Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder.

  BMC psychiatry 20110101

• Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder.

  BMC psychiatry 20110101

• Knowledge of ghostwriting and financial conflicts-of-interest reduces the perceived credibility of biomedical research.

  BMC research notes 20110101

• Conflicted medical journals and the failure of trust.

  Accountability in research 20110101

• Perpetuating fears: bias against the null hypothesis in fetal safety of drugs as expressed in scientific citations.

  Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique 20110101

• Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington's disease.

  PloS one 20110101

• Neurotransmitter Transporter-Like: a male germline-specific SLC6 transporter required for Drosophila spermiogenesis.

  PloS one 20110101

• Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis.

  BMC psychiatry 20110101

• Serotonin transporter (SERT) and translocator protein (TSPO) expression in the obese ob/ob mouse.

  BMC neuroscience 20110101

• Clearance of fear memory from the hippocampus through neurogenesis by omega-3 fatty acids: a novel preventive strategy for posttraumatic stress disorder?

  BioPsychoSocial medicine 20110101

• Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice.

  Journal of neuroinflammation 20110101

• Weight gain, obesity, and psychotropic prescribing.

  Journal of obesity 20110101

• Treatment of postpartum depression: clinical, psychological and pharmacological options.

  International journal of women's health 20110101

• Toward evidence-based genetic research on lifelong premature ejaculation: a critical evaluation of methodology.

  Korean journal of urology 20110101

• Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy.

  Journal of pain research 20110101

• Disability and health-related quality of life in outpatients with generalised anxiety disorder treated in psychiatric clinics: is there still room for improvement?

  Annals of general psychiatry 20110101

• Sex differences in drug disposition.

  Journal of biomedicine & biotechnology 20110101

• Sustained remission of rheumatoid arthritis with a specific serotonin reuptake inhibitor antidepressant: a case report and review of the literature.

  Journal of medical case reports 20110101

• Comparative efficacy of escitalopram in the treatment of major depressive disorder.

  Neuropsychiatric disease and treatment 20110101

• Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?

  Annals of general psychiatry 20110101

• 5-hydroxyindolacetic acid (5-HIAA), a main metabolite of serotonin, is responsible for complete Freund's adjuvant-induced thermal hyperalgesia in mice.

  Molecular pain 20110101

• Analyzing clinical and electrophysiological characteristics of Paroxysmal Dyskinesia.

  Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 20110101

• Paliperidone extended-release: does it have a place in antipsychotic therapy?

  Drug design, development and therapy 20110101

• The effect of ascertainment bias in evaluating gestational antidepressant exposure.

  Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique 20110101

• Cost-effectiveness of internet-based cognitive behavior therapy for irritable bowel syndrome: results from a randomized controlled trial.

  BMC public health 20110101

• Psychotic symptoms in social anxiety disorder patients: report of three cases.

  International archives of medicine 20110101

• Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria.

  PloS one 20110101

• The influence of serotonin transporter polymorphisms on cortical activity: a resting EEG study.

  BMC neuroscience 20110101

• The role of molecular imaging in the diagnosis and management of neuropsychiatric disorders.

  Journal of biomedicine & biotechnology 20110101

• New trends in tinnitus management.

  The open neurology journal 20110101

• Serotonin transporter gene polymorphisms and brain function during emotional distraction from cognitive processing in posttraumatic stress disorder.

  BMC psychiatry 20110101

• Combined venlafaxine and olanzapine prescription in women with psychotic major depression: a case series.

  Case reports in medicine 20110101

• Effects of early life trauma are dependent on genetic predisposition: a rat study.

  Behavioral and brain functions : BBF 20110101

• Impulse control disorders: updated review of clinical characteristics and pharmacological management.

  Frontiers in psychiatry 20110101

• Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder.

  Frontiers in psychiatry 20110101

• Toward an anti-inflammatory strategy for depression.

  Frontiers in behavioral neuroscience 20110101

• Nonconvulsive seizures and dementia: a case report.

  International journal of Alzheimer's disease 20110101

• Recurrent syncope in a cancer patient: a case report and review of the literature.

  Cardiology research and practice 20110101

• Should we treat depression with drugs or psychological interventions? A reply to Ioannidis.

  Philosophy, ethics, and humanities in medicine : PEHM 20110101

• Evaluating treatments in health care: the instability of a one-legged stool.

  BMC medical research methodology 20110101

• Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response.

  PloS one 20110101

• Antidepressant-resistant depression and antidepressant-associated suicidal behaviour: the role of underlying bipolarity.

  Depression research and treatment 20110101

• Evaluation of quantitative EEG by classification and regression trees to characterize responders to antidepressant and placebo treatment.

  The open medical informatics journal 20110101

• Antidepressant and antipsychotic use in an Italian pediatric population.

  BMC pediatrics 20110101

• Expert opinion on detecting and treating depression in palliative care: A Delphi study.

  BMC palliative care 20110101

• Diagnosis of depression by MRI scans with the use of VSRAD - a promising auxiliary means of diagnosis: a report of 10 years research.

  International journal of general medicine 20110101

• Selective serotonin reuptake inhibitors and gastrointestinal bleeding: a case-control study.

  PloS one 20110101

• Risk factors for the development of depression in patients with hepatitis C taking interferon-α.

  Neuropsychiatric disease and treatment 20110101

• Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder.

  Neuropsychiatric disease and treatment 20110101

• Role of sublingual asenapine in treatment of schizophrenia.

  Neuropsychiatric disease and treatment 20110101

• [Analgesic prescription habits in a population of patients with chronic rheumatic disease].

  Acta medica portuguesa 20110101

• BDNF gene polymorphisms are associated with Alzheimer's disease-related depression and antidepressant response.

  Journal of Alzheimer's disease : JAD 20110101

• [Depression, its therapy and venous thromboembolism: three cases of pulmonary embolism].

  Kardiologia polska 20110101

• [Influence of fluoxetine and paroxetine on anxiety-like behavior in young and adult prenatally stressed male rats].

  Eksperimental'naia i klinicheskaia farmakologiia 20110101

• Aripiprazole augmentation in patients with resistant obsessive compulsive disorder: a pilot study.

  Clinical practice and epidemiology in mental health : CP & EMH 20110101

• Pharmacogenetics of antidepressants.

  Frontiers in pharmacology 20110101

• Neurobiology of depression and anxiety in Parkinson's disease.

  Parkinson's disease 20110101

• The mothers, Omega-3 and mental health study.

  BMC pregnancy and childbirth 20110101

• Effects of fluoxetine and escitalopram on C-reactive protein in patients of depression.

  Journal of pharmacology & pharmacotherapeutics 20110101

• Acamprosate and Baclofen were Not Effective in the Treatment of Pathological Gambling: Preliminary Blind Rater Comparison Study.

  Frontiers in psychiatry 20110101

• The effect of paroxetine on ouabain-induced toxicity in isolated guinea pig atria.

  Acta medica Iranica 20110101

• Modulation of cortisol responses to the DEX/CRH test by polymorphisms of the interleukin-1beta gene in healthy adults.

  Behavioral and brain functions : BBF 20110101

• Antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control study.

  PloS one 20110101

• Remission with venlafaxine extended release or selective serotonin reuptake inhibitors in depressed patients: a randomized, open-label study.

  The primary care companion for CNS disorders 20110101

• Complete Long-Term Remission of an Inflammatory Pseudotumor under Corticosteroid Therapy.

  Case reports in oncology 20110101

• Amitriptyline-mediated cognitive enhancement in aged 3×Tg Alzheimer's disease mice is associated with neurogenesis and neurotrophic activity.

  PloS one 20110101

• The strategy of combining antidepressants in the treatment of major depression: clinical experience in spanish outpatients.

  Depression research and treatment 20110101

• Antidepressant therapy in severe depression may have different effects on ego-dystonic and ego-syntonic suicidal ideation.

  Depression research and treatment 20110101

• Dysthymia and apathy: diagnosis and treatment.

  Depression research and treatment 20110101

• Improvement of the noradrenergic symptom cluster following treatment with milnacipran.

  Neuropsychiatric disease and treatment 20110101

• Tamoxifen and CYP 2D6 inhibitors: caution.

  Prescrire international 20110101

• Clinical potential of lurasidone in the management of schizophrenia.

  Therapeutics and clinical risk management 20110101

• Antidepressant prescribing and suicides in emilia-romagna region (Italy) from 1999 to 2008: an ecological study.

  Clinical practice and epidemiology in mental health : CP & EMH 20110101

• Indianizing psychiatry - Is there a case enough?

  Indian journal of psychiatry 20110101

• Antidepressants: From MAOIs to SSRIs and more.

  Indian journal of psychiatry 20110101

• Pharmacotherapy for fibromyalgia.

  Frontiers in pharmacology 20110101

• Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression.

  Frontiers in psychology 20110101

• Clinical therapeutics in pregnancy.

  Journal of biomedicine & biotechnology 20110101

• Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder.

  Patient preference and adherence 20110101

• A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase.

  Neuropsychiatric disease and treatment 20110101

• Depression in vascular pathologies: the neurologist's point of view.

  Vascular health and risk management 20110101

• Efficacy of chronic antidepressant treatments in a new model of extreme anxiety in rats.

  Depression research and treatment 20110101

• Antidepressant use and risk of adverse outcomes in older people: population based cohort study.

  BMJ (Clinical research ed.) 20110101

• Remembering and forgetting: directed forgetting effect in obsessive-compulsive disorder.

  Neuropsychiatric disease and treatment 20110101

• Duloxetine in the management of diabetic peripheral neuropathic pain.

  Patient preference and adherence 20110101

• Radioelectric brain stimulation in the treatment of generalized anxiety disorder with comorbid major depression in a psychiatric hospital: a pilot study.

  Neuropsychiatric disease and treatment 20110101

• Differential effects of prenatal stress in 5-Htt deficient mice: towards molecular mechanisms of gene × environment interactions.

  PloS one 20110101

• Bilateral testicular self-castration due to cannabis abuse: a case report.

  Journal of medical case reports 20110101

• Knowledge, attitudes and practices of health professionals and women towards medication use in breastfeeding: A review.

  International breastfeeding journal 20110101

• Marked mydriasis and neuritis nervi optici associated with galactorrhea following citalopram treatment: a case report and discussion.

  Case reports in medicine 20110101

• Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis.

  Medical science monitor : international medical journal of experimental and clinical research 20110101

• Efficacy of paroxetine in primary palmoplantar hyperhidrosis occurring with juvenile myoclonic epilepsy.

  Dermatology (Basel, Switzerland) 20110101

• Update on the management of diabetic polyneuropathies.

  Diabetes, metabolic syndrome and obesity : targets and therapy 20110101

• [Treatment of anxiety disorders in the elderly].

  Tijdschrift voor psychiatrie 20110101

• Identification of novel functional inhibitors of acid sphingomyelinase.

  PloS one 20110101

• Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence.

  PloS one 20110101

• Bladder, bowel, and sexual dysfunction in Parkinson's disease.

  Parkinson's disease 20110101

• Psychotherapy and medication management strategies for obsessive-compulsive disorder.

  Neuropsychiatric disease and treatment 20110101

• An in vitro evaluation of guanfacine as a substrate for P-glycoprotein.

  Neuropsychiatric disease and treatment 20110101

• Permanent relief from intermittent cold stress-induced fibromyalgia-like abnormal pain by repeated intrathecal administration of antidepressants.

  Molecular pain 20110101

• Hippocampal neurogenesis and dendritic plasticity support running-improved spatial learning and depression-like behaviour in stressed rats.

  PloS one 20110101

• Understanding the prescription of antidepressants: a Qualitative study among French GPs.

  BMC family practice 20110101

• Psychopharmacological neuroprotection in neurodegenerative diseases, part III: criteria-based assessment: a report of the ANPA committee on research.

  The Journal of neuropsychiatry and clinical neurosciences 20110101

• Increased activity imbalance in fronto-subcortical circuits in adolescents with major depression.

  PloS one 20110101

• Fluvoxamine may prevent onset of psychosis: a case report of a patient at ultra-high risk of psychotic disorder.

  Annals of general psychiatry 20110101

• Quality of online pharmacies and websites selling prescription drugs: a systematic review.

  Journal of medical Internet research 20110101

• Effects of Hypericum perforatum extract on rat irritable bowel syndrome.

  Pharmacognosy magazine 20110101

• Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment.

  Genome medicine 20110101

• Effects of periadolescent fluoxetine and paroxetine on elevated plus-maze, acoustic startle, and swimming immobility in rats while on and off-drug.

  Behavioral and brain functions : BBF 20110101

• Evaluation and management of fatigue in oncology: a multidimensional approach.

  Indian journal of palliative care 20110101

• Spectrofluorimetric determination of sertraline in dosage forms and human plasma through derivatization with 9-fluorenylmethyl chloroformate.

  Chemistry Central journal 20110101

• Novel microwell-based spectrophotometric assay for determination of atorvastatin calcium in its pharmaceutical formulations.

  Chemistry Central journal 20110101

• Hypnosis for hot flashes among postmenopausal women study: a study protocol of an ongoing randomized clinical trial.

  BMC complementary and alternative medicine 20110101

• Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial.

  BMC gastroenterology 20110101

• Prescribing medications in patients with decompensated liver cirrhosis.

  International journal of hepatology 20110101

• Development and validation of stability indicating method for determination of sertraline following ICH guidlines and its determination in pharmaceuticals and biological fluids.

  Chemistry Central journal 20110101

• Unraveling the association between SSRI use and falls: an experimental study of risk factors for accidental falls in long-term paroxetine users.

  Clinical neuropharmacology 20110101

• Cancer patients' perspectives on discontinuing depression treatment: the 'drop out' phenomenon.

  Patient preference and adherence 20110101

• The management of schizophrenia: focus on extended-release quetiapine fumarate.

  Neuropsychiatric disease and treatment 20110101

• Current management of obsessive and phobic states.

  Neuropsychiatric disease and treatment 20110101

• Clinical Psychology and Cardiovascular Disease: An Up-to-Date Clinical Practice Review for Assessment and Treatment of Anxiety and Depression.

  Clinical practice and epidemiology in mental health : CP & EMH 20110101

• 'Comorbid' insomnia.

  Indian journal of psychological medicine 20110101

• Management of bipolar depression.

  Indian journal of psychological medicine 20110101

• Management of Bipolar II Disorder.

  Indian journal of psychological medicine 20110101

• What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association.

  BMC clinical pharmacology 20110101

• Generalised anxiety disorder.

  BMJ clinical evidence 20110101

• Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms.

  BMC psychiatry 20110101

• Social anxiety disorder in genuine halitosis patients.

  Health and quality of life outcomes 20110101

• Nucleus caudalis lesioning: Case report of chronic traumatic headache relief.

  Surgical neurology international 20110101

• Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition.

  Neuropsychiatric disease and treatment 20110101

• Psychiatric diseases: Need for an increased awareness among the anesthesiologists.

  Journal of anaesthesiology, clinical pharmacology 20110101

• The efficacy of low-dose aripiprazole treatment for trichotillomania.

  Clinical neuropharmacology 20110101

• Delayed-onset obsessive-compulsive symptoms after brain infarctions treated with paroxetine.

  Clinical neuropharmacology 20110101

• Depression screening and patient outcomes in cancer: a systematic review.

  PloS one 20110101

• Positive predictive value of automated database records for diabetic ketoacidosis (DKA) in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid Study.

  BMC medical research methodology 20110101

• Why we need easy access to all data from all clinical trials and how to accomplish it.

  Trials 20110101

• Treatment-resistant depression in adolescents: is the addition of cognitive behavioral therapy of benefit?

  Psychology research and behavior management 20110101

• Drug interaction in psycho-oncology: antidepressants and antineoplastics.

  Pharmacology 20110101

• Lithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patients.

  PloS one 20110101

• 'Blues' ain't good for the heart.

  Indian journal of psychiatry 20110101

• Development of a murine animal model of depression for repeated dosing with human interferon alpha.

  Indian journal of psychiatry 20110101

• Subchronic treatment with fluoxetine attenuates the proerectile effect of Aspidosperma ulei Markgr (Apocyanaceae).

  Indian journal of pharmacology 20110101

• Publication trends in newspapers and scientific journals for SSRIs and suicidality: a systematic longitudinal study.

  BMJ open 20110101

• Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study.

  BMC psychiatry 20110101

• Abnormal left-sided orbitomedial prefrontal cortical-amygdala connectivity during happy and fear face processing: a potential neural mechanism of female MDD.

  Frontiers in psychiatry 20110101

• Neurosteroids and GABA(A) Receptor Interactions: A Focus on Stress.

  Frontiers in neuroscience 20110101

• Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants.

  PloS one 20110101

• Parasomnias and antidepressant therapy: a review of the literature.

  Frontiers in psychiatry 20110101

• Can depression be diagnosed by response to mother's face? A personalized attachment-based paradigm for diagnostic fMRI.

  PloS one 20110101

• Use of antipsychotic and antidepressant within the Psychiatric Disease Centre, Regional Health Service of Ferrara.

  BMC clinical pharmacology 20110101

• Insulin-like growth factor-I peptides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolysaccharide.

  Journal of neuroinflammation 20110101

• Systematic drug repositioning based on clinical side-effects.

  PloS one 20110101

• Identification of new alleles and the determination of alleles and genotypes frequencies at the CYP2D6 gene in Emiratis.

  PloS one 20110101

• Visual and auditory hallucinations during normal use of paroxetine for treatment of major depressive disorder.

  The Journal of neuropsychiatry and clinical neurosciences 20110101

• Cellular correlates of enhanced anxiety caused by acute treatment with the selective serotonin reuptake inhibitor fluoxetine in rats.

  Frontiers in behavioral neuroscience 20110101

• Metabolism of oxycodone in human hepatocytes from different age groups and prediction of hepatic plasma clearance.

  Frontiers in pharmacology 20110101

• Serotonin transporter gene polymorphism and psychiatric disorders: is there a link?

  Indian journal of psychiatry 20110101

• Proton magnetic resonance spectroscopy in depression.

  Indian journal of psychiatry 20110101

• How to read a research paper: Reading between and beyond the lines.

  Indian journal of psychiatry 20110101

• Serotonin syndrome while switching antidepressants.

  Indian journal of psychiatry 20110101

• The Relationship between Intelligence and Anxiety: An Association with Subcortical White Matter Metabolism.

  Frontiers in evolutionary neuroscience 20110101

• Apathy and anhedonia in Parkinson's disease.

  ISRN neurology 20110101

• Targeting fatigue in stroke patients.

  ISRN neurology 20110101

• The effects of depression and use of antidepressive medicines during pregnancy on the methylation status of the IGF2 imprinted control regions in the offspring.

  Clinical epigenetics 20110101

• A comparison of the effects of reboxetine and placebo on reaction time in adults with Attention Deficit-Hyperactivity Disorder (ADHD).

  Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101

• Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expression.

  Frontiers in endocrinology 20110101

• Neurosteroids as neuromodulators in the treatment of anxiety disorders.

  Frontiers in endocrinology 20110101

• Paroxetine augmentation in patients with generalised social anxiety disorder, non-responsive to mirtazapine or placebo.

  Human psychopharmacology 20110101

• Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter.

  The Journal of biological chemistry 20101210

• Give up the ghosts.

  Nature 20101209

• The chemical basis of pharmacology.

  Biochemistry 20101207

• The rules of retraction.

  BMJ (Clinical research ed.) 20101207

• Acute and chronic treatment with serotonin reuptake inhibitors exert opposite effects on respiration in rats: possible implications for panic disorder.

  Journal of psychopharmacology (Oxford, England) 20101201

• Anxiety disorders and sensory over-responsivity in children with autism spectrum disorders: is there a causal relationship?

  Journal of autism and developmental disorders 20101201

• Effect of catechol-O-methyltransferase Val(108/158)Met polymorphism on antidepressant efficacy of fluvoxamine.

  European psychiatry : the journal of the Association of European Psychiatrists 20101201

• A review of SSRIs and SNRIs in neuropathic pain.

  Expert opinion on pharmacotherapy 20101201

• Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.

  British journal of pharmacology 20101201

• The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics.

  Journal of cardiovascular pharmacology and therapeutics 20101201

• The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter.

  Molecular pharmacology 20101201

• A predictive ligand-based Bayesian model for human drug-induced liver injury.

  Drug metabolism and disposition: the biological fate of chemicals 20101201

• Switching to hypomania and mania: differential neurochemical, neuropsychological, and pharmacologic triggers and their mechanisms.

  Current psychiatry reports 20101201

• Managing menopausal symptoms and depression in tamoxifen users: implications of drug and medicinal interactions.

  Maturitas 20101201

• Characterisation of zuclopenthixol metabolism by in vitro and therapeutic drug monitoring studies.

  Acta psychiatrica Scandinavica 20101201

• Slow vs standard up-titration of paroxetine in the treatment of panic disorder: a prospective randomized trial.

  Psychiatry and clinical neurosciences 20101201

• Auditory hallucinations associated with clinical dosage of paroxetine: a case report.

  Psychiatry and clinical neurosciences 20101201

• [SSRIs and pregnancy: a review of the literature].

  L'Encephale 20101201

• Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms.

  The Journal of clinical psychiatry 20101201

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20101201

• The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment.

  Psychiatry investigation 20101201

• [Clinical observation on treatment of major depressive disorder by paroxetine combined with chaihu xiaoyao mixture].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20101201

• Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability.

  Current neuropharmacology 20101201

• Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method.

  Healthcare informatics research 20101201

• Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive-compulsive disorder as assessed by brain FDG PET.

  Psychiatry research 20101130

• Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats.

  European journal of pharmacology 20101125

• Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitors.

  Journal of medicinal chemistry 20101111

• Thalidomide for the control of severe paraneoplastic pruritus associated with Hodgkin's disease.

  The American journal of hospice & palliative care 20101101

• Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study.

  Journal of affective disorders 20101101

• Optimization and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the determination of 13 top-prescribed pharmaceuticals in influent wastewater.

  Analytical and bioanalytical chemistry 20101101

• Sigma1-receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice.

  American journal of physiology. Heart and circulatory physiology 20101101

• Differences in clinical effect and tolerance between fluvoxamine and paroxetine: a switching study in patients with depression.

  Human psychopharmacology 20101101

• Comment on 'Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease'.

  Journal of immunology (Baltimore, Md. : 1950) 20101101

• Antidepressants in pregnancy: a systematic review.

  The Australian and New Zealand journal of psychiatry 20101101

• CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine.

  Pharmacogenomics 20101101

• Human health risk assessment of pharmaceuticals in water: issues and challenges ahead.

  International journal of environmental research and public health 20101101

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20101101

• QEEG Measures in Huntington's Disease: A Pilot Study.

  PLoS currents 20101025

• Effects of selective serotonin reuptake inhibitors on GABAergic inhibition in the hippocampus of normal and pilocarpine induced epileptic rats.

  Brain research 20101021

• Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium.

  Journal of psychopharmacology (Oxford, England) 20101001

• Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data.

  Psychological medicine 20101001

• A randomized, controlled trial of aerobic exercise in combination with paroxetine in the treatment of panic disorder.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20101001

• Predictors of alternative antidepressant agent initiation among U. S. veterans diagnosed with depression.

  Pharmacoepidemiology and drug safety 20101001

• Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder.

  The journal of sexual medicine 20101001

• Inhibitory effects of SSRIs on IFN-γ induced microglial activation through the regulation of intracellular calcium.

  Progress in neuro-psychopharmacology & biological psychiatry 20101001

• 5-HT2C receptor activation prevents stress-induced enhancement of brain 5-HT turnover and extracellular levels in the mouse brain: modulation by chronic paroxetine treatment.

  Journal of neurochemistry 20101001

• Treatment options for bipolar depression: a systematic review of randomized, controlled trials.

  Journal of clinical psychopharmacology 20101001

• Psychotropic drugs on in vitro brain-derived neurotrophic factor production in whole blood cell cultures from healthy subjects.

  Journal of clinical psychopharmacology 20101001

• Nonhormonal management of hot flashes for women on risk reduction therapy.

  Journal of the National Comprehensive Cancer Network : JNCCN 20101001

• [Efficacy of escitalopram vs paroxetine on severe depression with associated anxiety: data from the 'Boulenger' study].

  L'Encephale 20101001

• Antidepressants and body weight: a comprehensive review and meta-analysis.

  The Journal of clinical psychiatry 20101001

• A case of paroxetine-induced galactorrhoea with normal serum prolactin level.

  Indian journal of pharmacology 20101001

• [Comparative efficacy of selective serotonin reuptake inhibitors in young prenatally stressed female rats].

  Eksperimental'naia i klinicheskaia farmakologiia 20101001

• [(3R,4S)-4-(4-Fluoro-phen-yl)-1-methyl-piperidin-3-yl]methyl 4-methyl-benzene-sulfonate.

  Acta crystallographica. Section E, Structure reports online 20101001

• The multi-systemic nature of diabetes mellitus: Genotype or phenotype?

  North American journal of medical sciences 20101001

• Pindolol potentiates the panicolytic effect of paroxetine in the elevated T-maze.

  Life sciences 20100925

• The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer.

  British journal of cancer 20100907

• HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.

  Neuromolecular medicine 20100901

• The role of proteomics in depression research.

  European archives of psychiatry and clinical neuroscience 20100901

• Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine.

  Acta psychiatrica Scandinavica 20100901

• A possible explanation for dizziness following SSRI discontinuation.

  Acta oto-laryngologica 20100901

• Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs).

  Reproductive toxicology (Elmsford, N.Y.) 20100901

• S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: a comparison to aprepitant (MK869) and paroxetine.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100901

• Antidepressant-like pharmacological profile of 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene: Involvement of serotonergic system.

  Neuropharmacology 20100901

• Amelioration of sexual adverse effects in the early breast cancer patient.

  Journal of cancer survivorship : research and practice 20100901

• Heart-focused anxiety as a mediating variable in the treatment of noncardiac chest pain by cognitive-behavioral therapy and paroxetine.

  Journal of psychosomatic research 20100901

• Heart-focused anxiety as a mediating variable in the treatment of non-cardiac chest pain by cognitive-behavioural and psychopharmacological treatment by paroxetine.

  Journal of psychosomatic research 20100901

• Escitalopram: a review of its use in the management of major depressive disorder in adults.

  CNS drugs 20100901

• Literature mining for the discovery of hidden connections between drugs, genes and diseases.

  PLoS computational biology 20100901

• Changes in Cerebral Cortex and Limbic Brain Functions after Short-Term Paroxetine Treatment in Panic Disorder: An [F]FDG-PET Pilot Study.

  Psychiatry investigation 20100901

• A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.

  Current neuropharmacology 20100901

• Abstracts of the 5(th) Cachexia Conference, Barcelona, Spain, December 5-8, 2009.

  Journal of cachexia, sarcopenia and muscle 20100901

• Restless legs syndrome following the combined use of quetiapine and paroxetine.

  Progress in neuro-psychopharmacology & biological psychiatry 20100816

• Nitric oxide is involved in the regulation of marble-burying behavior.

  Neuroscience letters 20100809

• A pilot study of the effects of chronic paroxetine administration on hippocampal N-acetylaspartate in generalized anxiety disorder.

  Journal of psychopharmacology (Oxford, England) 20100801

• Proteomic analysis of rat hippocampus exposed to the antidepressant paroxetine.

  Journal of psychopharmacology (Oxford, England) 20100801

• Adverse effect of paroxetine on sperm.

  Fertility and sterility 20100801

• A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons.

  Neurotoxicity research 20100801

• Can pharmacotherapists be too supportive? A process study of active medication and placebo in the treatment of depression.

  Psychological medicine 20100801

• Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression.

  Journal of psychopharmacology (Oxford, England) 20100801

• Early telephone intervention for psychiatric outpatients starting antidepressant treatment.

  Nordic journal of psychiatry 20100801

• The SPECT tracer [123I]ADAM binds selectively to serotonin transporters: a double-blind, placebo-controlled study in healthy young men.

  European journal of nuclear medicine and molecular imaging 20100801

• Evaluation of tramadol on demand vs. daily paroxetine as a long-term treatment of lifelong premature ejaculation.

  The journal of sexual medicine 20100801

• ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression.

  Pharmacogenetics and genomics 20100801

• Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.

  Journal of clinical psychopharmacology 20100801

• Microextraction in packed sorbent for analysis of antidepressants in human plasma by liquid chromatography and spectrophotometric detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100801

• Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.

  Expert review of neurotherapeutics 20100801

• Paroxetine use in pregnancy and increased risk of heart defects: Evaluating the evidence.

  Canadian family physician Medecin de famille canadien 20100801

• No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations.

  Human psychopharmacology 20100801

• Serotonin and catecholaminergic polymorphic ventricular tachycardia: a possible therapeutic role for SSRIs?

  Cardiovascular journal of Africa 20100801

• Do Hospital and Community SSRI Usage Patterns in Children and Adolescents Match the Evidence?

  Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent 20100801

• Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease.

  The American journal of geriatric pharmacotherapy 20100801

• Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease.

  Journal of immunology (Baltimore, Md. : 1950) 20100715

• Use of antidepressants during pregnancy and the risk of spontaneous abortion.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20100713

• Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors.

  Biochemistry 20100713

• Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD).

  The Cochrane database of systematic reviews 20100707

• Elevated BDNF protein level in cortex but not in hippocampus of MDMA-treated Dark Agouti rats: a potential link to the long-term recovery of serotonergic axons.

  Neuroscience letters 20100705

• Paroxetine pretreatment does not change the effects induced in the rat cortical beta-adrenergic receptor system by repetitive transcranial magnetic stimulation and electroconvulsive shock.

  The international journal of neuropsychopharmacology 20100701

• A randomized controlled study of paroxetine and cognitive-behavioural therapy for late-life panic disorder.

  Acta psychiatrica Scandinavica 20100701

• Oxazepam and temazepam attenuate paroxetine-induced elevation of serotonin levels in guinea-pig hippocampus.

  The international journal of neuropsychopharmacology 20100701

• Two separate dose-dependent effects of paroxetine: mydriasis and inhibition of tramadol's O-demethylation via CYP2D6.

  European journal of clinical pharmacology 20100701

• Paroxetine-induced increase in activity of locus coeruleus neurons in adolescent rats: implication of a countertherapeutic effect of an antidepressant.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100701

• Resolution of Brugada-pattern ECG after withdrawal of the selective serotonin reuptake inhibitor paroxetine.

  Heart (British Cardiac Society) 20100701

• Research indicates antidepressants may be best for severe depression.

  Mayo Clinic women's healthsource 20100701

• Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.

  International clinical psychopharmacology 20100701

• Addendum: Paroxetine-induced increase in activity of locus coeruleus neurons in adolescent rats: implication of a countertherapeutic effect of an antidepressant.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100701

• Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression.

  International clinical psychopharmacology 20100701

• First trimester exposure to paroxetine and prevalence of cardiac defects: Meta-analysis of the literature: Unfortunately incomplete.

  Birth defects research. Part A, Clinical and molecular teratology 20100701

• Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone.

  British journal of clinical pharmacology 20100701

• Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.

  Postgraduate medicine 20100701

• Effects of antidepressants in patients with irritable bowel syndrome and comorbid depression.

  Clinical therapeutics 20100701

• Available and future therapies for premature ejaculation.

  Drugs of today (Barcelona, Spain : 1998) 20100701

• Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors.

  Behavioural pharmacology 20100701

• Synthesis of (-)-paroxetine via enantioselective phase-transfer catalytic monoalkylation of malonamide ester.

  Organic letters 20100618

• ACP Journal Club. Use of paroxetine during tamoxifen therapy for breast cancer was associated with increased breast-cancer and all-cause mortality.

  Annals of internal medicine 20100615

• Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism.

  Journal of affective disorders 20100601

• Depression and comorbid panic in primary care patients.

  Journal of affective disorders 20100601

• A comparative study of non-fatal self-poisoning with antidepressants relative to prescribing in three centres in England.

  Journal of affective disorders 20100601

• Effects of cognitive-behavioral therapy on Eating Disorders: neurotransmitter secretory response to treatment.

  Psychoneuroendocrinology 20100601

• Selective serotonin reuptake inhibitors and the risk of cataracts: a nested case-control study.

  Ophthalmology 20100601

• Antidepressants, but not antipsychotics, modulate GR function in human whole blood: an insight into molecular mechanisms.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100601

• Guideline recommendations for long-term treatment of depression with antidepressants in primary care--a critical review.

  The European journal of general practice 20100601

• Prescription patterns of antidepressants: findings from a US claims database.

  Current medical research and opinion 20100601

• Sustained stress-induced changes in mice as a model for chronic depression.

  Psychopharmacology 20100601

• Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder.

  CNS neuroscience & therapeutics 20100601

• Frontotemporal dementia presenting as pathological gambling.

  Nature reviews. Neurology 20100601

• Update on antithrombotic therapy for stroke prevention in atrial fibrillation.

  Current treatment options in cardiovascular medicine 20100601

• Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.

  The Journal of clinical psychiatry 20100601

• [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].

  L'Encephale 20100601

• Differences of clinical characteristics and phenotypes between prepubertal- and adolescent-onset bipolar disorders.

  Journal of Korean medical science 20100601

• Pharmacologic management of chronic pain.

  The Korean journal of pain 20100601

• Translational neuroimaging research in pediatric obsessive-compulsive disorder.

  Dialogues in clinical neuroscience 20100601

• Pathological gambling and compulsive buying: do they fall within an obsessive-compulsive spectrum?

  Dialogues in clinical neuroscience 20100601

• Drug treatment of obsessive-compulsive disorder.

  Dialogues in clinical neuroscience 20100601

• Body dysmorphic disorder.

  Dialogues in clinical neuroscience 20100601

• Compulsive hoarding: current controversies and new directions.

  Dialogues in clinical neuroscience 20100601

• Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agents.

  Experimental neurobiology 20100601

• Evaluation of Krebs cycle enzymes in the brain of rats after chronic administration of antidepressants.

  Brain research bulletin 20100531

• Effects of the 5-HT(4) receptor agonist RS67333 and paroxetine on hippocampal extracellular 5-HT levels.

  Neuroscience letters 20100531

• Manic switch and serotonin syndrome induced by augmentation of paroxetine with methylphenidate in a patient with major depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20100530

• Deaths involving serotonergic drugs.

  Forensic science international 20100520

• Roles of paroxetine and corticosterone on adult mammalian ciliary body cell proliferation.

  Chinese medical journal 20100520

• Acute tryptophan depletion potentiates 3,4-methylenedioxymethamphetamine-induced cerebrovascular hyperperfusion in adult male Wistar rats.

  Journal of neuroscience research 20100515

• Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice.

  Journal of psychopharmacology (Oxford, England) 20100501

• Is the increase in LDL cholesterol induced by selective serotonin reuptake inhibitor therapy a blessing in disguise?

  Medical hypotheses 20100501

• Inhibitory mechanisms and binding site location for serotonin selective reuptake inhibitors on nicotinic acetylcholine receptors.

  The international journal of biochemistry & cell biology 20100501

• A review of clinical pharmacokinetics and pharmacodynamics of galantamine, a reversible acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, in healthy subjects and patients.

  Current clinical pharmacology 20100501

• The intermuscular 3-7 Hz drive is not affected by distal proprioceptive input in myoclonus-dystonia.

  Experimental brain research 20100501

• Effectiveness of milnacipran for a patient with pain disorder and long QT syndrome.

  Clinical neuropharmacology 20100501

• Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.

  Pediatrics 20100501

• Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.

  Archives of general psychiatry 20100501

• 5-HT2B receptors are expressed on astrocytes from brain and in culture and are a chronic target for all five conventional 'serotonin-specific reuptake inhibitors'.

  Neuron glia biology 20100501

• Platelet serotonin transporter function after short-term paroxetine treatment in patients with panic disorder.

  Psychiatry research 20100430

• Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: a study using (1)H magnetic resonance spectroscopy.

  Psychiatry research 20100430

• N-heterocycle construction via cyclic sulfamidates. Applications in synthesis.

  Organic & biomolecular chemistry 20100407

• Generic substitution of commonly used medications: Australia-wide experience, 2007-2008.

  The Medical journal of Australia 20100405

• The N terminus of monoamine transporters is a lever required for the action of amphetamines.

  The Journal of biological chemistry 20100402

• The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.

  Journal of psychopharmacology (Oxford, England) 20100401

• Successful management of depression with reboxetine in a patient who developed Parkinsonism related to paroxetine use.

  Journal of psychopharmacology (Oxford, England) 20100401

• Antidepressant use during pregnancy: a critical systematic review of the literature.

  Current drug safety 20100401

• Association of a functional polymorphism in the adrenomedullin gene (ADM) with response to paroxetine.

  The pharmacogenomics journal 20100401

• Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study.

  The international journal of neuropsychopharmacology 20100401

• Altered gene expression of histone deacetylases in mood disorder patients.

  Journal of psychiatric research 20100401

• Whole embryo culture and the identification of 'teratogenicity'.

  Reproductive toxicology (Elmsford, N.Y.) 20100401

• Effects of selective serotonin reuptake inhibitors on timolol metabolism in human liver microsomes and cryo-preserved hepatocytes.

  Basic & clinical pharmacology & toxicology 20100401

• Use of the dried blood spot sampling process coupled with fast gas chromatography and negative-ion chemical ionization tandem mass spectrometry: application to fluoxetine, norfluoxetine, reboxetine, and paroxetine analysis.

  Analytical and bioanalytical chemistry 20100401

• Evidence that MDMA ('ecstasy') increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain.

  Journal of neurochemistry 20100401

• Syndrome of inappropriate secretion of anti-diuretic hormone in an elderly depressive patient receiving paroxetine: a case report.

  International journal of geriatric psychiatry 20100401

• Platelet serotonin transporter function and heart rate variability in patients with panic disorder.

  Journal of Korean medical science 20100401

• Chronic thromboembolic pulmonary hypertension.

  Current treatment options in cardiovascular medicine 20100401

• Clinical features and treatment characteristics of compulsive hoarding in Japanese patients with obsessive-compulsive disorder.

  CNS spectrums 20100401

• Changes in the QTc interval after administration of flecainide acetate, with and without coadministered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects.

  Clinical therapeutics 20100401

• [Possibility of a pharmacogenetic approach for prediction and personalized medication in major depressive disorder treatment].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20100401

• Possible cross-sensitivity between sertraline and paroxetine in a panic disorder patient.

  Indian journal of pharmacology 20100401

• Antidepressant pharmaceuticals in two U.S. effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue.

  Environmental science & technology 20100315

• Antagonists and substrates differentially regulate serotonin transporter cell surface expression in serotonergic neurons.

  European journal of pharmacology 20100310

• SSRIs and tamoxifen. Why condemn fluoxetine?

  BMJ (Clinical research ed.) 20100310

• FKBP5 polymorphisms and antidepressant response in geriatric depression.

  American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20100305

• Intravenous anti-obsessive agents: a review.

  Journal of psychopharmacology (Oxford, England) 20100301

• First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies.

  Birth defects research. Part A, Clinical and molecular teratology 20100301

• Paroxetine increases brain-derived neurotrophic factor in postmenopausal women.

  Menopause (New York, N.Y.) 20100301

• Paroxetine exposure during pregnancy and the risk of cardiac malformations: what is the evidence?

  Birth defects research. Part A, Clinical and molecular teratology 20100301

• Identification of cytochrome P450 isoforms involved in the metabolism of paroxetine and estimation of their importance for human paroxetine metabolism using a population-based simulator.

  Drug metabolism and disposition: the biological fate of chemicals 20100301

• Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.

  The American journal of psychiatry 20100301

• Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine.

  Current medical research and opinion 20100301

• The role of the striatum in compulsive behavior in intact and orbitofrontal-cortex-lesioned rats: possible involvement of the serotonergic system.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100301

• Paroxetine exposure during pregnancy and cardiac malformations.

  Birth defects research. Part A, Clinical and molecular teratology 20100301

• Abstracts of the 16th Annual Society on NeuroImmune Pharmacology (SNIP) Conference. April 13-17, 2010. Manhattan Beach, California, USA.

  Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20100301

• Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20100301

• [Therapy for male patients with sexual dysfunction].

  Therapeutische Umschau. Revue therapeutique 20100301

• Human lymphoblastoid cell line panels: novel tools for assessing shared drug pathways.

  Pharmacogenomics 20100301

• [Persistent interactions].

  Medizinische Monatsschrift fur Pharmazeuten 20100301

• Advancing bipolar disorder: key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20100301

• Psychiatric pharmacogenomic testing in clinical practice.

  Dialogues in clinical neuroscience 20100301

• Antidepressant-Induced Sexual Dysfunction among Newer Antidepressants in a Naturalistic Setting.

  Psychiatry investigation 20100301

• Assessing anxiolytic-like effects of selective serotonin reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors using the elevated plus maze in mice.

  Methods and findings in experimental and clinical pharmacology 20100301

• Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20100215

• Best practice guide for the treatment of REM sleep behavior disorder (RBD).

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20100215

• The selective serotonin reuptake inhibitor fluoxetine reduces striatal in vivo levels of voltammetric nitric oxide (NO): a feature of its antidepressant activity?

  Neuroscience letters 20100212

• Pharmacy students' knowledge of black box warnings.

  American journal of pharmaceutical education 20100210

• Interaction of serotonin reuptake inhibitors with tamoxifen.

  BMJ (Clinical research ed.) 20100208

• Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective.

  The European journal of health economics : HEPAC : health economics in prevention and care 20100201

• Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors.

  International psychogeriatrics 20100201

• Inhibition of thoughts and actions in obsessive-compulsive disorder: extending the endophenotype?

  Psychological medicine 20100201

• Solid-phase extraction and analysis of paroxetine in human plasma by ultra performance liquid chromatography-electrospray ionization mass spectrometry.

  Biomedical chromatography : BMC 20100201

• The oxidative metabolism of dimemorfan by human cytochrome P450 enzymes.

  Journal of pharmaceutical sciences 20100201

• Paroxetine inhibited the relaxations induced by EFS in mice corpus cavernosum: is it a NOS inhibition?

  Fundamental & clinical pharmacology 20100201

• Inverse relationship between numbers of 5-HT transporter binding sites and life history of aggression and intermittent explosive disorder.

  Journal of psychiatric research 20100201

• [Pharmacological hypotheses and therapeutic strategies for gait disorders in Parkinson's disease].

  Revue neurologique 20100201

• First-trimester use of paroxetine and congenital heart defects: a population-based case-control study.

  Birth defects research. Part A, Clinical and molecular teratology 20100201

• Hyponatremia associated with paroxetine induced by sodium-restricted diet and hypotonic saline.

  Pharmacy world & science : PWS 20100201

• Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100201

• Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions.

  Pharmacoepidemiology and drug safety 20100201

• Building a tiered approach to in vitro predictive toxicity screening: a focus on assays with in vivo relevance.

  Combinatorial chemistry & high throughput screening 20100201

• Effects of the serotonin 1A, 2A, 2C, 3A, and 3B and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome.

  Journal of clinical psychopharmacology 20100201

• Nonadherence to paroxetine: a study based on monitoring plasma paroxetine levels.

  Journal of clinical psychopharmacology 20100201

• Paroxetine mesylate: comparable to paroxetine hydrochloride?

  Expert opinion on pharmacotherapy 20100201

• A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).

  The Journal of clinical psychiatry 20100201

• Ghostwriting at elite academic medical centers in the United States.

  PLoS medicine 20100201

• [Paroxetine treatment of 3 cases of cholestatic pruritus due to gastrointestinal malignancy].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20100201

• When is a 'generic' medication not really a generic?

  Journal of psychosocial nursing and mental health services 20100201

• Balneotherapy versus paroxetine in the treatment of generalized anxiety disorder.

  Complementary therapies in medicine 20100201

• Management of hot flashes in women with breast cancer.

  Current oncology (Toronto, Ont.) 20100201

• Effect of curcumin on quinpirole induced compulsive checking: An approach to determine the predictive and construct validity of the model.

  North American journal of medical sciences 20100201

• Sertraline versus other antidepressive agents for depression.

  The Cochrane database of systematic reviews 20100120

• A highly sensitive HPLC method with automated on-line sample pre-treatment and fluorescence detection for determination of reboxetine in human plasma.

  Talanta 20100115

• Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale.

  Journal of psychopharmacology (Oxford, England) 20100101

• Clinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapy.

  Journal of affective disorders 20100101

• Effects of paroxetine on emotional functioning and treatment awareness: a 4-week randomized placebo-controlled study in healthy clinicians.

  Psychopharmacology 20100101

• Effects of selective serotonin reuptake inhibitor on treating tinnitus in patients stratified for presence of depression or anxiety.

  Audiology & neuro-otology 20100101

• Gestational exposure to antidepressants and the risk of spontaneous abortion: a review.

  Current drug delivery 20100101

• CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100101

• Comparative efficacy and acceptability of pharmacotherapeutic agents for anxiety disorders in children and adolescents: a mixed treatment comparison meta-analysis.

  Current medical research and opinion 20100101

• Trace analysis of antidepressants in environmental waters by molecularly imprinted polymer-based solid-phase extraction followed by ultra-performance liquid chromatography coupled to triple quadrupole mass spectrometry.

  Analytical and bioanalytical chemistry 20100101

• Successful treatment by paroxetine of delusional disorder, somatic type, accompanied by severe secondary depression.

  Clinical neuropharmacology 20100101

• Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics.

  Naunyn-Schmiedeberg's archives of pharmacology 20100101

• Antidepressants and suicide risk: how did specific information in FDA safety warnings affect treatment patterns?

  Psychiatric services (Washington, D.C.) 20100101

• Role of the amygdala in antidepressant effects on hippocampal cell proliferation and survival and on depression-like behavior in the rat.

  PloS one 20100101

• Dissecting dementia, depression, and drug effects in older adults.

  Journal of psychosocial nursing and mental health services 20100101

• Antidepressant stimulation of CDP-diacylglycerol synthesis does not require monoamine reuptake inhibition.

  BMC neuroscience 20100101

• Role of platelets in neuroinflammation: a wide-angle perspective.

  Journal of neuroinflammation 20100101

• Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study.

  BMJ (Clinical research ed.) 20100101

• Extrapyramidal side effects and suicidal ideation under fluoxetine treatment: a case report.

  Annals of general psychiatry 20100101

• Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's disease.

  Annals of general psychiatry 20100101

• Anti-inflammatory effects of antidepressant and atypical antipsychotic medication for the treatment of major depression and comorbid arthritis: a case report.

  Journal of medical case reports 20100101

• Combining poly (methacrylic acid-co-ethylene glycol dimethacrylate) monolith microextraction and octadecyl phosphonic acid-modified zirconia-coated CEC with field-enhanced sample injection for analysis of antidepressants in human plasma and urine.

  Electrophoresis 20100101

• Impulsivity, gender, and the platelet serotonin transporter in healthy subjects.

  Neuropsychiatric disease and treatment 20100101

• Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.

  PloS one 20100101

• Depression, suicidality and antidepressants: A coincidence?

  Indian journal of psychiatry 20100101

• The influence of negative mood on heart rate complexity measures and baroreflex sensitivity in healthy subjects.

  Indian journal of psychiatry 20100101

• Continuing medical education: SSRIs and pregnancy.

  Indian journal of psychiatry 20100101

• Cost-effectiveness analysis of treatments for premenstrual dysphoric disorder.

  Applied health economics and health policy 20100101

• Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine.

  Annals of general psychiatry 20100101

• Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with major depressive disorder--the EMC trial.

  Trials 20100101

• Lymphocytic colitis presenting as difficult diarrhoea in an African woman: a case report and review of the literature.

  Journal of medical case reports 20100101

• A nuclear factor-binding domain in the 5'-untranslated region of the amyloid precursor protein promoter: implications for the regulation of gene expression.

  BMC research notes 20100101

• Changes in clinical trials methodology over time: a systematic review of six decades of research in psychopharmacology.

  PloS one 20100101

• Neck pain and anxiety do not always go together.

  Chiropractic & osteopathy 20100101

• Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

  Molecular neurodegeneration 20100101

• Psychosocial functioning in patients with Treatment-Resistant Depression after group cognitive behavioral therapy.

  BMC psychiatry 20100101

• EVITA: a tool for the early evaluation of pharmaceutical innovations with regard to therapeutic advantage.

  BMC clinical pharmacology 20100101

• A Canadian naturalistic study of a community-based cohort treated for bipolar disorder.

  BMC psychiatry 20100101

• Prenatal exposure to serotonin reuptake inhibitors: a case report.

  Italian journal of pediatrics 20100101

• Impact of treatment for depression on desire for hastened death in patients with advanced AIDS.

  Psychosomatics 20100101

• Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice.

  PloS one 20100101

• Quantification of paroxetine in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry.

  Journal of AOAC International 20100101

• Incidence of self-reported brain injury and the relationship with substance abuse: findings from a longitudinal community survey.

  BMC public health 20100101

• The outcome of health anxiety in primary care. A two-year follow-up study on health care costs and self-rated health.

  PloS one 20100101

• Psychiatric disorder as clinical presentation of primary Sjögren's syndrome: two case reports.

  Annals of general psychiatry 20100101

• Recent advances in the treatment of premature ejaculation.

  Drug design, development and therapy 20100101

• Continuation treatment of major depressive disorder: is there a case for duloxetine?

  Drug design, development and therapy 20100101

• New atypical antipsychotics for schizophrenia: iloperidone.

  Drug design, development and therapy 20100101

• Aripiprazole Improves Depressive Symptoms and Immunological Response to Antiretroviral Therapy in an HIV-Infected Subject with Resistant Depression.

  Case reports in medicine 20100101

• Reporting bias in medical research - a narrative review.

  Trials 20100101

• Sertraline versus other antidepressive agents for depression.

  The Cochrane database of systematic reviews 20100101

• Aggression and anxiety: social context and neurobiological links.

  Frontiers in behavioral neuroscience 20100101

• Sigma-1 receptor agonist fluvoxamine for delirium in intensive care units: report of five cases.

  Annals of general psychiatry 20100101

• A comprehensive molecular interaction map for rheumatoid arthritis.

  PloS one 20100101

• Protocol for a randomised controlled trial investigating the effectiveness of an online e-health application compared to attention placebo or sertraline in the treatment of generalised anxiety disorder.

  Trials 20100101

• Cognitive behavioural therapy in elderly type 2 diabetes patients with minor depression or mild major depression: study protocol of a randomized controlled trial (MIND-DIA).

  BMC geriatrics 20100101

• How possible is the development of an operational psychometric method to assess the presence of the 5-HTTLPR s allele? Equivocal preliminary findings.

  Annals of general psychiatry 20100101

• Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials.

  Arthritis research & therapy 20100101

• The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's disease.

  The Journal of neuropsychiatry and clinical neurosciences 20100101

• Delusion of Cotard's syndrome successfully treated with a dopamine agonist.

  The Journal of neuropsychiatry and clinical neurosciences 20100101

• Comparison of the consumption of antidepressants in the immigrant and native populations in a Spanish health region: an observational study.

  BMC public health 20100101

• Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males.

  Mediators of inflammation 20100101

• The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report.

  Annals of general psychiatry 20100101

• Strategy to Accelerate or Augment the Antidepressant Response and for An Early Onset of SSRI Activity. Adjunctive Amisulpride to Fluvoxamine in Major Depressive Disorder.

  Clinical practice and epidemiology in mental health : CP & EMH 20100101

• Legislation for trial registration and data transparency.

  Trials 20100101

• The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes.

  Neuropsychiatric disease and treatment 20100101

• The role of rasagiline in the treatment of Parkinson's disease.

  Clinical interventions in aging 20100101

• Current trends in drug treatment of obsessive-compulsive disorder.

  Neuropsychiatric disease and treatment 20100101

• Trazodone effects on [H]-paroxetine and alpha(2)-adrenoreceptors in platelets of patients with major depression.

  Neuropsychiatric disease and treatment 20100101

• Psychometric evaluation of a visual analog scale for the assessment of anxiety.

  Health and quality of life outcomes 20100101

• Melancholic versus non-melancholic depression: differences on cognitive function. A longitudinal study protocol.

  BMC psychiatry 20100101

• Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.

  BMC neurology 20100101

• A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach.

  Psychopharmacology bulletin 20100101

• The 'antisocial' person: an insight in to biology, classification and current evidence on treatment.

  Annals of general psychiatry 20100101

• Line bisection performance in patients with generalized anxiety disorder and treatment-resistant depression.

  International journal of medical sciences 20100101

• Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management.

  Neuropsychiatric disease and treatment 20100101

• Evolving refractory major depressive disorder diagnostic and treatment paradigms: toward closed-loop therapeutics.

  Frontiers in neuroengineering 20100101

• Pseudotumor cerebri in a patient being treated for bipolar disorder.

  General hospital psychiatry 20100101

• Can antidepressants prevent interferon-alpha-induced depression? A review of the literature.

  General hospital psychiatry 20100101

• Augmentation of clozapine with aripiprazole in severe psychotic bipolar and schizoaffective disorders: a pilot study.

  Clinical practice and epidemiology in mental health : CP & EMH 20100101

• The Factors Influencing Depression Endpoints Research (FINDER) study: final results of Italian patients with depression.

  Annals of general psychiatry 20100101

• Differences in efficacy and safety of pharmaceutical treatments between men and women: an umbrella review.

  PloS one 20100101

• Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs.

  Primary care companion to the Journal of clinical psychiatry 20100101

• The 6-month persistence on SSRIs and associated economic burden.

  Journal of medical economics 20100101

• Serotonin synthesis, release and reuptake in terminals: a mathematical model.

  Theoretical biology & medical modelling 20100101

• Adherence to antidepressant therapy for major depressive patients in a psychiatric hospital in Thailand.

  BMC psychiatry 20100101

• Further Electrochemical and Behavioural Evidence of a Direct Relationship Between Central 5-HT and Cytoskeleton in the Control of Mood.

  The open neurology journal 20100101

• Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed.

  Environmental toxicology and chemistry 20100101

• [Efficacy of adepress (paroxetin) in generalized anxiety disorder].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101

• Serotonin syndrome after a massive overdose of controlled-release paroxetine.

  Psychosomatics 20100101

• Colorimetric method for the estimation of escitalopram oxalate in tablet dosage form.

  Indian journal of pharmaceutical sciences 20100101

• Aripiprazole for late-life schizophrenia.

  Clinical interventions in aging 20100101

• Milnacipran: a unique antidepressant?

  Neuropsychiatric disease and treatment 20100101

• Getting the balance right: Established and emerging therapies for major depressive disorders.

  Neuropsychiatric disease and treatment 20100101

• Emerging role of sertindole in the management of schizophrenia.

  Neuropsychiatric disease and treatment 20100101

• Emerging treatments in the management of schizophrenia - focus on sertindole.

  Drug design, development and therapy 20100101

• Tailoring therapeutic strategies for treating posttraumatic stress disorder symptom clusters.

  Neuropsychiatric disease and treatment 20100101

• Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection.

  Patient preference and adherence 20100101

• [Dose-escalation of SSRIS in major depressive disorder. Should not be recommended in current guidelines].

  Tijdschrift voor psychiatrie 20100101

• Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis.

  Clinical epidemiology 20100101

• Clinical expert guidelines for the management of cough in lung cancer: report of a UK task group on cough.

  Cough (London, England) 20100101

• eIF4A inhibition allows translational regulation of mRNAs encoding proteins involved in Alzheimer's disease.

  PloS one 20100101

• Gut inflammation in chronic fatigue syndrome.

  Nutrition & metabolism 20100101

• Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.

  BMJ (Clinical research ed.) 20100101

• Approaching patients with irritable bowel syndrome.

  F1000 medicine reports 20100101

• Pharmaceutical treatment of acute bipolar depression.

  F1000 medicine reports 20100101

• Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors.

  Neuropsychiatric disease and treatment 20100101

• Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease.

  Neuropsychiatric disease and treatment 20100101

• Role of paliperidone extended-release in treatment of schizoaffective disorder.

  Neuropsychiatric disease and treatment 20100101

• [Selective serotonin reuptake inhibitors and mammary pathologies].

  Voprosy onkologii 20100101

• The Nordic health registers - an important source when evaluating the safety of antidepressants during pregnancy.

  Clinical epidemiology 20100101

• Gender differences in antidepressant drug response.

  International review of psychiatry (Abingdon, England) 20100101

• Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions.

  International journal of women's health 20100101

• Optimal management of perimenopausal depression.

  International journal of women's health 20100101

• A case of neurotoxic syndrome with the use of long-acting risperidone and subsequent olanzapine and paroxetine.

  Primary care companion to the Journal of clinical psychiatry 20100101

• Depression in primary care: interpersonal counseling vs selective serotonin reuptake inhibitors. The DEPICS Study. A multicenter randomized controlled trial. Rationale and design.

  BMC psychiatry 20100101

• The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder.

  BMC psychiatry 20100101

• Gene expression profiling in whole blood identifies distinct biological pathways associated with obesity.

  BMC medical genomics 20100101

• JULIDE: a software tool for 3D reconstruction and statistical analysis of autoradiographic mouse brain sections.

  PloS one 20100101

• Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities.

  Neuropsychiatric disease and treatment 20100101

• Adding 5-hydroxytryptamine receptor type 3 antagonists may reduce drug-induced nausea in poor insight obsessive-compulsive patients taking off-label doses of selective serotonin reuptake inhibitors: a 52-week follow-up case report.

  Annals of general psychiatry 20100101

• A new strategy for antidepressant prescription.

  Frontiers in neuroscience 20100101

• Advanced Age, Female Gender and Delay in Pacemaker Implantation May Cause TdP in Patients With Complete Atrioventricular Block.

  Indian pacing and electrophysiology journal 20100101

• Complex and multidimensional lipid raft alterations in a murine model of Alzheimer's disease.

  International journal of Alzheimer's disease 20100101

• Controversies in Breast Cancer 2010. Session 6 introduction.

  Breast cancer research : BCR 20100101

• Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?

  Breast cancer research : BCR 20100101

• A population-based case-control study of Selective Serotonin Reuptake Inhibitors (SSRIs) and breast cancer: the impact of duration of use, cumulative dose and latency.

  BMC medicine 20100101

• 3D-QSAR design of new escitalopram derivatives for the treatment of major depressive disorders.

  Scientia pharmaceutica 20100101

• Behavioral and developmental changes in rats with prenatal exposure of mirtazapine.

  Scientia pharmaceutica 20100101

• Prescription drugs associated with reports of violence towards others.

  PloS one 20100101

• [Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder].

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20100101

• Classification of drugs based on properties of sodium channel inhibition: a comparative automated patch-clamp study.

  PloS one 20100101

• Evaluation of degarelix in the management of prostate cancer.

  Cancer management and research 20100101

• The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis.

  Frontiers in neurology 20100101

• New and emerging therapeutic agents for the treatment of fibromyalgia: an update.

  Journal of pain research 20100101

• Gaucher disease: clinical profile and therapeutic developments.

  Biologics : targets & therapy 20100101

• Late-life depression with comorbid cognitive impairment and disability: nonpharmacological interventions.

  Clinical interventions in aging 20100101

• An autopsy case of poisoning with selective serotonin reuptake inhibitor, paroxetine.

  Soudni lekarstvi 20100101

• Effectiveness of pharmaceutical therapy of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults - health technology assessment.

  GMS health technology assessment 20100101

• The geriatric population and psychiatric medication.

  Mens sana monographs 20100101

• Lactating mother and psychotropic drugs.

  Mens sana monographs 20100101

• Of sophists and spin-doctors: industry-sponsored ghostwriting and the crisis of academic medicine.

  Mens sana monographs 20100101

• Agomelatine: A novel melatonergic antidepressant.

  Journal of pharmacology & pharmacotherapeutics 20100101

• Strain-specific battery of tests for domains of mania: effects of valproate, lithium and imipramine.

  Frontiers in psychiatry 20100101

• Association between Genotype of the Serotonin Transporter-Linked Polymorphic Region of the Serotonin Transporter Gene and Age of Onset of Methamphetamine Use: a Preliminary Analysis.

  Frontiers in psychiatry 20100101

• Long-term use of adalimumab in the treatment of moderate to severe plaque psoriasis: a review of the literature.

  Clinical, cosmetic and investigational dermatology 20100101

• Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine.

  Diabetes, metabolic syndrome and obesity : targets and therapy 20100101

• Tackling obesity: new therapeutic agents for assisted weight loss.

  Diabetes, metabolic syndrome and obesity : targets and therapy 20100101

• Antidepressant-associated sexual dysfunction: impact, effects, and treatment.

  Drug, healthcare and patient safety 20100101

• Suicide incidence and epidemiology.

  Indian journal of psychological medicine 20100101

• Post-traumatic stress disorder.

  BMJ clinical evidence 20100101

• Development and validation of stability indicating method for the quantitative determination of venlafaxine hydrochloride in extended release formulation using high performance liquid chromatography.

  Journal of pharmacy & bioallied sciences 20100101

• Research on antidepressants in India.

  Indian journal of psychiatry 20100101

• Development and validation of an ultra performance liquid chromatography method for venlafaxine hydrochloride in bulk and capsule dosage form.

  Indian journal of pharmaceutical sciences 20100101

• Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder.

  International journal of tryptophan research : IJTR 20100101

• Emerging strategies in the treatment of poststroke depression and psychiatric distress in patients.

  Psychology research and behavior management 20100101

• Extreme thermal sensitivity and pain-induced sensitization in a fibromyalgia patient.

  Pain research and treatment 20100101

• The role of funding and policies on innovation in cancer drug development.

  Ecancermedicalscience 20100101

• Paroxetine and neonatal withdrawal syndrome.

  BMJ case reports 20100101

• Brain creatine kinase activity is increased by chronic administration of paroxetine.

  Brain research bulletin 20091216

• Delayed onset of the diurnal melatonin rise in patients with Huntington's disease.

  Journal of neurology 20091201

• Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened.

  Cancer causes & control : CCC 20091201

• Paroxetine may cause increase in carcinoebmryonic antigen (CEA).

  European journal of clinical pharmacology 20091201

• Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins.

  Drug metabolism and disposition: the biological fate of chemicals 20091201

• Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial.

  Diabetes care 20091201

• Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.

  Journal of neural transmission (Vienna, Austria : 1996) 20091201

• Photosensitivity associated with selective serotonin reuptake inhibitors.

  Clinical and experimental dermatology 20091201

• Dialysis-associated increase in the saliva level of paroxetine.

  Journal of clinical psychopharmacology 20091201

• Screening for depression in adult patients in primary care settings: a systematic evidence review.

  Annals of internal medicine 20091201

• Personality change during depression treatment: a placebo-controlled trial.

  Archives of general psychiatry 20091201

• [Efficacy of escitalopram and severity of depression: new data].

  L'Encephale 20091201

• Agomelatine: new drug. Adverse effects and no proven efficacy.

  Prescrire international 20091201

• A new paradigm for the prediction of antidepressant treatment response.

  Dialogues in clinical neuroscience 20091201

• The pNNx Heart Rate Variability Statistics: An Application to Neuroautonomic Dysfunction of Clozapine-Treated Subjects.

  Psychiatry investigation 20091201

• Interactions between tamoxifen and antidepressants via cytochrome P450 2D6.

  The Journal of clinical psychiatry 20091201

• A treatment algorithm for neuropathic pain: an update.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20091201

• Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise.

  Current neuropharmacology 20091201

• Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine.

  Progress in neuro-psychopharmacology & biological psychiatry 20091113

• Determination of antidepressants in human postmortem blood, brain tissue, and hair using gas chromatography-mass spectrometry.

  International journal of legal medicine 20091101

• Depletion of selective serotonin reuptake inhibitors during sewage sludge composting.

  Waste management (New York, N.Y.) 20091101

• Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation.

  Psychopharmacology 20091101

• The role of sodium channels in the mechanism of action of antidepressants and mood stabilizers.

  Current drug targets 20091101

• Use of antidepressants for management of hot flashes.

  Pharmacotherapy 20091101

• Painful diabetic neuropathy: advantage of novel drugs over old drugs?

  Diabetes care 20091101

• Drinking histories in alcohol-use-disordered youth: preliminary findings on relationships to platelet serotonin transporter expression with genotypes of the serotonin transporter.

  Journal of studies on alcohol and drugs 20091101

• [Frequent drug interactions in old age].

  Praxis 20091021

• GlaxoSmithKline told to pay family $2.5m after jury finds paroxetine caused son's heart defects.

  BMJ (Clinical research ed.) 20091015

• GSK is sued in US over alleged link of paroxetine to birth defects.

  BMJ (Clinical research ed.) 20091012

• Physical binding pocket induction for affinity prediction.

  Journal of medicinal chemistry 20091008

• Nitric oxide production and monoamine oxidase activity in cancer patients during interferon-alpha therapy.

  Amino acids 20091001

• Use of anti-depressants and the risk of fracture of the hip or femur.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20091001

• Pharmacogenomics of tamoxifen therapy.

  Clinical chemistry 20091001

• NMDA receptor/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test.

  Psychopharmacology 20091001

• Proapoptotic and chemosensitizing effects of selective serotonin reuptake inhibitors on T cell lymphoma/leukemia (Jurkat) in vitro.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20091001

• Acceptance of and discontinuation rate from paroxetine treatment in patients with lifelong premature ejaculation.

  The journal of sexual medicine 20091001

• Persistent genital arousal disorder (PGAD): case report of long-term symptomatic management with electroconvulsive therapy.

  The journal of sexual medicine 20091001

• Are selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmur.

  Birth defects research. Part A, Clinical and molecular teratology 20091001

• Effects of paroxetine and sertraline on low-density lipoprotein cholesterol: an observational cohort study.

  CNS drugs 20091001

• Accuracy of Veterans Affairs databases for diagnoses of chronic diseases.

  Preventing chronic disease 20091001

• Retrobulbar hematoma associated with selective serotonin reuptake inhibitor: a case report.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20091001

• [Comparative efficacy and acceptability of new-generation antidepressants. Synthesis meta-analysis Cipriani].

  L'Encephale 20091001

• [Pharmaceutical treatment of cancer-associated fatigue--a survey of a Cochrane review].

  Ugeskrift for laeger 20090921

• Paroxetine-induced increase in LDL cholesterol levels.

  Journal of psychopharmacology (Oxford, England) 20090901

• Early prediction of the effectiveness of antidepressants: inputs from an animal model.

  Journal of molecular neuroscience : MN 20090901

• In vitro and in vivo reproduction toxicology of 12 monoaminergic reuptake inhibitors: possible mechanisms of infrequent cardiovascular anomalies.

  Reproductive toxicology (Elmsford, N.Y.) 20090901

• Neural origins of human sickness in interoceptive responses to inflammation.

  Biological psychiatry 20090901

• Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity.

  Biological psychiatry 20090901

• Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice.

  Psychopharmacology 20090901

• Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials.

  Clinical rheumatology 20090901

• Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone.

  Journal of sleep research 20090901

• Role of nitric oxide in obsessive-compulsive behavior and its involvement in the anti-compulsive effect of paroxetine in mice.

  Nitric oxide : biology and chemistry 20090901

• Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine.

  Neuropharmacology 20090901

• Cognitive behavioral therapy versus paroxetine in the treatment of hypochondriasis: an 18-month naturalistic follow-up.

  Journal of behavior therapy and experimental psychiatry 20090901

• Antidepressant medication use during breastfeeding.

  Clinical obstetrics and gynecology 20090901

• The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists.

  Obstetrics and gynecology 20090901

• Pharmacotherapy treatment of PTSD and comorbid disorders.

  Psychiatria Danubina 20090901

• Influence of the media on women taking antidepressants during pregnancy.

  The Journal of clinical psychiatry 20090901

• Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression.

  Dialogues in clinical neuroscience 20090901

• The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders--relation to drug treatment.

  Dialogues in clinical neuroscience 20090901

• Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship.

  Central nervous system agents in medicinal chemistry 20090901

• History of depressive and/or anxiety disorders as a predictor of treatment response: a post hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release in patients with fibromyalgia.

  Progress in neuro-psychopharmacology & biological psychiatry 20090831

• Expression and association analyses of promoter variants of the neurogenic gene HES6, a candidate gene for mood disorder susceptibility and antidepressant response.

  Neuroscience letters 20090828

• A sleepy patient with REM rebound.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20090815

• 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.

  Neuroreport 20090805

• Lipidomic analyses of the mouse brain after antidepressant treatment: evidence for endogenous release of long-chain fatty acids?

  The international journal of neuropsychopharmacology 20090801

• Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice.

  The international journal of neuropsychopharmacology 20090801

• Sex influences the effect of a lifelong increase in serotonin transporter function on cerebral metabolism.

  Journal of neuroscience research 20090801

• Sensitivity of the Montgomery Asberg Depression Rating Scale to response and its consequences for the assessment of efficacy.

  Journal of psychiatric research 20090801

• Antidepressant-like effects of paroxetine are produced by lower doses than those which produce nausea.

  Pharmacology, biochemistry, and behavior 20090801

• Is psychopharmacologic treatment associated with neuropsychological deficits in bipolar youth?

  The Journal of clinical psychiatry 20090801

• Influence of antidepressant use on glycemic control in patients with diabetes mellitus: an open-label comparative study.

  Journal of clinical psychopharmacology 20090801

• Comments on 'An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder'.

  Journal of clinical psychopharmacology 20090801

• Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients.

  Human psychopharmacology 20090801

• TORDIA: unique opportunity to explore half-life theory.

  The American journal of psychiatry 20090801

• Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders.

  Expert review of neurotherapeutics 20090801

• Serotonin toxicity caused by moclobemide too soon after paroxetine-selegiline.

  Journal of the Chinese Medical Association : JCMA 20090801

• Fibromyalgia: poorly understood; treatments are disappointing.

  Prescrire international 20090801

• Agomelatine: a novel pharmacological approach to treating depression.

  Drugs of today (Barcelona, Spain : 1998) 20090801

• Compounding risks to patients: selective disclosure is not an option.

  The American journal of bioethics : AJOB 20090801

• Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance.

  Current cardiology reviews 20090801

• Rapid HPLC method for the simultaneous monitoring of duloxetine, venlaflaxine, fluoxetine and paroxetine in biofluids.

  Bioanalysis 20090801

• Fluoxetine (Prozac) binding to serotonin transporter is modulated by chloride and conformational changes.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20090729

• Fast separation of selective serotonin reuptake inhibitors antidepressants in plasma sample by nonaqueous capillary electrophoresis.

  Journal of chromatography. A 20090724

• The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease.

  Movement disorders : official journal of the Movement Disorder Society 20090715

• Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.

  Psychiatry research 20090715

• Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder.

  European journal of clinical pharmacology 20090701

• Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090701

• Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine.

  Psychopharmacology 20090701

• Pindolol augmentation enhances response outcomes in first depressive episodes.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090701

• Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.

  Neuroscience research 20090701

• Delirium in a patient with toxic flecainide plasma concentrations: the role of a pharmacokinetic drug interaction with paroxetine.

  The Annals of pharmacotherapy 20090701

• Central regulation of ejaculation and the therapeutic role of serotonergic agents in premature ejaculation.

  Current opinion in investigational drugs (London, England : 2000) 20090701

• The effects of paroxetine on the pharmacokinetics of paliperidone extended-release tablets.

  Pharmacopsychiatry 20090701

• An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.

  Current oncology (Toronto, Ont.) 20090701

• Safety of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.

  Current oncology (Toronto, Ont.) 20090701

• Lessons continue: serotonin toxicity.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20090701

• Challenges in the identification and management of HSDD.

  The Journal of family practice 20090701

• Comparison of antidepressant effects of azafan, tianeptine, and paroxetine.

  Bulletin of experimental biology and medicine 20090701

• Hyponatremic brain edema: correlation with serial computed tomography scans.

  The Israel Medical Association journal : IMAJ 20090701

• Enantioseparation of paroxetine intermediate on an amylose-derived chiral stationary phase by supercritical fluid chromatography.

  Journal of chromatography. A 20090626

• Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090610

• Neuroimaging in anxiety disorders.

  Journal of neural transmission (Vienna, Austria : 1996) 20090601

• The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders.

  Journal of neural transmission (Vienna, Austria : 1996) 20090601

• Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons.

  The international journal of neuropsychopharmacology 20090601

• Serotonin augmentation reduces response to attack in aggressive individuals.

  Psychological science 20090601

• A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.

  The Journal of clinical psychiatry 20090601

• Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.

  Journal of clinical psychopharmacology 20090601

• Aripiprazole augmentation for a patient with partial remission of panic disorder.

  Journal of clinical psychopharmacology 20090601

• [Two years' experience in a specific autonomic nervous system service].

  Revista de neurologia 20090601

• The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration.

  Journal of neurochemistry 20090601

• Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development.

  Xenobiotica; the fate of foreign compounds in biological systems 20090601

• [Indications for crenotherapy].

  L'Encephale 20090601

• Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.

  Clinical therapeutics 20090601

• Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.

  Clinical therapeutics 20090601

• Treatment with selective serotonin reuptake inhibitors and mirtapazine results in differential brain activation by visual erotic stimuli in patients with major depressive disorder.

  Psychiatry investigation 20090601

• 5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials.

  Journal of clinical medicine research 20090601

• A pilot study of impulsivity and compulsivity in pathological gambling.

  Psychiatry research 20090515

• Gender differences in the association between antidepressant use and restless legs syndrome.

  Movement disorders : official journal of the Movement Disorder Society 20090515

• 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients.

  Psychiatry research 20090515

• Sociodemographic correlates of antidepressant utilisation in Australia.

  The Medical journal of Australia 20090504

• Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.

  Journal of affective disorders 20090501

• Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin.

  Biological psychiatry 20090501

• Running wheel activity is sensitive to acute treatment with selective inhibitors for either serotonin or norepinephrine reuptake.

  Psychopharmacology 20090501

• Clavulanic acid stimulates sexual behaviour in male rats.

  European journal of pharmacology 20090501

• Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus.

  The American journal of psychiatry 20090501

• Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?

  International clinical psychopharmacology 20090501

• Polymorphisms of sepiapterin reductase gene alter promoter activity and may influence risk of bipolar disorder.

  Pharmacogenetics and genomics 20090501

• [Frontotemporal dementia: neurotransmitter and clinical symptoms with focus on therapeutic targets].

  Fortschritte der Neurologie-Psychiatrie 20090501

• Post-operative nystagmus and anisocoria due to serotonin toxicity?

  Acta anaesthesiologica Scandinavica 20090501

• Inhibitory effect of selective serotonin reuptake inhibitors on the vesicular monoamine transporter 2.

  Neuroscience letters 20090501

• Placental transfer of SSRI and SNRI antidepressants and effects on the neonate.

  Pharmacopsychiatry 20090501

• Sertraline in the treatment of panic disorder.

  Drugs of today (Barcelona, Spain : 1998) 20090501

• [Kallmann syndrome--a form of hypogonadotropic hypogonadism].

  Deutsche medizinische Wochenschrift (1946) 20090501

• Selective serotonin reuptake inhibitors for premenstrual syndrome.

  The Cochrane database of systematic reviews 20090415

• Sertraline versus other antidepressive agents for depression.

  The Cochrane database of systematic reviews 20090415

• Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: a pharmacological characterization.

  Psychopharmacology 20090401

• Methylphenidate restores link between stop-signal sensory impact and successful stopping in adults with attention-deficit/hyperactivity disorder.

  Biological psychiatry 20090401

• The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.

  European archives of psychiatry and clinical neuroscience 20090401

• Effects of acute alcohol intoxication and paroxetine on aggression in men.

  Alcoholism, clinical and experimental research 20090401

• Superiority of escitalopram to paroxetine in the treatment of depression.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090401

• Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.

  The American journal of psychiatry 20090401

• Baseline severity of depression predicts antidepressant drug response relative to escitalopram.

  Expert opinion on pharmacotherapy 20090401

• Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20090401

• High-dose paroxetine treatment for an adolescent with obsessive-compulsive disorder comorbid with Asperger's disorder.

  Psychiatry and clinical neurosciences 20090401

• [Severe forms of depression: the efficacy of escitalopram].

  L'Encephale 20090401

• Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.

  CNS spectrums 20090401

• Antidepressant-associated myoclonic status in a patient with symptomatic generalized epilepsy: does risk occur with therapeutic doses?

  Epilepsy & behavior : E&B 20090401

• Use of drugs that act on the cytochrome P450 system in the elderly.

  Clinics (Sao Paulo, Brazil) 20090401

• Big interest in heavy drugs.

  Nature 20090319

• A controlled trial of antidepressants in patients with Parkinson disease and depression.

  Neurology 20090310

• Intracerebroventricular infusion of cytosine-arabinoside causes prepulse inhibition disruption.

  Neuroreport 20090304

• Evidence why paroxetine dose escalation is not effective in major depressive disorder: a randomized controlled trial with assessment of serotonin transporter occupancy.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090301

• The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting.

  Psychopharmacology 20090301

• Evaluation of risk factors for elevated tricyclic antidepressant plasma concentrations.

  Pharmacoepidemiology and drug safety 20090301

• Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.

  Journal of the American Academy of Child and Adolescent Psychiatry 20090301

• Solid-phase microextraction using poly(pyrrole) film and liquid chromatography with UV detection for analysis of antidepressants in plasma samples.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090301

• Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.

  The Journal of clinical psychiatry 20090301

• Olanzapine treatment in anorexia nervosa: case report.

  Psychiatria Danubina 20090301

• An imperfect literature and evidence-based medicine.

  The Journal of clinical psychiatry 20090301

• Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States.

  Clinical therapeutics 20090301

• Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element.

  International journal of molecular sciences 20090301

• Psychoactive medication and traffic safety.

  International journal of environmental research and public health 20090301

• [Efficacy and safety of selective serotonin re-uptake inhibitors in the treatment of premature ejaculation: a systematic evaluation].

  Zhonghua nan ke xue = National journal of andrology 20090301

• Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.

  Lancet (London, England) 20090227

• Changes in circulating cytokine levels in midlife women with psychological symptoms with selective serotonin reuptake inhibitor and Japanese traditional medicine.

  Maturitas 20090220

• Polydimethylsiloxane/polypyrrole stir bar sorptive extraction and liquid chromatography (SBSE/LC-UV) analysis of antidepressants in plasma samples.

  Analytica chimica acta 20090202

• Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy.

  The pharmacogenomics journal 20090201

• Binding of paroxetine to the serotonin transporter in membranes from different cells, subcellular fractions and species.

  Neurochemical research 20090201

• Short onset of action of a serotonin reuptake inhibitor when used to reduce premenstrual irritability.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090201

• An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts.

  Tobacco control 20090201

• 5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor.

  Neuropharmacology 20090201

• Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).

  Journal of psychiatric research 20090201

• The effects of desvenlafaxine and paroxetine on the pharmacokinetics of the cytochrome P450 2D6 substrate desipramine in healthy adults.

  Journal of clinical pharmacology 20090201

• Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis.

  Progress in neuro-psychopharmacology & biological psychiatry 20090201

• Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database.

  Therapeutic drug monitoring 20090201

• Childhood abuse and treatment response in patients with irritable bowel syndrome: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.

  Journal of clinical pharmacy and therapeutics 20090201

• Should adjunctive antipsychotic treatment be continued in remitted patients with depression?

  Psychiatry and clinical neurosciences 20090201

• Seroxat and the suppression of clinical trial data: regulatory failure and the uses of legal ambiguity.

  Journal of medical ethics 20090201

• Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review.

  Advances in therapy 20090201

• Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes.

  Pediatric research 20090201

• Real-World Data on SSRI Antidepressant Side Effects.

  Psychiatry (Edgmont (Pa. : Township)) 20090201

• Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression: a randomized, placebo-controlled study.

  Psychiatry research 20090130

• A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Clinical cough VI: the need for new therapies for cough: disease-specific and symptom-related antitussives.

  Handbook of experimental pharmacology 20090101

• Chronic social stress during adolescence in mice alters fat distribution in late life: prevention by antidepressant treatment.

  Stress (Amsterdam, Netherlands) 20090101

• Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder.

  Pharmacogenetics and genomics 20090101

• Effects of intrathecal administration of newer antidepressants on mechanical allodynia in rat models of neuropathic pain.

  Neuroscience research 20090101

• An open-label, noncomparative, dose escalation pilot study of the effect of paroxetine in treatment of burning mouth syndrome.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20090101

• Altered functioning of the executive control circuit in late-life depression: episodic and persistent phenomena.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20090101

• Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial.

  The Journal of clinical psychiatry 20090101

• Headache and hormone replacement therapy in the postmenopausal woman.

  Current treatment options in neurology 20090101

• Depression in patients with heart failure: clinical implications and management.

  Pharmacotherapy 20090101

• Insulin-like growth factor-I (IGF-I) serum concentrations in depressed patients: relationship to saliva cortisol and changes during antidepressant treatment.

  Pharmacopsychiatry 20090101

• The risks and benefits of switching antipsychotics: a case study approach.

  Perspectives in psychiatric care 20090101

• An analysis of correlations among four outcome scales employed in clinical trials of patients with major depressive disorder.

  Annals of general psychiatry 20090101

• Development of 5-HT transporter density and long-term effects of methylphenidate in an animal model of ADHD.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Current considerations in the treatment of generalized anxiety disorder.

  CNS drugs 20090101

• Breast cancer in young women and its impact on reproductive function.

  Human reproduction update 20090101

• The combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depression.

  PloS one 20090101

• Frontotemporal dementia: therapeutic interventions.

  Frontiers of neurology and neuroscience 20090101

• The Pediatric Obsessive-Compulsive Disorder Treatment Study II: rationale, design and methods.

  Child and adolescent psychiatry and mental health 20090101

• Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study.

  Acta dermato-venereologica 20090101

• Neuropsychological functioning in patients with posttraumatic stress disorder following short-term paroxetine treatment.

  Psychopharmacology bulletin 20090101

• Escitalopram in the treatment of major depressive disorder: a meta-analysis.

  Current medical research and opinion 20090101

• High worry severity is associated with poorer acute and maintenance efficacy of antidepressants in late-life depression.

  Depression and anxiety 20090101

• A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome.

  Psychosomatics 20090101

• Treatment of social anxiety with paroxetine: mediation of changes in anxiety and depression symptoms.

  Comprehensive psychiatry 20090101

• Clinical evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A): a new instrument to assess the onset of symptomatic improvement in generalized anxiety disorder.

  CNS neuroscience & therapeutics 20090101

• Transcranial magnetic stimulation, synaptic plasticity and network oscillations.

  Journal of neuroengineering and rehabilitation 20090101

• Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs.

  BMC clinical pharmacology 20090101

• Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study.

  Journal of the American Medical Informatics Association : JAMIA 20090101

• A case study of delayed serotonin syndrome: lessons learned.

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20090101

• Panic disorder: is the PAG involved?

  Neural plasticity 20090101

• Selective serotonin reuptake inhibitor-induced akathisia.

  Journal of the American Pharmacists Association : JAPhA 20090101

• Assessing the efficiency of mixed effects modelling in quantifying metabolism based drug-drug interactions: using in vitro data as an aid to assess study power.

  Pharmaceutical statistics 20090101

• Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD).

  Trials 20090101

• A hypomorphic vasopressin allele prevents anxiety-related behavior.

  PloS one 20090101

• Drug monitoring in child and adolescent psychiatry for improved efficacy and safety of psychopharmacotherapy.

  Child and adolescent psychiatry and mental health 20090101

• Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology.

  PloS one 20090101

• Reliability and validity of the self-report version of the Panic Disorder Severity Scale in Korea.

  Depression and anxiety 20090101

• What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia?

  Comprehensive psychiatry 20090101

• Age distribution and gender differences in psychogenic fever patients.

  BioPsychoSocial medicine 20090101

• History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101

• Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief.

  Molecular pain 20090101

• Sequestered evidence and the distortion of clinical practice guidelines.

  Perspectives in biology and medicine 20090101

• Differential stress-induced neuronal activation patterns in mouse lines selectively bred for high, normal or low anxiety.

  PloS one 20090101

• Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine.

  BMC emergency medicine 20090101

• Toxic epidermal necrolysis associated with paroxetine.

  General hospital psychiatry 20090101

• Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA.

  Drug safety 20090101

• Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada.

  BMJ (Clinical research ed.) 20090101

• Melatonin receptor agonist agomelatine: a new drug for treating unipolar depression.

  Current pharmaceutical design 20090101

• Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

  Paediatric drugs 20090101

• Depression in children and adolescents.

  BMJ clinical evidence 20090101

• Obsessive-compulsive disorder and related disorders: a comprehensive survey.

  Annals of general psychiatry 20090101

• Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue.

  BMC gastroenterology 20090101

• Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI.

  Journal of sex & marital therapy 20090101

• A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study.

  BMC psychiatry 20090101

• The self-reported Montgomery-Asberg Depression Rating Scale is a useful evaluative tool in Major Depressive Disorder.

  BMC psychiatry 20090101

• A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder.

  BMC psychiatry 20090101

• Factors Influencing Depression Endpoints Research (FINDER): baseline results of Italian patients with depression.

  Annals of general psychiatry 20090101

• Protocol for investigating genetic determinants of posttraumatic stress disorder in women from the Nurses' Health Study II.

  BMC psychiatry 20090101

• The posttraumatic stress disorder project in Brazil: neuropsychological, structural and molecular neuroimaging studies in victims of urban violence.

  BMC psychiatry 20090101

• Improvement of selective serotonin reuptake inhibitor-induced sexual dysfunction without worsening of depressive symptom after switching to milnacipran.

  Clinical neuropharmacology 20090101

• Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders.

  CNS neuroscience & therapeutics 20090101

• Stepped care for depression and anxiety: from primary care to specialized mental health care: a randomised controlled trial testing the effectiveness of a stepped care program among primary care patients with mood or anxiety disorders.

  BMC health services research 20090101

• Late life depression with cognitive impairment: evaluation and treatment.

  Clinical interventions in aging 20090101

• Persistence and compliance to antidepressant treatment in patients with depression: a chart review.

  BMC psychiatry 20090101

• Aripiprazole in the treatment of Huntington's disease: a case series.

  Neuropsychiatric disease and treatment 20090101

• Duloxetine for the treatment of generalized anxiety disorder: a review.

  Neuropsychiatric disease and treatment 20090101

• Emerging treatments for premature ejaculation: focus on dapoxetine.

  Neuropsychiatric disease and treatment 20090101

• Desvenlafaxine in the treatment of major depressive disorder.

  Neuropsychiatric disease and treatment 20090101

• Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patients.

  Neuropsychiatric disease and treatment 20090101

• Psychopharmacology of ADHD in pediatrics: current advances and issues.

  Neuropsychiatric disease and treatment 20090101

• Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review.

  Neuropsychiatric disease and treatment 20090101

• Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group).

  Neuropsychiatric disease and treatment 20090101

• Update on the management of symptoms in schizophrenia: focus on amisulpride.

  Neuropsychiatric disease and treatment 20090101

• Management of obsessive-compulsive disorder with fluvoxamine extended release.

  Neuropsychiatric disease and treatment 20090101

• A novel flow cytometric high throughput assay for a systematic study on molecular mechanisms underlying T cell receptor-mediated integrin activation.

  PloS one 20090101

• Gluten encephalopathy with psychiatric onset: case report.

  Clinical practice and epidemiology in mental health : CP & EMH 20090101

• [Major depressive disorder, antidepressants and sexual dysfunction].

  Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater 20090101

• Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adults.

  BMC medical imaging 20090101

• Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues.

  Neuropsychiatric disease and treatment 20090101

• Depression during pregnancy: views on antidepressant use and information sources of general practitioners and pharmacists.

  BMC health services research 20090101

• Investigating the efficacy of paroxetine in developmental stuttering.

  Clinical neuropharmacology 20090101

• Revisiting the effectiveness of standard antidepressants in bipolar disorder: are monoamine oxidase inhibitors superior?

  Psychopharmacology bulletin 20090101

• Prognostic and diagnostic potential of the structural neuroanatomy of depression.

  PloS one 20090101

• Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review.

  Annals of general psychiatry 20090101

• Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder.

  BMC geriatrics 20090101

• Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression.

  Neuropsychiatric disease and treatment 20090101

• Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration.

  BMJ (Clinical research ed.) 20090101

• Adverse effects of androgen deprivation therapy in prostate cancer: Current management issues.

  Indian journal of urology : IJU : journal of the Urological Society of India 20090101

• The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists.

  General hospital psychiatry 20090101

• Extracorporeal life support in severe drug intoxication: a retrospective cohort study of seventeen cases.

  Critical care (London, England) 20090101

• Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir.

  Therapeutics and clinical risk management 20090101

• Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature.

  Biologics : targets & therapy 20090101

• Psychoeducation versus treatment as usual in diabetic patients with subthreshold depression: preliminary results of a randomized controlled trial.

  Trials 20090101

• Chronic citalopram administration causes a sustained suppression of serotonin synthesis in the mouse forebrain.

  PloS one 20090101

• Interactions between herbal medicines and prescribed drugs: an updated systematic review.

  Drugs 20090101

• Brain-derived neurotrophic factor: role in depression and suicide.

  Neuropsychiatric disease and treatment 20090101

• Impaired prefrontal hemodynamic maturation in autism and unaffected siblings.

  PloS one 20090101

• Narcolepsy and psychotic states--a case report.

  The Israel journal of psychiatry and related sciences 20090101

• Mean and variability of QT-interval: Relevance to psychiatric illness and psychotropic medication.

  Indian journal of psychiatry 20090101

• More questions than answers! Clinical dilemmas in psychopharmacology in pregnancy and lactation.

  Indian journal of psychiatry 20090101

• Effect of cytochrome P450 2D6 genotype on maternal paroxetine plasma concentrations during pregnancy.

  Clinical pharmacokinetics 20090101

• Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia.

  Clinical interventions in aging 20090101

• Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study.

  BMJ (Clinical research ed.) 20090101

• Drugs associated with more suicidal ideations are also associated with more suicide attempts.

  PloS one 20090101

• The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.

  Depression and anxiety 20090101

• Benzodiazepine prescription and length of hospital stay at a Japanese university hospital.

  BioPsychoSocial medicine 20090101

• Serotonin reuptake inhibitor and fluvoxamine-induced severe hyponatremia in a 49-year-old man.

  Case reports in medicine 20090101

• Psychogenic nonepileptic seizures after head injury: a case report.

  Case reports in medicine 20090101

• Surgical treatment of obsessive compulsive disorders: Current status.

  Indian journal of psychiatry 20090101

• Postgraduate corner: Continuing medical education: Psychopharmacology.

  Indian journal of psychiatry 20090101

• Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis.

  Therapeutics and clinical risk management 20090101

• New nonextractive and highly sensitive high-performance liquid chromatographic method for determination of paroxetine in plasma after offline precolumn derivatization with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole.

  Journal of AOAC International 20090101

• Single prolonged stress: toward an animal model of posttraumatic stress disorder.

  Depression and anxiety 20090101

• Indiplon in the management of insomnia.

  Drug design, development and therapy 20090101

• Algorithms for the assessment and management of insomnia in primary care.

  Patient preference and adherence 20090101

• Predictors of premature discontinuation of treatment in multiple disease states.

  Patient preference and adherence 20090101

• Persistent orocutaneous and anal fistulae induced by nicorandil: a case report.

  Journal of medical case reports 20090101

• Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability.

  Therapeutics and clinical risk management 20090101

• Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults.

  Neuropsychiatric disease and treatment 20090101

• Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety.

  Behavioral and brain functions : BBF 20090101

• Obsessive-compulsive disorder following cavernous sinus thrombosis.

  The Journal of neuropsychiatry and clinical neurosciences 20090101

• Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptors.

  Annals of general psychiatry 20090101

• Possible Role of Platelet GluR1 Receptors in Comorbid Depression and Cardiovascular Disease.

  Cardiovascular psychiatry and neurology 20090101

• Desvenlafaxine.

  Indian journal of psychiatry 20090101

• [SSRI discontinuation syndrome: incidence and differences on three groups of patients treated with paroxetine].

  Rivista di psichiatria 20090101

• [SSRI antidepressants and negative schizophrenic symptoms: differences between paroxetine and fluvoxamine in patients treated with olanzapine].

  Rivista di psichiatria 20090101

• [Sibutramine-related panic attack: a clinical case of apparent resolution with paroxetine].

  Rivista di psichiatria 20090101

• Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality.

  Cardiology research and practice 20090101

• Simple spectrophotometric method for determination of paroxetine in tablets using 1,2-naphthoquinone-4-sulphonate as a chromogenic reagent.

  International journal of analytical chemistry 20090101

• New spectrophotometric and fluorimetric methods for determination of fluoxetine in pharmaceutical formulations.

  International journal of analytical chemistry 20090101

• Antidepressant drugs for chronic urological pelvic pain: an evidence-based review.

  Advances in urology 20090101

• Spectroscopic and electrochemical analysis of psychotropic drugs.

  Indian journal of pharmaceutical sciences 20090101

• High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period.

  Neural plasticity 20090101

• [Extinction of emotional response as a novel approach of pharmacotherapy of anxiety disorders].

  Psychiatria polska 20090101

• [Wind phobia (ancraophobia)--as an example of simple phobia. The case report].

  Psychiatria polska 20090101

• Duloxetine in the treatment of generalized anxiety disorder.

  International journal of general medicine 20090101

• Simultaneous RP-HPLC and HPTLC Estimation of Fluoxetine Hydrochloride and Olanzapine in Tablet Dosage Forms.

  Indian journal of pharmaceutical sciences 20090101

• Neurobiology of inflammation-associated anorexia.

  Frontiers in neuroscience 20090101

• Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy.

  Core evidence 20090101

• Agomelatine: The evidence for its place in the treatment of depression.

  Core evidence 20090101

• The ABCB1 transporter gene and antidepressant response.

  F1000 biology reports 20090101

• Monoamines, BDNF, Dehydroepiandrosterone, DHEA-Sulfate, and Childhood Depression-An Animal Model Study.

  Advances in pharmacological sciences 20090101

• Ixabepilone: a new treatment option for the management of taxane-resistant metastatic breast cancer.

  Cancer management and research 20090101

• Behavioral and psychological symptoms of dementia and their management.

  Indian journal of psychiatry 20090101

• The impact of biologics on health-related quality of life in patients with inflammatory bowel disease.

  Clinical and experimental gastroenterology 20090101

• Neuroanatomical, neurochemical, and neurodevelopmental basis of obsessive-compulsive symptoms in schizophrenia.

  Indian journal of psychological medicine 20090101

• Lower side effects of milnacipran than paroxetine in the treatment of major depression disorder among Han Chinese in Taiwan.

  The Chinese journal of physiology 20081231

• Interaction of zinc with antidepressants in the tail suspension test.

  Progress in neuro-psychopharmacology & biological psychiatry 20081212

• Reduced efficacy of fluoxetine following MDMA ('Ecstasy')-induced serotonin loss in rats.

  Progress in neuro-psychopharmacology & biological psychiatry 20081212

• Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20081201

• Comparative study of the inhibitory effect of antidepressants on cholinesterase activity in Bungarus sindanus (krait) venom, human serum and rat striatum.

  Journal of enzyme inhibition and medicinal chemistry 20081201

• Is co-administration of bupropion with SSRIs and SNRIs in forced swimming test in mice, predictive of efficacy in resistant depression?

  Behavioural brain research 20081201

• Selective serotonin re-uptake inhibitor warnings and trends in exposures reported to poison control centres in Texas.

  Public health 20081201

• Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety.

  Acta psychiatrica Scandinavica 20081201

• Flesinoxan challenge suggests that chronic treatment with paroxetine in rats does not desensitize receptors controlling 5-HT synthesis.

  Neurochemistry international 20081201

• The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20081201

• Antidepressants targeting the serotonin reuptake transporter act via a competitive mechanism.

  The Journal of pharmacology and experimental therapeutics 20081201

• Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API).

  Journal of pharmaceutical and biomedical analysis 20081201

• Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism.

  Journal of thrombosis and haemostasis : JTH 20081201

• An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

  Journal of clinical psychopharmacology 20081201

• Agomelatine treatment of major depressive disorder.

  The Annals of pharmacotherapy 20081201

• Pharmacogenetics and the serotonin transporter in late-life depression.

  Expert opinion on drug metabolism & toxicology 20081201

• Clinical evaluation of paroxetine in post-traumatic stress disorder (PTSD): 52-week, non-comparative open-label study for clinical use experience.

  Psychiatry and clinical neurosciences 20081201

• A pilot pharmacotherapy trial for depressed youths at high genetic risk for bipolarity.

  Journal of child and adolescent psychopharmacology 20081201

• Re: alcohol and pregnancy: the pivotal role of the obstetrician.

  The Australian & New Zealand journal of obstetrics & gynaecology 20081201

• Treatment strategies to improve and sustain remission in major depressive disorder.

  Dialogues in clinical neuroscience 20081201

• Cellular and molecular mechanisms in the long-term action of antidepressants.

  Dialogues in clinical neuroscience 20081201

• Pharmacogenomic strategy for individualizing antidepressant therapy.

  Dialogues in clinical neuroscience 20081201

• Toward achieving optimal response: understanding and managing antidepressant side effects.

  Dialogues in clinical neuroscience 20081201

• Incomplete response in late-life depression: getting to remission.

  Dialogues in clinical neuroscience 20081201

• Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder.

  Dialogues in clinical neuroscience 20081201

• Incomplete remission in depression: role of psychiatric and somatic comorbidity.

  Dialogues in clinical neuroscience 20081201

• Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications.

  Dialogues in clinical neuroscience 20081201

• Newer treatments for fibromyalgia syndrome.

  Therapeutics and clinical risk management 20081201

• Treatment options and patient perspectives in the management of fibromyalgia: future trends.

  Neuropsychiatric disease and treatment 20081201

• Duloxetine in the treatment of generalized anxiety disorder.

  Neuropsychiatric disease and treatment 20081201

• New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine.

  Neuropsychiatric disease and treatment 20081201

• Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes.

  Neuropsychiatric disease and treatment 20081201

• Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure.

  Current neuropharmacology 20081201

• Tianeptine: an antidepressant with memory-protective properties.

  Current neuropharmacology 20081201

• Pharmacology and therapeutic potential of sigma(1) receptor ligands.

  Current neuropharmacology 20081201

• Antidepressant prescribing by specialty and treatment of premenstrual dysphoric disorder.

  Psychiatry (Edgmont (Pa. : Township)) 20081201

• Pain, pain, go away: antidepressants and pain management.

  Psychiatry (Edgmont (Pa. : Township)) 20081201

• Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians.

  Annals of internal medicine 20081118

• Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians.

  Annals of internal medicine 20081118

• Fatigue: an overview.

  American family physician 20081115

• Epileptic seizures but not pseudoseizures are associated with decreased density of the serotonin transporter in blood platelet membranes.

  Neurochemical research 20081101

• In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain.

  Neurochemical research 20081101

• A controlled evaluation of monthly maintenance interpersonal psychotherapy in late-life depression with varying levels of cognitive function.

  International journal of geriatric psychiatry 20081101

• Restless legs syndrome as side effect of second generation antidepressants.

  Journal of psychiatric research 20081101

• Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant action.

  Journal of molecular neuroscience : MN 20081101

• Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine.

  Psychopharmacology 20081101

• Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D6*10 allele in healthy Korean subjects.

  British journal of clinical pharmacology 20081101

• Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.

  British journal of clinical pharmacology 20081101

• Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder.

  International journal of clinical practice 20081101

• Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.

  Neuropharmacology 20081101

• Mechanism of paroxetine-induced cell death in renal tubular cells.

  Basic & clinical pharmacology & toxicology 20081101

• Should paroxetine be used to treat depression during pregnancy?

  The American journal of psychiatry 20081101

• Paroxetine: safety and tolerability issues.

  Expert opinion on drug safety 20081101

• Effect of desvenlafaxine on the cytochrome P450 2D6 enzyme system.

  Journal of psychiatric practice 20081101

• Clitoral priapism with no known risk factors.

  The western journal of emergency medicine 20081101

• Using cation-selective exhaustive injection and sweeping micellar electrokinetic chromatography to determine selective serotonin reuptake inhibitors.

  Journal of chromatography. A 20081031

• A fatal case due to combined toxicity of psychotropic drugs.

  Forensic science international 20081025

• Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission.

  European journal of pharmacology 20081010

• Strain differences in paroxetine-induced reduction of immobility time in the forced swimming test in mice: role of serotonin.

  European journal of pharmacology 20081010

• Maternal para-chlorophenylalanine exposure modifies central monoamines and behaviors in the adult offspring.

  Brain research 20081009

• Development and evaluation of the Daily Assessment of Symptoms - Anxiety (DAS-A) scale to evaluate onset of symptom relief in patients with generalized anxiety disorder.

  Journal of psychiatric research 20081001

• Sensitivity of the individual items of the Hamilton depression rating scale to response and its consequences for the assessment of efficacy.

  Journal of psychiatric research 20081001

• Relationship of the serotonin transporter with prolactin response to meta-chlorophenylpiperazine in cocaine dependence.

  Journal of psychiatric research 20081001

• Evaluation of treatment response in depression studies using a Bayesian parametric cure rate model.

  Journal of psychiatric research 20081001

• Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20081001

• Calcium/calmodulin-dependent kinase II regulates the interaction between the serotonin transporter and syntaxin 1A.

  Neuropharmacology 20081001

• Impact of multiple inhibitors or substrates of cytochrome P450 2D6 on plasma risperidone levels in patients on polypharmacy.

  Therapeutic drug monitoring 20081001

• A 60-year-old woman with mild memory impairment: review of mild cognitive impairment.

  JAMA 20081001

• Catatonic features in major depression relieved by electroconvulsive treatment: parallel evaluation of the status of platelet serotonin transporter.

  The International journal of neuroscience 20081001

• Effectiveness of a multifactorial cardiovascular risk reduction clinic for diabetes patients with depression.

  Preventing chronic disease 20081001

• The alpha 2A-adrenergic receptor gene polymorphism modifies antidepressant responses to milnacipran.

  Journal of clinical psychopharmacology 20081001

• Nocturnal enuresis after paroxetine abrupt discontinuation: a case report.

  Journal of clinical psychopharmacology 20081001

• Primary care management of major depression in patients aged > or =55 years: outcome of a randomised clinical trial.

  The British journal of general practice : the journal of the Royal College of General Practitioners 20081001

• Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants.

  Psychiatric services (Washington, D.C.) 20081001

• [Paroxetine-induced severe hyponatremic rhabdomyolisis].

  Medicina intensiva 20081001

• Pharmacologic treatment options for cancer-related fatigue: current state of clinical research.

  Clinical journal of oncology nursing 20081001

• The relationships of leptin, adiponectin levels and paraoxonase activity with metabolic and cardiovascular risk factors in females treated with psychiatric drugs.

  Clinics (Sao Paulo, Brazil) 20081001

• Unusual weight fluctuation under corticosteroid and psychotropic treatment.

  Psychiatry and clinical neurosciences 20081001

• Nature against nurture: calcification in the right thalamus in a young man with anorexia nervosa and obsessive-compulsive personality disorder.

  CNS spectrums 20081001

• Comparison of drug concentrations taken from clamped and unclamped femoral vessels.

  Journal of analytical toxicology 20081001

• [Sleep spindles in post traumatic stress disorder: significant importance of selective serotonin reuptake inhibitors].

  Harefuah 20081001

• Attention-deficit-hyperactivity disorder and reward deficiency syndrome.

  Neuropsychiatric disease and treatment 20081001

• Augmentation treatment in major depressive disorder: focus on aripiprazole.

  Neuropsychiatric disease and treatment 20081001

• The efficacy of mirtazapine in agitated patients with Alzheimer's disease: A 12-week open-label pilot study.

  Neuropsychiatric disease and treatment 20081001

• Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis.

  The Journal of clinical psychiatry 20081001

• Neuropharmacology.

  Indian journal of pharmacology 20081001

• [Upper gastrointestinal bleeding associated with clopidogrel and paroxetine].

  Medicina clinica 20080920

• A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome.

  Arthritis and rheumatism 20080915

• Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.

  Bioorganic & medicinal chemistry letters 20080915

• [Aquagenic pruritus from polycythaemia vera--treatment with paroxetine, a selective serotonin reuptake inhibitor].

  Ugeskrift for laeger 20080915

• Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression.

  European journal of pharmacology 20080911

• An automated, high-throughput, 384 well Cytochrome P450 cocktail IC50 assay using a rapid resolution LC-MS/MS end-point.

  Journal of pharmaceutical and biomedical analysis 20080910

• LC-MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma. Study of correlation between venlafaxine concentrations in both matrices.

  Journal of pharmaceutical and biomedical analysis 20080910

• beta-adrenoceptor affinity as a biological predictor of treatment response to paroxetine in patients with acute panic disorder.

  Journal of affective disorders 20080901

• Acute hepatitis associated with use of paroxetine.

  Internal and emergency medicine 20080901

• Breastfeeding and antidepressants.

  Infant behavior & development 20080901

• Sequence of improvement in depressive symptoms across cognitive therapy and pharmacotherapy.

  Journal of affective disorders 20080901

• Model-based approach and signal detection theory to evaluate the performance of recruitment centers in clinical trials with antidepressant drugs.

  Clinical pharmacology and therapeutics 20080901

• The pharmacological treatment of premature ejaculation.

  BJU international 20080901

• Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice.

  British journal of pharmacology 20080901

• Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals.

  Diabetes 20080901

• Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.

  Chemical research in toxicology 20080901

• Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression.

  Brain structure & function 20080901

• Utilization, price, and spending trends for antidepressants in the US Medicaid Program.

  Research in social & administrative pharmacy : RSAP 20080901

• Publication of clinical trials supporting successful new drug applications: a literature analysis.

  PLoS medicine 20080901

• [Efficacy and tolerability of escitalopram in anxiety disorders: a review].

  L'Encephale 20080901

• Neurobiological mechanisms of anhedonia.

  Dialogues in clinical neuroscience 20080901

• Effects of different antidepressant treatments on the core of depression.

  Dialogues in clinical neuroscience 20080901

• Sleep disorders as core symptoms of depression.

  Dialogues in clinical neuroscience 20080901

• Pathways linking late-life depression to persistent cognitive impairment and dementia.

  Dialogues in clinical neuroscience 20080901

• Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.

  The Journal of clinical psychiatry 20080901

• The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacology.

  Current neuropharmacology 20080901

• Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout models.

  Current neuropharmacology 20080901

• Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

  Current neuropharmacology 20080901

• Serum S100B Levels and Major Depressive Disorder: Its Characteristics and Role in Antidepressant Response.

  Psychiatry investigation 20080901

• Expressions of hippocampal mineralocorticoid receptor (MR) and glucocorticoid receptor (GR) in the single-prolonged stress-rats.

  Acta histochemica et cytochemica 20080828

• A modified single-prolonged stress model for post-traumatic stress disorder.

  Neuroscience letters 20080822

• A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue.

  Journal of the National Cancer Institute 20080820

• Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram.

  British journal of cancer 20080819

• 3-(4-(6-Fluoroalkoxy-3,4-dihydroisoquinoline-2(1H)-yl)cyclohexyl)-1H-indole-5-carbonitriles for SERT imaging: chemical synthesis, evaluation in vitro and radiofluorination.

  Bioorganic & medicinal chemistry letters 20080815

• Antidepressant-like effect of lamotrigine is reversed by veratrine: a possible role of sodium channels in bipolar depression.

  Behavioural brain research 20080805

• Bupropion and bradycardia.

  The Medical journal of Australia 20080804

• Consequences of changes in BDNF levels on serotonin neurotransmission, 5-HT transporter expression and function: studies in adult mice hippocampus.

  Pharmacology, biochemistry, and behavior 20080801

• Effects of fibrates, anti-inflammatory drugs and antidepressants in the fish hepatoma cell line PLHC-1: cytotoxicity and interactions with cytochrome P450 1A.

  Toxicology in vitro : an international journal published in association with BIBRA 20080801

• Using nurses and office staff to report prescribing errors in primary care.

  International journal for quality in health care : journal of the International Society for Quality in Health Care 20080801

• Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan.

  Psychopharmacology 20080801

• Resolution of sexual dysfunction during acute treatment of major depression with milnacipran.

  Human psychopharmacology 20080801

• MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20080801

• Death from undiagnosed glioblastoma multiforme and toxic self-medication presenting with concurrent dysfunctional behavior.

  Journal of forensic and legal medicine 20080801

• Recent advances in compulsive hoarding.

  Current psychiatry reports 20080801

• Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice.

  International journal of oncology 20080801

• CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response.

  Therapeutic drug monitoring 20080801

• Review: paroxetine and placebo do not differ for treatment discontinuation in major depression.

  Evidence-based medicine 20080801

• Serotonin toxicity caused by an interaction between fentanyl and paroxetine.

  Canadian journal of anaesthesia = Journal canadien d'anesthesie 20080801

• Off-target effects of psychoactive drugs revealed by genome-wide assays in yeast.

  PLoS genetics 20080801

• Does paroxetine cause cardiac malformations?

  Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 20080801

• Current approaches to the treatment of Parkinson's disease.

  Neuropsychiatric disease and treatment 20080801

• Pharmacotherapy of panic disorder.

  Neuropsychiatric disease and treatment 20080801

• Psychiatric disorders and traumatic brain injury.

  Neuropsychiatric disease and treatment 20080801

• Very early onset and greater vulnerability in schizophrenia: A clinical and neuroimaging study.

  Neuropsychiatric disease and treatment 20080801

• Fluoxetine overdose-induced seizure.

  The western journal of emergency medicine 20080801

• Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.

  Psychiatry research 20080715

• Determination of basic antidepressants and their N-desmethyl metabolites in raw sewage and wastewater using solid-phase extraction and liquid chromatography-tandem mass spectrometry.

  Analytical chemistry 20080715

• Is bigger better for depression trials?

  Journal of psychiatric research 20080701

• Behavioral and pharmacological validation of the gerbil forced-swim test: effects of neurokinin-1 receptor antagonists.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080701

• Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080701

• A comparison of antidepressant use in Nova Scotia, Canada and Australia.

  Pharmacoepidemiology and drug safety 20080701

• Similar discontinuation symptoms for withdrawal from medium-dose paroxetine and venlafaxine after nine years in the same patient.

  Journal of psychopharmacology (Oxford, England) 20080701

• The effects of acute treatment with paroxetine, amitriptyline, and placebo on driving performance and cognitive function in healthy Japanese subjects: a double-blind crossover trial.

  Human psychopharmacology 20080701

• Common adverse events associated with an SSRI: meta-analysis of early paroxetine data.

  Pharmacoepidemiology and drug safety 20080701

• Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment.

  Psychopharmacology 20080701

• Sequential serotonin and noradrenalin associated processes involved in postpartum blues.

  Progress in neuro-psychopharmacology & biological psychiatry 20080701

• Anticholinergic activity of 107 medications commonly used by older adults.

  Journal of the American Geriatrics Society 20080701

• The coadministration of paroxetine and low-dose aspirin synergistically enhances gastric ulcerogenic risk in rats.

  Biological & pharmaceutical bulletin 20080701

• Personalizing the care of geriatric depression.

  The American journal of psychiatry 20080701

• Recognition and treatment of serotonin syndrome.

  Canadian family physician Medecin de famille canadien 20080701

• Flat dose-response curves for efficacy: what do they mean to the clinician?

  Journal of psychiatric practice 20080701

• [Effects of paroxetine on protein kinase PKA, PKC and CaMKII activity in different brain regions in a rat depression model].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20080701

• Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update.

  Clinical therapeutics 20080701

• [Effects of pingyu capsule on signal transduction of rats with chronic stress-induced depression].

  Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20080701

• Carbon-11 labeled indolylpropylamine analog as a new potential PET agent for imaging of the serotonin transporter.

  Bioorganic & medicinal chemistry 20080615

• Selective serotonin reuptake inhibitors and raft inhibitors shorten the period of Period1-driven circadian bioluminescence rhythms in rat-1 fibroblasts.

  Life sciences 20080606

• Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice.

  The pharmacogenomics journal 20080601

• Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy.

  The American journal of psychiatry 20080601

• The effect of paroxetine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects.

  European journal of clinical pharmacology 20080601

• Indolealkylamines: biotransformations and potential drug-drug interactions.

  The AAPS journal 20080601

• Activation syndrome caused by paroxetine in a cancer patient.

  Palliative & supportive care 20080601

• The relationship between somatisation and outcome in patients with severe irritable bowel syndrome.

  Journal of psychosomatic research 20080601

• Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled trial in Canadian women.

  The Journal of clinical psychiatry 20080601

• [Thermotherapy: the treatment of generalized anxiety disorder].

  L'Encephale 20080601

• Escitalopram in obsessive-compulsive disorder: response of symptom dimensions to pharmacotherapy.

  CNS spectrums 20080601

• Expert opinion: migraine, psychiatric comorbidities, and treatment.

  Headache 20080601

• Relapse of tic symptoms in a patient diagnosed with obsessive-compulsive disorder and treated with high-dose paroxetine.

  Journal of child and adolescent psychopharmacology 20080601

• Observation of treatment of depression in primary care setting in first week - what happens in first week of treatment with antidepressants?

  Psychiatria Danubina 20080601

• Two cases of burning mouth syndrome treated with olanzapine.

  Psychiatry and clinical neurosciences 20080601

• Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder.

  Psychiatry and clinical neurosciences 20080601

• Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.

  Journal of managed care pharmacy : JMCP 20080601

• Reproductive neuroscience: biology, environment, and clinical implications in women's mental health.

  The Journal of clinical psychiatry 20080601

• Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.

  Clinical interventions in aging 20080601

• Cognitive neuroscience and brain imaging in bipolar disorder.

  Dialogues in clinical neuroscience 20080601

• Bipolar depression: trial-based insights to guide patient care.

  Dialogues in clinical neuroscience 20080601

• Promising avenues of therapeutics for bipolar illness.

  Dialogues in clinical neuroscience 20080601

• Disruption of bradycardia associated with discriminative conditioning in combat veterans with PTSD.

  Neuropsychiatric disease and treatment 20080601

• Three cases of reversible agranulocytosis after treatment with lamotrigine.

  Psychiatry investigation 20080601

• Toxic epidermal necrolysis after paroxetine treatment.

  The New Zealand medical journal 20080523

• Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients.

  Progress in neuro-psychopharmacology & biological psychiatry 20080515

• Cerebral metabolic effects of fluoxetine, fluvoxamine, paroxetine and sertraline in the conscious rat.

  Neuroscience letters 20080509

• The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports.

  European journal of clinical pharmacology 20080501

• Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings.

  Psychopharmacology 20080501

• The effect of lamotrigine on platelet serotonin concentration in patients with bipolar depression.

  Psychopharmacology 20080501

• Serotonin transporter polymorphism and bleeding time during SSRI therapy.

  British journal of clinical pharmacology 20080501

• [Treatment of generalized anxiety disorders].

  Presse medicale (Paris, France : 1983) 20080501

• Efficacy and tolerability of second-generation antidepressants in social anxiety disorder.

  International clinical psychopharmacology 20080501

• Cost-effectiveness of escitalopram for generalized anxiety disorder in Canada.

  Current medical research and opinion 20080501

• Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.

  Obstetrics and gynecology 20080501

• Complete atrioventricular block associated with concomitant use of metoprolol and paroxetine.

  Mayo Clinic proceedings 20080501

• Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables.

  Pharmacopsychiatry 20080501

• The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study.

  Journal of psychopharmacology (Oxford, England) 20080501

• [Painful palate and xerostomia after using paroxetine].

  Nederlands tijdschrift voor tandheelkunde 20080501

• Do new-generation antidepressants work?

  Irish medical journal 20080501

• (3S,4R)-4-(4-Fluoro-phen-yl)-3-(hydroxy-meth-yl)piperidinium chloride.

  Acta crystallographica. Section E, Structure reports online 20080501

• Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists.

  European journal of pharmacology 20080407

• Organocatalytic asymmetric total synthesis of (R)-rolipram and formal synthesis of (3S,4R)-paroxetine.

  Organic letters 20080403

• Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST).

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20080401

• Patient satisfaction with antidepressants: an Internet-based study.

  Journal of affective disorders 20080401

• Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.

  British journal of clinical pharmacology 20080401

• Evidence for an inhibitory immunomodulatory effect of selected antidepressants on rat splenocytes: possible relevance to depression and hyperactive-immune disorders.

  International immunopharmacology 20080401

• The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.

  Journal of clinical psychopharmacology 20080401

• Paroxetine.

  Expert opinion on pharmacotherapy 20080401

• Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine.

  The Journal of clinical psychiatry 20080401

• Pathological hoarding.

  Australian family physician 20080401

• Treatment of adults with attention-deficit/hyperactivity disorder.

  Neuropsychiatric disease and treatment 20080401

• Psychiatric issues in renal failure and dialysis.

  Indian journal of nephrology 20080401

• Occurrence of selective serotonin reuptake inhibitors in sewage and receiving waters at Spitsbergen and in Norway.

  Journal of chromatography. A 20080328

• Effect of pharmacological treatment on temperament and character in panic disorder.

  Psychiatry research 20080315

• Opposite effects of SSRIs and tandospirone in the treatment of REM sleep behavior disorder.

  Sleep medicine 20080301

• Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea.

  The international journal of neuropsychopharmacology 20080301

• Inhibition of metoprolol metabolism and potentiation of its effects by paroxetine in routinely treated patients with acute myocardial infarction (AMI).

  European journal of clinical pharmacology 20080301

• Enhancement of atomoxetine serum levels by co-administration of paroxetine.

  The international journal of neuropsychopharmacology 20080301

• Risks of suicide and poisoning among elderly patients prescribed selective serotonin reuptake inhibitors: a retrospective cohort study.

  The Journal of clinical psychiatry 20080301

• Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment.

  Pharmacopsychiatry 20080301

• Menopause.

  Lancet (London, England) 20080301

• Mind/Body psychological treatments for irritable bowel syndrome.

  Evidence-based complementary and alternative medicine : eCAM 20080301

• Clinical inquiries. What's the best drug treatment for premature ejaculation?

  The Journal of family practice 20080301

• Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients.

  Journal of psychiatry & neuroscience : JPN 20080301

• Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy.

  The Journal of clinical psychiatry 20080301

• Paroxetine hydrochloride controlled release POLYOX matrix tablets: screening of formulation variables using Plackett-Burman screening design.

  Archives of pharmacal research 20080301

• Block of persistent late Na+ currents by antidepressant sertraline and paroxetine.

  The Journal of membrane biology 20080301

• Treatment of menopausal hot flashes.

  Medicine and health, Rhode Island 20080301

• The effectiveness of anticonvulsants in psychiatric disorders.

  Dialogues in clinical neuroscience 20080301

• Electroconvulsive therapy and its different indications.

  Dialogues in clinical neuroscience 20080301

• End of life care in chronic obstructive pulmonary disease: in search of a good death.

  International journal of chronic obstructive pulmonary disease 20080301

• Biological studies on alcohol-induced neuronal damage.

  Psychiatry investigation 20080301

• The relation between anger management style and organ system-related somatic symptoms in patients with depressive disorders and somatoform disorders.

  Yonsei medical journal 20080227

• Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.

  JAMA 20080227

• Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.

  Biological psychiatry 20080215

• ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20080215

• Regulation of extracellular serotonin levels and brain-derived neurotrophic factor in rats with high and low exploratory activity.

  Brain research 20080215

• Synthesis and evaluation of PSSRI-based inhibitors of Staphylococcus aureus multidrug efflux pumps.

  Bioorganic & medicinal chemistry letters 20080215

• Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype.

  The international journal of neuropsychopharmacology 20080201

• Proteomic analysis of embryonic stem cell-derived neural cells exposed to the antidepressant paroxetine.

  Journal of neuroscience research 20080201

• Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20080201

• In-tube solid-phase microextraction coupled to liquid chromatography (in-tube SPME/LC) analysis of nontricyclic antidepressants in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080201

• Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.

  Behavioural pharmacology 20080201

• Once-daily high-dose pindolol for paroxetine-refractory premature ejaculation: a double-blind, placebo-controlled and randomized study.

  Journal of clinical psychopharmacology 20080201

• Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture.

  Calcified tissue international 20080201

• Restless legs syndrome induced by escitalopram: case report and review of the literature.

  Pharmacotherapy 20080201

• Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders.

  International review of psychiatry (Abingdon, England) 20080201

• Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder.

  The British journal of psychiatry : the journal of mental science 20080201

• Antidepressants in the postpartum period: additional considerations.

  The American journal of psychiatry 20080201

• [Pharmacokinetics of paroxetine tablet in healthy Chinese volunteers].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20080201

• Determination of risperidone in human plasma by HPLC-MS/MS and its application to a pharmacokinetic study in Chinese volunteers.

  Journal of Zhejiang University. Science. B 20080201

• Paroxetine versus placebo for women in midlife after hormone therapy discontinuation.

  The American journal of medicine 20080201

• Six-month paroxetine treatment of premenstrual dysphoric disorder: continuous versus intermittent treatment protocols.

  Psychiatry and clinical neurosciences 20080201

• Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.

  PLoS medicine 20080201

• Shortened protocol in practical [11C]SA4503-PET studies for sigma1 receptor quantification.

  Annals of nuclear medicine 20080201

• Paroxetine in the treatment of post traumatic stress disorder: our experiences.

  Bosnian journal of basic medical sciences 20080201

• [Acute dystonia following paroxetine withdrawal].

  Revista de neurologia 20080201

• Carvedilol in hypertension treatment.

  Vascular health and risk management 20080201

• Serotonin receptor modulators in the treatment of irritable bowel syndrome.

  Therapeutics and clinical risk management 20080201

• Quetiapine monotherapy for bipolar depression.

  Neuropsychiatric disease and treatment 20080201

• Epidemiology and treatment of post-stroke depression.

  Neuropsychiatric disease and treatment 20080201

• Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?

  Neuropsychiatric disease and treatment 20080201

• Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression.

  Neuropsychiatric disease and treatment 20080201

• Treatment of adults with attention-deficit/hyperactivity disorder.

  Neuropsychiatric disease and treatment 20080201

• Depression in Parkinson's disease: health risks, etiology, and treatment options.

  Neuropsychiatric disease and treatment 20080201

• Treatment of adult ADHD: is current knowledge useful to clinicians?

  Neuropsychiatric disease and treatment 20080201

• Pharmacological management of panic disorder.

  Neuropsychiatric disease and treatment 20080201

• Rasagiline in treatment of Parkinson's disease.

  Neuropsychiatric disease and treatment 20080201

• Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20080129

• Selective serotonin reuptake inhibitors fluvoxamine and paroxetine restore forced exercise-induced temperature dysregulation in ovariectomized mice.

  European journal of pharmacology 20080128

• Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.

  Journal of medicinal chemistry 20080124

• Drug therapy for the management of cancer related fatigue.

  The Cochrane database of systematic reviews 20080123

• Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder.

  Journal of anxiety disorders 20080101

• Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting.

  Pharmacy world & science : PWS 20080101

• Prenatal maternal paroxetine treatment and neonatal mortality in the rat: a preliminary study.

  Neonatology 20080101

• Selective serotonin re-uptake inhibitor treatment-emergent sexual dysfunction: randomized double-blind placebo-controlled parallel-group fixed-dose study of a potential adjuvant compound, VML-670.

  Journal of psychopharmacology (Oxford, England) 20080101

• Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20080101

• Paroxetine-induced modulation of cortical activity supporting language representations of action.

  Psychopharmacology 20080101

• Currently available cough suppressants for chronic cough.

  Lung 20080101

• Delirium following abrupt discontinuation of fluoxetine.

  Clinical neurology and neurosurgery 20080101

• Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?

  Progress in neuro-psychopharmacology & biological psychiatry 20080101

• A complex relationship between co-occurring social anxiety and alcohol use disorders: what effect does treating social anxiety have on drinking?

  Alcoholism, clinical and experimental research 20080101

• Structural and functional plasticity of the human brain in posttraumatic stress disorder.

  Progress in brain research 20080101

• Duloxetine does not relieve painful physical symptoms in depression: a meta-analysis.

  Psychotherapy and psychosomatics 20080101

• Trial registration for public trust: making the case for medical devices.

  Journal of general internal medicine 20080101

• Kinetic and equilibrium study of the enantioseparation of paroxetine intermediate on amylose and tartaric acid-based chiral stationary phases.

  Journal of separation science 20080101

• Trajectories of improvement for six depression-related outcomes.

  General hospital psychiatry 20080101

• Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis.

  General hospital psychiatry 20080101

• Serotonin syndrome following methylene blue infusion during parathyroidectomy: a case report and literature review.

  Canadian journal of anaesthesia = Journal canadien d'anesthesie 20080101

• The association of depressive symptoms with inflammatory factors and adipokines in middle-aged and older Chinese.

  PloS one 20080101

• Effects of Food and Drug Administration warnings on antidepressant use in a national sample.

  Archives of general psychiatry 20080101

• Nutritional therapies for mental disorders.

  Nutrition journal 20080101

• Diverse antidepressants increase CDP-diacylglycerol production and phosphatidylinositide resynthesis in depression-relevant regions of the rat brain.

  BMC neuroscience 20080101

• Prevalence of contraindications to mefloquine use among USA military personnel deployed to Afghanistan.

  Malaria journal 20080101

• Relevant issues in the monitoring and the toxicology of antidepressants.

  Critical reviews in clinical laboratory sciences 20080101

• [Psychopharmacological treatment and quality of life in obsessive compulsive disorder].

  Turk psikiyatri dergisi = Turkish journal of psychiatry 20080101

• [Paroxetine-induced hyponatremia in an elderly man due to the syndrome of inappropriate secretion of antidiuretic hormone].

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20080101

• [Agoraphobia: combined treatment and virtual reality. Preliminary results].

  Actas espanolas de psiquiatria 20080101

• Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores.

  Arthritis research & therapy 20080101

• Clozapine and co-prescribed psychotropics: a short report.

  Clinical practice and epidemiology in mental health : CP & EMH 20080101

• Treating the physical symptoms of depression with second-generation antidepressants: a systematic review and metaanalysis.

  Psychosomatics 20080101

• Decreased density of the platelet serotonin transporter in pathological gamblers.

  Neuropsychobiology 20080101

• Prediction of response within the first 3 days to treatment with paroxetine for depression.

  Primary care companion to the Journal of clinical psychiatry 20080101

• Serotonin syndrome with paroxetine overdose: a case report.

  Primary care companion to the Journal of clinical psychiatry 20080101

• GENetic and clinical predictors of treatment response in depression: the GenPod randomised trial protocol.

  Trials 20080101

• Placebo as good as paroxetine for treating acute moderate-to-severe major depression.

  Medscape journal of medicine 20080101

• Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?

  Philosophy, ethics, and humanities in medicine : PEHM 20080101

• Selecting an appropriate medication for treating neuropathic pain in patients with diabetes: a study using the U.K. and Germany Mediplus databases.

  Pain practice : the official journal of World Institute of Pain 20080101

• Effects of antidepressant treatment on heart rate variability in major depression: a quantitative review.

  BioPsychoSocial medicine 20080101

• Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways.

  PloS one 20080101

• The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease.

  Health and quality of life outcomes 20080101

• Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.

  PloS one 20080101

• Benefits of consumer psychoeducation: a pilot program in South Africa.

  International journal of psychiatry in medicine 20080101

• Chronic hypokalemia due to excessive cola consumption: a case report.

  Cases journal 20080101

• iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: understanding the interface between physiology and disease.

  PloS one 20080101

• Mourning and melancholia revisited: correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatry.

  Annals of general psychiatry 20080101

• Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants.

  Neuropsychobiology 20080101

• Managing the patient with co-morbid depression and an anxiety disorder.

  Drugs 20080101

• [Evaluation of the effectiveness of crenotherapy in treating generalized anxiety disorder].

  Sante publique (Vandoeuvre-les-Nancy, France) 20080101

• Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities.

  PloS one 20080101

• The co-administration of quetiapine or placebo to cognitive-behavior therapy in treatment refractory depression: a preliminary trial.

  BMC psychiatry 20080101

• Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis.

  Drug safety 20080101

• Intractable chronic pruritus in a 67-year-old man.

  Acta dermato-venereologica 20080101

• Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use.

  PloS one 20080101

• The significance of treating somatic symptoms on functional outcome improvement in patients with major depressive disorder: a post hoc analysis of 2 trials.

  Primary care companion to the Journal of clinical psychiatry 20080101

• Industry-sponsored ghostwriting in clinical trial reporting: a case study.

  Accountability in research 20080101

• [The anxyolytic effect of mild hypobaric hypoxia in a model of post-traumatic stress disorder in rats].

  Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova 20080101

• Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.

  CNS drugs 20080101

• Effects of milnacipran and paroxetine on overactive bladder due to neurologic diseases: a urodynamic assessment.

  Urologia internationalis 20080101

• Depression treatment with selective serotonin reuptake inhibitors for the postacute coronary syndrome population: a literature review.

  The Journal of cardiovascular nursing 20080101

• Elevated stress-hemoconcentration in major depression is normalized by antidepressant treatment: secondary analysis from a randomized, double-blind clinical trial and relevance to cardiovascular disease risk.

  PloS one 20080101

• The clinical-familial correlates and naturalistic outcome of panic-disorder-agoraphobia with and without lifetime bipolar II comorbidity.

  Annals of general psychiatry 20080101

• Comorbidity of Asperger's syndrome and Bipolar disorder.

  Clinical practice and epidemiology in mental health : CP & EMH 20080101

• Early intervention in panic: randomized controlled trial and cost-effectiveness analysis.

  Trials 20080101

• Pharmaceutical research in paediatric populations and the new EU Paediatric Legislation: an industry perspective.

  Child and adolescent psychiatry and mental health 20080101

• Nocturnal urinary cortisol excretion over a randomized controlled trial with paroxetine vs. placebo combined with relaxation training or aerobic exercise in panic disorder.

  Current pharmaceutical design 20080101

• Physiological and pathological aspects of Abeta in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators.

  BMC neuroscience 20080101

• Aripiprazole augmentation in poor insight obsessive-compulsive disorder: a case report.

  Annals of general psychiatry 20080101

• History of depressive and anxiety disorders and paroxetine response in patients with irritable bowel syndrome: post hoc analysis from a placebo-controlled study.

  Primary care companion to the Journal of clinical psychiatry 20080101

• [Cerebral physiopathology and treatment of Asperger disorder].

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20080101

• [Application of liquid chromatography coupled with mass spectrometry (LC/MS) to determine antidepressants in blood samples].

  Archiwum medycyny sadowej i kryminologii 20080101

• Deliberate self-harm (and attempted suicide).

  BMJ clinical evidence 20080101

• New spectrofluorimetric method with enhanced sensitivity for determination of paroxetine in dosage forms and plasma.

  Analytical chemistry insights 20080101

• Management of fibromyalgia syndrome--an interdisciplinary evidence-based guideline.

  German medical science : GMS e-journal 20080101

• Continuing medical education.

  Indian journal of psychiatry 20080101

• Medical and licit drug use in an urban/rural study population with a refugee background, 7-8 years into resettlement.

  Psycho-social medicine 20080101

• Cough up for just a cup of coffee: Pharmacoeconomics of depression.

  Indian journal of psychiatry 20080101

• Serotonin transporter gene polymorphism and treatment response to serotonin reuptake inhibitor (escitalopram) in depression: An open pilot study.

  Indian journal of psychiatry 20080101

• Medication adherence in schizophrenia: patient perspectives and the clinical utility of paliperidone ER.

  Patient preference and adherence 20080101

• Brief report: Characteristics of antidepressant use in patients with heart failure.

  Patient preference and adherence 20080101

• Antidepressant interactions with the NMDA NR1-1b subunit.

  Journal of biophysics (Hindawi Publishing Corporation : Online) 20080101

• RP-HPLC Estimation of Venlafaxine Hydrochloride in Tablet Dosage Forms.

  Indian journal of pharmaceutical sciences 20080101

• The changing microbial environment and chronic inflammatory disorders.

  Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20080101

• Spectrofluorimetric method for determination of citalopram in bulk and pharmaceutical dosage forms.

  Indian journal of pharmaceutical sciences 20080101

• Treatment of depression as part of end-of-life care.

  BMJ case reports 20080101

• Our censored journals.

  Mens sana monographs 20080101

• Hypotension following cardiac surgery associated with paroxetine and mirtazapine withdrawal.

  The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG 20080101

• Comparison of electron and chemical ionization modes by validation of a quantitative gas chromatographic-mass spectrometric assay of new generation antidepressants and their active metabolites in plasma.

  Journal of chromatography. A 20071228

• Simultaneous analysis of the enantiomers of verapamil and norverapamil in rat plasma by liquid chromatography-tandem mass spectrometry.

  Journal of pharmaceutical and biomedical analysis 20071221

• 1-Aminocyclopentane-1,2,4-tricarboxylic acids screening on glutamatergic and serotonergic systems.

  Bioorganic & medicinal chemistry 20071215

• [Pharmacological treatment options in frontotemporal dementia].

  Fortschritte der Neurologie-Psychiatrie 20071201

• Statistical analysis of longitudinal psychiatric data with dropouts.

  Journal of psychiatric research 20071201

• Preparation of antidepressants for use in preclinical research.

  The international journal of neuropsychopharmacology 20071201

• Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia.

  The international journal of neuropsychopharmacology 20071201

• Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20071201

• Acute and constitutive increases in central serotonin levels reduce social play behaviour in peri-adolescent rats.

  Psychopharmacology 20071201

• Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.

  Psychopharmacology 20071201

• Lack of evidence for reduced prefrontal cortical serotonin and dopamine efflux after acute tryptophan depletion.

  Psychopharmacology 20071201

• Progress curve analysis of CYP1A2 inhibition: a more informative approach to the assessment of mechanism-based inactivation?

  Drug metabolism and disposition: the biological fate of chemicals 20071201

• Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system.

  European journal of clinical pharmacology 20071201

• Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics.

  The Journal of pharmacology and experimental therapeutics 20071201

• Missed symptoms of menopause.

  International journal of clinical practice 20071201

• Spinal cord stimulator relieves neuropathic pain in a patient with radiation-induced transverse myelitis.

  Pain practice : the official journal of World Institute of Pain 20071201

• Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder.

  Journal of clinical psychopharmacology 20071201

• MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding.

  The European journal of neuroscience 20071201

• The promiscuity of the dopamine transporter: implications for the kinetic analysis of [3H]serotonin uptake in rat hippocampal and striatal synaptosomes.

  Neuropharmacology 20071201

• Homeopathy, fundamentalism, and the memory of water.

  Current oncology (Toronto, Ont.) 20071201

• Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy.

  Current oncology (Toronto, Ont.) 20071201

• Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis.

  The Journal of clinical psychiatry 20071201

• Comparing the rapidity of response during treatment of major depressive disorder with bupropion and the SSRIs: a pooled survival analysis of 7 double-blind, randomized clinical trials.

  The Journal of clinical psychiatry 20071201

• CRH-sub-1 receptor antagonists for the treatment of depression and anxiety.

  Experimental and clinical psychopharmacology 20071201

• Effect of Jin-3-needling therapy on plasma corticosteroid, adrenocorticotrophic hormone and platelet 5-HT levels in patients with generalized anxiety disorder.

  Chinese journal of integrative medicine 20071201

• Behavioral disinhibition without persistent mood elevation after high dose citalopram treatment.

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20071201

• Review of duloxetine in the management of diabetic peripheral neuropathic pain.

  Vascular health and risk management 20071201

• The stomatognathic system in the elderly. Useful information for the medical practitioner.

  Clinical interventions in aging 20071201

• Yoga as a complementary treatment of depression: effects of traits and moods on treatment outcome.

  Evidence-based complementary and alternative medicine : eCAM 20071201

• Prolong QT interval and 'torsades de pointes' associated with different group of drugs.

  Georgian medical news 20071201

• Psychopharmacology news.

  Journal of child and adolescent psychopharmacology 20071201

• Indiplon in the treatment of sleep disorders.

  Neuropsychiatric disease and treatment 20071201

• The therapeutic potential of escitalopram in the treatment of panic disorder.

  Neuropsychiatric disease and treatment 20071201

• Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies.

  Neuropsychiatric disease and treatment 20071201

• A review of quetiapine in combination with antidepressant therapy in patients with depression.

  Neuropsychiatric disease and treatment 20071201

• Current therapeutic options for Alzheimer's disease.

  Current genomics 20071201

• An antidepressant that extends lifespan in adult Caenorhabditis elegans.

  Nature 20071122

• L-thyroxine augmentation of serotonergic antidepressants in female patients with refractory depression.

  Journal of affective disorders 20071101

• A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C.

  Journal of affective disorders 20071101

• Residual symptoms and recurrence during maintenance treatment of late-life depression.

  Journal of affective disorders 20071101

• Repeated paroxetine treatment reverses anhedonia induced in rats by chronic mild stress or dexamethasone.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20071101

• Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review.

  Archives of gynecology and obstetrics 20071101

• The guinea pig forced swim test as a new behavioral despair model to characterize potential antidepressants.

  Psychopharmacology 20071101

• Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia?

  Biochemical pharmacology 20071101

• The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: a critical analysis of basic science and clinical data.

  European urology 20071101

• Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases.

  Molecular and cellular neurosciences 20071101

• NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.

  Chemical research in toxicology 20071101

• Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder.

  International clinical psychopharmacology 20071101

• A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.

  International clinical psychopharmacology 20071101

• Premature ejaculation: state of the art.

  The Urologic clinics of North America 20071101

• Role of paroxetine in interferon-alpha-induced immune and behavioural changes in male Wistar rats.

  Journal of psychopharmacology (Oxford, England) 20071101

• An effect-size analysis of pharmacologic treatments for generalized anxiety disorder.

  Journal of psychopharmacology (Oxford, England) 20071101

• Medical histories of 61 aviation accident pilots with postmortem SSRI antidepressant residues.

  Aviation, space, and environmental medicine 20071101

• Update on psychotropic medications for cancer-related fatigue.

  Journal of the National Comprehensive Cancer Network : JNCCN 20071101

• Paroxetine oral solution is bioequivalent to paroxetine tablets--advantages of the solution.

  International journal of clinical pharmacology and therapeutics 20071101

• [Separation of paroxetine and its intermediate enantiomers by high performance liquid chromatography using carboxymethyl-beta-cyclodextrin as chiral mobile phase additive].

  Se pu = Chinese journal of chromatography 20071101

• High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503.

  Biological psychiatry 20071015

• Hippocampal volume reduction and HPA-system activity in major depression.

  Journal of psychiatric research 20071001

• Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors.

  The international journal of neuropsychopharmacology 20071001

• SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20071001

• Synergistic effects of tandospirone and selective serotonin reuptake inhibitors on the contextual conditioned fear stress response in rats.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20071001

• A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.

  Psychopharmacology 20071001

• A monoamine oxidase B gene variant and short-term antidepressant treatment response.

  Progress in neuro-psychopharmacology & biological psychiatry 20071001

• Thermal balneotherapy induces changes of the platelet serotonin transporter in healthy subjects.

  Progress in neuro-psychopharmacology & biological psychiatry 20071001

• Effects of acute paroxetine treatment on the consumption of cigarette smoking and caffeine in depressed patients.

  Human psychopharmacology 20071001

• Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.

  Pharmacoepidemiology and drug safety 20071001

• Paroxetine in the first trimester and the prevalence of congenital malformations.

  Pharmacoepidemiology and drug safety 20071001

• Escitalopram therapy for major depression and anxiety disorders.

  The Annals of pharmacotherapy 20071001

• Effect of serotonergic antidepressant therapy on temperament and character scales in patients with chronic tension-type headache.

  Psychiatry and clinical neurosciences 20071001

• Irritable bowel syndrome in psychiatric perspectives: a comprehensive review.

  International journal of clinical practice 20071001

• A decade of letrozole: FACE.

  Breast cancer research and treatment 20071001

• Treatment of depression in cancer patients.

  Current oncology (Toronto, Ont.) 20071001

• Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.

  The Journal of clinical psychiatry 20071001

• Pharmacological causes of hyperprolactinemia.

  Therapeutics and clinical risk management 20071001

• Transdermal selegiline for the treatment of major depressive disorder.

  Neuropsychiatric disease and treatment 20071001

• Review of olanzapine in the management of bipolar disorders.

  Neuropsychiatric disease and treatment 20071001

• Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer's disease.

  Neuropsychiatric disease and treatment 20071001

• Increase of plasma brain-derived neurotrophic factor levels in two psychotic depressed patients responding to lithium addition to paroxetine treatment.

  Neuropsychiatric disease and treatment 20071001

• Effect of high-dose milnacipran in patients with depression.

  Neuropsychiatric disease and treatment 20071001

• Analysis of paroxetine, fluoxetine and norfluoxetine in fish tissues using pressurized liquid extraction, mixed mode solid phase extraction cleanup and liquid chromatography-tandem mass spectrometry.

  Journal of chromatography. A 20070907

• Paroxetine treatment of compulsive hoarding.

  Journal of psychiatric research 20070901

• Are psychotropics drugs used in pregnancy?

  Pharmacoepidemiology and drug safety 20070901

• [Inappropriate ADH secretion-induced hyponatremia and associated with paroxetine use].

  La Revue de medecine interne 20070901

• Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005).

  Pharmacoepidemiology and drug safety 20070901

• Suppressive effect of paroxetine, a selective serotonin uptake inhibitor, on tetrahydrobiopterin levels and dopamine as well as serotonin turnover in the mesoprefrontal system of mice.

  Synapse (New York, N.Y.) 20070901

• Prevalence and predictors of antidepressant use in a cohort of pregnant women.

  BJOG : an international journal of obstetrics and gynaecology 20070901

• Inhibitory effects of paroxetine on the development of atopic dermatitis-like lesions in NC/Nga mice.

  Journal of dermatological science 20070901

• Paroxetine administration decreases AD-like pathology and reverses memory impairments in a transgenic model of Alzheimer disease.

  Experimental neurology 20070901

• Triple uptake inhibitors: therapeutic potential in depression and beyond.

  Expert opinion on investigational drugs 20070901

• Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy.

  Journal of the American Geriatrics Society 20070901

• St John's wort versus paroxetine for depression.

  Canadian family physician Medecin de famille canadien 20070901

• Delirium associated with paroxetine in an elderly depressive patient: a case report.

  Pharmacopsychiatry 20070901

• Reversible paroxetine-induced symptomatic hypothyroidism.

  Pharmacopsychiatry 20070901

• [Review of pharmacological efficacies and side effects of antidepressants].

  Nihon rinsho. Japanese journal of clinical medicine 20070901

• [Childhood and adolescent depression].

  Nihon rinsho. Japanese journal of clinical medicine 20070901

• Neuroleptic malignant syndrome resulting from a complex drug-drug interaction: 'I don't see 'em!'.

  Journal of psychiatric practice 20070901

• Clinical observation on treatment of depression by electro-acupuncture combined with Paroxetine.

  Chinese journal of integrative medicine 20070901

• Pharmacogenetics in modern psychiatry.

  Psychiatria Danubina 20070901

• Recent advances in pathophysiology and current management of itch.

  Annals of the Academy of Medicine, Singapore 20070901

• Eszopiclone for late-life insomnia.

  Clinical interventions in aging 20070901

• Pharmacologic management of overactive bladder.

  Clinical interventions in aging 20070901

• [Clinical study of super crush-run Tongxinluo capsule on treatment of stroke].

  Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20070901

• Neurotoxic syndrome developed after taking sertraline and risperidone.

  Journal of clinical neurology (Seoul, Korea) 20070901

• An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials.

  Psychiatry research 20070830

• Stability-indicating high performance thin layer chromatography determination of Paroxetine hydrochloride in bulk drug and pharmaceutical formulations.

  Analytica chimica acta 20070829

• Reliable HPLC method for therapeutic drug monitoring of frequently prescribed tricyclic and nontricyclic antidepressants.

  Journal of pharmaceutical and biomedical analysis 20070815

• Violent dreaming and antidepressant drugs: or how paroxetine made me dream that I was fighting Saddam Hussein.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20070815

• Benefits and harms of pediatric antidepressant medications.

  JAMA 20070808

• Stimulation programs for pediatric drug research--do children really benefit?

  European journal of pediatrics 20070801

• Tandem regulation of phosphoinositide signaling and acute behavioral effects induced by antidepressant agents in rats.

  Psychopharmacology 20070801

• Effectiveness and tolerability of paroxetine controlled release (CR) in the treatment of major depressive disorder: an open-label, prospective, multi-center trial in Korea.

  Human psychopharmacology 20070801

• Anorexia nervosa with chronic episodes for more than 30 years in a patient with a comorbid schizotypal personality disorder.

  Psychiatry and clinical neurosciences 20070801

• Augmentation of paroxetine with clocapramine in panic disorder.

  Psychiatry and clinical neurosciences 20070801

• Venlafaxine vs. paroxetine in the acute phase of treatment for major depressive disorder among Han Chinese population in Taiwan.

  Journal of clinical pharmacy and therapeutics 20070801

• Neonatal withdrawal syndrome following in utero exposure to paroxetine, clonazepam and olanzapine.

  Journal of perinatology : official journal of the California Perinatal Association 20070801

• Mixture and single-substance acute toxicity of selective serotonin reuptake inhibitors in Ceriodaphnia dubia.

  Environmental toxicology and chemistry 20070801

• A randomized study examining the effect of 3 SSRI on premature ejaculation using a validated questionnaire.

  Therapeutics and clinical risk management 20070801

• Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol.

  Therapeutics and clinical risk management 20070801

• Agomelatine and its therapeutic potential in the depressed patient.

  Neuropsychiatric disease and treatment 20070801

• An emerging role for escitalopram in the treatment of obsessive-compulsive disorder.

  Neuropsychiatric disease and treatment 20070801

• Post-traumatic stress disorder.

  BMJ clinical evidence 20070801

• Antidepressant response in the elderly.

  Psychiatry research 20070730

• Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.

  The Cochrane database of systematic reviews 20070718

• Allosteric effects of R- and S-citalopram on the human 5-HT transporter: evidence for distinct high- and low-affinity binding sites.

  European journal of pharmacology 20070712

• Pharmacotherapy of aphasia: myth or reality?

  Brain and language 20070701

• Antidepressant-induced liver injury.

  The Annals of pharmacotherapy 20070701

• Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.

  Expert review of neurotherapeutics 20070701

• The majority of men with lifelong premature ejaculation prefer daily drug treatment: an observation study in a consecutive group of Dutch men.

  The journal of sexual medicine 20070701

• Cost-efficacy of individual and combined treatments for panic disorder.

  The Journal of clinical psychiatry 20070701

• The safety of antidepressant drugs during pregnancy.

  Expert opinion on drug safety 20070701

• [Clinical observation on catgut implantation at acupoint for treatment of somatic form disorders].

  Zhongguo zhen jiu = Chinese acupuncture & moxibustion 20070701

• A budget-impact and cost-effectiveness model for second-line treatment of major depression.

  Journal of managed care pharmacy : JMCP 20070701

• Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients.

  Progress in neuro-psychopharmacology & biological psychiatry 20070630

• Successful treatment of refractory hypochondriasis with duloxetine.

  Progress in neuro-psychopharmacology & biological psychiatry 20070630

• A simple and reliable procedure for the determination of psychoactive drugs in oral fluid by gas chromatography-mass spectrometry.

  Journal of pharmaceutical and biomedical analysis 20070628

• First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.

  The New England journal of medicine 20070628

• [Effects of paroxetine with or without zolpidem on depression with insomnia: a multi-center randomized comparative study].

  Zhonghua yi xue za zhi 20070619

• Risk of acute liver injury associated with the use of drugs: a multicentre population survey.

  Alimentary pharmacology & therapeutics 20070615

• Selective serotonin reuptake inhibitors in the treatment of premature ejaculation.

  Chinese medical journal 20070605

• Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine.

  European journal of pharmacology 20070601

• Hypothermia following antipsychotic drug use.

  European journal of clinical pharmacology 20070601

• Reversal of resistance in microorganisms by help of non-antibiotics.

  The Journal of antimicrobial chemotherapy 20070601

• Persistent neuroendocrine and behavioral effects of a novel, etiologically relevant mouse paradigm for chronic social stress during adolescence.

  Psychoneuroendocrinology 20070601

• Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.

  Psychiatry and clinical neurosciences 20070601

• Open trials in psychiatry: comments on article by Uchida et Al.

  Journal of clinical psychopharmacology 20070601

• Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy.

  The American journal of psychiatry 20070601

• The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.

  The Journal of clinical psychiatry 20070601

• Association of suicide and antidepressant prescription rates in Japan, 1999-2003.

  The Journal of clinical psychiatry 20070601

• Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression.

  Dialogues in clinical neuroscience 20070601

• Dapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculation.

  Therapeutics and clinical risk management 20070601

• Current aproach to cancer pain management: Availability and implications of different treatment options.

  Therapeutics and clinical risk management 20070601

• Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapy.

  Therapeutics and clinical risk management 20070601

• Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics.

  Neuropsychiatric disease and treatment 20070601

• Determination of the antidepressant paroxetine and its three main metabolites in human plasma by liquid chromatography with fluorescence detection.

  Analytica chimica acta 20070522

• Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C.

  Alimentary pharmacology & therapeutics 20070515

• Serotonin transporter density and anxiolytic-like effects of antidepressants in mice.

  Progress in neuro-psychopharmacology & biological psychiatry 20070509

• Time course of response to paroxetine: influence of plasma level.

  Progress in neuro-psychopharmacology & biological psychiatry 20070509

• Stir bar sorptive extraction and liquid chromatography with UV detection for determination of antidepressants in plasma samples.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501

• Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice.

  Experimental neurology 20070501

• A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure.

  American heart journal 20070501

• Escitalopram 10 mg daily is more effective than paroxetine and placebo for generalised anxiety disorder.

  Evidence-based mental health 20070501

• A randomized, controlled, trial of controlled release paroxetine in fibromyalgia.

  The American journal of medicine 20070501

• Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial.

  The American journal of psychiatry 20070501

• Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management.

  Clinical toxicology (Philadelphia, Pa.) 20070501

• Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial.

  The Journal of clinical psychiatry 20070501

• Mania in a case of polypsychopharmacology: pharmacodynamic and pharmacokinetic considerations. Do you believe in magic?

  Journal of psychiatric practice 20070501

• Fatal hyponatremia and other metabolic disturbances associated with psychotropic drug polypharmacy.

  International journal of clinical pharmacology and therapeutics 20070501

• Modulation of the suppressive effect of corticosterone on adult rat hippocampal cell proliferation by paroxetine.

  Neuroscience bulletin 20070501

• Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.

  Clinical therapeutics 20070501

• Effectiveness of adjunctive antidepressant treatment for bipolar depression.

  The New England journal of medicine 20070426

• Strain differences in 'compulsive' lever-pressing.

  Behavioural brain research 20070416

• Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20070413

• Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20070413

• The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression.

  American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20070405

• Antidepressant therapy in tinnitus.

  Hearing research 20070401

• Sodium channel blockade may contribute to the analgesic efficacy of antidepressants.

  The journal of pain : official journal of the American Pain Society 20070401

• Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.

  Birth defects research. Part A, Clinical and molecular teratology 20070401

• Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine.

  Psychopharmacology 20070401

• The effect of antidepressant warnings on prescribing trends in Ontario, Canada.

  American journal of public health 20070401

• Secondary obsessive-compulsive disorder related to diaschisis after pontine infarction, successfully treated with paroxetine.

  Psychiatry and clinical neurosciences 20070401

• Safety of newer antidepressants in pregnancy.

  Pharmacotherapy 20070401

• Serotonin syndrome.

  Emergency medicine journal : EMJ 20070401

• Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review.

  Human psychopharmacology 20070401

• Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study.

  Current medical research and opinion 20070401

• An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.

  Journal of clinical psychopharmacology 20070401

• Motor cortex excitability after vagus nerve stimulation in major depression.

  Journal of clinical psychopharmacology 20070401

• An independent meta-analysis using summary data for clinical response, remission, and discontinuation for any reason from the 6 pivotal phase III randomized clinical trials of duloxetine in major depressive disorder.

  Journal of clinical psychopharmacology 20070401

• Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression.

  Journal of consulting and clinical psychology 20070401

• Can sildenafil treat primary premature ejaculation? A prospective clinical study.

  International journal of urology : official journal of the Japanese Urological Association 20070401

• [SSRI during pregnancy can cause bleeding complications].

  Lakartidningen 20070401

• Assessing the onset of antidepressant-induced sexual dysfunction using interactive voice response technology.

  The Journal of clinical psychiatry 20070401

• Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis.

  The Journal of clinical psychiatry 20070401

• Role of pregabalin in the treatment of generalized anxiety disorder.

  Neuropsychiatric disease and treatment 20070401

• Duloxetine in the treatment of major depressive disorder.

  Neuropsychiatric disease and treatment 20070401

• The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic.

  Neuropsychiatric disease and treatment 20070401

• Obsessive compulsive disorder.

  BMJ clinical evidence 20070401

• Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20070330

• Epileptiformic activity induced by antidepressants in amygdala-kindled rats.

  European journal of pharmacology 20070329

• [Possible serotoninergic syndrome associated with coadministration of paroxetine and tramadol].

  Medicina clinica 20070324

• 11-year-old boy with panic disorder responding to paroxetine.

  The Tokai journal of experimental and clinical medicine 20070320

• Altered brain activation pattern associated with drug-induced attenuation of enhanced depression-like behavior in rats bred for high anxiety.

  Biological psychiatry 20070315

• Antipsychotics inhibit TREK but not TRAAK channels.

  Biochemical and biophysical research communications 20070302

• Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070301

• Selective serotonin reuptake inhibitors, fluoxetine and paroxetine, attenuate the expression of the established behavioral sensitization induced by methamphetamine.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070301

• Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability.

  Neuropharmacology 20070301

• Differential and synergistic effects of selective norepinephrine and serotonin reuptake inhibitors in rodent models of pain.

  The Journal of pharmacology and experimental therapeutics 20070301

• Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipran.

  Naunyn-Schmiedeberg's archives of pharmacology 20070301

• Antidepressant utilization in primary care in a Spanish region: impact of generic and reference-based pricing policy (2000-2004).

  Social psychiatry and psychiatric epidemiology 20070301

• The treatment of child and adolescent depression: a matter of concern?

  Acta psychiatrica Scandinavica 20070301

• Depression and poor sleep: the effect of monoaminergic antidepressants in a pre-clinical model in rats.

  Pharmacology, biochemistry, and behavior 20070301

• Depression in epilepsy: phenomenology, diagnosis and management.

  Epileptic disorders : international epilepsy journal with videotape 20070301

• Retrospective case review of lamotrigine use for affective instability of borderline personality disorder.

  CNS spectrums 20070301

• Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20070301

• Treating vasomotor symptoms of menopause: the nurse practitioner's perspective.

  Journal of the American Academy of Nurse Practitioners 20070301

• Drug evaluation: Vilazodone--a combined SSRI and 5-HT1A partial agonist for the treatment of depression.

  IDrugs : the investigational drugs journal 20070301

• Neonatal convulsions secondary to paroxetine withdrawal.

  JPMA. The Journal of the Pakistan Medical Association 20070301

• Management of clozapine-induced obsessive-compulsive symptoms in a man with schizophrenia.

  The Australian and New Zealand journal of psychiatry 20070301

• Frontotemporal dementia: recommendations for therapeutic studies, designs, and approaches.

  The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20070301

• Influence of antidepressants on hemostasis.

  Dialogues in clinical neuroscience 20070301

• Venlafaxine extended release (XR) in the treatment of panic disorder.

  Therapeutics and clinical risk management 20070301

• Stereospecific construction of substituted piperidines. Synthesis of (-)-paroxetine and (+)-laccarin.

  Chemical communications (Cambridge, England) 20070221

• Non-parametric estimation for baseline hazards function and covariate effects with time-dependent covariates.

  Statistics in medicine 20070220

• Neuronal proteins involved in synaptic targeting of AMPA receptors in rat hippocampus by antidepressant drugs.

  Biochemical and biophysical research communications 20070216

• Discontinuation symptoms in depression and anxiety disorders.

  The international journal of neuropsychopharmacology 20070201

• Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.

  The international journal of neuropsychopharmacology 20070201

• [Psychotropic drug-induced change of weight: a review].

  Fortschritte der Neurologie-Psychiatrie 20070201

• Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.

  The international journal of neuropsychopharmacology 20070201

• Effect of antidepressant drugs on 6-OHDA-treated mice in the FST.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20070201

• Emergence, persistence, and resolution of suicidal ideation during treatment of depression in old age.

  Journal of affective disorders 20070201

• In vivo drug metabolism model for human cytochrome P450 enzyme using chimeric mice with humanized liver.

  Journal of pharmaceutical sciences 20070201

• The treatment of depression in cancer patients: a systematic review.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20070201

• Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests.

  Psychopharmacology 20070201

• [Treatment of hydroxychloroquine poisoning with extracorporeal circulation].

  Annales francaises d'anesthesie et de reanimation 20070201

• Severe citrate toxicity complicating volunteer apheresis platelet donation.

  Journal of clinical apheresis 20070201

• Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor.

  Analytical and bioanalytical chemistry 20070201

• Acute and repeated administration of fluoxetine, citalopram, and paroxetine significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.

  Synapse (New York, N.Y.) 20070201

• Paroxetine-induced apoptosis in human osteosarcoma cells: activation of p38 MAP kinase and caspase-3 pathways without involvement of [Ca2+]i elevation.

  Toxicology and applied pharmacology 20070201

• First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.

  Birth defects research. Part B, Developmental and reproductive toxicology 20070201

• Psychomotor and memory effects of haloperidol, olanzapine, and paroxetine in healthy subjects after short-term administration.

  Journal of clinical psychopharmacology 20070201

• Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder.

  Journal of psychosomatic research 20070201

• Paroxetine: current status in psychiatry.

  Expert review of neurotherapeutics 20070201

• High plasma concentrations of paroxetine impede clinical response in patients with panic disorder.

  Therapeutic drug monitoring 20070201

• Effect of itraconazole on pharmacokinetics of paroxetine: the role of gut transporters.

  Therapeutic drug monitoring 20070201

• [Clinical observation on treatment of melancholia by acupuncture following principle of relieving depression and regulating mentality].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20070201

• Determination of paroxetine in human saliva by reversed-phase high-performance liquid chromatography with UV detection.

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20070201

• Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review.

  Clinical therapeutics 20070201

• Severe serotonin toxicity and manic switch induced by combined use of tramadol and paroxetine.

  The Australian and New Zealand journal of psychiatry 20070201

• Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan.

  Neuropsychiatric disease and treatment 20070201

• Venlafaxine in the treatment of panic disorder.

  Neuropsychiatric disease and treatment 20070201

• Why does milnacipran produce so few discontinuation syndromes following abrupt withdrawal?

  Neuropsychiatric disease and treatment 20070201

• Planning and analysis of three-arm non-inferiority trials with binary endpoints.

  Statistics in medicine 20070130

• Serotonin syndrome in a case of depression with various somatic symptoms: the difficulty in differential diagnosis.

  Progress in neuro-psychopharmacology & biological psychiatry 20070130

• Basilar artery blood flow velocity changes in patients with panic disorder following 35% carbon dioxide challenge.

  Progress in neuro-psychopharmacology & biological psychiatry 20070130

• Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze.

  Behavioural brain research 20070125

• Antidepressants for smoking cessation.

  The Cochrane database of systematic reviews 20070124

• [Pharmacovigilance and teratovigilance].

  Revue medicale suisse 20070124

• Chemoselective hydrogenation of imides catalyzed by Cp*Ru(PN) complexes and its application to the asymmetric synthesis of paroxetine.

  Journal of the American Chemical Society 20070117

• Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain.

  Biological psychiatry 20070115

• Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients.

  Psychiatry research 20070115

• Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls.

  Journal of psychiatric research 20070101

• Resistin and adiponectin in major depression: the association with free cortisol and effects of antidepressant treatment.

  Journal of psychiatric research 20070101

• Effects of OPC-14523, a combined sigma and 5-HT1a ligand, on pre- and post-synaptic 5-HT1a receptors.

  Journal of psychopharmacology (Oxford, England) 20070101

• A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteers.

  Journal of psychopharmacology (Oxford, England) 20070101

• 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.

  Psychopharmacology 20070101

• The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.

  Journal of psychopharmacology (Oxford, England) 20070101

• Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifene.

  British journal of clinical pharmacology 20070101

• A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults.

  Depression and anxiety 20070101

• A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

  Depression and anxiety 20070101

• Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070101

• Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects.

  European journal of clinical pharmacology 20070101

• Effect of acute dapoxetine administration on the pudendal motoneuron reflex in anesthetized rats: comparison with paroxetine.

  The Journal of urology 20070101

• Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned?

  Psychotherapy and psychosomatics 20070101

• Analysis of pharmaceutical formulations using atmospheric pressure ion mobility spectrometry combined with liquid chromatography and nano-electrospray ionisation.

  The Analyst 20070101

• SSRIs and the syndrome of inappropriate antidiuretic hormone secretion.

  The American journal of nursing 20070101

• Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial.

  The American journal of psychiatry 20070101

• Protocol for the THREAD (THREshold for AntiDepressants) study: a randomised controlled trial to determine the clinical and cost-effectiveness of antidepressants plus supportive care, versus supportive care alone, for mild to moderate depression in UK general practice.

  BMC family practice 20070101

• Selective serotonin reuptake inhibitors reduce the attack frequency in familial mediterranean Fever.

  The Tohoku journal of experimental medicine 20070101

• Oxytocin involvement in SSRI-induced delayed ejaculation: a review of animal studies.

  The journal of sexual medicine 20070101

• The potential for clinically significant drug-drug interactions involving the CYP 2D6 system: effects with fluoxetine and paroxetine versus sertraline.

  Journal of psychiatric practice 20070101

• Platelet serotonin levels support depression scores for women with postpartum depression.

  Journal of psychiatry & neuroscience : JPN 20070101

• Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index.

  Drug safety 20070101

• Reboxetine and cytochrome P450--comparison with paroxetine treatment in humans.

  International journal of clinical pharmacology and therapeutics 20070101

• Mixture and single-substance toxicity of selective serotonin reuptake inhibitors toward algae and crustaceans.

  Environmental toxicology and chemistry 20070101

• Dissecting the determinants of depressive disorders outcome: an in depth analysis of two clinical cases.

  Annals of general psychiatry 20070101

• Depression in cancer patients: a critical review.

  Clinical practice and epidemiology in mental health : CP & EMH 20070101

• Combining an SSRI with an anticonvulsant in depressed patients with dysphoric mood: an open study.

  Clinical practice and epidemiology in mental health : CP & EMH 20070101

• Paediatric adverse drug reaction reporting: understanding and future directions.

  The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 20070101

• Paroxetine-induced bruxism effectively treated with tandospirone.

  The Journal of neuropsychiatry and clinical neurosciences 20070101

• Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: a case-control study.

  Annals of general psychiatry 20070101

• [Antidepressant drugs and breastfeeding].

  Recenti progressi in medicina 20070101

• Clinical decision support tools: analysis of online drug information databases.

  BMC medical informatics and decision making 20070101

• Premature ejaculation: definition and drug treatment.

  Drugs 20070101

• Which panic disorder patients benefit from which treatment: cognitive therapy or antidepressants?

  Psychotherapy and psychosomatics 20070101

• The ethics of CYP2D6 testing for patients considering tamoxifen.

  Breast cancer research : BCR 20070101

• [Clinical picture and treatment of panic disorder accompanied with generalized anxiety].

  Voenno-meditsinskii zhurnal 20070101

• Suicide risk and symptom reduction in patients assigned to placebo in duloxetine and escitalopram clinical trials: analysis of the FDA summary basis of approval reports.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20070101

• Considering the case for an antidepressant drug trial involving temporary deception: a qualitative enquiry of potential participants.

  BMC health services research 20070101

• Corticosteroid decreases subventricular zone cell proliferation, which could be reversed by paroxetine.

  Restorative neurology and neuroscience 20070101

• QTc and psychopharmacs: are there any differences between monotherapy and polytherapy.

  Annals of general psychiatry 20070101

• Panic disorder in a child with recurrent chest pain.

  The Turkish journal of pediatrics 20070101

• Authorized generic drugs, price competition, and consumers' welfare.

  Health affairs (Project Hope) 20070101

• Age and gender differences of psychogenic fever: a review of the Japanese literature.

  BioPsychoSocial medicine 20070101

• Simple options for improving signal detection in antidepressant clinical trials.

  Psychopharmacology bulletin 20070101

• An electrospray ionisation tandem mass spectrometric investigation of selected psychoactive pharmaceuticals and its application in drug and metabolite profiling by liquid chromatography/electrospray ionisation tandem mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20070101

• Links among paroxetine-induced sexual dysfunctions, gender, and CYP2D6 activity.

  Journal of sex & marital therapy 20070101

• Pilot study of fluvoxamine treatment for climacteric symptoms in Japanese women.

  BioPsychoSocial medicine 20070101

• Newer antipsychotics and the rabbit syndrome.

  Clinical practice and epidemiology in mental health : CP & EMH 20070101

• Frontotemporal dementias: a review.

  Annals of general psychiatry 20070101

• Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial.

  BMC family practice 20070101

• Pharmacologic treatment of cancer-related fatigue.

  The oncologist 20070101

• Duloxetine: a review of its use in the treatment of major depressive disorder.

  CNS drugs 20070101

• Treatment of temporomandibular pain with the selective serotonin reuptake inhibitor paroxetine.

  Primary care companion to the Journal of clinical psychiatry 20070101

• Characterization of the potent 5-HT(1A/B) receptor antagonist and serotonin reuptake inhibitor SB-649915: preclinical evidence for hastened onset of antidepressant/anxiolytic efficacy.

  CNS drug reviews 20070101

• Massive epistaxis and subconjunctival hemorrhage due to combination of paroxetine and limaprost alfadex: a case report.

  Primary care companion to the Journal of clinical psychiatry 20070101

• Effect of dissociative experiences on drug treatment of panic disorder.

  Clinical drug investigation 20070101

• Addiction to the nicotine gum in never smokers.

  BMC public health 20070101

• Hippocampal neurogenesis, depressive disorders, and antidepressant therapy.

  Neural plasticity 20070101

• Pharmacotherapy of mood disorders and treatment discontinuation.

  Drugs 20070101

• Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk.

  BMC musculoskeletal disorders 20070101

• Use of the novel Contact Heat Evoked Potential Stimulator (CHEPS) for the assessment of small fibre neuropathy: correlations with skin flare responses and intra-epidermal nerve fibre counts.

  BMC neurology 20070101

• Combined brief dynamic therapy and pharmacotherapy in the treatment of major depressive disorder: a pilot study.

  Psychotherapy and psychosomatics 20070101

• Information from the Internet and the doctor-patient relationship: the patient perspective--a qualitative study.

  BMC family practice 20070101

• Atypical antipsychotics in bipolar disorder: systematic review of randomised trials.

  BMC psychiatry 20070101

• Lack of association between the Serotonin Transporter Promoter Polymorphism (5-HTTLPR) and Panic Disorder: a systematic review and meta-analysis.

  Behavioral and brain functions : BBF 20070101

• Duloxetine in the treatment of major depressive disorder: an open-label study.

  BMC psychiatry 20070101

• Simultaneous determination of nontricyclic antidepressants in human plasma by solid-phase microextraction and liquid chromatography (SPME-LC).

  Journal of analytical toxicology 20070101

• Quantification of eight new antidepressants and five of their active metabolites in whole blood by high-performance liquid chromatography-tandem mass spectrometry.

  Journal of analytical toxicology 20070101

• Protocol of a prospective study on the diagnostic value of transcranial duplex scanning of the substantia nigra in patients with parkinsonian symptoms.

  BMC neurology 20070101

• Determination of paroxetine in plasma by liquid chromatography coupled to tandem mass spectrometry for pharmacokinetic and bioequivalence studies.

  Arzneimittel-Forschung 20070101

• [Charles-Bonnet Syndrome: a report of two cases].

  Turk psikiyatri dergisi = Turkish journal of psychiatry 20070101

• A fatal case of bupropion (Zyban) hepatotoxicity with autoimmune features: Case report.

  Journal of medical case reports 20070101

• Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.

  PharmacoEconomics 20070101

• 'It doesn't do any harm, but patients feel better': a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease.

  BMC gastroenterology 20070101

• Dapoxetine and paroxetine for the treatment of premature ejaculation.

  Clinical neuropharmacology 20070101

• Carbon dioxide inhalation induces dose-dependent and age-related negative affectivity.

  PloS one 20070101

• Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder.

  Annals of general psychiatry 20070101

• Sequence variation and linkage disequilibrium in the GABA transporter-1 gene (SLC6A1) in five populations: implications for pharmacogenetic research.

  BMC genetics 20070101

• The impact of prescribed psychotropics on youth.

  Clinical practice and epidemiology in mental health : CP & EMH 20070101

• [Clinical relevance of antidepressant-induced activation syndrome: from a perspective of bipolar spectrum disorder].

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20070101

• Transgenic mice expressing constitutive active MAPKAPK5 display gender-dependent differences in exploration and activity.

  Behavioral and brain functions : BBF 20070101

• Remission of panic disorder with mirtazapine augmentation of paroxetine: a case report.

  Primary care companion to the Journal of clinical psychiatry 20070101

• Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine.

  BioPsychoSocial medicine 20070101

• Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).

  Neuropsychobiology 20070101

• Add-on quetiapine in the treatment of major depressive disorder in elderly patients with cerebrovascular damage.

  Clinical practice and epidemiology in mental health : CP & EMH 20070101

• Recurrence of suicidal ideation due to treatment with antidepressants in anxiety disorder: a case report.

  Journal of medical case reports 20070101

• Perception versus polysomnographic assessment of sleep in CFS and non-fatigued control subjects: results from a population-based study.

  BMC neurology 20070101

• Intravenous zolpidem abuse: a case for serotonin depletion.

  The American journal on addictions 20070101

• Clinical effectiveness of usual care with or without antidepressant medication for primary care patients with minor or mild-major depression: a randomized equivalence trial.

  BMC medicine 20070101

• A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.

  Clinical neuropharmacology 20070101

• Adverse drug interactions involving common prescription and over-the-counter analgesic agents.

  Clinical therapeutics 20070101

• Solving the problem of antidepressant selection in Lithuania.

  Advances in medical sciences 20070101

• [How do Argentinean psychiatrists treat depression?].

  Vertex (Buenos Aires, Argentina) 20070101

• Generalised anxiety disorder.

  BMJ clinical evidence 20070101

• Premature ejaculation.

  Indian journal of urology : IJU : journal of the Urological Society of India 20070101

• Escitalopram induced mania.

  Indian journal of psychiatry 20070101

• Paliperidone: the evidence of its therapeutic value in schizophrenia.

  Core evidence 20070101

• [Clinical effectiveness and safety of paroxetine in post-stroke depression: results from a phase 4, open label, multicenter clinical trial with 26 weeks of follow-up].

  Orvosi hetilap 20061217

• Epidemiologic and clinical updates on impulse control disorders: a critical review.

  European archives of psychiatry and clinical neuroscience 20061201

• Effect of paroxetine on enhanced contextual fear induced by single prolonged stress in rats.

  Psychopharmacology 20061201

• Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study.

  Psychopharmacology 20061201

• Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.

  Neuropharmacology 20061201

• 'My new Alfa Romeo GT is not in the garage any more': Cognitive behavioural therapy of panic disorder with agoraphobia co morbid with psychosis.

  Psychiatria Danubina 20061201

• Abnormal pontine activation in pathological laughing as shown by functional magnetic resonance imaging.

  Journal of neurology, neurosurgery, and psychiatry 20061201

• Resolving the onset of antidepressants' clinical actions: critical for clinical practice and new drug development.

  Journal of clinical psychopharmacology 20061201

• Comment: paroxetine use during pregnancy: is it safe?

  The Annals of pharmacotherapy 20061201

• ACOG Committee Opinion No. 354: Treatment with selective serotonin reuptake inhibitors during pregnancy.

  Obstetrics and gynecology 20061201

• Hold on tight.

  Psychiatric services (Washington, D.C.) 20061201

• Pharmacokinetic variability of aripiprazole and the active metabolite dehydroaripiprazole in psychiatric patients.

  Therapeutic drug monitoring 20061201

• SSRI antidepressants and birth defects.

  Prescrire international 20061201

• [Paroxetine (Deroxat and spontaneous ecchymosis].

  Annales de dermatologie et de venereologie 20061201

• Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine.

  The Journal of clinical psychiatry 20061201

• Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: the Hordaland Health Study.

  The Journal of clinical psychiatry 20061201

• [A case of hyponatremia associated with combination therapy of systemic chemotherapy and paroxetine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061201

• A possible mechanism for anxiolytic and antidepressant effects of alpha- and beta-amyrin from Protium heptaphyllum (Aubl.) March.

  Pharmacology, biochemistry, and behavior 20061201

• Pharmacotherapy of post-traumatic stress disorder.

  Drugs of today (Barcelona, Spain : 1998) 20061201

• Traumatic stress: effects on the brain.

  Dialogues in clinical neuroscience 20061201

• Is there any treatment other than drugs to alleviate dyspnea in COPD patients?

  International journal of chronic obstructive pulmonary disease 20061201

• Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidence.

  Clinical interventions in aging 20061201

• Atomoxetine: a novel treatment for child and adult ADHD.

  Neuropsychiatric disease and treatment 20061201

• New agents in the treatment of premature ejaculation.

  Neuropsychiatric disease and treatment 20061201

• Antidepressants in the treatment of fibromyalgia.

  Neuropsychiatric disease and treatment 20061201

• The Effect of Paroxetine on the Reduction of Migraine Frequency is Independent of Its Anxiolytic Effect.

  Journal of clinical neurology (Seoul, Korea) 20061201

• Ergotism with ischemia in all four extremities: a case report.

  Journal of clinical neurology (Seoul, Korea) 20061201

• Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials.

  Reproductive toxicology (Elmsford, N.Y.) 20061101

• Phenytoin as an augmentation for SSRI failures: a small controlled study.

  Journal of affective disorders 20061101

• Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression.

  Psychoneuroendocrinology 20061101

• Continuing paroxetine treatment reduces recurrence of major depression in the elderly.

  Evidence-based mental health 20061101

• Impact of prior treatment exposure on response to antidepressant treatment in late life.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20061101

• Inhibition of G protein-activated inwardly rectifying K+ channels by the antidepressant paroxetine.

  Journal of pharmacological sciences 20061101

• Antidepressant-induced inhibition of genital vascular responses is reversed by vardenafil in female rabbits.

  The journal of sexual medicine 20061101

• Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.

  Pharmacopsychiatry 20061101

• Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.

  The Journal of clinical psychiatry 20061101

• [Role of the serotonergic nervous system in anxiety disorders and the anxiolytic mechanism of selective serotonin reuptake inhibitors].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20061101

• Differential effects of antidepressants on dexamethasone-induced nuclear translocation and expression of glucocorticoid receptor.

  Brain research 20061030

• Effects of amantadine and budipine on antidepressant drug-evoked changes in extracellular dopamine in the frontal cortex of freely moving rats.

  Brain research 20061030

• Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061020

• Solid-phase extraction and analysis of 20 antidepressant drugs in human plasma by LC/MS with SSI method.

  Forensic science international 20061016

• Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20061001

• Paroxetine treatment improves motor symptoms in patients with multiple system atrophy.

  Parkinsonism & related disorders 20061001

• Antidepressant withdrawal symptoms-telephone calls to a national medication helpline.

  Journal of affective disorders 20061001

• Cost-effectiveness of a disease management program for major depression in elderly primary care patients.

  Journal of general internal medicine 20061001

• Prevalence and patterns of antidepressant drug use during pregnancy.

  European journal of clinical pharmacology 20061001

• Paroxetine use during pregnancy: is it safe?

  The Annals of pharmacotherapy 20061001

• Paroxetine useful for palmar-plantar hyperhidrosis.

  The Annals of pharmacotherapy 20061001

• Pharmacotherapy of child and adolescent depression.

  Child and adolescent psychiatric clinics of North America 20061001

• Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic.

  Psychiatry and clinical neurosciences 20061001

• Delirium and multiple electrolyte abnormalities associated with high dose paroxetine exposure.

  Psychiatry and clinical neurosciences 20061001

• Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder.

  Psychopharmacology 20061001

• Quetiapine augmentation in lactation: a series of case reports.

  Journal of clinical psychopharmacology 20061001

• Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels.

  Journal of clinical psychopharmacology 20061001

• Cost-effectiveness analysis of escitalopram compared with paroxetine in treatment of generalized anxiety disorder in the United Kingdom.

  The Annals of pharmacotherapy 20061001

• Disappointment of patients on antidepressant therapy after excimer laser treatment.

  Journal of cataract and refractive surgery 20061001

• [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].

  Presse medicale (Paris, France : 1983) 20061001

• Use of single-dose activated charcoal among Canadian pediatric emergency physicians.

  Pediatric emergency care 20061001

• Maintenance treatment with paroxetine, but not psychotherapy, prevented recurrent major depression in older people.

  Evidence-based nursing 20061001

• Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.

  The Journal of clinical psychiatry 20061001

• Personality disorders and response to medication treatment in panic disorder: a 1-year naturalistic study.

  Progress in neuro-psychopharmacology & biological psychiatry 20060930

• Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine.

  European journal of pharmacology 20060928

• Electroanalytical determination of paroxetine in pharmaceuticals.

  Journal of pharmaceutical and biomedical analysis 20060926

• Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test.

  Behavioural brain research 20060925

• The auditory startle response in post-traumatic stress disorder.

  Experimental brain research 20060901

• Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

  European psychiatry : the journal of the Association of European Psychiatrists 20060901

• Women with depression--'You Can't Tell by Looking'.

  Maternal and child health journal 20060901

• Effects of repeated milnacipran administration on brain serotonergic and noradrenergic functions in healthy volunteers.

  Psychopharmacology 20060901

• Serotonin and premature ejaculation: from physiology to patient management.

  European urology 20060901

• Treatment benefits of duloxetine in major depressive disorder as assessed by number needed to treat.

  International clinical psychopharmacology 20060901

• Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults.

  The Annals of pharmacotherapy 20060901

• Alopecia areata with comorbid depression: early resolution with combined paroxetine-triamcinolone treatment.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20060901

• Paroxetine treatment of primary insomnia in older adults.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20060901

• Escitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study.

  The British journal of psychiatry : the journal of mental science 20060901

• Antidepressants and violence: problems at the interface of medicine and law.

  PLoS medicine 20060901

• [Efficacy of selective serotonin reuptake inhibitor treatment in children and adolescents].

  Presse medicale (Paris, France : 1983) 20060901

• Night sweats and elevated follicle-stimulating hormone levels while taking selective serotonin reuptake inhibitors.

  Obstetrics and gynecology 20060901

• Membrane transporter proteins: a challenge for CNS drug development.

  Dialogues in clinical neuroscience 20060901

• Pharmacologic treatment of rapid ejaculation: levels of evidence-based review.

  Current clinical pharmacology 20060901

• Prophylaxis of migraine.

  Neuropsychiatric disease and treatment 20060901

• Obstructive sleep apnea - management update.

  Neuropsychiatric disease and treatment 20060901

• The under-recognition of depression in Parkinson's disease.

  Neuropsychiatric disease and treatment 20060901

• The genetic studies of obsessive-compulsive disorder and its future directions.

  Yonsei medical journal 20060831

• Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam.

  Progress in neuro-psychopharmacology & biological psychiatry 20060830

• Increased expression of the 5-HT transporter confers a low-anxiety phenotype linked to decreased 5-HT transmission.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20060830

• The interference of pharmaceuticals with endogenous and xenobiotic metabolizing enzymes in carp liver: an in-vitro study.

  Environmental science & technology 20060815

• Effects of antipsychotic and antidepressant drugs on action monitoring in healthy volunteers.

  Brain research 20060811

• [Expert statements concerning the Seroxat issue].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20060810

• Intrafamilial correspondences on platelet [3H-]paroxetine-binding indices in bulimic probands and their unaffected first-degree relatives.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060801

• Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060801

• Ghrelin concentrations and cardiac vagal tone are decreased after pharmacologic and cognitive-behavioral treatment in patients with bulimia nervosa.

  Hormones and behavior 20060801

• The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder.

  International immunopharmacology 20060801

• [Present status and prospects about an animal model of post-traumatic stress disorder in rats using a shuttle box].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20060801

• [A case of Parkinson's disease with neuroleptic malignant syndrome induced by paroxetine].

  Rinsho shinkeigaku = Clinical neurology 20060801

• Maintenance treatment with paroxetine, but not psychotherapy, prevented recurrent major depression in older people.

  Evidence-based medicine 20060801

• Did regulators fail over selective serotonin reuptake inhibitors?

  BMJ (Clinical research ed.) 20060708

• Gender differences in response to antidepressant treatment prescribed in primary care. Does menopause make a difference?

  Journal of affective disorders 20060701

• The four-plates test: anxiolytic or analgesic paradigm?

  Progress in neuro-psychopharmacology & biological psychiatry 20060701

• Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety.

  Neuropharmacology 20060701

• Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002.

  Pharmacoepidemiology and drug safety 20060701

• Do antidepressants cure or create abnormal brain states?

  PLoS medicine 20060701

• MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature.

  British journal of pharmacology 20060701

• Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting.

  The American journal of cardiology 20060701

• Relevance of assessing drug concentration exposure in pharmacogenetic and imaging studies.

  Journal of psychopharmacology (Oxford, England) 20060701

• Application of microarray technology in psychotropic drug trials.

  Journal of psychopharmacology (Oxford, England) 20060701

• A rare case of combined syndrome of inappropriate antidiuretic hormone secretion and Fanconi syndrome in an elderly woman.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20060701

• Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.

  Expert review of neurotherapeutics 20060701

• A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.

  Current medical research and opinion 20060701

• RNA therapeutics directed to the non coding regions of APP mRNA, in vivo anti-amyloid efficacy of paroxetine, erythromycin, and N-acetyl cysteine.

  Current Alzheimer research 20060701

• Bupropion augmentation in the treatment of chronic fatigue syndrome with coexistent major depression episode.

  Pharmacopsychiatry 20060701

• Generalised urticaria in a young woman treated with clomipramine and after ingestion of codfish.

  Pharmacopsychiatry 20060701

• The relationship between cognitive and brain changes in posttraumatic stress disorder.

  Annals of the New York Academy of Sciences 20060701

• Alterations in stress reactivity after long-term treatment with paroxetine in women with posttraumatic stress disorder.

  Annals of the New York Academy of Sciences 20060701

• Organocatalytic conjugate addition of malonates to alpha,beta-unsaturated aldehydes: asymmetric formal synthesis of (-)-paroxetine, chiral lactams, and lactones.

  Angewandte Chemie (International ed. in English) 20060626

• Low density and high affinity of platelet [3H]paroxetine binding in women with bulimia nervosa.

  Psychiatry research 20060615

• Reduced platelet [3H]paroxetine binding in anorexia nervosa: relationship to eating symptoms and personality pathology.

  Psychiatry research 20060615

• Usefulness of paroxetine in depressed men with paroxysmal atrial fibrillation.

  The American journal of cardiology 20060615

• Gene expression and association analysis of LIM (PDLIM5) in major depression.

  Neuroscience letters 20060612

• Maintenance treatment of depression in old age.

  The New England journal of medicine 20060608

• Maintenance treatment of depression in old age.

  The New England journal of medicine 20060608

• A video method for the evaluation of antidepressant clinical and behavioural actions.

  The international journal of neuropsychopharmacology 20060601

• Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060601

• Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060601

• Late-onset obsessive-compulsive disorder: the role of stressful life events.

  International psychogeriatrics 20060601

• Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake.

  Psychopharmacology 20060601

• Partial lesion of the serotonergic system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test.

  Neuropharmacology 20060601

• Risperidone in the treatment of psychotic depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20060601

• Antidepressants: general practitioners' opinions and clinical practice.

  Acta psychiatrica Scandinavica 20060601

• Effects of serotonin transporter inhibition on gastrointestinal motility and colonic sensitivity in the mouse.

  Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20060601

• Hypothermia in a patient receiving risperidone and paroxetine.

  Journal of clinical psychopharmacology 20060601

• Ear dyskinesia.

  Journal of neurology, neurosurgery, and psychiatry 20060601

• Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.

  Journal of the American Academy of Child and Adolescent Psychiatry 20060601

• Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression.

  European journal of endocrinology 20060601

• Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder.

  Psychiatry and clinical neurosciences 20060601

• [Neonatal withdrawal syndrome to selective serotonin reuptake inhibitors: case report and literature review].

  Revista de neurologia 20060601

• Back to basics.

  The American journal of medicine 20060601

• Syntheses of biologically active natural products and leading compounds for new pharmaceuticals employing effective construction of a polycyclic skeleton.

  Chemical & pharmaceutical bulletin 20060601

• Fatal neuroleptic malignant syndrome in a previously long-term user of clozapine following its reintroduction in combination with paroxetine.

  Aging clinical and experimental research 20060601

• The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham controlled study.

  Neuro endocrinology letters 20060601

• [Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations].

  No to shinkei = Brain and nerve 20060601

• Changes in the immune system in depression and dementia: causal or coincidental effects?

  Dialogues in clinical neuroscience 20060601

• Future prospects in depression research.

  Dialogues in clinical neuroscience 20060601

• Treatments in depression.

  Dialogues in clinical neuroscience 20060601

• Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury.

  Fukushima journal of medical science 20060601

• The return of fixed combinations in psychiatry: fluoxetine and olanzapine combination.

  Therapeutics and clinical risk management 20060601

• Risperidone in the treatment of bipolar mania.

  Neuropsychiatric disease and treatment 20060601

• The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder.

  Neuropsychiatric disease and treatment 20060601

• Dose-dependent rapid-onset akathisia with aripiprazole in patients with schizoaffective disorder.

  Neuropsychiatric disease and treatment 20060601

• Manufacturer admits increase in suicidal behaviour in patients taking paroxetine.

  BMJ (Clinical research ed.) 20060520

• Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway.

  Journal of chromatography. A 20060519

• Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn.

  The New England journal of medicine 20060518

• [Anxiety disorders: diagnosis and therapy from the family physician's perspective].

  MMW Fortschritte der Medizin 20060515

• Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography-tandem mass spectrometry analysis in hospital effluent wastewaters.

  Journal of chromatography. A 20060512

• Counseling pregnant women treated with paroxetine. Concern about cardiac malformations.

  Canadian family physician Medecin de famille canadien 20060510

• The impact of CYP2D6 genotypes on the plasma concentration of paroxetine in Japanese psychiatric patients.

  Progress in neuro-psychopharmacology & biological psychiatry 20060501

• Development of 5-HT1A receptor radioligands to determine receptor density and changes in endogenous 5-HT.

  Synapse (New York, N.Y.) 20060501

• Treatment of bereavement-related depression and traumatic grief.

  Journal of affective disorders 20060501

• The spermicidal and antitrichomonas activities of SSRI antidepressants.

  Bioorganic & medicinal chemistry letters 20060501

• A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder.

  International clinical psychopharmacology 20060501

• Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder.

  International clinical psychopharmacology 20060501

• Antidepressant therapy and C-reactive protein levels.

  The British journal of psychiatry : the journal of mental science 20060501

• Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling.

  British journal of clinical pharmacology 20060501

• Mechanism-based inhibition of human liver microsomal cytochrome P450 2D6 (CYP2D6) by alkamides of Piper nigrum.

  Planta medica 20060501

• Is paroxetine an effective treatment for hot flashes?

  Nature clinical practice. Endocrinology & metabolism 20060501

• Effects of Paroxetine CR on Depressive and Anxiety Symptoms: In a Community Sample of Adult Hispanic Women with Major Depression or Generalized Anxiety Disorder.

  Psychiatry (Edgmont (Pa. : Township)) 20060501

• [Effects of antidepressants on sleep].

  Orvosi hetilap 20060430

• Drug therapy for obstructive sleep apnoea in adults.

  The Cochrane database of systematic reviews 20060419

• Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression).

  Biological psychiatry 20060415

• Associations between the use of common medications and sleep architecture in patients with untreated obstructive sleep apnea.

  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20060415

• Efficient Heck arylations of cyclic and acyclic acrylate derivatives using arenediazonium tetrafluoroborates. A new synthesis of the antidepressant drug (+/-)-paroxetine.

  Organic letters 20060413

• [Selective serotonin reuptake inhibitors (SSRIs) in pregnancy].

  Revue medicale suisse 20060412

• Use of antidepressant medications in relation to the incidence of breast cancer.

  British journal of cancer 20060410

• [The seroxat issue--a reply].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20060406

• Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive compulsive disorder.

  Psychoneuroendocrinology 20060401

• Pharmacological characterization of (E)-N-(4-fluorobut-2-enyl)-2beta-carbomethoxy-3beta-(4'-tolyl)nortropane (LBT-999) as a highly promising fluorinated ligand for the dopamine transporter.

  The Journal of pharmacology and experimental therapeutics 20060401

• Antidepressant drugs during pregnancy and infant congenital heart defect.

  Reproductive toxicology (Elmsford, N.Y.) 20060401

• T3 augmentation of SSRI resistant depression.

  Journal of affective disorders 20060401

• Characterization of voltage-gated sodium-channel blockers by electrical stimulation and fluorescence detection of membrane potential.

  Nature biotechnology 20060401

• Antiplatelet activity during coadministration of the selective serotonin reuptake inhibitor paroxetine and aspirin in male smokers: a randomized, placebo-controlled, double-blind trial.

  Journal of clinical pharmacology 20060401

• The serotonin syndrome complicating co-prescription of paroxetine and clarithromycin.

  The American journal of medicine 20060401

• I have read about a new study that showed antidepressants can increase the risk of abdominal bleeding. I'm currently taking Prozac, and my husband takes Zoloft. Should we worry?

  Health news (Waltham, Mass.) 20060401

• Paroxetine-induced excessive yawning.

  Psychiatry and clinical neurosciences 20060401

• Spectrofluorimetric determination of paroxetine hydrochloride in its formulations and human plasma.

  Chemical & pharmaceutical bulletin 20060401

• Disease mongering in drug promotion: do governments have a regulatory role?

  PLoS medicine 20060401

• Analysis of electrocardiographic data following use of paroxetine in pediatric depression and obsessive-compulsive disorder.

  Journal of the American Academy of Child and Adolescent Psychiatry 20060401

• Tolerability and safety of fluvoxamine and other antidepressants.

  International journal of clinical practice 20060401

• [Treatment of non cognitive symptoms of Alzheimer's disease].

  Revista de neurologia 20060401

• Determination of paroxetine in human plasma by high-performance liquid chromatography using 7,7,8,8-tetracyanoquinodimethane as the derivatization reagent.

  Therapeutic drug monitoring 20060401

• Paxil: part of the process.

  Nature reviews. Drug discovery 20060401

• Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches.

  Journal of clinical gastroenterology 20060401

• Symptom-onset treatment for women with premenstrual dysphoric disorder.

  Journal of clinical psychopharmacology 20060401

• Low serum concentrations of paroxetine in CYP2D6 ultrarapid metabolizers.

  Journal of clinical psychopharmacology 20060401

• A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults.

  The Journal of clinical psychiatry 20060401

• [An animal model of posttraumatic stress disorder in rats using a shuttle box].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20060401

• Maintenance treatment of major depression in old age.

  The New England journal of medicine 20060316

• Digitalis intoxication induced by paroxetine co-administration.

  Lancet (London, England) 20060304

• A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters.

  Biological psychiatry 20060301

• Effect of gender on antinociceptive effect of paroxetine in hot plate test in mice.

  Progress in neuro-psychopharmacology & biological psychiatry 20060301

• Emerging drugs for premature ejaculation.

  Expert opinion on emerging drugs 20060301

• Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro.

  Journal of psychopharmacology (Oxford, England) 20060301

• Noradrenergic and serotonergic modulation to treat vasomotor symptoms.

  The journal of the British Menopause Society 20060301

• The alkaloid alstonine: a review of its pharmacological properties.

  Evidence-based complementary and alternative medicine : eCAM 20060301

• Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study.

  Pharmacopsychiatry 20060301

• Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.

  Journal of psychiatry & neuroscience : JPN 20060301

• Elevation in plasma Abeta42 in geriatric depression: a pilot study.

  Neurochemical research 20060301

• Antidepressants and risk of upper gastrointestinal bleeding.

  Basic & clinical pharmacology & toxicology 20060301

• Sexual function during bupropion or paroxetine treatment of major depressive disorder.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20060301

• Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.

  The Journal of clinical psychiatry 20060301

• Clinical interventions for late-life anxious depression.

  Clinical interventions in aging 20060301

• Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia.

  Therapeutics and clinical risk management 20060301

• A neuropsychiatric review of pediatric obsessive-compulsive disorder: etiology and efficacious treatments.

  Neuropsychiatric disease and treatment 20060301

• Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications.

  Neuropsychiatric disease and treatment 20060301

• A review of SPECT studies in psychiatry in China.

  Neuropsychiatric disease and treatment 20060301

• The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review.

  British journal of cancer 20060213

• Acute and long-term effects of a single dose of MDMA on aggression in Dark Agouti rats.

  The international journal of neuropsychopharmacology 20060201

• Posttraumatic stress disorder: a state-of-the-science review.

  Journal of psychiatric research 20060201

• Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder.

  Biological psychiatry 20060201

• Selective serotonin re-uptake inhibition attenuates evoked glutamate release in the dorsal horn of the anaesthetised rat in vivo.

  Pharmacological research 20060201

• Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin.

  Journal of affective disorders 20060201

• Olanzapine augmentation in treatment-resistant panic disorder: a 12-week, fixed-dose, open-label trial.

  Journal of clinical psychopharmacology 20060201

• Paroxetine toxicity in a newborn after in utero exposure: clinical symptoms correlate with serum levels.

  Therapeutic drug monitoring 20060201

• A fully automated turbulent-flow liquid chromatography-tandem mass spectrometry technique for monitoring antidepressants in human serum.

  Therapeutic drug monitoring 20060201

• Defective alleles may not have contributed to adverse effects.

  Therapeutic drug monitoring 20060201

• Defective alleles may not have contributed to adverse effects.

  Therapeutic drug monitoring 20060201

• Did intense adverse media publicity impact on prescribing of paroxetine and the notification of suspected adverse drug reactions? Analysis of routine databases, 2001-2004.

  British journal of clinical pharmacology 20060201

• Clinical efficacy of agomelatine in depression: the evidence.

  International clinical psychopharmacology 20060201

• Efficacy and tolerance profile of agomelatine and practical use in depressed patients.

  International clinical psychopharmacology 20060201

• Drug interactions between linezolid and selective serotonin reuptake inhibitors: case report involving sertraline and review of the literature.

  Pharmacotherapy 20060201

• Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study.

  CNS spectrums 20060201

• One-year outcomes of a randomized clinical trial treating depression in low-income minority women.

  Journal of consulting and clinical psychology 20060201

• A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

  The Journal of clinical psychiatry 20060201

• Paroxetine may increase risk for congenital malformations.

  Dermatology nursing 20060201

• Comparison of first refill rates among users of sertraline, paroxetine, and citalopram.

  Clinical therapeutics 20060201

• Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants.

  The Journal of biological chemistry 20060127

• Late developmental stage-specific role of tryptophan hydroxylase 1 in brain serotonin levels.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20060111

• Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors.

  Brain research 20060105

• Escitalopram versus paroxetine for social anxiety disorder: an analysis of efficacy for different symptom dimensions.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060101

• Time course of dopamine D2 receptor occupancy by clozapine with medium and high plasma concentrations.

  Progress in neuro-psychopharmacology & biological psychiatry 20060101

• Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060101

• Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.

  Journal of psychopharmacology (Oxford, England) 20060101

• Investigation of the syndrome of apotemnophilia and course of a cognitive-behavioural therapy.

  Psychopathology 20060101

• Perspectives on the efficacy of antidepressants for child and adolescent depression.

  PLoS medicine 20060101

• Salmeterol and paroxetine: more evidence for paradoxical medicine.

  Medical hypotheses 20060101

• Social inequalities in response to antidepressant treatment in older adults.

  Archives of general psychiatry 20060101

• Upregulated genes in sporadic, idiopathic pulmonary arterial hypertension.

  Respiratory research 20060101

• Advances in the enantioseparation of second-generation antidepressant drugs by electrodriven methods.

  Electrophoresis 20060101

• Botulinum toxin treatment of social anxiety disorder with hyperhidrosis: a placebo-controlled double-blind trial.

  The Journal of clinical psychiatry 20060101

• Remission of generalized anxiety disorder: a review of the paroxetine clinical trials database.

  The Journal of clinical psychiatry 20060101

• Common alterations in the serotonin transporter in platelets and lymphocytes of psychotic patients.

  Pharmacopsychiatry 20060101

• Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena.

  The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 20060101

• An open trial of paroxetine for the 'offensive subtype' of taijin kyofusho and social anxiety disorder.

  Depression and anxiety 20060101

• Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension.

  Pulmonary pharmacology & therapeutics 20060101

• Sensitive capillary GC-MS-SIM determination of selective serotonin reuptake inhibitors: reliability evaluation by validation and robustness study.

  Journal of separation science 20060101

• The effect of 5-hydroxytryptamine 3A and 3B receptor genes on nausea induced by paroxetine.

  The pharmacogenomics journal 20060101

• Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms.

  Treatments in endocrinology 20060101

• Postmarketing surveillance of suicidal adverse events with pediatric use of antidepressants.

  Journal of child and adolescent psychopharmacology 20060101

• An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder.

  Journal of child and adolescent psychopharmacology 20060101

• Evaluation of suicidal thoughts and behaviors in children and adolescents taking paroxetine.

  Journal of child and adolescent psychopharmacology 20060101

• The relevance of pharmacokinetic studies in designing efficacy trials in juvenile major depression.

  Journal of child and adolescent psychopharmacology 20060101

• Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain.

  Neuroscience 20060101

• Pharmacologic treatment of acute and chronic stress following trauma: 2006.

  The Journal of clinical psychiatry 20060101

• Syndrome of inappropriate secretion of antidiuretic hormone associated with paroxetine.

  Journal of anesthesia 20060101

• Treatment of eating disorders improves eating symptoms but not alexithymia and dissociation proneness.

  Comprehensive psychiatry 20060101

• The characterisation of selected antidepressant drugs using electrospray ionisation with ion trap mass spectrometry and with quadrupole time-of-flight mass spectrometry and their determination by high-performance liquid chromatography/electrospray ionisation tandem mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20060101

• Antinociceptive effects of fluoxetine and paroxetine with their related actions on glycemia in mice.

  Neuro endocrinology letters 20060101

• Paxil and the risk of birth defects.

  FDA consumer 20060101

• Oxcarbazepine treatment for paroxetine-induced restless leg syndrome.

  General hospital psychiatry 20060101

• Topiramate plus citalopram in the treatment of Compulsive-Impulsive Sexual Behaviors.

  Clinical practice and epidemiology in mental health : CP & EMH 20060101

• Lowe syndrome.

  Orphanet journal of rare diseases 20060101

• Association between two distinct executive tasks in schizophrenia: a functional transcranial Doppler sonography study.

  BMC psychiatry 20060101

• Long-term pharmacotherapy for post-traumatic stress disorder.

  CNS drugs 20060101

• [Effectiveness of venlafaxine extended release and conventional antidepressants in elderly patients with depressive disorder].

  Actas espanolas de psiquiatria 20060101

• About the cover: St. John's wort.

  Journal of the Society for Integrative Oncology 20060101

• Biology and therapy of fibromyalgia. New therapies in fibromyalgia.

  Arthritis research & therapy 20060101

• [Treatment of non-psychotic depression in outpatient clinic].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20060101

• Recurrence of panic disorder during pregnancy: a 7-year naturalistic follow-up study.

  Clinical neuropharmacology 20060101

• Pilot evaluation of selective serotonin reuptake inhibitor antidepressants in hot flash patients under androgen-deprivation therapy for prostate cancer.

  Prostate cancer and prostatic diseases 20060101

• A national survey of cardiovascular physicians' beliefs and clinical care practices when diagnosing and treating depression in patients with cardiovascular disease.

  Cardiology in review 20060101

• Alteration of serotonin transporter density and activity in fibromyalgia.

  Arthritis research & therapy 20060101

• Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].

  BMC medicine 20060101

• Maintenance treatment with paroxetine, but not psychotherapy, prevented recurrent major depression in older persons.

  ACP journal club 20060101

• A novel treatment option of bipolar depression with psychotic and catatonic features.

  General hospital psychiatry 20060101

• Dresden PTSD treatment study: randomized controlled trial of motor vehicle accident survivors.

  BMC psychiatry 20060101

• Hypersensitivity to paroxetine.

  Allergologia et immunopathologia 20060101

• Court filing makes public my previously suppressed analysis of Paxil's effects.

  Ethical human psychology and psychiatry 20060101

• Discontinuation syndrome associated with paroxetine in depressed patients: a retrospective analysis of factors involved in the occurrence of the syndrome.

  CNS drugs 20060101

• Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons.

  BMC psychiatry 20060101

• Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.

  Neuropsychobiology 20060101

• Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome.

  Arthritis research & therapy 20060101

• Paroxetine for somatic pain associated with physical illness: a review.

  Primary care companion to the Journal of clinical psychiatry 20060101

• Potential interactions of methylphenidate and atomoxetine with dextromethorphan.

  Journal of the American Pharmacists Association : JAPhA 20060101

• Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid program.

  Journal of managed care pharmacy : JMCP 20060101

• Escitalopram: a review of its use in the management of anxiety disorders.

  CNS drugs 20060101

• [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].

  Tijdschrift voor psychiatrie 20060101

• Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study.

  Clinical neuropharmacology 20060101

• The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trials.

  Primary care companion to the Journal of clinical psychiatry 20060101

• Antidepressants and inflammatory bowel disease: a systematic review.

  Clinical practice and epidemiology in mental health : CP & EMH 20060101

• [Swallowing phobia: symptoms, diagnosis and treatment].

  Actas espanolas de psiquiatria 20060101

• A randomized controlled trial of paroxetine for noncardiac chest pain.

  Psychopharmacology bulletin 20060101

• Brief report: paroxetine in younger and adult individuals at high risk for suicide.

  Psychopharmacology bulletin 20060101

• Induction of a mixed depressive episode during rTMS treatment in a patient with refractory major depression.

  The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20060101

• Cost-utility of selective serotonin reuptake inhibitors for depression in primary care in Catalonia.

  Acta psychiatrica Scandinavica. Supplementum 20060101

• Pharmacotherapy of social anxiety disorder: what does the evidence tell us?

  The Journal of clinical psychiatry 20060101

• [Methadone: from pharmacokinetic profile to clinical pharmacology].

  L'Encephale 20060101

• Rare case of serotonin syndrome with therapeutic doses of paroxetine.

  American journal of therapeutics 20060101

• Even more suicide attempts in clinical trials with paroxetine randomised against placebo.

  BMC psychiatry 20060101

• Diastereoselective synthesis of some novel benzopyranopyridine derivatives.

  Beilstein journal of organic chemistry 20060101

• Depression and psoriasis comorbidity. Treatment with paroxetine: two case reports.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20060101

• Efficacy and safety of selective serotonin reuptake inhibitors in the treatment of depression in children and adolescents: practitioner review.

  Clinical drug investigation 20060101

• Resistant social anxiety disorder response to Escitalopram.

  Clinical practice and epidemiology in mental health : CP & EMH 20060101

• [The Multidisciplinary Guideline for Depression: a commentary].

  Tijdschrift voor psychiatrie 20060101

• Anthroposophic therapy for chronic depression: a four-year prospective cohort study.

  BMC psychiatry 20060101

• [A comparative study of efficacy and tolerability of antidepressants from different classes in mild and moderate depression].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20060101

• [An additional short-term use of benzodiazepine anxiolytics at the initial stage of the treatment of panic disorders].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20060101

• Cytotoxicity of different selective serotonin reuptake inhibitors (SSRIs) against cancer cells.

  Journal of experimental therapeutics & oncology 20060101

• Effects of the antidepressant duloxetine on body weight: analyses of 10 clinical studies.

  Primary care companion to the Journal of clinical psychiatry 20060101

• [Case report of an elderly woman who developed a pain disorder following her husband's death].

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20060101

• Urticarial vasculitis secondary to paroxetine.

  Journal of drugs in dermatology : JDD 20060101

• Paroxetine use in the treatment of premenstrual dysphoric disorder.

  Women's health (London, England) 20060101

• An HPLC method for the indirect quantification of a quinone adduct of the drug paroxetine.

  Acta poloniae pharmaceutica 20060101

• Centrally active nonhormonal hot flash therapies.

  The American journal of medicine 20051219

• [The seroxat issue].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20051215

• Development of a solid phase extraction for 13 'new' generation antidepressants and their active metabolites for gas chromatographic-mass spectrometric analysis.

  Journal of chromatography. A 20051209

• Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies.

  Pharmacoepidemiology and drug safety 20051201

• Bacterial efflux systems and efflux pumps inhibitors.

  Biochimie 20051201

• Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20051201

• Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment.

  Neuropharmacology 20051201

• The effect of pharmacotherapy on personality disorders in panic disorder: a one year naturalistic study.

  Journal of affective disorders 20051201

• Sustained pharmacological blockade of NK1 substance P receptors causes functional desensitization of dorsal raphe 5-HT 1A autoreceptors in mice.

  Journal of neurochemistry 20051201

• Serotonin and depression: a disconnect between the advertisements and the scientific literature.

  PLoS medicine 20051201

• Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients.

  Journal of clinical psychopharmacology 20051201

• Combined treatment with sulpiride and paroxetine for accelerated response in patients with major depressive disorder.

  Journal of clinical psychopharmacology 20051201

• An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.

  Journal of clinical psychopharmacology 20051201

• Increased cholesterol levels after paroxetine treatment in patients with panic disorder.

  Journal of clinical psychopharmacology 20051201

• Successful use of continuation electroconvulsive therapy in a case of late-onset Leonhard's confusion psychosis.

  The journal of ECT 20051201

• Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20051201

• A mathematical model for paroxetine antidepressant effect time course and its interaction with pindolol.

  Journal of pharmacokinetics and pharmacodynamics 20051201

• Depression treatment during outpatient visits by U.S. children and adolescents.

  The Journal of adolescent health : official publication of the Society for Adolescent Medicine 20051201

• Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder.

  Expert opinion on pharmacotherapy 20051201

• Post-traumatic stress disorder: evidence-based research for the third millennium.

  Evidence-based complementary and alternative medicine : eCAM 20051201

• Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview.

  International journal of clinical practice 20051201

• Separation-induced ultrasonic vocalization in rat pups: further pharmacological characterization.

  Pharmacology, biochemistry, and behavior 20051201

• View point. Journalists get it wrong about mental health mostly through ignorance, not malice, argues Shelley Jofre.

  Mental health today (Brighton, England) 20051201

• Influence of personality disorder on the treatment of panic disorder--comparison study.

  Neuro endocrinology letters 20051201

• Effect of paroxetine on marble-burying behavior in mice.

  Methods and findings in experimental and clinical pharmacology 20051201

• A severe (type II) hepatopulmonary syndrome in a patient with idiopathic portal hypertension and treatment with paroxetine.

  The Netherlands journal of medicine 20051201

• Antidepressant treatment outcomes of psychogenic movement disorder.

  The Journal of clinical psychiatry 20051201

• Sleep and psychiatry.

  Dialogues in clinical neuroscience 20051201

• Contribution of sleep research to the development of new antidepressants.

  Dialogues in clinical neuroscience 20051201

• Efficacy and tolerability of controlled-release paroxetine in the treatment of severe depression: post hoc analysis of pooled data from a subset of subjects in four double-blind clinical trials.

  Clinical therapeutics 20051201

• Duloxetine in the treatment of stress urinary incontinence.

  Therapeutics and clinical risk management 20051201

• Fluvoxamine in the treatment of anxiety disorders.

  Neuropsychiatric disease and treatment 20051201

• Combination/augmentation strategies for improving the treatment of depression.

  Neuropsychiatric disease and treatment 20051201

• Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment.

  Neuropsychiatric disease and treatment 20051201

• Duration of untreated illness in panic disorder: a poor outcome risk factor?

  Neuropsychiatric disease and treatment 20051201

• Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine.

  Neuroscience letters 20051125

• Paroxetine (Paxil) and congenital malformations.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20051122

• Effects of paroxetine on cardiovascular response to mental stress in subjects with a history of coronary artery disease and no psychiatric diagnoses.

  Psychopharmacology 20051101

• Impaired platelet [3H]paroxetine binding in female patients with borderline personality disorder.

  Psychopharmacology 20051101

• Quantitative 1H NMR method for the routine spectroscopic determination of enantiomeric purity of active pharmaceutical ingredients fenfluramine, sertraline, and paroxetine.

  Magnetic resonance in chemistry : MRC 20051101

• Effect of prolonged exposure to milnacipran on norepinephrine transporter in cultured bovine adrenal medullary cells.

  Biochemical pharmacology 20051101

• Metabotropic glutamate II receptor agonists in panic disorder: a double blind clinical trial with LY354740.

  International clinical psychopharmacology 20051101

• Paroxetine-associated spontaneous sexual stimulation.

  International clinical psychopharmacology 20051101

• Mood- and restraint-based antecedents to binge episodes in bulimia nervosa: possible influences of the serotonin system.

  Psychological medicine 20051101

• Beyond trial registration: a global trial bank for clinical trial reporting.

  PLoS medicine 20051101

• Suicide and self-harm following prescription of SSRIs and other antidepressants: confounding by indication.

  British journal of clinical pharmacology 20051101

• St John's wort is at least as effective as paroxetine in reducing severity of depression and is better tolerated.

  Evidence-based mental health 20051101

• Differential effects of simultaneous or sequential administration of paroxetine and WAY-100,635 on ejaculatory behavior.

  Pharmacology, biochemistry, and behavior 20051101

• Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.

  Journal of psychopharmacology (Oxford, England) 20051101

• Is the platelet serotonin transporter different in venous vs. arterial blood?

  Neurochemical research 20051101

• Galactorrhea during treatment with trimipramine. A case report.

  Pharmacopsychiatry 20051101

• [Treatment of anxiety syndrome. A systematic literature review. Summary and conclusions by the SBU].

  Lakartidningen 20051101

• Reexamining paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety.

  The Journal of clinical psychiatry 20051101

• Abrupt discontinuation of psychotropic drugs following confirmation of pregnancy: a risky practice.

  Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 20051101

• Later results don't confirm antidepressant suicide link.

  Nature 20051027

• Differential effects of paroxetine on raphe and cortical 5-HT1A binding: a PET study in monkeys.

  NeuroImage 20051015

• alpha2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice.

  Behavioural brain research 20051014

• Evaluation of the role of P-glycoprotein in the uptake of paroxetine, clozapine, phenytoin and carbamazapine by bovine retinal endothelial cells.

  Neuropharmacology 20051001

• Are they being used safely? A retrospective cross-sectional tertiary health care survey of selective serotonin reuptake inhibitors prescribing practice in Singapore.

  Human psychopharmacology 20051001

• Effects of paroxetine and venlafaxine XR on heart rate variability in depression.

  Journal of clinical psychopharmacology 20051001

• Somatic symptoms of depression in elderly patients with medical comorbidities.

  International journal of geriatric psychiatry 20051001

• Defective alleles may not have contributed to adverse effects.

  Therapeutic drug monitoring 20051001

• Neonatal signs following exposure to SSRIs.

  Human psychopharmacology 20051001

• Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051001

• Treatment approaches to symptoms associated with frontotemporal degeneration.

  Current psychiatry reports 20051001

• Influence of fluoxetine and paroxetine in behavioral sensitization induced by ethanol in mice.

  Pharmacology, biochemistry, and behavior 20051001

• [The serotonin syndrome].

  Psychiatrische Praxis 20051001

• Differences in total medical costs across the SSRIs for the treatment of depression and anxiety.

  The American journal of managed care 20051001

• Adherence to paroxetine CR compared with paroxetine IR in a Medicare-eligible population with anxiety disorders.

  The American journal of managed care 20051001

• Implications of an SSRI generic step therapy pharmacy benefit design: an economic model in anxiety disorders.

  The American journal of managed care 20051001

• Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.

  Journal of palliative medicine 20051001

• Differences in compliance patterns across the selective serotonin reuptake inhibitors (SSRIs).

  Current medical research and opinion 20051001

• Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.

  Current drug metabolism 20051001

• Paroxetine response and tolerability among ethnic minority patients with mood or anxiety disorders: a pooled analysis.

  The Journal of clinical psychiatry 20051001

• [Cannabis dependence and social phobia].

  L'Encephale 20051001

• Selective serotonin reuptake inhibitors treatment effects on auditory measures in depressed female subjects.

  European journal of pharmacology 20050927

• Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.

  Journal of medicinal chemistry 20050922

• Reversal of inappropriate peripheral vascular responses in hypertrophic cardiomyopathy.

  Journal of the American College of Cardiology 20050906

• Postpartum depression without delivering a child?

  Acta psychiatrica Scandinavica 20050901

• Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals.

  Environmental health perspectives 20050901

• The pharmacological management of depression.

  Dialogues in clinical neuroscience 20050901

• Pharmacogenomics in depression and antidepressants.

  Dialogues in clinical neuroscience 20050901

• The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.

  Dialogues in clinical neuroscience 20050901

• Dose-response relationship of recent antidepressants in the short-term treatment of depression.

  Dialogues in clinical neuroscience 20050901

• Neuroendocrine predictors of the evolution of depression.

  Dialogues in clinical neuroscience 20050901

• Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?

  Journal of psychopharmacology (Oxford, England) 20050901

• Does psychological treatment help only those patients with severe irritable bowel syndrome who also have a concurrent psychiatric disorder?

  The Australian and New Zealand journal of psychiatry 20050901

• 'Fear of falling' gait: a potentially reversible psychogenic gait disorder.

  Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 20050901

• Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment.

  The Journal of clinical psychiatry 20050901

• Risperidone half-life in a patient taking paroxetine -- a case report.

  Pharmacopsychiatry 20050901

• [The impact of antidepressive therapy on work productivity and life satisfaction--a one-year follow-up study].

  Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20050901

• Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder.

  Neuropsychiatric disease and treatment 20050901

• Posttraumatic Stress Disorder and Acute Stress Disorder II: Considerations for Treatment and Prevention.

  Psychiatry (Edgmont (Pa. : Township)) 20050901

• Adult suicides linked to popular antidepressant.

  Nature 20050825

• Validation of a selective method for determination of paroxetine in human plasma by LC-MS/MS.

  Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20050817

• Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain.

  Brain research 20050816

• Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer.

  NeuroImage 20050815

• Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects.

  NeuroImage 20050815

• Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism.

  American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20050805

• High- and low-affinity binding of S-citalopram to the human serotonin transporter mutated at 20 putatively important amino acid positions.

  Neuroscience letters 20050805

• Automated screening with confirmation of mechanism-based inactivation of CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2 in pooled human liver microsomes.

  Drug metabolism and disposition: the biological fate of chemicals 20050801

• Platelet serotonergic markers as endophenotypes for obsessive-compulsive disorder.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050801

• Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment.

  Journal of neurochemistry 20050801

• Exposure assessment and microcosm fate of selected selective serotonin reuptake inhibitors.

  Regulatory toxicology and pharmacology : RTP 20050801

• Trajectories of treatment response in late-life depression: psychosocial and clinical correlates.

  Journal of clinical psychopharmacology 20050801

• Cost-effectiveness of evidence-based pharmacotherapy or cognitive behavior therapy compared with community referral for major depression in predominantly low-income minority women.

  Archives of general psychiatry 20050801

• A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder.

  Current medical research and opinion 20050801

• Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials.

  The Journal of clinical psychiatry 20050801

• Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder.

  American journal of obstetrics and gynecology 20050801

• Dysphonia induced by selective serotonin reuptake inhibitors.

  Southern medical journal 20050801

• Duloxetine hydrochloride: a new dual-acting medication for the treatment of major depressive disorder.

  Clinical therapeutics 20050801

• [St. John's wort in depression. The question is not whether it is effective but how do we use it].

  MMW Fortschritte der Medizin 20050721

• [Serotonin syndrome as a result of concomitant use of paroxetine and sumatriptan].

  Nederlands tijdschrift voor geneeskunde 20050716

• Substance P in serum and cerebrospinal fluid of depressed patients: no effect of antidepressant treatment.

  Psychiatry research 20050715

• Effects of amantadine and budipine on antidepressant drug-evoked changes in extracellular 5-HT in the frontal cortex of freely moving rats.

  British journal of pharmacology 20050701

• Paroxetine is effective in desensitizing 5-HT1A receptor function in adult offspring exposed prenatally to cocaine.

  Psychopharmacology 20050701

• Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.

  International clinical psychopharmacology 20050701

• Toxic hepatitis associated with paroxetine.

  International journal of clinical practice 20050701

• What happens with adverse events during 6 months of treatment with selective serotonin reuptake inhibitors?

  The Journal of clinical psychiatry 20050701

• Late-onset major depression: clinical and treatment-response variability.

  International journal of geriatric psychiatry 20050701

• Paroxetine-related tremor.

  Geriatrics 20050701

• Responsiveness of 5-HT(1A) and 5-HT2 receptors in the rat orbitofrontal cortex after long-term serotonin reuptake inhibition.

  Journal of psychiatry & neuroscience : JPN 20050701

• Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder.

  Psychiatry research 20050630

• Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI).

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050605

• Evidence-based pharmacotherapy of Generalized Anxiety Disorder.

  The international journal of neuropsychopharmacology 20050601

• In vitro-in vivo extrapolation of CYP2D6 inactivation by paroxetine: prediction of nonstationary pharmacokinetics and drug interaction magnitude.

  Drug metabolism and disposition: the biological fate of chemicals 20050601

• Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients.

  International immunopharmacology 20050601

• Anxiolytic suppression of repetitive transcranial magnetic stimulation-induced anxiety in the rats.

  Progress in neuro-psychopharmacology & biological psychiatry 20050601

• Effect of repeated administration of paroxetine and electroconvulsive shock on the proliferative response of lymphocytes and the synthesis of nitric oxide by macrophages in rats.

  The journal of ECT 20050601

• Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation.

  European journal of clinical pharmacology 20050601

• The four-plates test-retest paradigm to discriminate anxiolytic effects.

  Psychopharmacology 20050601

• Positional asphyxiation from paroxetine.

  The American journal of psychiatry 20050601

• Toxicity with selective serotonin reuptake inhibitors.

  The American journal of psychiatry 20050601

• Lifelong premature ejaculation: definition, serotonergic neurotransmission and drug treatment.

  World journal of urology 20050601

• Treatment of hot flushes in breast and prostate cancer.

  Expert opinion on pharmacotherapy 20050601

• Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder.

  The Journal of clinical psychiatry 20050601

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20050601

• Deliberate self harm (and attempted suicide).

  Clinical evidence 20050601

• Inhibitory effects of psychotropic drugs on mexiletine metabolism in human liver microsomes: prediction of in vivo drug interactions.

  Xenobiotica; the fate of foreign compounds in biological systems 20050601

• Effect of treating depression on quality-of-life and exercise tolerance in severe COPD.

  COPD 20050601

• Possible deleterious effects of adjunctive omega-3 fatty acids in post-traumatic stress disorder patients.

  Neuropsychiatric disease and treatment 20050601

• Atypical presentations of atypical antipsychotics.

  Psychiatry (Edgmont (Pa. : Township)) 20050601

• Short-term paroxetine treatment does not alter the motor response to levodopa in PD.

  Neurology 20050524

• [Journalist and professor].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20050519

• Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

  JAMA 20050518

• St John's for depression, worts and all.

  BMJ (Clinical research ed.) 20050514

• Convenient synthesis of substituted piperidinones from alpha,beta-unsaturated amides: formal synthesis of deplancheine, tacamonine, and paroxetine.

  The Journal of organic chemistry 20050513

• Selective serotonin reuptake inhibitors in familial Mediterranean fever: are we treating depression or inflammation?

  Rheumatology international 20050501

• Selective serotonin reuptake inhibitors induce spontaneous interneuronal activity in the leech nervous system.

  Journal of neurophysiology 20050501

• Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine.

  Psychopharmacology 20050501

• Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.

  International clinical psychopharmacology 20050501

• Dopaminergic mechanism of antidepressant action in depressed patients.

  Journal of affective disorders 20050501

• Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test.

  Psychopharmacology 20050501

• Reduced density of platelet-binding sites for [3H]paroxetine in remitted bulimic women.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050501

• The monoamine-mediated antiallodynic effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a rat model of neuropathic pain.

  Anesthesia and analgesia 20050501

• Developmental exposure of rats to chlorpyrifos leads to behavioral alterations in adulthood, involving serotonergic mechanisms and resembling animal models of depression.

  Environmental health perspectives 20050501

• A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.

  Health technology assessment (Winchester, England) 20050501

• Accelerating symptom-reduction in late-life depression: a double-blind, randomized, placebo-controlled trial of sleep deprivation.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20050501

• Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram.

  Pharmacotherapy 20050501

• Paroxetine serum concentrations in depressed patients and response to treatment.

  Pharmacopsychiatry 20050501

• An evaluation of paroxetine in generalised social anxiety disorder.

  Expert opinion on pharmacotherapy 20050501

• Validation of a revised visual analog scale for premenstrual mood symptoms: results from prospective and retrospective trials.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050501

• Determination of fluoxetine and its N-desmethyl metabolite in human plasma by high-performance liquid chromatography.

  Talanta 20050430

• Breast cancer risk in a large cohort of female antidepressant medication users.

  Cancer letters 20050418

• [Serotonin syndrome as a result of concomitant use of paroxetine and sumatriptan].

  Nederlands tijdschrift voor geneeskunde 20050416

• Co-prescription of cytochrome P450 2D6/3A4 inhibitor-substrate pairs in clinical practice. A retrospective analysis of data from Norwegian primary pharmacies.

  European journal of clinical pharmacology 20050401

• Antidepressant-induced sweating.

  The Annals of pharmacotherapy 20050401

• Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine.

  Journal of clinical psychopharmacology 20050401

• Synthesis, structural identification, and ligand binding of tropane ring analogs of paroxetine and an unexpected aza-bicyclo[3.2.2]nonane rearrangement product.

  Bioorganic & medicinal chemistry 20050401

• Do venlafaxine XR and paroxetine equally influence negative and positive affect?

  Journal of affective disorders 20050401

• Cognitive therapy vs medications in the treatment of moderate to severe depression.

  Archives of general psychiatry 20050401

• Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.

  Archives of general psychiatry 20050401

• Selective serotonin reuptake blockade increases extracellular dopamine in noradrenaline-rich isocortical but not prefrontal areas: dependence on serotonin-1A receptors and independence from noradrenergic innervation.

  Journal of neurochemistry 20050401

• Paroxetine and improvement of visual hallucinations in patients with dementia with lewy bodies.

  Journal of the American Geriatrics Society 20050401

• Paroxetine, a cytochrome P450 2D6 inhibitor, diminishes the stereoselective O-demethylation and reduces the hypoalgesic effect of tramadol.

  Clinical pharmacology and therapeutics 20050401

• Pilot study of the reducing effect on amyloidosis in vivo by three FDA pre-approved drugs via the Alzheimer's APP 5' untranslated region.

  Current Alzheimer research 20050401

• [Use of paroxetine on-demand in premature ejaculation].

  Actas urologicas espanolas 20050401

• Decrease of serotonin transporters in blood platelets after epileptic seizures.

  Neurochemical research 20050401

• [Hepatotoxicity induced by paroxetine].

  Medicina clinica 20050319

• Tamoxifen pharmacogenetics moves closer to reality.

  Journal of the National Cancer Institute 20050316

• Binding of S-citalopram and paroxetine discriminates between species.

  Synapse (New York, N.Y.) 20050315

• Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.

  European journal of pharmacology 20050307

• Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine.

  BMJ (Clinical research ed.) 20050305

• Paroxetine combined with a 5-HT(1A) receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats.

  Psychopharmacology 20050301

• Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.

  British journal of pharmacology 20050301

• The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20050301

• Improvement of dry mouth by replacing paroxetine with fluvoxamine.

  The Annals of pharmacotherapy 20050301

• Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment.

  Journal of neurochemistry 20050301

• Body pain and treatment response in late-life depression.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20050301

• Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence.

  Addiction (Abingdon, England) 20050301

• Interview quality and signal detection in clinical trials.

  The American journal of psychiatry 20050301

• Hyponatremia upon resumption of paroxetine therapy.

  Internal medicine (Tokyo, Japan) 20050301

• A drug may help hot flashes after prostate cancer treatment.

  Mayo Clinic health letter (English ed.) 20050301

• [Methadone and sleep apnea syndrome].

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050301

• The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis.

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20050301

• What moderator characteristics are associated with better prognosis for depression?

  Neuropsychiatric disease and treatment 20050301

• Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.

  Neuropsychiatric disease and treatment 20050301

• Onset of improvement and response to mirtazapine in depression: a multicenter naturalistic study of 4771 patients.

  Neuropsychiatric disease and treatment 20050301

• Characterization of serotonin transporter in blood lymphocytes of rats. Modulation by in vivo administration of mitogens.

  Journal of neuroimmunology 20050201

• Chronoamperometry to determine differential reductions in uptake in brain synaptosomes from serotonin transporter knockout mice.

  Analytical chemistry 20050201

• Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.

  Pediatrics 20050201

• Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.

  Archives of general psychiatry 20050201

• Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis.

  Lancet (London, England) 20050201

• Antidepressant-associated chronic irritable dysphoria (acid) in bipolar disorder: a case series.

  Journal of affective disorders 20050201

• Re: Paroxetine in the treatment of severe non-dermatological pruritus.

  Journal of pain and symptom management 20050201

• Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy.

  Breast cancer research and treatment 20050201

• Nonaqueous capillary electrophoresis method for the analysis of tamoxifen, imipramine and their main metabolites in urine.

  Talanta 20050115

• Development and validation method for determination of fluoxetine and its main metabolite norfluoxetine by nonaqueous capillary electrophoresis in human urine.

  Talanta 20050115

• CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

  Journal of the National Cancer Institute 20050105

• The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression.

  The pharmacogenomics journal 20050101

• Role of the orbital cortex and of the serotonergic system in a rat model of obsessive compulsive disorder.

  Neuroscience 20050101

• The role of venlafaxine in the treatment of obsessive-compulsive disorder.

  The Annals of pharmacotherapy 20050101

• Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: a double-blind placebo-controlled study.

  International clinical psychopharmacology 20050101

• A population-based assessment of the potential interaction between serotonin-specific reuptake inhibitors and digoxin.

  British journal of clinical pharmacology 20050101

• Characterization of an allosteric citalopram-binding site at the serotonin transporter.

  Journal of neurochemistry 20050101

• Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.

  Progress in neuro-psychopharmacology & biological psychiatry 20050101

• Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.

  BMC psychiatry 20050101

• Treatment of depression and effect of antidepression treatment on nutritional status in chronic hemodialysis patients.

  The American journal of the medical sciences 20050101

• The different roles of 5-HT(2) and 5-HT(3) receptors on antinociceptive effect of paroxetine in chemical stimuli in mice.

  Journal of pharmacological sciences 20050101

• Olanzapine in the treatment of resistant depression.

  The Australian and New Zealand journal of psychiatry 20050101

• DA-8159 reverses selective serotonin reuptake inhibitor-induced erectile dysfunction in rats.

  Urology 20050101

• Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.

  The Journal of clinical psychiatry 20050101

• Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline.

  The Journal of clinical psychiatry 20050101

• Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.

  The Journal of clinical psychiatry 20050101

• Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment.

  Journal of psychopharmacology (Oxford, England) 20050101

• The 5HTTLPR polymorphism, psychopathologic symptoms, and platelet [3H-] paroxetine binding in bulimic syndromes.

  The International journal of eating disorders 20050101

• The safety of newer antidepressants in pregnancy and breastfeeding.

  Drug safety 20050101

• [Clinical effects of paxil in poststroke rehabilitation].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20050101

• Generalised anxiety disorder in elderly patients : epidemiology, diagnosis and treatment options.

  Drugs & aging 20050101

• Use of biological based therapy in patients with cardiovascular diseases in a university-hospital in New York City.

  BMC complementary and alternative medicine 20050101

• Development and validation of spectrophotometric methods for determination of fluoxetine, sertraline, and paroxetine in pharmaceutical dosage forms.

  Journal of AOAC International 20050101

• Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis: a case report.

  Critical care (London, England) 20050101

• Pharmacological treatments of pathological gambling.

  Journal of gambling studies 20050101

• Selective methodologies for the synthesis of biologically active piperidinic compounds.

  Chemical record (New York, N.Y.) 20050101

• Genomic studies of mood disorders -- the brain as a muscle?

  Genome biology 20050101

• Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.

  Neuropsychobiology 20050101

• Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients.

  Archives of medical research 20050101

• Pharmacotherapy of post-traumatic stress disorder: a family practitioners guide to management of the disease.

  Expert review of neurotherapeutics 20050101

• Spectrophotometric methods for the determination of the antidepressant drug paroxetine hydrochloride in tablets.

  Journal of AOAC International 20050101

• The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label study.

  BMC psychiatry 20050101

• Neuropharmacological therapy of polycythemia vera: roles of circulating catecholamines and serotonin.

  Thrombosis and haemostasis 20050101

• Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe.

  Clinical pharmacokinetics 20050101

• Reported sexual abuse predicts impaired functioning but a good response to psychological treatments in patients with severe irritable bowel syndrome.

  Psychosomatic medicine 20050101

• Herb-drug interactions: a literature review.

  Drugs 20050101

• Are SSRIs really more effective for anxious depression?

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20050101

• Selective serotonin-reuptake inhibitors in the treatment of premature ejaculation.

  The Annals of pharmacotherapy 20050101

• Interpersonal psychotherapy for depression with panic spectrum symptoms: a pilot study.

  Depression and anxiety 20050101

• The use of selective serotonin reuptake inhibitors in children and adolescents with major depression.

  Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc 20050101

• The level of recognition of physical symptoms in patients with a major depression episode in the outpatient psychiatric practice in Puerto Rico: an observational study.

  BMC psychiatry 20050101

• Depression and Obstructive Sleep Apnea (OSA).

  Annals of general psychiatry 20050101

• Effects of chronic paroxetine pretreatment on (+/-)-8-hydroxy-2-(di-n-propyl-amino)tetralin induced c-fos expression following sexual behavior.

  Neuroscience 20050101

• Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvement.

  Journal of molecular neuroscience : MN 20050101

• A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20050101

• Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study.

  Depression and anxiety 20050101

• Suicide attempts in clinical trials with paroxetine randomised against placebo.

  BMC medicine 20050101

• Drug treatment of depression in HIV-positive patients : safety considerations.

  Drug safety 20050101

• Manufacturing violations prompt seizure of Paxil CR, Avandamet.

  FDA consumer 20050101

• Antidepressants and suicide: a commentary on a significant contribution to this debate.

  Crisis 20050101

• [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].

  L'Encephale 20050101

• Treatment of diarrhea-predominant irritable bowel syndrome with paroxetine.

  Primary care companion to the Journal of clinical psychiatry 20050101

• Efavirenz induces depressive-like behaviour, increased stress response and changes in the immune response in rats.

  Neuroimmunomodulation 20050101

• Pregnancy and delivery while receiving vagus nerve stimulation for the treatment of major depression: a case report.

  Annals of general psychiatry 20050101

• RLIP76, a non-ABC transporter, and drug resistance in epilepsy.

  BMC neuroscience 20050101

• Citalopram associated with acute angle-closure glaucoma: case report.

  BMC ophthalmology 20050101

• Comorbidity issues in the pharmacological treatment of Pathological Gambling: a critical review.

  Clinical practice and epidemiology in mental health : CP & EMH 20050101

• Frequent attenders in general practice: problem solving treatment provided by nurses [ISRCTN51021015].

  BMC family practice 20050101

• Selective serotonin reuptake inhibitors and the risk for suicidality in adolescents: an update.

  International journal of adolescent medicine and health 20050101

• [Comment. The role of regulatory agencies in the evaluation of drug safety: speaking about of selective serotonin receptor inhibitors].

  Gaceta sanitaria 20050101

• Treatment with medications affecting dopaminergic and serotonergic mechanisms: effects on fluency and anxiety in persons who stutter.

  Journal of fluency disorders 20050101

• [Likely serotoninergic syndrome from an interaction between amitryptiline, paroxetine, and linezolid].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20050101

• [Comparative efficacy and tolerability of paroxetine and amitriptiline in long-term therapy preventing depressive recurrences].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20050101

• Itch in systemic disease: therapeutic options.

  Dermatologic therapy 20050101

• Randomized placebo-controlled trial of a selective serotonin reuptake inhibitor in the treatment of nondepressed tinnitus subjects.

  Psychosomatic medicine 20050101

• Primary care use of antipsychotic drugs: an audit and intervention study.

  Annals of general psychiatry 20050101

• [Rexetin in the therapy of depressive states].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20050101

• Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.

  Drug safety 20050101

• Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK.

  Drug safety 20050101

• Use of atypical antipsychotics in refractory depression and anxiety.

  The Journal of clinical psychiatry 20050101

• Diagnosis and management of trichotillomania in children and adolescents.

  Paediatric drugs 20050101

• An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology.

  BMC women's health 20050101

• Escitalopram in adolescent major depression.

  MedGenMed : Medscape general medicine 20050101

• On the origin of great ideas: science in the age of big pharma.

  The Hastings Center report 20050101

• Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20050101

• [Mechanism of action of antidepressant drugs: importance of genetically modified mice in the pharmacological in vivo approach].

  Therapie 20050101

• Development of early malignant bilateral breast disease in relation to antidepressant treatment.

  Acta chirurgica Belgica 20050101

• Selective serotonine reuptake inhibitors prevents emotional lability in healthy subjects.

  European review for medical and pharmacological sciences 20050101

• Paroxetine overdose.

  Indian journal of psychiatry 20050101

• Factitious schizophrenia.

  Indian journal of psychiatry 20050101

• Obsessive-compulsive disorder: An interface with possible psychotic features.

  Indian journal of psychiatry 20050101

• Estimating treatment effects from longitudinal clinical trial data with missing values: comparative analyses using different methods.

  Psychiatry research 20041215

• Antidepressants and the risk of suicidal behaviors.

  JAMA 20041215

• In-vivo modulation of central 5-hydroxytryptamine (5-HT1A) receptor-mediated responses by the cholinergic system.

  The international journal of neuropsychopharmacology 20041201

• A multivantaged behavioural method for measuring onset and sequence of the clinical actions of antidepressants.

  The international journal of neuropsychopharmacology 20041201

• Serotonin 1A receptor binding and treatment response in late-life depression.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20041201

• From the editor--drug companies under investigation.

  Issues in mental health nursing 20041201

• A comparative study of milnacipran and paroxetine in outpatients with major depression.

  Journal of affective disorders 20041201

• A taxpayer-funded clinical trials registry and results database.

  PLoS medicine 20041201

• Effects of oral administration of extracts of Hypericum perforatum (St John's wort) on brain serotonin transporter, serotonin uptake and behaviour in mice.

  The Journal of pharmacy and pharmacology 20041201

• Severe adverse effects in a newborn with two defective CYP2D6 alleles after exposure to paroxetine during late pregnancy.

  Therapeutic drug monitoring 20041201

• Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine.

  Human psychopharmacology 20041201

• Triiodothyronine addition to paroxetine in the treatment of major depressive disorder.

  The Journal of clinical endocrinology and metabolism 20041201

• Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period.

  Pharmacology, biochemistry, and behavior 20041201

• The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder.

  Journal of psychopharmacology (Oxford, England) 20041201

• Is dopamine a limiting factor of the antidepressant-like effect in the mouse forced swimming test?

  Progress in neuro-psychopharmacology & biological psychiatry 20041201

• Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20041201

• [Narcoleptic syndrome as a possible side effect of paroxetine].

  Revista de neurologia 20041201

• Register or perish. Looking to make the downside of therapies known.

  Scientific American 20041201

• Is it ethical to use enhancement technologies to make us better than well?

  PLoS medicine 20041201

• Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.

  The Journal of clinical psychiatry 20041201

• Remission rates in patients with anxiety disorders treated with paroxetine.

  The Journal of clinical psychiatry 20041201

• Risperidone and paroxetine given singly and in combination for bipolar depression.

  The Journal of clinical psychiatry 20041201

• Neuroanatomical changes associated with pharmacotherapy in posttraumatic stress disorder.

  Annals of the New York Academy of Sciences 20041201

• The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region.

  Annals of the New York Academy of Sciences 20041201

• Premature ejaculation. 3. Therapy.

  Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 20041201

• Late bilateral acute angle-closure glaucoma after administration of paroxetine in a patient with plateau iris configuration.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20041201

• Deliberate self harm.

  Clinical evidence 20041201

• In-patient psychiatric-psychotherapeutic treatment of mothers with a generalized anxiety disorder--does the co-admission of their children influence the treatment results? A prospective, controlled study.

  Wiener klinische Wochenschrift 20041130

• Liquid chromatography--electrospray ionisation mass spectrometry method for the determination of escitalopram in human plasma and its application in bioequivalence study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041125

• [Posttraumatic stress disorder (PTSD)].

  Orvosi hetilap 20041114

• A novel antipsychotic, perospirone, has antiserotonergic and antidopaminergic effects in human brain: findings from neuroendocrine challenge tests.

  Psychopharmacology 20041101

• Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.

  The Journal of pharmacology and experimental therapeutics 20041101

• Paroxetine administration failed [corrected] to influence human exercise capacity, perceived effort or hormone responses during prolonged exercise in a warm environment.

  Experimental physiology 20041101

• Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.

  Journal of the American Academy of Child and Adolescent Psychiatry 20041101

• Differential effects of milnacipran, fluvoxamine and paroxetine for inhibited and agitated depression.

  European psychiatry : the journal of the Association of European Psychiatrists 20041101

• A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder.

  Archives of general psychiatry 20041101

• Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.

  Archives of general psychiatry 20041101

• Life-threatening serotonin syndrome in a patient with chronic heart failure and CYP2D6*1/*5.

  Mayo Clinic proceedings 20041101

• Effect of short-term SSRI treatment on cognitive bias in generalised anxiety disorder.

  Psychopharmacology 20041101

• Open-label non-randomized versus double-blind randomized antidepressive treatment: what are the advantages of clinical decision over randomization?

  Pharmacopsychiatry 20041101

• [Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements].

  Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 20041101

• The intangible magic of celebrity marketing.

  PLoS medicine 20041101

• Antidepressant treatment-associated behavioural expression of hypomania: a case series.

  Progress in neuro-psychopharmacology & biological psychiatry 20041101

• Recurrent paroxetine-induced hyponatremia.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20041101

• Institutional review boards and clinical trials registry.

  Human research report 20041101

• Can paroxetine improve well-being in patients with irritable bowel syndrome who do not respond to a high-fiber diet?

  Nature clinical practice. Gastroenterology & hepatology 20041101

• In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain.

  Life sciences 20041029

• Antidepressants for smoking cessation.

  The Cochrane database of systematic reviews 20041018

• In vivo rat model to measure hypogastric nerve stimulation-induced seminal vesicle and vasal pressure responses simultaneously.

  International journal of impotence research 20041001

• The chicken serotonin transporter discriminates between serotonin-selective reuptake inhibitors. A species-scanning mutagenesis study.

  The Journal of biological chemistry 20041001

• Effects of lesopitron on the central nervous system arising from its interaction with 5-HT1A receptors.

  Pharmacology 20041001

• Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20041001

• Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.

  Journal of clinical psychopharmacology 20041001

• Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment.

  Journal of clinical psychopharmacology 20041001

• Early effects of paroxetine on serotonin storage, plasma levels, and urinary excretion: a randomized, double-blind, placebo-controlled trial.

  Journal of clinical psychopharmacology 20041001

• Evaluating the economic consequences of early antidepressant treatment discontinuation: a comparison between controlled-release and immediate-release paroxetine.

  Journal of clinical psychopharmacology 20041001

• SSRI-induced enuresis: a case report.

  Journal of clinical psychopharmacology 20041001

• Effects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetine.

  European journal of clinical pharmacology 20041001

• On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment.

  European urology 20041001

• Drugs vs. talk therapy: 3,079 readers rate their care for depression and anxiety.

  Consumer reports 20041001

• Treatment-resistant posttraumatic stress disorder: strategies for intervention.

  CNS spectrums 20041001

• Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors.

  Biological psychiatry 20041001

• Major medical journals will require registration of clinical trials for publication.

  Report on medical guidelines & outcomes research 20041001

• Pilot evaluation of paroxetine for treating hot flashes in men.

  Mayo Clinic proceedings 20041001

• A case report of a poor metabolizer of CYP2D6 presented with unusual responses to nortriptyline medication.

  Journal of Korean medical science 20041001

• Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

  The Journal of clinical psychiatry 20041001

• Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.

  The Journal of clinical psychiatry 20041001

• Fluvoxamine: new indication. No progress in obsessive-compulsive disorder.

  Prescrire international 20041001

• Paroxetine during lactation: is it really safe for the infant?

  Acta paediatrica (Oslo, Norway : 1992) 20041001

• [Inappropriate secretion of antidiuretic hormone secondary to paroxetine].

  Anales de medicina interna (Madrid, Spain : 1984) 20041001

• Nitroglycerin in the treatment of the serotonin syndrome.

  The American journal of emergency medicine 20041001

• The effectiveness of lithium augmentation of milnacipran: preliminary data using the modified Japanese Psychopharmacology Algorithm.

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20041001

• [An animal model of posttraumatic stress disorder and its validity: effect of paroxetine on a PTSD model in rats].

  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20041001

• Changes in lymphocyte subsets after short-term pharmacotherapy in patients with panic disorder.

  Psychiatry research 20040930

• Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice.

  European journal of pharmacology 20040919

• A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate.

  The international journal of neuropsychopharmacology 20040901

• Fatal venous thromboembolism associated with antipsychotic therapy.

  The Annals of pharmacotherapy 20040901

• Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study.

  International clinical psychopharmacology 20040901

• Treating functional impairment of autism with selective serotonin-reuptake inhibitors.

  The Annals of pharmacotherapy 20040901

• Treatment of glossodynia with olanzapine.

  Journal of the American Academy of Dermatology 20040901

• Comparison of the treatment with paroxetine and reboxetine in panic disorder: a randomized, single-blind study.

  Pharmacopsychiatry 20040901

• The use of selective serotonin reuptake inhibitors in pregnancy.

  Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 20040901

• Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment.

  European psychiatry : the journal of the Association of European Psychiatrists 20040901

• Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes.

  The Journal of clinical psychiatry 20040901

• The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial.

  The Journal of clinical psychiatry 20040901

• Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia.

  Environmental toxicology and chemistry 20040901

• Serum levels of substance P and response to antidepressant pharmacotherapy.

  Pharmacopsychiatry 20040901

• Olanzapine augmentation in panic disorder: a case report.

  Pharmacopsychiatry 20040901

• A male case of monosymptomatic hypochondriacal psychosis responding to olanzapine: a case report.

  Pharmacopsychiatry 20040901

• Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.

  Clinical therapeutics 20040901

• Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression.

  Drugs of today (Barcelona, Spain : 1998) 20040901

• Eating fiber still treats IBS, but... When raw fruits and vegetables fail, the antidepressive Paxil can curb symptoms of irritable bowel syndrome.

  Health news (Waltham, Mass.) 20040901

• Fatigue and cancer: causes, prevalence and treatment approaches.

  British journal of cancer 20040831

• Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders.

  American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20040815

• Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis.

  International journal of impotence research 20040801

• Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus.

  The Journal of pharmacology and experimental therapeutics 20040801

• Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine.

  Journal of clinical psychopharmacology 20040801

• Changes in energy after switching from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine.

  Journal of clinical psychopharmacology 20040801

• The outcome of physical symptoms with treatment of depression.

  Journal of general internal medicine 20040801

• Paroxetine in the treatment of generalised anxiety disorder.

  Expert opinion on pharmacotherapy 20040801

• NMR studies of the inclusion complex between beta-cyclodextrin and paroxetine.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20040801

• Prevalence of induced mania in patients treated with milnacipran: a comparison with paroxetine.

  European psychiatry : the journal of the Association of European Psychiatrists 20040801

• Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.

  The Australian and New Zealand journal of psychiatry 20040801

• Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients.

  Psychiatry and clinical neurosciences 20040801

• Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats.

  Pharmacology, biochemistry, and behavior 20040801

• Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.

  Human psychopharmacology 20040801

• Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to age.

  Human psychopharmacology 20040801

• Calls for full disclosure of clinical trials.

  Nature reviews. Drug discovery 20040801

• 'Dopamine-dependent' side effects of selective serotonin reuptake inhibitors: a clinical review.

  The Journal of clinical psychiatry 20040801

• Successful treatment of sexual dysfunction with dronabinol: a case report.

  The Journal of clinical psychiatry 20040801

• Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: a systematic review of published randomized controlled trials.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040801

• A question of balance.

  Nature 20040722

• Antidepressants and the risk of suicidal behaviors.

  JAMA 20040721

• Tracking system for studies should be in place.

  BMJ (Clinical research ed.) 20040717

• NAMS releases position statement on the treatment of vasomotor symptoms associated with menopause.

  American family physician 20040715

• [Depressed, lacking motivation, unconcentrated. Signs of central deficiency of noradrenaline].

  MMW Fortschritte der Medizin 20040708

• Mechanisms for the inhibition of genital vascular responses by antidepressants in a female rabbit model.

  The Journal of pharmacology and experimental therapeutics 20040701

• Heart rate variability in premenstrual dysphoric disorder.

  Psychoneuroendocrinology 20040701

• Influence of menstrual cycle on platelet serotonin uptake site and serotonin2A receptor binding.

  Psychoneuroendocrinology 20040701

• Management of hot flashes in breast cancer survivors and men with prostate cancer.

  Current oncology reports 20040701

• Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting.

  European journal of clinical pharmacology 20040701

• AUA guideline on the pharmacologic management of premature ejaculation.

  The Journal of urology 20040701

• Genetics in pharmacokinetics?

  The American journal of psychiatry 20040701

• Paroxetine, a selective serotonin reuptake inhibitor, reduces depressive symptoms and subjective handicaps in patients with dizziness.

  Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20040701

• Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression.

  Human psychopharmacology 20040701

• Paroxetine treatment of delusional disorder, somatic type.

  Human psychopharmacology 20040701

• Possible serotonin syndrome arising from an interaction between caffeine and serotonergic antidepressants.

  Human psychopharmacology 20040701

• Antihyperalgesic effects of cizolirtine in diabetic rats: behavioral and biochemical studies.

  Pain 20040701

• Targeting energy metabolism in Huntington's disease.

  Lancet (London, England) 20040701

• Paroxetine, other antidepressants, and youth suicide in New York City: 1993 through 1998.

  The Journal of clinical psychiatry 20040701

• Extrapyramidal symptoms related to adjunctive nizatidine therapy in an adolescent receiving quetiapine and paroxetine.

  Pharmacotherapy 20040701

• Impaired declarative memory in depressed patients is slow to recover: clinical experience.

  Pharmacopsychiatry 20040701

• Lilly goes off Prozac.

  Fortune 20040628

• GlaxoSmithKline to publish clinical trials after US lawsuit.

  BMJ (Clinical research ed.) 20040626

• British drug company to put data online as criticism mounts.

  Nature 20040624

• [Unfortunate title?].

  Lakartidningen 20040624

• Structural differences between paroxetine and femoxetine responsible for differential inhibition of Staphylococcus aureus efflux pumps.

  Bioorganic & medicinal chemistry letters 20040621

• Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development.

  Brain research. Developmental brain research 20040621

• Environmental risk assessment of paroxetine.

  Environmental science & technology 20040615

• GlaxoSmithKline faces US lawsuit over concealment of trial results.

  BMJ (Clinical research ed.) 20040612

• Is GSK guilty of fraud?

  Lancet (London, England) 20040612

• Antidepressants and children. Buried data can be hazardous to a company's health.

  Science (New York, N.Y.) 20040611

• Spitzer sues drug giant for deceiving doctors.

  Nature 20040610

• Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.

  Journal of the National Cancer Institute 20040602

• Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.

  Journal of the National Cancer Institute 20040602

• Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.

  Journal of the National Cancer Institute 20040602

• Prenatal cocaine exposure potentiates paroxetine-induced desensitization of 5-HT2A receptor function in adult male rat offspring.

  Neuropharmacology 20040601

• Evaluation of the effect of chronic antidepressant treatment on neurokinin-1 receptor expression in the rat brain.

  Neuropharmacology 20040601

• Lack of pharmacologic interaction between paroxetine and alprazolam at steady state in healthy volunteers.

  Journal of clinical psychopharmacology 20040601

• Modulation of hyperreactivity to 35% CO2 after one week of treatment with paroxetine and reboxetine: a double-blind, randomized study.

  Journal of clinical psychopharmacology 20040601

• Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants.

  The American journal of psychiatry 20040601

• Making advances where it matters: improving outcomes in mood and anxiety disorders.

  CNS spectrums 20040601

• Pharmacologic differences among the SSRIs: focus on monoamine transporters and the HPA axis.

  CNS spectrums 20040601

• Neonatal complications after intrauterine exposure to SSRI antidepressants.

  Prescrire international 20040601

• Obsessive-compulsive symptoms associated with clozapine and risperidone treatment: three case reports and review of the literature.

  The Kaohsiung journal of medical sciences 20040601

• Pharmacokinetic interactions of drugs with St John's wort.

  Journal of psychopharmacology (Oxford, England) 20040601

• Serotonin function, personality-trait variations, and childhood abuse in women with bulimia-spectrum eating disorders.

  The Journal of clinical psychiatry 20040601

• Hydrolysis and photolysis of paroxetine, a selective serotonin reuptake inhibitor, in aqueous solutions.

  Environmental toxicology and chemistry 20040601

• Cellular abnormalities in depression: evidence from postmortem brain tissue.

  Dialogues in clinical neuroscience 20040601

• Neuroplasticity in mood disorders.

  Dialogues in clinical neuroscience 20040601

• Neural plasticity: consequences of stress and actions of antidepressant treatment.

  Dialogues in clinical neuroscience 20040601

• Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.

  Proceedings of the National Academy of Sciences of the United States of America 20040525

• Depressing misrepresentation?

  Lancet (London, England) 20040522

• [Hyponatremia due to carbamazepine and paroxetine].

  Atencion primaria 20040515

• ADAM is an effective tool for in vivo study of serotonergic function: validation in rat models.

  Synapse (New York, N.Y.) 20040501

• Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?

  European journal of clinical pharmacology 20040501

• Pindolol does not augment cortisol and prolactin responses to paroxetine in healthy subjects.

  Progress in neuro-psychopharmacology & biological psychiatry 20040501

• Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorder.

  Journal of affective disorders 20040501

• The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care.

  International clinical psychopharmacology 20040501

• Limbic-frontal circuitry in major depression: a path modeling metanalysis.

  NeuroImage 20040501

• Response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants.

  Biological psychiatry 20040501

• Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

  The American journal of psychiatry 20040501

• Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, placebo-controlled trial.

  The American journal of gastroenterology 20040501

• Antidepressants in IBS: are we deluding ourselves?

  The American journal of gastroenterology 20040501

• Current concepts in pharmacotherapy for posttraumatic stress disorder.

  Psychiatric services (Washington, D.C.) 20040501

• Paroxetine in major depression: correlating plasma concentrations and clinical response.

  Pharmacopsychiatry 20040501

• 'Compulsive' lever-pressing in rats is attenuated by the serotonin re-uptake inhibitors paroxetine and fluvoxamine but not by the tricyclic antidepressant desipramine or the anxiolytic diazepam.

  Behavioural pharmacology 20040501

• It's an ill pill.

  Mental health today (Brighton, England) 20040501

• Re: Depression, stroke diagnosis, and SSRI discontinuation syndrome.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040501

• Rapidly progressive dementia due to Mycobacterium neoaurum meningoencephalitis.

  Emerging infectious diseases 20040501

• [Combination of serotonergic agents resulted in severe adverse effects].

  Lakartidningen 20040429

• Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data.

  Lancet (London, England) 20040424

• [Gynecomastia-galactorrhea during treatment with mirtazapine].

  Presse medicale (Paris, France : 1983) 20040410

• Antidepressant medications in children.

  The New England journal of medicine 20040408

• Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial.

  Psychopharmacology 20040401

• Paroxetine inhibits acute effects of 3,4-methylenedioxymethamphetamine on the immune system in humans.

  The Journal of pharmacology and experimental therapeutics 20040401

• Transient ischemic attack reported with paroxetine use.

  The Annals of pharmacotherapy 20040401

• Amygdala volume reductions in pediatric patients with obsessive-compulsive disorder treated with paroxetine: preliminary findings.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040401

• Bupropion and paroxetine differentially influence cardiovascular and neuroendocrine responses to stress in depressed patients.

  Journal of affective disorders 20040401

• Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice.

  Journal of neurochemistry 20040401

• Paroxetine retards disease onset and progression in Huntingtin mutant mice.

  Annals of neurology 20040401

• Long term therapy of generalized anxiety disorder.

  European psychiatry : the journal of the Association of European Psychiatrists 20040401

• Trends in the development of new antidepressants. Is there a light at the end of the tunnel?

  Current medicinal chemistry 20040401

• Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms?

  Current drug targets. CNS and neurological disorders 20040401

• Pruritus induced by interruption of paroxetine therapy.

  The British journal of dermatology 20040401

• The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test.

  Pharmacology, biochemistry, and behavior 20040401

• A comparative solid-phase extraction study for the simultaneous determination of fluvoxamine, mianserin, doxepin, citalopram, paroxetine, and etoperidone in whole blood by capillary gas-liquid chromatography with nitrogen-phosphorus detection.

  Journal of analytical toxicology 20040401

• Neonatal encephalopathy after antidepressant exposure during pregnancy. Herbst F, Gortner L. Paroxetine withdrawal syndrome as differential diagnosis of acute neonatal encephalophathy? Z Geburtsh Neonatol 2003; 207: 232-234.

  Zeitschrift fur Geburtshilfe und Neonatologie 20040401

• Paroxetine treatment of depression with posttraumatic stress disorder: effects on autonomic reactivity and cortisol secretion.

  Journal of clinical psychopharmacology 20040401

• Clastogenicity of selective serotonin-reuptake inhibitors.

  Mutation research 20040314

• Drug company experts advised staff to withhold data about SSRI use in children.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20040302

• Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040301

• Paroxetine during breast-feeding: infant weight gain and maternal adherence to counsel.

  European journal of pediatrics 20040301

• Spasmodic dysphonia, a rare form of tardive dystonia, induced by low-dose risperidone?

  The Australian and New Zealand journal of psychiatry 20040301

• Comorbid cannabis use and panic disorder: short term and long term follow-up study.

  Human psychopharmacology 20040301

• Effects of deep brain stimulation of the subthalamic nucleus on sleep architecture in parkinsonian patients.

  Sleep medicine 20040301

• The effects of selective serotonin-reuptake inhibitor on visual evoked potential in rats.

  Journal of pharmacological sciences 20040301

• Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence.

  International journal of clinical pharmacology and therapeutics 20040301

• Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP.

  Pharmacopsychiatry 20040301

• Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers.

  Psychiatric genetics 20040301

• Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison.

  The Journal of clinical psychiatry 20040301

• Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue.

  The Journal of clinical psychiatry 20040301

• Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms.

  Journal of psychopharmacology (Oxford, England) 20040301

• Incidences of new prescribing by British child and adolescent psychiatrists: a prospective study over 12 months.

  Journal of psychopharmacology (Oxford, England) 20040301

• Long-term goals in the management of acute and chronic anxiety disorders.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040301

• Paroxetine in panic disorder: clinical management and long-term follow-up.

  Expert review of neurotherapeutics 20040301

• Treatments for generalized anxiety disorder.

  Expert review of neurotherapeutics 20040301

• Spectral EEG sleep profiles as a tool for prediction of clinical response to antidepressant treatment.

  Dialogues in clinical neuroscience 20040301

• Current perspectives in the management of treatment-resistant depression.

  Dialogues in clinical neuroscience 20040301

• Treatment-refractory schizophrenia.

  Dialogues in clinical neuroscience 20040301

• Poor response to treatment: beyond medication.

  Dialogues in clinical neuroscience 20040301

• Pharmacotherapy and regional cerebral blood flow in children with obsessive compulsive disorder.

  Yonsei medical journal 20040227

• Effect of paroxetine on a model of posttraumatic stress disorder in rats.

  Neuroscience letters 20040226

• Once-daily high-dose pindolol for SSRI-refractory depression.

  Psychiatry research 20040215

• Paroxetine-induced hyponatremia in older adults: a 12-week prospective study.

  Archives of internal medicine 20040209

• Anxiolytic-like effects of escitalopram, citalopram, and R-citalopram in maternally separated mouse pups.

  The Journal of pharmacology and experimental therapeutics 20040201

• Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatment.

  Journal of clinical psychopharmacology 20040201

• Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder.

  Journal of clinical psychopharmacology 20040201

• Paroxetine and the FDA.

  Journal of the American Academy of Child and Adolescent Psychiatry 20040201

• Effect of the novel anxiolytic drug deramciclane on cytochrome P(450) 2D6 activity as measured by desipramine pharmacokinetics.

  European journal of clinical pharmacology 20040201

• Serotonin syndrome with elevated paroxetine concentrations.

  The Annals of pharmacotherapy 20040201

• Regulation of the norepinephrine transporter by chronic administration of antidepressants.

  Biological psychiatry 20040201

• A novel system for the determination of antidepressant concentrations in human breast milk.

  Therapeutic drug monitoring 20040201

• Gamma-hydroxybutyrate dependence with social phobia.

  The American journal of psychiatry 20040201

• Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients.

  International journal of geriatric psychiatry 20040201

• Development and validation method for determination of Paroxetine and its metabolites by nonaqueous capillary electrophoresis in human urine. Experimental design for evaluating the ruggedness of the method.

  Electrophoresis 20040201

• Severe hyponatremia associated with the combined use of thiazide diuretics and selective serotonin reuptake inhibitors.

  The American journal of the medical sciences 20040201

• Paroxetine and the FDA.

  Journal of the American Academy of Child and Adolescent Psychiatry 20040201

• Paroxetine and the FDA.

  Journal of the American Academy of Child and Adolescent Psychiatry 20040201

• Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain.

  Journal of pharmacological sciences 20040201

• Controlled-release paroxetine in the treatment of patients with social anxiety disorder.

  The Journal of clinical psychiatry 20040201

• Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

  The Journal of clinical psychiatry 20040201

• Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial.

  The Journal of clinical psychiatry 20040201

• Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder.

  The Journal of clinical psychiatry 20040201

• Suicidal ideas with paroxetine or venlafaxine.

  Prescrire international 20040201

• What has dry cough in common with pruritus? Treatment of dry cough with paroxetine.

  Journal of pain and symptom management 20040201

• Diabetic neuropathy: an intensive review.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20040115

• Paroxetine alters KCl- or ATP-induced contractile responses of isolated vas deferens in rats chronically treated with ethanol.

  Pharmacological research 20040101

• Paroxetine influences respiration in rats: implications for the treatment of panic disorder.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20040101

• Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy.

  Archives of general psychiatry 20040101

• Early Alzheimer's disease.

  The New England journal of medicine 20040101

• Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.

  Menopause (New York, N.Y.) 20040101

• Paroxetine in the treatment of depressed patients with haematological malignancy: an open-label study.

  Human psychopharmacology 20040101

• Different effects of selective serotonin reuptake inhibitors on a patient suffering from panic disorder.

  Human psychopharmacology 20040101

• Severe symptomatic hyponatremia during citalopram therapy--a case report.

  BMC nephrology 20040101

• Nonhormonal alternatives for the treatment of hot flashes.

  Pharmacotherapy 20040101

• A randomized, placebo-controlled, crossover study of ephedrine for SSRI-induced female sexual dysfunction.

  Journal of sex & marital therapy 20040101

• A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder.

  The Journal of clinical psychiatry 20040101

• Impact of pain on depression treatment response in primary care.

  Psychosomatic medicine 20040101

• Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometric method for the analysis of paroxetine in human plasma.

  Biomedical chromatography : BMC 20040101

• Self-report of depressed mood and depression in women with type 2 diabetes.

  Issues in mental health nursing 20040101

• SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.

  Drugs 20040101

• Paroxetine for hepatopulmonary syndrome?

  Medical hypotheses 20040101

• Paroxetine decreases respiratory irregularity of linear and nonlinear measures of respiration in patients with panic disorder. A preliminary report.

  Neuropsychobiology 20040101

• Delirium induced by abrupt discontinuation of paroxetine.

  The Journal of neuropsychiatry and clinical neurosciences 20040101

• Using antipsychotic agents in older patients.

  The Journal of clinical psychiatry 20040101

• [Detection of new antidepressive agents using thin-layer chromatography].

  Soudni lekarstvi 20040101

• Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine.

  The Journal of clinical psychiatry 20040101

• Cost effectiveness of representatives of three classes of antidepressants used in major depression in the UK.

  PharmacoEconomics 20040101

• Combination of bupropion, paroxetine and quetiapine as adjuvant treatment for multiple myeloma.

  Medical hypotheses 20040101

• Paroxetine use throughout pregnancy: does it pose any risk to the neonate?

  Journal of toxicology. Clinical toxicology 20040101

• Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.

  Clinical pharmacokinetics 20040101

• Paroxetine controlled release.

  CNS drugs 20040101

• Thyroid function in clinical subtypes of major depression: an exploratory study.

  BMC psychiatry 20040101

• A case of social phobia with obsessive-compulsive symptoms improved by paroxetine in combination with risperidone.

  General hospital psychiatry 20040101

• SSRIs do not cause affective blunting in healthy elderly volunteers.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20040101

• Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.

  CNS drugs 20040101

• Pharmacological treatment of adolescent major depression.

  Journal of child and adolescent psychopharmacology 20040101

• Successful treatment of trichotillomania with olanzapine augmentation in an adolescent.

  Journal of child and adolescent psychopharmacology 20040101

• Cognitive behavioral group therapy in panic disorder patients: the efficacy of CBGT versus drug treatment.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20040101

• SSRI treatment-associated stroke: causality assessment in two cases.

  The Annals of pharmacotherapy 20040101

• Serotonin-mediated cyclic AMP inhibitory pathway in platelets of patients affected by panic disorder.

  Neuropsychobiology 20040101

• New formulations of existing antidepressants: advantages in the management of depression.

  CNS drugs 20040101

• Three year naturalistic outcome study of panic disorder patients treated with paroxetine.

  BMC psychiatry 20040101

• [Selective serotonin reuptake inhibitors--current knowledge].

  Psychiatria polska 20040101

• Some aspects of genetic polymorphism in the biotransformation of antidepressants.

  Therapie 20040101

• The association between panic disorder and the L/L genotype of catechol-O-methyltransferase.

  Journal of psychiatric research 20040101

• Worsening of depressive symptoms prior to randomization in clinical trials: a possible screen for placebo responders?

  Journal of psychiatric research 20040101

• Efficacy of quality criteria to identify potentially harmful information: a cross-sectional survey of complementary and alternative medicine web sites.

  Journal of medical Internet research 20040101

• Executive functioning, illness course, and relapse/recurrence in continuation and maintenance treatment of late-life depression: is there a relationship?

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20040101

• Posttraumatic stress disorder: acquisition, recognition, course, and treatment.

  The Journal of neuropsychiatry and clinical neurosciences 20040101

• Psychopharmacology in the New York Times.

  MedGenMed : Medscape general medicine 20040101

• Changes in tolerance to rectal distension correlate with changes in psychological state in patients with severe irritable bowel syndrome.

  Psychosomatic medicine 20040101

• Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: randomised, double-blind, placebo-controlled, fixed-dose study.

  Depression and anxiety 20040101

• [Depression and epilepsy].

  Atencion primaria 20040101

• [Estimation of therapeutical efficacy of weak variable magnetic fields with low value of induction in patients with depression].

  Psychiatria polska 20040101

• FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein.

  Journal of molecular neuroscience : MN 20040101

• Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder.

  BMC psychiatry 20040101

• The Kutcher Generalized Social Anxiety Disorder Scale for Adolescents: assessment of its evaluative properties over the course of a 16-week pediatric psychopharmacotherapy trial.

  Journal of child and adolescent psychopharmacology 20040101

• Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

  Current pharmaceutical design 20040101

• Development of a capillary zone electrophoretic method to determine six antidepressants in their pharmaceutical preparations. Experimental design for evaluating the ruggedness of method.

  Journal of separation science 20040101

• Is remission of depressive symptoms in primary care a realistic goal? A meta-analysis.

  BMC family practice 20040101

• Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose.

  Journal of toxicology. Clinical toxicology 20040101

• Antidepressant treatment and dehydroepiandrosterone sulfate: different effects of amitriptyline and paroxetine.

  Neuropsychobiology 20040101

• Changes in anxiety sensitivity with pharmacotherapy for panic disorder.

  Journal of psychiatric research 20040101

• Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial.

  Psychosomatic medicine 20040101

• [A case of probable neuroleptic malignant syndrome induced by monotherapy with paroxetine].

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20040101

• Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram.

  BMC psychiatry 20040101

• A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions.

  CNS drugs 20040101

• Itch and skin rash from chocolate during fluoxetine and sertraline treatment: case report.

  BMC psychiatry 20040101

• [Leukopenia as side effect of paroxetine].

  Actas espanolas de psiquiatria 20040101

• Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives.

  Clinical pharmacokinetics 20040101

• American Society for Clinical Oncology 40th annual meeting, New Orleans, LA, 5-8 June 2004: breast cancer highlights.

  Breast cancer research : BCR 20040101

• [Neurobiology and pharmacotherapy of social phobia].

  L'Encephale 20040101

• Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.

  Drug safety 20040101

• Pharmacotherapy of pervasive developmental disorders in children and adolescents.

  CNS drugs 20040101

• Duloxetine for the long-term treatment of major depressive disorder in patients aged 65 and older: an open-label study.

  BMC geriatrics 20040101

• Qualitative review of SNRIs in anxiety.

  The Journal of clinical psychiatry 20040101

• Long-term management of major depressive disorder: are differences among antidepressant treatments meaningful?

  The Journal of clinical psychiatry 20040101

• Induction of the rabbit syndrome following coadministration of paroxetine, perphenazine, and amitriptyline.

  Clinical neuropharmacology 20040101

• Occurrence of priapism with risperidone-paroxetine combination in an autistic child.

  Journal of child and adolescent psychopharmacology 20040101

• Biological pathophysiology of mood disorders special reference to the neurotransmitter receptors.

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20040101

• A case of bipolar disorder and typhoid fever.

  International journal of psychiatry in medicine 20040101

• Randomized trial of paroxetine in end-stage COPD.

  Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 20040101

• Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition.

  Journal of medicine 20040101

• Regional pattern of binding and c-Fos induction by (R)- and (S)-citalopram in rat brain.

  Neuroreport 20031219

• Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031215

• Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.

  Journal of medicinal chemistry 20031204

• A hot flash on tamoxifen metabolism.

  Journal of the National Cancer Institute 20031203

• Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.

  Journal of the National Cancer Institute 20031203

• Effects of fenfluramine and antidepressants on protein kinase C activity in rat cortical synaptoneurosomes.

  Synapse (New York, N.Y.) 20031201

• Good treatment outcomes in late-life depression with comorbid anxiety.

  Journal of affective disorders 20031201

• Effects of sertraline on sleep architecture in patients with depression.

  Journal of clinical psychopharmacology 20031201

• A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder.

  Journal of clinical psychopharmacology 20031201

• Paroxetine-induced increase in metabolic end products of nitric oxide.

  Journal of clinical psychopharmacology 20031201

• Neuroleptic malignant syndrome after addition of paroxetine to olanzapine.

  Journal of clinical psychopharmacology 20031201

• Polymorphisms in the CYP 2D6 gene: association with plasma concentrations of fluoxetine and paroxetine.

  Therapeutic drug monitoring 20031201

• Effect of nortriptyline and paroxetine on measures of chaos of heart rate time series in patients with panic disorder.

  Journal of psychosomatic research 20031201

• alpha1-acid glycoprotein in late-life depression: relationship to medical burden and genetics.

  Journal of geriatric psychiatry and neurology 20031201

• Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial.

  Journal of pain and symptom management 20031201

• Serotonin and its transporter on proliferation of fetal heart cells.

  International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20031201

• Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.

  European psychiatry : the journal of the Association of European Psychiatrists 20031201

• Antidepressant medication use and breast cancer risk: a case-control study.

  International journal of epidemiology 20031201

• P-glycoprotein modulation by the designer drugs methylenedioxymethamphetamine, methylenedioxyethylamphetamine and paramethoxyamphetamine.

  Addiction biology 20031201

• Should children take antidepressants?

  The Harvard mental health letter 20031201

• Increased cholesterol levels during paroxetine administration in healthy men.

  The Journal of clinical psychiatry 20031201

• Comparison of managed care charges among patients treated with selective serotonin reuptake inhibitors for premenstrual dysphoric disorder.

  The Journal of clinical psychiatry 20031201

• Time to antidepressant discontinuation: a comparison of controlled-release paroxetine and immediate-release selective serotonin-reuptake inhibitors.

  Managed care interface 20031201

• Deliberate self harm.

  Clinical evidence 20031201

• Light treatment of mood disorders.

  Dialogues in clinical neuroscience 20031201

• Diagnosis and treatment of sleep disorders: a brief review for clinicians.

  Dialogues in clinical neuroscience 20031201

• Enantiomeric separation of the key intermediate of paroxetine using chiral chromatography.

  Journal of pharmaceutical and biomedical analysis 20031124

• Which SSRI?

  The Medical letter on drugs and therapeutics 20031124

• Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3.

  Bioorganic & medicinal chemistry letters 20031117

• Thyroid hormones in the rat amygdala as common targets for antidepressant drugs, mood stabilizers, and sleep deprivation.

  Biological psychiatry 20031115

• Aging, estradiol and time of day differentially affect serotonin transporter binding in the central nervous system of female rats.

  Brain research 20031114

• FDA questions antidepressant safety for children.

  Lancet (London, England) 20031108

• Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice.

  British journal of pharmacology 20031101

• A score for predicting response to pharmacotherapy in obsessive-compulsive disorder.

  International clinical psychopharmacology 20031101

• Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.

  Biological psychiatry 20031101

• Selective serotonin reuptake inhibitors in pilot fatalities of civil aviation accidents, 1990-2001.

  Aviation, space, and environmental medicine 20031101

• Biopsychosocial treatment of irritable bowel syndrome.

  Gastroenterology 20031101

• Psychotherapy and paroxetine: cost effective for severe IBS, or a waste of resources.

  Gastroenterology 20031101

• Neonatal intraventricular haemorrhage associated with maternal use of paroxetine.

  British journal of clinical pharmacology 20031101

• Suicidal ideation reports from pediatric trials for paroxetine and venlafaxine.

  The Canadian child and adolescent psychiatry review = La revue canadienne de psychiatrie de l'enfant et de l'adolescent 20031101

• Sertraline for social anxiety disorder.

  Expert review of neurotherapeutics 20031101

• Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption.

  Biological psychiatry 20031015

• Implications of compulsive and impulsive traits for serotonin status in women with bulimia nervosa.

  Psychiatry research 20031015

• [Pharmacotherapy of generalized anxiety disorder: state of the art].

  Praxis 20031015

• The effects of paroxetine on rat isolated vas deferens.

  Pharmacological research 20031001

• Paroxetine withdrawal in a neonate with historical and laboratory confirmation.

  European journal of pediatrics 20031001

• Visual and auditory hallucinations with excessive intake of paroxetine.

  Psychiatry and clinical neurosciences 20031001

• D2 dopamine receptor gene polymorphism: paroxetine and social functioning in posttraumatic stress disorder.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20031001

• Brain neurosteroid changes after paroxetine administration in mice.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20031001

• A high-performance liquid chromatography method with photodiode-array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs.

  Therapeutic drug monitoring 20031001

• High-performance liquid chromatographic method with diode array detection for identification and quantification of the eight new antidepressants and five of their active metabolites in plasma after overdose.

  Therapeutic drug monitoring 20031001

• Treating chronic tension-type headache not responding to amitriptyline hydrochloride with paroxetine hydrochloride: a pilot evaluation.

  Headache 20031001

• The apolipoprotein E epsilon4 allele and antidepressant efficacy in cognitively intact elderly depressed patients.

  Biological psychiatry 20031001

• Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder.

  Biological psychiatry 20031001

• Pharmacogenetics of antidepressant medication intolerance.

  The American journal of psychiatry 20031001

• Adverse event reporting with selective serotonin-reuptake inhibitors.

  The Annals of pharmacotherapy 20031001

• Antidepressants and ejaculation: a double-blind, randomized, fixed-dose study with mirtazapine and paroxetine.

  Journal of clinical psychopharmacology 20031001

• Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studies.

  Expert opinion on pharmacotherapy 20031001

• Relationship between extent of inhibition and inhibitor dose: literature evaluation based on the metabolism and transport drug interaction database.

  Current drug metabolism 20031001

• Induction of mania in depression by paroxetine.

  Human psychopharmacology 20031001

• Trends in psychotropic medication costs for children and adolescents, 1997-2000.

  Archives of pediatrics & adolescent medicine 20031001

• Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology.

  International journal of impotence research 20031001

• Voltammetric and HPLC techniques for the determination of paroxetine hydrochloride.

  Die Pharmazie 20031001

• Paroxetine: new indication. In generalised anxiety: uncertain efficacy.

  Prescrire international 20031001

• Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control.

  The Journal of clinical psychiatry 20031001

• Metabolic drug interactions with new psychotropic agents.

  Fundamental & clinical pharmacology 20031001

• Phobic postural vertigo: a new proposed entity.

  The Israel Medical Association journal : IMAJ 20031001

• [Social anxiety and propranolol abuse: a case study].

  Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20031001

• Correlation of subjective and objective sleep measurements at different stages of the treatment of depression.

  Psychiatry research 20030930

• Enantioselective Michael additions to alpha,beta-unsaturated imides catalyzed by a Salen-Al complex.

  Journal of the American Chemical Society 20030917

• Catalytic enantioselective conjugate reduction of lactones and lactams.

  Journal of the American Chemical Society 20030917

• Paroxetine (Paxil, Seroxat): increased risk of suicide in pediatric patients.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20030902

• Regulatory effects of reboxetine treatment alone, or following paroxetine treatment, on brain noradrenergic and serotonergic systems.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030901

• Are gender differences important for the clinical effects of antidepressants?

  The American journal of psychiatry 20030901

• The safety of SSRIs in generalised anxiety disorder: any reason to be anxious?

  Expert opinion on drug safety 20030901

• Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study.

  Biological psychiatry 20030901

• Paroxetine-induced hyponatremia in the elderly due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH).

  Journal of geriatric psychiatry and neurology 20030901

• Recent placebo-controlled acute trials in bipolar depression: focus on methodology.

  The international journal of neuropsychopharmacology 20030901

• Paroxetine efficacy in stuttering treatment.

  The international journal of neuropsychopharmacology 20030901

• [Incidence, pathoetiology and treatment of interferon-alpha induced neuro-psychiatric side effects].

  Fortschritte der Neurologie-Psychiatrie 20030901

• [Anxiety in school refusal children with indefinite complaints: psychological estimation using State-Trait Anxiety Inventory and therapy by serotonin reuptake inhibitors].

  No to hattatsu = Brain and development 20030901

• Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus.

  International journal of antimicrobial agents 20030901

• Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder.

  Journal of psychopharmacology (Oxford, England) 20030901

• Efficacy of controlled-release paroxetine in the treatment of late-life depression.

  The Journal of clinical psychiatry 20030901

• Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine.

  The Journal of clinical psychiatry 20030901

• Obsessive-compulsive spectrum disorders.

  Dialogues in clinical neuroscience 20030901

• Medication dependence and anxiety.

  Dialogues in clinical neuroscience 20030901

• Sleep and anxiety disorders.

  Dialogues in clinical neuroscience 20030901

• Psychopharmacological treatment of major depressive disorder in children and adolescents.

  JAMA 20030827

• Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030825

• Antidepressant-like effects in various mice strains in the tail suspension test.

  Behavioural brain research 20030814

• Pharmacological heterogeneity limits antidepressant study.

  BMJ (Clinical research ed.) 20030802

• Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze.

  Pharmacological research 20030801

• Determination of paroxetine in geriatric depression by high-performance liquid chromatography.

  Pharmacological research 20030801

• Chiral HPLC method for chiral purity determination of paroxetine drug substance.

  Chirality 20030801

• Pindolol and the acceleration of the antidepressant response.

  Journal of affective disorders 20030801

• A review of pharmacologic treatments for obsessive-compulsive disorder.

  Psychiatric services (Washington, D.C.) 20030801

• Paroxetine: new indication. In social phobia: minimal assessment.

  Prescrire international 20030801

• Paroxetine withdrawal syndrome.

  Prescrire international 20030801

• Paroxetine-induced increase in metabolic end products of nitric oxide.

  Journal of clinical psychopharmacology 20030801

• Selective serotonin reuptake inhibitors combined with venlafaxine in depressed patients who had partial response to venlafaxine: four cases.

  Progress in neuro-psychopharmacology & biological psychiatry 20030801

• Differential period of onset of action of fluvoxamine, paroxetine and milnacipran for depression.

  Human psychopharmacology 20030801

• Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine.

  The European journal of neuroscience 20030801

• Pharmaceutical companies under increased scrutiny.

  Behavioral healthcare tomorrow 20030801

• Case of gynecomastia during paroxetine therapy.

  The Journal of clinical psychiatry 20030801

• WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults.

  CNS spectrums 20030801

• WCA recommendations for the long-term treatment of generalized anxiety disorder.

  CNS spectrums 20030801

• [Serotonin reuptake inhibitors in depression of Alzheimer's disease and other dementias].

  Presse medicale (Paris, France : 1983) 20030726

• Advances Toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT(1A) receptor antagonism/SSRI activities. Part 2.

  Bioorganic & medicinal chemistry letters 20030721

• [Do you treat patients with Seroxat?].

  Lakartidningen 20030710

• Are SSRIs safe for children?

  The Medical letter on drugs and therapeutics 20030707

• Treating depression in predominantly low-income young minority women: a randomized controlled trial.

  JAMA 20030702

• Maintenance efficacy of divalproex in the prevention of bipolar depression.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030701

• Antidepressants: psychiatrists' opinions and clinical practice.

  Acta psychiatrica Scandinavica 20030701

• Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.

  Journal of neurochemistry 20030701

• Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial.

  International clinical psychopharmacology 20030701

• Duloxetine: a review.

  Expert review of neurotherapeutics 20030701

• [Inapropriate secretion of antidiuretic hormone associated with paroxetine].

  Medicina clinica 20030628

• A reported case involving impaired driving following self-administration of xylazine.

  Forensic science international 20030624

• British panel bans use of antidepressant to treat children.

  Nature 20030619

• Paroxetine must not be given to patients under 18.

  BMJ (Clinical research ed.) 20030614

• Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.

  JAMA 20030604

• Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1.

  Bioorganic & medicinal chemistry letters 20030602

• Implantation of a slow release corticosterone pellet induces long-term alterations in serotonergic neurochemistry in the rat brain.

  Journal of neuroendocrinology 20030601

• Effect of different 5-HT1A receptor antagonists in combination with paroxetine on expression of the immediate-early gene Arc in rat brain.

  Neuropharmacology 20030601

• Bi-phasic change in BDNF gene expression following antidepressant drug treatment.

  Neuropharmacology 20030601

• Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro.

  Drug metabolism and disposition: the biological fate of chemicals 20030601

• A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance.

  Human psychopharmacology 20030601

• Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration.

  Journal of neurochemistry 20030601

• Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder.

  Progress in neuro-psychopharmacology & biological psychiatry 20030601

• Occurrence and course of suicidality during short-term treatment of late-life depression.

  Archives of general psychiatry 20030601

• Perinatal outcome following third-trimester exposure to paroxetine: an alternative interpretation.

  Archives of pediatrics & adolescent medicine 20030601

• Synthesis of the major metabolites of paroxetine.

  Bioorganic chemistry 20030601

• Benefits of multidatabase searching: a forensic case study.

  Psychological reports 20030601

• The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs.

  Clinical therapeutics 20030601

• Broken heart: depression in cardiovascular disease.

  Dialogues in clinical neuroscience 20030601

• Psychiatric side effects of medications prescribed in internal medicine.

  Dialogues in clinical neuroscience 20030601

• Neurosteroid secretion in panic disorder.

  Psychiatry research 20030530

• [Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].

  MMW Fortschritte der Medizin 20030526

• A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.

  International clinical psychopharmacology 20030501

• Paroxetine in major depression.

  Journal of the American Academy of Child and Adolescent Psychiatry 20030501

• Placental passage of antidepressant medications.

  The American journal of psychiatry 20030501

• Serotonergic activity measured by platelet [3H]paroxetine binding in patients with eating disorders.

  Psychiatry research 20030501

• Switch to mania upon discontinuation of antidepressants in patients with mood disorders: a review of the literature.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030501

• Minor strokes related to paroxetine discontinuation in an elderly subject: emergent adverse events.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030501

• A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine.

  Behavioural pharmacology 20030501

• [The 'Sisi syndrome': a new form of depression?].

  Der Nervenarzt 20030501

• [Circannual rhythm of drug use by a psychiatric clinic].

  Psychiatrische Praxis 20030501

• Anhydrides as acylating agents in the enzymatic resolution of an intermediate of (-)-Paroxetine.

  The Journal of organic chemistry 20030418

• Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells.

  Blood 20030415

• Drug safety. Conflict-of-interest allegations derail inquiry into antidepressant's 'dark side'.

  Science (New York, N.Y.) 20030404

• Serotonin transporter gene polymorphisms and platelet [3H] paroxetine binding in premenstrual dysphoria.

  Psychoneuroendocrinology 20030401

• Antidepressant-like effects in various mice strains in the forced swimming test.

  Psychopharmacology 20030401

• Paroxetine as a 5-HT neuroendocrine probe.

  Psychopharmacology 20030401

• Onset of major depression during treatment for nicotine dependence.

  Addictive behaviors 20030401

• 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study.

  Psychopharmacology 20030401

• Clinical and neurobiological effects of tianeptine and paroxetine in major depression.

  Journal of clinical psychopharmacology 20030401

• Antidepressive treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations.

  Journal of clinical psychopharmacology 20030401

• Inhibition of P-glycoprotein by newer antidepressants.

  The Journal of pharmacology and experimental therapeutics 20030401

• Use of antidepressants by general practitioners and psychiatrists in Australia.

  The Australian and New Zealand journal of psychiatry 20030401

• Olanzapine and serotonin toxicity.

  Psychiatry and clinical neurosciences 20030401

• Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.

  The American journal of psychiatry 20030401

• Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review.

  Human psychopharmacology 20030401

• Unemployment and emergency room visits predict poor treatment outcome in primary care panic disorder.

  The Journal of clinical psychiatry 20030401

• Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.

  The Journal of clinical psychiatry 20030401

• Paroxetine-induced somnambulism.

  The Journal of clinical psychiatry 20030401

• [Neonatal convulsions and subarachnoid hemorrhage after in utero exposure to paroxetine].

  Revista de neurologia 20030401

• Simple method of paroxetine determination using a single channel FIA with no in-line reaction process.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20030401

• Quantitative electroencephalography in OCD patients treated with paroxetine.

  Clinical EEG (electroencephalography) 20030401

• Vardenafil reverses erectile dysfunction induced by paroxetine in rats.

  International journal of impotence research 20030401

• Lawyers may seek judicial review of panel reviewing paroxetine.

  BMJ (Clinical research ed.) 20030322

• Clinical practice guidelines for depression in young people.

  The Medical journal of Australia 20030317

• Substance P serum levels are increased in major depression: preliminary results.

  Biological psychiatry 20030315

• Effect of isolation rearing on pre- and post-synaptic serotonergic function in the rat dorsal hippocampus.

  Synapse (New York, N.Y.) 20030301

• Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers.

  Psychopharmacology 20030301

• Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine.

  Drug metabolism and disposition: the biological fate of chemicals 20030301

• Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers.

  Psychopharmacology 20030301

• Seasonal variations in the binding of [3H]paroxetine to the platelet serotonin transporter sites in African-American cocaine-dependent patients and healthy volunteers.

  Human psychopharmacology 20030301

• Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression.

  The American journal of psychiatry 20030301

• Neuroactive steroid levels in patients with panic disorder.

  The American journal of psychiatry 20030301

• Mirtazapine for pruritus.

  Journal of pain and symptom management 20030301

• Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers.

  Clinical pharmacology and therapeutics 20030301

• [Neurobiology and genetics of anxiety in an animal model].

  Der Nervenarzt 20030301

• Birth outcomes after prenatal exposure to antidepressant medication.

  American journal of obstetrics and gynecology 20030301

• Combination risperidone and SSRI-induced serotonin syndrome.

  The Annals of pharmacotherapy 20030301

• [Can treatment associated with ticlopidine and nifedipine increase serum levels of phenobarbital?].

  Revista de neurologia 20030301

• Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex.

  Naunyn-Schmiedeberg's archives of pharmacology 20030301

• Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity.

  Neuropharmacology 20030301

• SSRIs antidepressant activity is influenced by G beta 3 variants.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20030301

• New dosage-reduction regime to avoid paroxetine discontinuation syndrome.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20030301

• Chronic paroxetine infusion influences macronutrient selection in male Sprague-Dawley rats.

  Pharmacology, biochemistry, and behavior 20030301

• Effects of Hypericum perforatum and paroxetine in the mouse defense test battery.

  Pharmacology, biochemistry, and behavior 20030301

• Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical care.

  Journal of psychopharmacology (Oxford, England) 20030301

• Platelet counts in depressed patients treated with amitriptyline or paroxetine.

  European psychiatry : the journal of the Association of European Psychiatrists 20030301

• Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder.

  The Journal of clinical psychiatry 20030301

• Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.

  The Journal of clinical psychiatry 20030301

• Paroxetine-induced conversion of cytochrome P450 2D6 phenotype and occurence of adverse effects.

  General physiology and biophysics 20030301

• Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation.

  The international journal of neuropsychopharmacology 20030301

• [Three cases of intestinal inflammatory disease caused by anti-depressant treatment with paroxetine].

  Atencion primaria 20030215

• Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans.

  Alimentary pharmacology & therapeutics 20030215

• Protein 4.1N is required for translocation of inositol 1,4,5-trisphosphate receptor type 1 to the basolateral membrane domain in polarized Madin-Darby canine kidney cells.

  The Journal of biological chemistry 20030207

• Serotonin in the developing stomatogastric system of the lobster, Homarus americanus.

  Journal of neurobiology 20030205

• Antidepressant induced cholestasis: hepatocellular redistribution of multidrug resistant protein (MRP2).

  Gut 20030201

• SSRIs and ejaculation.

  Journal of clinical psychopharmacology 20030201

• Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication.

  Therapeutic drug monitoring 20030201

• Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center.

  Psychiatric services (Washington, D.C.) 20030201

• The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome.

  Gastroenterology 20030201

• Platelet 3H ketanserin binding in tension-type headache.

  Headache 20030201

• Omega-3 fatty acids for depression in pregnancy.

  The American journal of psychiatry 20030201

• The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test.

  Behavioural pharmacology 20030201

• Platelet serotonin transporter in stroke patients.

  Acta neurologica Scandinavica 20030201

• Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030201

• Acute changes in cerebrospinal fluid 5-HIAA following oral paroxetine challenge in healthy humans.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030201

• State markers of depression in sleep EEG: dependency on drug and gender in patients treated with tianeptine or paroxetine.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030201

• Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030201

• Drug-related hyperprolactinemia.

  Prescrire international 20030201

• Reassessing the contraindication of zolmitriptan and serotonin reuptake inhibitors: an evidence-based pharmacotherapeutic case report.

  Journal of clinical pharmacy and therapeutics 20030201

• [Day care treatment of 2 siblings with elective mutism].

  Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 20030201

• Paroxetine-induced enuresis.

  European psychiatry : the journal of the Association of European Psychiatrists 20030201

• [Treatment of refractory irritable bowel syndrome with subclinical dosage of antidepressants].

  Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20030201

• Fox odour affects corticosterone release but not hippocampal serotonin reuptake and open field behaviour in rats.

  Brain research 20030124

• 5-Hydroxytryptamine and platelets: uptake and aggregation in hypoxic pulmonary hypertensive rats.

  European journal of pharmacology 20030110

• Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity.

  Brain research 20030103

• Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study.

  European neurology 20030101

• Influence of antidepressants on intracellular levels of cyclic adenosine monophosphate in human peripheral blood mononuclear cells.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20030101

• Increased concentration of corticosteroid-binding globulin due to antidepressant treatment with amitritpyline, but not paroxetine.

  Journal of psychiatric research 20030101

• Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health.

  American journal of physiology. Gastrointestinal and liver physiology 20030101

• Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity.

  The Journal of pharmacology and experimental therapeutics 20030101

• Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients.

  International clinical psychopharmacology 20030101

• Treatment of depression with comorbid anxiety disorders: differential efficacy of paroxetine versus moclobemide.

  International clinical psychopharmacology 20030101

• Effect of a pharmacological intervention on quality of life in patients with obsessive-compulsive disorder.

  International clinical psychopharmacology 20030101

• Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial.

  Journal of the American Academy of Child and Adolescent Psychiatry 20030101

• Itch: scratching more than the surface.

  QJM : monthly journal of the Association of Physicians 20030101

• Cerebral blood volume and clinical changes on the third day of placebo substitution for SSRI treatment.

  Biological psychiatry 20030101

• Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation.

  Urology 20030101

• Patient beliefs predict response to paroxetine among primary care patients with dysthymia and minor depression.

  The Journal of the American Board of Family Practice 20030101

• Paroxetine-induced limb anesthesia.

  General hospital psychiatry 20030101

• Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.

  The Journal of clinical psychiatry 20030101

• The drive to look for insight.

  Psychotherapy and psychosomatics 20030101

• Jealousy and subthreshold psychopathology: a serotonergic link.

  Neuropsychobiology 20030101

• Treating generalized anxiety disorder.

  The Journal of clinical psychiatry 20030101

• Anxiety induced by repetitive transcranial magnetic stimulation is suppressed by chronic treatment of paroxetine in rats.

  Pharmacopsychiatry 20030101

• Tail-suspension induced hyperthermia: a new measure of stress reactivity.

  Journal of psychiatric research 20030101

• Focus on paroxetine.

  Current medical research and opinion 20030101

• Relationship between platelet serotonin uptake sites and treatment outcome among African-American cocaine dependent individuals.

  Journal of addictive diseases 20030101

• Provoked bradycardia after paroxetine administration.

  General hospital psychiatry 20030101

• Cutaneous drug reaction case reports: from the world literature.

  American journal of clinical dermatology 20030101

• Short- and long-term effects of MDMA ('ecstasy') on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo.

  Neurochemistry international 20030101

• Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial.

  BMC family practice 20030101

• Decreased lymphocyte 3H-paroxetine binding in obsessive-compulsive disorder.

  Neuropsychobiology 20030101

• Usefulness of intravenous metoprolol during positive isoproterenol tilt-table test in the choice of treatment for neurocardiogenic syncope.

  Indian heart journal 20030101

• Antidepressants for smoking cessation.

  The Cochrane database of systematic reviews 20030101

• Antidepressants for generalized anxiety disorder.

  The Cochrane database of systematic reviews 20030101

• Quantitative determination of paroxetine and its 4-hydroxy-3-methoxy metabolite in plasma by high-performance liquid chromatography/electrospray ion trap mass spectrometry: application to pharmacokinetic studies.

  Rapid communications in mass spectrometry : RCM 20030101

• Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England.

  Drug safety 20030101

• Dopamine depletion abolishes apomorphine- and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: a microdialysis study.

  Neuroscience 20030101

• Ganser's syndrome in a man with AIDS.

  Psychosomatics 20030101

• Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine.

  Journal of psychiatric research 20030101

• Serotonin transporter and MAO-B levels in monoamine nuclei of the human brainstem are normal in major depression.

  Journal of psychiatric research 20030101

• [Pharmacokinetics and drug interaction of antidepressants and anti-manic drugs].

  Ryoikibetsu shokogun shirizu 20030101

• [Panic disorder and agoraphobia].

  Ryoikibetsu shokogun shirizu 20030101

• [The treatment of OCD].

  Ryoikibetsu shokogun shirizu 20030101

• [Eating disorders].

  Ryoikibetsu shokogun shirizu 20030101

• Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?

  Journal of child and adolescent psychopharmacology 20030101

• Higher plasma 5-hydroxyindoleacetic acid levels are associated with SSRI-induced nausea.

  Neuropsychobiology 20030101

• Pharmacotherapy of social phobia.

  Acta psychiatrica Scandinavica. Supplementum 20030101

• Evaluation of cost savings to a state Medicaid program following a sertraline tablet-splitting program.

  Journal of the American Pharmacists Association : JAPhA 20030101

• Duloxetine in treatment of anxiety symptoms associated with depression.

  Depression and anxiety 20030101

• The effect of alexithymic features on response to antidepressant medication in patients with major depression.

  Depression and anxiety 20030101

• Bibliometric analysis of biomedical publications on SSRI during 1980-2000.

  Depression and anxiety 20030101

• An in vitro assay for predicting successful imaging radiotracers.

  Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 20030101

• Drug discovery targeted to the Alzheimer's APP mRNA 5'-untranslated region: the action of paroxetine and dimercaptopropanol.

  Journal of molecular neuroscience : MN 20030101

• Diagnosis and treatment of dysthymia in children and adolescents.

  CNS drugs 20030101

• Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists.

  CNS drugs 20030101

• Advancing the treatment of mood and anxiety disorders: the first 10 years' experience with paroxetine.

  Psychopharmacology bulletin 20030101

• Neuropharmacology of paroxetine.

  Psychopharmacology bulletin 20030101

• Clinical management of perinatal depression: focus on paroxetine.

  Psychopharmacology bulletin 20030101

• In vivo neuroimaging correlates of the efficacy of paroxetine in the treatment of mood and anxiety disorders.

  Psychopharmacology bulletin 20030101

• Pharmacokinetics, drug interactions, and tolerability of paroxetine and paroxetine CR.

  Psychopharmacology bulletin 20030101

• Paroxetine treatment of major depressive disorder.

  Psychopharmacology bulletin 20030101

• Treatment of panic disorder: focus on paroxetine.

  Psychopharmacology bulletin 20030101

• Paroxetine treatment of generalized anxiety disorder.

  Psychopharmacology bulletin 20030101

• Treatment of posttraumatic stress disorder: the impact of paroxetine.

  Psychopharmacology bulletin 20030101

• Obsessive-compulsive disorder: implications of the efficacy of an SSRI, paroxetine.

  Psychopharmacology bulletin 20030101

• Advances in recognition and treatment of social anxiety disorder: a 10-year retrospective.

  Psychopharmacology bulletin 20030101

• Paroxetine use in medically ill patients.

  Psychopharmacology bulletin 20030101

• Paroxetine treatment of depression in late life.

  Psychopharmacology bulletin 20030101

• Paroxetine treatment of mood disorders in women: premenstrual dysphoric disorder and hot flashes.

  Psychopharmacology bulletin 20030101

• Paroxetine treatment of mood and anxiety disorders in children and adolescents.

  Psychopharmacology bulletin 20030101

• Efficacy and tolerability of controlled-release paroxetine.

  Psychopharmacology bulletin 20030101

• Antidepressant drug treatment induces Arc gene expression in the rat brain.

  Neuroscience 20030101

• Causality and collateral estoppel: process and content of recent SSRI litigation.

  The journal of the American Academy of Psychiatry and the Law 20030101

• SR 58611A: SR 58611.

  Drugs in R&D 20030101

• The renin-angiotensin-aldosterone system in patients with depression compared to controls--a sleep endocrine study.

  BMC psychiatry 20030101

• The effect of paroxetine on Taijinkyofusho: a report of three cases.

  Psychiatry 20030101

• Methodologic pitfalls in measurement of 5-hydroxytriptamine uptake transporters in human platelets by [3H]-paroxetine binding assay.

  Archives of medical research 20030101

• Antidepressant discontinuation syndrome.

  Perspectives in psychiatric care 20030101

• Weight uniformity of split tablets required by a Veterans Affairs policy.

  Journal of managed care pharmacy : JMCP 20030101

• [A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression].

  L'Encephale 20030101

• [Interest of the use of pindolol in the treatment of depression: review].

  L'Encephale 20030101

• [A case of obsessive symptoms in Huntington's disease].

  Actas espanolas de psiquiatria 20030101

• High vitamin B12 level and good treatment outcome may be associated in major depressive disorder.

  BMC psychiatry 20030101

• The Kutcher Adolescent Depression Scale: assessment of its evaluative properties over the course of an 8-week pediatric pharmacotherapy trial.

  Journal of child and adolescent psychopharmacology 20030101

• The effectiveness of various postpartum depression treatments and the impact of antidepressant drugs on nursing infants.

  The Journal of the American Board of Family Practice 20030101

• Relationship between platelet serotonin uptake sites and measures of impulsivity, aggression, and craving among African-American cocaine abusers.

  The American journal on addictions 20030101

• Concerns about Paxil for children.

  FDA consumer 20030101

• [Paroxetine withdrawal syndrome as differential diagnosis of acute neonatal encephalopathy?].

  Zeitschrift fur Geburtshilfe und Neonatologie 20030101

• Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea.

  The Journal of clinical psychiatry 20030101

• Improving antidepressant adherence.

  The Journal of clinical psychiatry 20030101

• Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential.

  American journal of respiratory medicine : drugs, devices, and other interventions 20030101

• [Case of prolonged recovery from serotonin syndrome caused by paroxetine].

  Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20030101

• Pharmaceutical drug overdose case reports. From the World Literature.

  Toxicological reviews 20030101

• New therapeutic approaches for hot flashes in women.

  The journal of supportive oncology 20030101

• A renaissance for fluoxetine in the management of depression in the elderly?

  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20030101

• [Increased perioperative blood loss during treatment with paroxetine].

  Nederlands tijdschrift voor geneeskunde 20021228

• Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.

  Biological psychiatry 20021215

• Functional consequences of perinatal exposure to 3,4-methylenedioxymethamphetamine in rat brain.

  British journal of pharmacology 20021201

• The treatment of generalised anxiety disorder. A systematic review.

  Panminerva medica 20021201

• A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation.

  The Journal of urology 20021201

• Paroxetine-associated psoriasis.

  The American journal of psychiatry 20021201

• Quetiapine therapy for posttraumatic stress disorder.

  The Annals of pharmacotherapy 20021201

• Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with 11C McN 5652.

  Psychopharmacology 20021201

• Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder.

  Archives of general psychiatry 20021201

• Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study.

  Archives of general psychiatry 20021201

• Selective serotonin reuptake inhibitor. Discontinuation syndrome.

  Journal of psychosocial nursing and mental health services 20021201

• The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20021201

• Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.

  Journal of psychopharmacology (Oxford, England) 20021201

• Acute dystonic reaction in an elderly patient with mood disorder after titration of paroxetine: possible mechanisms and implications for clinical care.

  Journal of psychopharmacology (Oxford, England) 20021201

• Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus.

  Neuropharmacology 20021201

• Serotonin transporter modulation in blood lymphocytes from patients with major depression.

  Cellular and molecular neurobiology 20021201

• Neurogenetics of emotional reactivity to stress in animals.

  Dialogues in clinical neuroscience 20021201

• Subtyping of psychiatric disorders: implications for drug development.

  Dialogues in clinical neuroscience 20021201

• Sleep-wake mechanisms and drug discovery: sleep EEG as a tool for the development of CNS-acting drugs.

  Dialogues in clinical neuroscience 20021201

• Challenges in the development of clinical trials for major depressive disorder: lessons learned from trials in minor depression.

  Dialogues in clinical neuroscience 20021201

• High-performance liquid chromatography-mass spectrometry method for the determination of paroxetine in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20021125

• Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramine.

  European journal of pharmacology 20021115

• Kinetics of allopregnanolone formation catalyzed by human 3 alpha-hydroxysteroid dehydrogenase type III (AKR1C2).

  Biochemistry 20021112

• Improved sample preparation for the quantitative analysis of paroxetine in human plasma by stable isotope dilution negative ion chemical ionisation gas chromatography-mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20021105

• Predosing with the unlabeled 'inactive' enantiomer as a tool for improvement of the PET signal.

  Synapse (New York, N.Y.) 20021101

• Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine.

  International clinical psychopharmacology 20021101

• Paroxetine in the treatment of adolescent major depression.

  Journal of the American Academy of Child and Adolescent Psychiatry 20021101

• Paroxetine in the treatment of adolescent major depression.

  Journal of the American Academy of Child and Adolescent Psychiatry 20021101

• Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics.

  Journal of clinical pharmacology 20021101

• Perinatal outcome following third trimester exposure to paroxetine.

  Archives of pediatrics & adolescent medicine 20021101

• A case of paroxetine-induced galactorrhea.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20021101

• A retrospective analysis of the revocation of prior authorization restrictions and the use of antidepressant medications for treating major depressive disorder.

  Clinical therapeutics 20021101

• Efficacy and tolerability of Paroxetine 20 mg daily in the treatment of depression and depression associated anxiety.

  JPMA. The Journal of the Pakistan Medical Association 20021101

• Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization.

  Administration and policy in mental health 20021101

• Morphine, cocaine and antidepressant induced motivational activity and midbrain dopaminergic neurotransmission.

  European journal of pharmacology 20021025

• MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentrations: effects on serotonin transporter densities.

  European journal of pharmacology 20021025

• A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes.

  Psychiatry research 20021010

• Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine.

  Pharmacology, biochemistry, and behavior 20021001

• Antidepressant-induced sexual dysfunction.

  The Annals of pharmacotherapy 20021001

• Effect of nortriptyline and paroxetine on CYP2D6 activity in depressed elderly patients.

  Journal of clinical psychopharmacology 20021001

• Antidepressant-related hypomania in a patient with premenstrual dysphoric disorder.

  Journal of clinical psychopharmacology 20021001

• Re: Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies.

  The Journal of urology 20021001

• Angela.

  The American journal of psychiatry 20021001

• Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine.

  The American journal of psychiatry 20021001

• Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study.

  The American journal of psychiatry 20021001

• Risk factors for falls during treatment of late-life depression.

  The Journal of clinical psychiatry 20021001

• Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20021001

• [Increased perioperative blood loss during treatment with paroxetine].

  Nederlands tijdschrift voor geneeskunde 20020921

• Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers.

  Circulation 20020917

• Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment.

  International clinical psychopharmacology 20020901

• Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study.

  International clinical psychopharmacology 20020901

• [Improvement of tardive dyskinesia after treatment with olanzapine].

  Psychiatrische Praxis 20020901

• The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020901

• Selective serotonin reuptake inhibitors decrease impulsive behavior as measured by an adjusting delay procedure in the pigeon.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020901

• Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man.

  Journal of psychopharmacology (Oxford, England) 20020901

• Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures.

  Biological psychiatry 20020901

• A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone.

  The Journal of clinical psychiatry 20020901

• High vs low anxiety-related behavior rats: an animal model of extremes in trait anxiety.

  Behavior genetics 20020901

• Variations in antidepressant prescribing practice: clinical need or market influences?

  Pharmacoepidemiology and drug safety 20020901

• Gateways to Clinical Trials.

  Methods and findings in experimental and clinical pharmacology 20020901

• Psychopharmacology of anxiety disorders.

  Dialogues in clinical neuroscience 20020901

• Nonpharmacological treatments for anxiety disorders.

  Dialogues in clinical neuroscience 20020901

• [Hallucinations caused by paroxetine taken together with a levodopa-carbidopa preparation].

  Nederlands tijdschrift voor geneeskunde 20020831

• Different distributions of the 5-HT reuptake complex and the postsynaptic 5-HT(2A) receptors in Brodmann areas and brain hemispheres.

  Psychiatry research 20020830

• [Hyponatremia caused by thiazide diuretics: be aware of drug combinations which enhance this effect].

  Nederlands tijdschrift voor geneeskunde 20020817

• Serotonin agents in the treatment of acquired brain injury.

  The Journal of head trauma rehabilitation 20020801

• Block of volume-regulated anion channels by selective serotonin reuptake inhibitors.

  Naunyn-Schmiedeberg's archives of pharmacology 20020801

• A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder.

  Journal of affective disorders 20020801

• Very long half-life of paroxetine following intoxication in an extensive cytochrome P4502D6 metabolizer.

  Therapeutic drug monitoring 20020801

• Paroxetine for multiple chemical sensitivity syndrome.

  The American journal of psychiatry 20020801

• Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory.

  Psychopharmacology 20020801

• CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6.

  Pharmacotherapy 20020801

• Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study.

  The Journal of clinical psychiatry 20020801

• The potential of pill splitting to achieve cost savings.

  The American journal of managed care 20020801

• Photosensitivity induced by paroxetine.

  Contact dermatitis 20020801

• 7,7,8,8-Tetracyanoquinodimethane as a new derivatization reagent for high-performance liquid chromatography and thin-layer chromatography: rapid screening of plasma for some antidepressants.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020715

• Differential modulation of efficiency in a food-rewarded 'differential reinforcement of low-rate' 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors.

  Psychopharmacology 20020701

• Predicting treatment-outcome in cocaine dependence from admission urine drug screen and peripheral serotonergic measures.

  Journal of substance abuse treatment 20020701

• Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.

  The Journal of clinical psychiatry 20020701

• Paroxetine-induced vaginal anaesthesia.

  Pharmacopsychiatry 20020701

• Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study.

  Clinical therapeutics 20020701

• [Correction of affective disorders in patients with alcohol dependence].

  Voenno-meditsinskii zhurnal 20020701

• Aging alters in a region-specific manner serotonin transporter sites and 5-HT(1A) receptor-G protein interactions in hamster brain.

  Neuropharmacology 20020701

• Tonic immobility in guinea pigs: a behavioural response for detecting an anxiolytic-like effect?

  Behavioural pharmacology 20020701

• A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression.

  European psychiatry : the journal of the Association of European Psychiatrists 20020701

• Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative.

  Brain research 20020628

• Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients.

  British journal of cancer 20020617

• Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020615

• Reduced (+/-)-3,4-methylenedioxymethamphetamine ('Ecstasy') metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro.

  Biochemical pharmacology 20020615

• Antipanic drug modulation of 35% CO2 hyperreactivity and short-term treatment outcome.

  Journal of clinical psychopharmacology 20020601

• Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder.

  Journal of clinical psychopharmacology 20020601

• Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20020601

• Leflunomide-associated skin ulceration.

  The Annals of pharmacotherapy 20020601

• Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C.

  Alimentary pharmacology & therapeutics 20020601

• Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression.

  The British journal of psychiatry : the journal of mental science 20020601

• [Hallucinations caused by paroxetine in combined usage of levodopa-carbidopa].

  Nederlands tijdschrift voor geneeskunde 20020601

• A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling.

  The Journal of clinical psychiatry 20020601

• A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.

  The Journal of clinical psychiatry 20020601

• Surprising results in the study of paroxetine for generalized anxiety disorder.

  The Journal of clinical psychiatry 20020601

• Acute effects of amperozide and paroxetine on social cohesion in male conspecifics.

  Brain research bulletin 20020601

• Reports of withdrawal syndrome with the use of SSRIs: a case/non-case study in the French Pharmacovigilance database.

  Pharmacoepidemiology and drug safety 20020601

• An overview of the clinical efficacy of mirtazapine.

  Human psychopharmacology 20020601

• Onset of action of antidepressants: results of different analyses.

  Human psychopharmacology 20020601

• Rationale and options for the long-term treatment of depression.

  Human psychopharmacology 20020601

• Cytochrome P450 2D6 genotype does not predict SSRI (fluoxetine or paroxetine) induced hyponatraemia.

  Human psychopharmacology 20020601

• Penetrating the blind in a study of an SSRI.

  Journal of behavior therapy and experimental psychiatry 20020601

• Treatment of depression associated with the menstrual cycle: premenstrual dysphoria, postpartum depression, and the perimenopause.

  Dialogues in clinical neuroscience 20020601

• Gonadal steroids, brain, and behavior: role of context.

  Dialogues in clinical neuroscience 20020601

• [Galactorrhea induced by paroxetine].

  Medicina clinica 20020525

• Differential effects of chronic antidepressant treatments on micro- and delta-opioid receptors in rat brain.

  European journal of pharmacology 20020517

• Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT(1B) receptor knock-out mice.

  European journal of pharmacology 20020517

• Extended action of MKC-242, a selective 5-HT(1A) receptor agonist, on light-induced Per gene expression in the suprachiasmatic nucleus in mice.

  Journal of neuroscience research 20020515

• Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020501

• Targeting cell surface receptors with ligand-conjugated nanocrystals.

  Journal of the American Chemical Society 20020501

• Treatment of generalized anxiety disorder with citalopram.

  International clinical psychopharmacology 20020501

• A case of acquired stuttering resulting from left parietal infarction.

  Acta neurologica Scandinavica 20020501

• Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20020501

• Psychotropic drugs and the ECG: focus on the QTc interval.

  Expert opinion on pharmacotherapy 20020501

• Response styles among patients with minor depression and dysthymia in primary care.

  Journal of abnormal psychology 20020501

• Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.

  Naunyn-Schmiedeberg's archives of pharmacology 20020501

• Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients.

  The Journal of clinical psychiatry 20020501

• SSRIs: take your pick.

  The Harvard mental health letter 20020501

• Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20020501

• Protection against 3,4-methylenedioxymethamphetamine-induced neurodegeneration produced by glutathione depletion in rats is mediated by attenuation of hyperthermia.

  Journal of neurochemistry 20020501

• How well do antidepressants work in older people? A systematic review of Number Needed to Treat.

  Journal of affective disorders 20020501

• Course and rate of antidepressant response in the very old.

  Journal of affective disorders 20020501

• EEG correlates of acute and chronic paroxetine treatment in depression.

  Journal of affective disorders 20020501

• Paroxetine associated hepatotoxicity: a report of 3 cases and a review of the literature.

  Pharmacopsychiatry 20020501

• [Adverse effects after switching to a different generic form of paroxetine: paroxetine mesylate instead of paroxetine HCl hemihydrate].

  Nederlands tijdschrift voor geneeskunde 20020427

• Serotonin transporter function and pharmacology are sensitive to expression level: evidence for an endogenous regulatory factor.

  The Journal of biological chemistry 20020426

• Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

  The Journal of biological chemistry 20020419

• Is one selective serotonin reuptake inhibitor better than another?

  JAMA 20020417

• Is one selective serotonin reuptake inhibitor better than another?

  JAMA 20020417

• Is one selective serotonin reuptake inhibitor better than another?

  JAMA 20020417

• Is one selective serotonin reuptake inhibitor better than another?

  JAMA 20020417

• Effect of SB-243213, a selective 5-HT(2C) receptor antagonist, on the rat sleep profile: a comparison to paroxetine.

  Pharmacology, biochemistry, and behavior 20020401

• Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.

  Pharmacology, biochemistry, and behavior 20020401

• 5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors.

  Blood 20020401

• Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.

  Journal of clinical psychopharmacology 20020401

• In vitro inhibition of pimozide N-dealkylation by selective serotonin reuptake inhibitors and azithromycin.

  Journal of clinical psychopharmacology 20020401

• Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers.

  Journal of clinical psychopharmacology 20020401

• Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers.

  Journal of clinical psychopharmacology 20020401

• Amitriptyline and paroxetine: effects upon peripheral nervous system (PNS).

  Journal of clinical psychopharmacology 20020401

• Pathologic laughter associated with paroxetine treatment.

  Journal of clinical psychopharmacology 20020401

• Cross-sensitivity between paroxetine and sertraline.

  The Annals of pharmacotherapy 20020401

• Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response.

  Pediatric research 20020401

• Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex.

  Psychopharmacology 20020401

• Selective serotonin reuptake inhibitors are effective in the treatment of polycythemia vera-associated pruritus.

  Blood 20020401

• Paroxetine in adolescent major depression.

  Journal of the American Academy of Child and Adolescent Psychiatry 20020401

• Paroxetine in adolescent major depression.

  Journal of the American Academy of Child and Adolescent Psychiatry 20020401

• Selective serotonin reuptake inhibitor-induced rash: case report and review of the literature.

  Pharmacotherapy 20020401

• Characterization of cocaine and antidepressant-sensitive norepinephrine transporters in rat placental trophoblasts.

  British journal of pharmacology 20020401

• Rational treatment choices for non-major depressions in primary care: an evidence-based review.

  Journal of general internal medicine 20020401

• A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer.

  Journal of pain and symptom management 20020401

• Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study.

  The Journal of clinical psychiatry 20020401

• Prevalence of sexual dysfunction among newer antidepressants.

  The Journal of clinical psychiatry 20020401

• Combined antidepressant treatment: a risk factor for switching in bipolar patients.

  The Journal of clinical psychiatry 20020401

• Palinopsia and paroxetine withdrawal.

  The Journal of clinical psychiatry 20020401

• Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension?

  The Journal of laboratory and clinical medicine 20020401

• Detecting drug-drug interactions in medication profiles of psychiatric inpatients: a two-stage approach.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20020401

• The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice.

  European journal of pharmacology 20020329

• [Hallucinations caused by paroxetine taken together with a levodopa-carbidopa preparation].

  Nederlands tijdschrift voor geneeskunde 20020323

• Reputations at stake.

  New scientist (1971) 20020316

• Johanson-Blizzard syndrome--a case study, behavioral manifestations, and successful treatment strategies.

  Biological psychiatry 20020315

• Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 2: 4-substituted 6-nitroquipazines.

  Bioorganic & medicinal chemistry letters 20020311

• Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.

  Archives of general psychiatry 20020301

• Credibility of problem-solving therapy and medication for the treatment of depression among primary care patients.

  Medical science monitor : international medical journal of experimental and clinical research 20020301

• The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment.

  Psychopharmacology 20020301

• Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20020301

• Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.

  The Journal of clinical psychiatry 20020301

• Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.

  The Journal of clinical psychiatry 20020301

• Rapid resolution of social anxiety disorder, selective mutism, and separation anxiety with paroxetine in an 8-year-old girl.

  Journal of psychiatry & neuroscience : JPN 20020301

• Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine.

  Journal of psychopharmacology (Oxford, England) 20020301

• Successful treatment of recurrent brief depression with reboxetine -- a single case analysis.

  Pharmacopsychiatry 20020301

• Are paroxetine, fluoxetine, and sertraline equally effective for depression?

  The Journal of family practice 20020301

• The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study.

  The international journal of neuropsychopharmacology 20020301

• Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.

  The international journal of neuropsychopharmacology 20020301

• Serotonin syndrome - 'potential' role of the CYP2D6 genetic polymorphism in Asians.

  The international journal of neuropsychopharmacology 20020301

• On the role of corticotropin-releasing hormone receptors in anxiety and depression.

  Dialogues in clinical neuroscience 20020301

• The role of substance P in depression: therapeutic implications.

  Dialogues in clinical neuroscience 20020301

• Pathophysiology of depression and mechanisms of treatment.

  Dialogues in clinical neuroscience 20020301

• The clinical pharmacology of depressive states.

  Dialogues in clinical neuroscience 20020301

• Withdrawal from paroxetine can be severe, warns FDA.

  BMJ (Clinical research ed.) 20020202

• Paroxetine modulates psychological and sympathetic responses during public speaking.

  Journal of clinical psychopharmacology 20020201

• The effects of antidepressant drug treatments on activator protein-1 binding activity in the rat brain.

  Progress in neuro-psychopharmacology & biological psychiatry 20020201

• Effect of paroxetine on extracellular serotonin and dopamine levels in the prefrontal cortex.

  Naunyn-Schmiedeberg's archives of pharmacology 20020201

• Appropriateness of prescribing practices for serotonergic antidepressants.

  Psychiatric services (Washington, D.C.) 20020201

• A randomized, controlled trial of panic disorder treatment initiation in an emergency department chest pain center.

  Annals of emergency medicine 20020201

• Reactivity of serotonin in whole blood.

  Biological psychiatry 20020201

• Obsessive-compulsive disorder: identification, neurobiology, and treatment.

  The Journal of the American Osteopathic Association 20020201

• Predictors of response to pharmacotherapy in social anxiety disorder: an analysis of 3 placebo-controlled paroxetine trials.

  The Journal of clinical psychiatry 20020201

• Duration of therapy and health care costs of fluoxetine, paroxetine, and sertraline in 6 health plans.

  The Journal of clinical psychiatry 20020201

• Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update.

  Current drug metabolism 20020201

• Paroxetine but not imipramine improved depression related outcomes in adolescents with DSM-IV major depression.

  Evidence-based mental health 20020201

• Paroxetine and sertraline delayed ejaculation in heterosexual men with lifelong rapid ejaculation.

  Evidence-based mental health 20020201

• [Critical ischaemia of the limbs and localized livedo in a case of ergotism].

  Deutsche medizinische Wochenschrift (1946) 20020125

• Chronic paroxetine increases [3H]nociceptin binding in rat dorsal raphe nucleus.

  Neuroreport 20020121

• Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma by temperature-programmed packed capillary liquid chromatography with on-column focusing of large injection volumes.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020105

• Shattered trust: technical and moral lessons from an interrupted first visit.

  Harvard review of psychiatry 20020101

• A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: double-blind, placebo-controlled, fMRI study in healthy subjects.

  NeuroImage 20020101

• Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.

  CNS drugs 20020101

• GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment.

  The American journal of psychiatry 20020101

• Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study.

  International clinical psychopharmacology 20020101

• Correlates of remission in primary care patients treated for minor depression.

  General hospital psychiatry 20020101

• Predictors of nonresponse to treatment in primary care patients with dysthymia.

  General hospital psychiatry 20020101

• The effect of changes in depression on health related quality of life (HRQoL) in HIV infection.

  General hospital psychiatry 20020101

• Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study.

  The Journal of clinical psychiatry 20020101

• A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.

  The Journal of clinical psychiatry 20020101

• Post exercise hypotension is not mediated by the serotonergic system in borderline hypertensive individuals.

  Journal of human hypertension 20020101

• A case of SSRI-induced hyponatremia.

  The Journal of the American Board of Family Practice 20020101

• Locus of control orientation in panic disorder and the differential effects of treatment.

  Psychotherapy and psychosomatics 20020101

• A survey of prescribing practices in the treatment of depression.

  Progress in neuro-psychopharmacology & biological psychiatry 20020101

• Effects of chronic paroxetine administration on measures of aggressive and impulsive responses of adult males with a history of conduct disorder.

  Psychopharmacology 20020101

• Antidepressants for smoking cessation.

  The Cochrane database of systematic reviews 20020101

• [Paroxetine (paxil): use in clinical practice].

  Voenno-meditsinskii zhurnal 20020101

• Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling.

  Journal of psychiatric research 20020101

• Intent-to-treat analysis for clinical trials: use of data collected after termination of treatment protocol.

  Journal of psychiatric research 20020101

• Effects of psychotropic drugs on seizure threshold.

  Drug safety 20020101

• Paroxetine: an update of its use in psychiatric disorders in adults.

  Drugs 20020101

• Evaluating changes in sexual functioning in depressed patients: sensitivity to change of the CSFQ.

  Journal of sex & marital therapy 20020101

• Impaired release of beta-endorphin in response to serotonin in a rat model of depression.

  Neuroscience 20020101

• Effects of nortriptyline and paroxetine on postural sway in depressed elderly patients.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20020101

• Treatment of psychotic depression associated with steroid therapy in Churg-Strauss syndrome.

  Irish medical journal 20020101

• Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.

  CNS drugs 20020101

• Permutation-validated principal components analysis of microarray data.

  Genome biology 20020101

• Potential savings from splitting newer antidepressant medications.

  CNS drugs 20020101

• A randomized, placebo-controlled trial of paroxetine in nursing home residents with non-major depression.

  Depression and anxiety 20020101

• Vibrational circular dichroism spectroscopy study of paroxetine and femoxetine precursors.

  Biopolymers 20020101

• Spotlight on paroxetine in psychiatric disorders in adults.

  CNS drugs 20020101

• Clinically significant drug interactions with antidepressants in the elderly.

  Drugs & aging 20020101

• Treatment of generalized anxiety disorder.

  The Journal of clinical psychiatry 20020101

• Generalized anxiety disorder in primary care: emerging issues in management and treatment.

  The Journal of clinical psychiatry 20020101

• Selective serotonin reuptake inhibitor paroxetine modulates motor behavior through practice. A double-blind, placebo-controlled, multi-dose study in healthy subjects.

  Neuropsychologia 20020101

• Psychogenic excoriation and cancer.

  Psychosomatics 20020101

• Delayed recurrent SIADH associated with SSRIs.

  The Annals of pharmacotherapy 20020101

• Confounding factors in diagnosing brain death: a case report.

  BMC neurology 20020101

• Discontinuing paroxetine: a personal account.

  Psychotherapy and psychosomatics 20020101

• Generalised anxiety disorder: treatment options.

  Drugs 20020101

• Neuropsychological profile in patients with obsessive-compulsive disorder over a period of 4-month treatment.

  Journal of psychiatric research 20020101

• The relevance of psychiatric and somatic comorbidity in depressed chronic benzodiazepine users.

  Psychotherapy and psychosomatics 20020101

• Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20020101

• Glucose metabolic response to total sleep deprivation, recovery sleep, and acute antidepressant treatment as functional neuroanatomic correlates of treatment outcome in geriatric depression.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20020101

• Response speed and rate of remission in primary and specialty care of elderly patients with depression.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20020101

• Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?

  Drugs 20020101

• Psychoeducation in panic disorder patients: effect of a self-information booklet in a randomized, masked-rater study.

  Depression and anxiety 20020101

• [Second generation SSRIS: human monoamine transporter binding profile of escitalopram and R-fluoxetine].

  L'Encephale 20020101

• [Paroxetine treatment for children and adolescents with anxiety disorders].

  Actas espanolas de psiquiatria 20020101

• [Clozapine-induced obsessive-compulsive disorder: a case report].

  Actas espanolas de psiquiatria 20020101

• Relationship between CYP 2D6 metabolic status and sexual dysfunction in paroxetine treatment.

  Journal of sex & marital therapy 20020101

• Depression treatment in rural California: preliminary survey of nonpsychiatric physicians.

  The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association 20020101

• Benefits and risks to mother and infant of drug treatment for postnatal depression.

  Drug safety 20020101

• [Antidepressants consumption in the global population in France].

  L'Encephale 20020101

• Goals in symptomatic pharmacologic management of frontotemporal lobar degeneration.

  American journal of Alzheimer's disease and other dementias 20020101

• Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.

  Clinical pharmacokinetics 20020101

• Severe weight gain induced by combination treatment with risperidone and paroxetine.

  Clinical neuropharmacology 20020101

• Citalopram treatment of paroxetine-intolerant depressed patients.

  Depression and anxiety 20020101

• Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate.

  Neuropsychobiology 20020101

• An exploratory study: the use of paroxetine for methamphetamine craving.

  Journal of psychoactive drugs 20020101

• Paroxetine for treatment of somatization disorder.

  The Journal of neuropsychiatry and clinical neurosciences 20020101

• Hepatic adverse events during highly active antiretroviral therapy containing nevirapine: a case report.

  Annals of clinical microbiology and antimicrobials 20020101

• Does a preexisting anxiety disorder predict response to paroxetine in irritable bowel syndrome?

  Psychosomatics 20020101

• [Effects of Seroxat on premature ejaculation: a clinical trial].

  Zhonghua nan ke xue = National journal of andrology 20020101

• Optimizing treatment outcomes for patients with depression and generalized anxiety disorder.

  Psychopharmacology bulletin 20020101

• [Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs].

  L'Encephale 20020101

• Depression after cardiac transplant treated with interpersonal psychotherapy and paroxetine.

  American journal of psychotherapy 20020101

• Pharmacotherapy of generalized anxiety disorder.

  The Journal of clinical psychiatry 20020101

• Clinical experience with substance P receptor (NK1) antagonists in depression.

  The Journal of clinical psychiatry 20020101

• Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats.

  Polish journal of pharmacology 20020101

• Effect of combined treatment with paroxetine and transcranial magnetic stimulation (TMS) on the mitogen-induced proliferative response of rat lymphocytes.

  Polish journal of pharmacology 20020101

• Drug treatment of orthostatic hypotension because of autonomic failure or neurocardiogenic syncope.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20020101

• SSRI efficacy-finding the right dose.

  Journal of psychiatric practice 20020101

• Pacing for vasovagal syncope.

  Indian pacing and electrophysiology journal 20020101

• Enzymatic resolution of trans-4-(4'-fluorophenyl)-3-hydroxymethylpiperidines, key intermediates in the synthesis of (-)-Paroxetine.

  The Journal of organic chemistry 20011228

• Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.

  JAMA 20011219

• Effects of long-term lithium treatment on monoaminergic functions in major depression.

  Psychiatry research 20011215

• Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons.

  Brain research 20011213

• Re: Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies.

  The Journal of urology 20011201

• Reduction in serotonin synthesis following acute and chronic treatments with paroxetine, a selective serotonin reuptake inhibitor, in rat brain: an autoradiographic study with alpha-[14C]methyl-L-tryptophan(2).

  Biochemical pharmacology 20011201

• Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study.

  The American journal of psychiatry 20011201

• Spontaneous lapses in dosing during chronic treatment with selective serotonin reuptake inhibitors.

  The British journal of psychiatry : the journal of mental science 20011201

• Have drug companies hyped social anxiety disorder to increase sales. Yes: marketing hinders discovery of long-term solutions.

  The Western journal of medicine 20011201

• Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro.

  The Journal of antimicrobial chemotherapy 20011201

• Pruritus in polycythaemia vera: prevalence, laboratory correlates and management.

  British journal of haematology 20011201

• Substance P in depression.

  The Harvard mental health letter 20011201

• SSRIs and ejaculation: a double-blind, randomized, fixed-dose study with paroxetine and citalopram.

  Journal of clinical psychopharmacology 20011201

• SSRIs associated with behavioral activation and suicidal ideation.

  Journal of the American Academy of Child and Adolescent Psychiatry 20011201

• Demographic and clinical features of 131 adult pathological gamblers.

  The Journal of clinical psychiatry 20011201

• Aggravation of glaucoma with fluvoxamine.

  The Annals of pharmacotherapy 20011201

• Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression.

  The Annals of pharmacotherapy 20011201

• Development of adult ethanol preference and anxiety as a consequence of neonatal maternal separation in Long Evans rats and reversal with antidepressant treatment.

  Psychopharmacology 20011201

• Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test?

  Psychopharmacology 20011201

• No association between dopamine D(2) and D(4) receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors.

  Psychiatry research 20011130

• Personality dimensions in pathological gambling disorder and obsessive-compulsive disorder.

  Psychiatry research 20011130

• In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.

  European journal of pharmacology 20011130

• LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.

  European journal of pharmacology 20011130

• Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults.

  Biological psychiatry 20011115

• Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study.

  The American journal of psychiatry 20011101

• Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats.

  Psychopharmacology 20011101

• Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue.

  British journal of pharmacology 20011101

• Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters.

  British journal of pharmacology 20011101

• The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder.

  Psychopharmacology 20011101

• [Paroxetine augmentation with risperidone in therapy-resistant depression].

  Psychiatrische Praxis 20011101

• Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline.

  Breast cancer research and treatment 20011101

• Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.

  The Journal of clinical psychiatry 20011101

• Pharmacotherapy of depression in older patients: a summary of the expert consensus guidelines.

  Journal of psychiatric practice 20011101

• 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20011015

• Balance control and posture in anxious mice improved by SSRI treatment.

  Neuroreport 20011008

• Synthesis of S-([18F]fluoromethyl)-(+)-McN5652 as a potential PET radioligand for the serotonin transporter.

  Nuclear medicine and biology 20011001

• Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study.

  The American journal of psychiatry 20011001

• Tolerability of combined treatment with lithium and paroxetine in patients with bipolar disorder and depression.

  Journal of clinical psychopharmacology 20011001

• Clinical predictors of drug response in obsessive-compulsive disorder.

  Journal of clinical psychopharmacology 20011001

• Paroxetine in the treatment of tinnitus.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20011001

• Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells.

  Journal of neurochemistry 20011001

• Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20011001

• Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.

  Clinical pharmacology and therapeutics 20011001

• Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine: a comparison with their abilities to evoke monoamine release.

  International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20011001

• Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants.

  Journal of neurochemistry 20011001

• Drugs or psychotherapy for the elderly?

  The Harvard mental health letter 20011001

• Antidepressant drug prescribing in Italy, 2000: analysis of a general practice database.

  European journal of clinical pharmacology 20011001

• Pharmacotherapy for post-traumatic stress disorder: a comprehensive review.

  Expert opinion on pharmacotherapy 20011001

• The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.

  Postgraduate medicine 20011001

• [Changes in antidepressants consumption in the health area of Zamora from 1996 to 1999].

  Atencion primaria 20010930

• Fetal and adolescent nicotine administration: effects on CNS serotonergic systems.

  Brain research 20010928

• High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum.

  Journal of chromatography. B, Biomedical sciences and applications 20010925

• Alterations in serotonin transporter expression in brain regions of rats exposed neonatally to chlorpyrifos.

  Brain research. Developmental brain research 20010923

• Decreased platelet [3H]paroxetine binding sites in suicide attempters.

  Psychiatry research 20010920

• [Depression and anxiety. Broad spectrum SSRI to control both].

  MMW Fortschritte der Medizin 20010906

• Binding characteristics of selective serotonin reuptake inhibitors with relation to emission tomography studies.

  Synapse (New York, N.Y.) 20010901

• Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice.

  The Journal of pharmacology and experimental therapeutics 20010901

• Prolactin response to dl-fenfluramine challenge before and after treatment with paroxetine.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010901

• The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain.

  British journal of pharmacology 20010901

• Influence of postmenopausal hormone replacement therapy on platelet serotonin uptake site and serotonin 2A receptor binding.

  Obstetrics and gynecology 20010901

• Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders.

  Acta psychiatrica Scandinavica 20010901

• Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.

  Biological psychiatry 20010901

• Association of serotonin and cortisol indices with childhood abuse in bulimia nervosa.

  Archives of general psychiatry 20010901

• A randomized effectiveness trial of collaborative care for patients with panic disorder in primary care.

  Archives of general psychiatry 20010901

• Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?

  Archives of disease in childhood. Fetal and neonatal edition 20010901

• A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment.

  Journal of psychopharmacology (Oxford, England) 20010901

• Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors.

  Journal of psychopharmacology (Oxford, England) 20010901

• Adjunctive osteopathic manipulative treatment in women with depression: a pilot study.

  The Journal of the American Osteopathic Association 20010901

• The effect of selective serotonin reuptake inhibitor treatment of panic disorder on emergency room and laboratory resource utilization.

  The Journal of clinical psychiatry 20010901

• Risperidone augmentation of specific serotonin reuptake inhibitors in the treatment of refractory obsessive-compulsive disorder: report of two cases.

  Chang Gung medical journal 20010901

• Paroxetine in alopecia areata.

  International journal of dermatology 20010901

• Cognitive toxicity of drugs used in the elderly.

  Dialogues in clinical neuroscience 20010901

• Paroxetine for the prevention of depression induced by interferon alfa.

  The New England journal of medicine 20010802

• Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment.

  Psychoneuroendocrinology 20010801

• Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.

  Therapeutic drug monitoring 20010801

• Use of sertraline, paroxetine and fluvoxamine by nursing women.

  The British journal of psychiatry : the journal of mental science 20010801

• Case study: caudate glutamatergic changes with paroxetine persist after medication discontinuation in pediatric OCD.

  Journal of the American Academy of Child and Adolescent Psychiatry 20010801

• Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates.

  Pharmacogenetics 20010801

• Severe hepatotoxicity with jaundice associated with paroxetine.

  The American journal of gastroenterology 20010801

• Brain metabolic changes associated with symptom factor improvement in major depressive disorder.

  Biological psychiatry 20010801

• [Selective serotonin reuptake inhibitor(SSRI)].

  Nihon rinsho. Japanese journal of clinical medicine 20010801

• [Pharmacokinetics and drug interactions of antidepressive agents].

  Nihon rinsho. Japanese journal of clinical medicine 20010801

• [Early internal treatment of mild depression].

  Nihon rinsho. Japanese journal of clinical medicine 20010801

• [Panic disorder and antidepressants].

  Nihon rinsho. Japanese journal of clinical medicine 20010801

• Stable isotope dilution negative ion chemical ionization gas chromatography-mass spectrometry for the quantitative analysis of paroxetine in human plasma.

  Journal of mass spectrometry : JMS 20010801

• Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal.

  The Journal of clinical psychiatry 20010801

• Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.

  Journal of the American Academy of Child and Adolescent Psychiatry 20010701

• An open study of paroxetine in hypochondriasis.

  Progress in neuro-psychopharmacology & biological psychiatry 20010701

• Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings.

  Archives of general psychiatry 20010701

• Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism?

  Biological psychiatry 20010701

• Serotonin receptor and transporter ligands - current status.

  Current medicinal chemistry 20010701

• Remission of SSRI-induced akathisia after switch to nefazodone.

  The Journal of clinical psychiatry 20010701

• Negative symptoms of schizophrenia are improved by paroxetine added to neuroleptics: a pilot study.

  The Journal of clinical psychiatry 20010701

• Effects of Hypericum perforatum (St. John's wort) on passive avoidance in the rat: evaluation of potential neurochemical mechanisms underlying its antidepressant activity.

  Pharmacopsychiatry 20010701

• Lithium augmentation in depressive patients not responding to selective serotonin reuptake inhibitors.

  Pharmacopsychiatry 20010701

• Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms.

  Journal of traumatic stress 20010701

• Influence of CYP2D6 genotype and medication on the sparteine metabolic ratio of psychiatric patients.

  European journal of clinical pharmacology 20010701

• Cancer fatigue: one drug fails but more are in the pipeline.

  Journal of the National Cancer Institute 20010620

• Mood disorders in children and adolescents: psychopharmacological treatment.

  Biological psychiatry 20010615

• Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine.

  Therapeutic drug monitoring 20010601

• Comparison of peripheral inhibitory effects of clomipramine with selective serotonin re-uptake inhibitors on contraction of vas deferens: in vitro and in vivo studies.

  The Journal of urology 20010601

• Retinopathy associated with high-dose interferon alfa-2b therapy.

  American journal of ophthalmology 20010601

• Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression.

  The American journal of psychiatry 20010601

• Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.

  The American journal of psychiatry 20010601

• Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone.

  Journal of clinical psychopharmacology 20010601

• Comments on 'Serotonin syndrome during treatment with paroxetine and risperidone'.

  Journal of clinical psychopharmacology 20010601

• A prospective study of 86 new patients with social anxiety disorder.

  Acta psychiatrica Scandinavica 20010601

• Dual-task performance in depressed geriatric patients.

  Psychiatry research 20010601

• Male breast neoplasia in association with selective serotonin re-uptake inhibitor therapy: a report of three cases.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20010601

• SSRI treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects.

  Journal of sleep research 20010601

• Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens.

  Psychopharmacology 20010601

• Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'.

  Journal of psychopharmacology (Oxford, England) 20010601

• The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers.

  Journal of psychopharmacology (Oxford, England) 20010601

• Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.

  The Journal of clinical psychiatry 20010601

• Psychosis in children: diagnosis and treatment.

  Dialogues in clinical neuroscience 20010601

• Development of a high throughput equilibrium dialysis method.

  Journal of pharmaceutical sciences 20010501

• Metoprolol-paroxetine interaction in human liver microsomes: stereoselective aspects and prediction of the in vivo interaction.

  Drug metabolism and disposition: the biological fate of chemicals 20010501

• Review of sertraline and its clinical applications in psychiatric disorders.

  Expert opinion on pharmacotherapy 20010501

• Improvement of acne in depressed patients treated with paroxetine.

  Journal of the American Academy of Child and Adolescent Psychiatry 20010501

• Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years.

  The Journal of family practice 20010501

• A meta-analysis of the efficacy and tolerability of paroxetine versus tricyclic antidepressants in the treatment of major depression.

  International clinical psychopharmacology 20010501

• Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.

  The Journal of clinical psychiatry 20010501

• Does mirtazapine have a more rapid onset than SSRIs?

  The Journal of clinical psychiatry 20010501

• Type II error and antidepressants.

  The Journal of clinical psychiatry 20010501

• [5-HT1B serotonin receptors and antidepressant effects of selective serotonin reuptake inhibitors ].

  Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie 20010501

• Risk profile of SSrIs in elderly depressive patients with co-morbid physical illness.

  Pharmacopsychiatry 20010501

• A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.

  Pharmacopsychiatry 20010501

• [Pharmacotherapy for neuropathic pain caused by injury to the afferent nerve fibers].

  Nederlands tijdschrift voor geneeskunde 20010428

• Methylenedioxymethamphetamine-induced suppression of interleukin-1beta and tumour necrosis factor-alpha is not mediated by serotonin.

  European journal of pharmacology 20010420

• Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors.

  Epilepsy research 20010401

• Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin.

  Journal of clinical psychopharmacology 20010401

• Changes in quantitatively assessed tremor during treatment of major depression with lithium augmented by paroxetine or amitriptyline.

  Journal of clinical psychopharmacology 20010401

• Antidepressive treatment with amitriptyline and paroxetine: comparable effects on heart rate variability.

  Journal of clinical psychopharmacology 20010401

• Chronic benzodiazepine use in general practice patients with depression: an evaluation of controlled treatment and taper-off: report on behalf of the Dutch Chronic Benzodiazepine Working Group.

  The British journal of psychiatry : the journal of mental science 20010401

• Prefrontal changes and treatment response prediction in depression.

  Seminars in clinical neuropsychiatry 20010401

• Involvement of 5-HT(2C) receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20010401

• Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20010401

• Economic evaluation of major selective serotonin-reuptake inhibitors in a managed care population.

  Managed care interface 20010401

• Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.

  The Journal of clinical psychiatry 20010401

• Paroxetine for the prevention of depression induced by high-dose interferon alfa.

  The New England journal of medicine 20010329

• Modafinil does not affect serotonin efflux from rat frontal cortex synaptosomes: comparison with known serotonergic drugs.

  Brain research 20010316

• Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to two animal models of depression?

  Behavioural brain research 20010315

• Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20010315

• Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study.

  The Journal of pharmacology and experimental therapeutics 20010301

• Neonatal paroxetine withdrawal syndrome.

  Archives of disease in childhood. Fetal and neonatal edition 20010301

• Cutaneous vasculitis induced by paroxetine.

  The American journal of psychiatry 20010301

• Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.

  The British journal of psychiatry : the journal of mental science 20010301

• Serotonergic function in major depression and effect of sertraline and paroxetine treatment.

  International clinical psychopharmacology 20010301

• Breast cancer and hot flashes. Options for relief.

  Mayo Clinic health letter (English ed.) 20010301

• Discontinuing antidepressants and benzodiazepines upon becoming pregnant. Beware of the risks of abrupt discontinuation.

  Canadian family physician Medecin de famille canadien 20010301

• Pharmacological treatment of childhood obsessive-compulsive disorder: from theory to practice.

  Journal of clinical child psychology 20010301

• Triiodothyronine augmentation of selective serotonin reuptake inhibitors in posttraumatic stress disorder.

  The Journal of clinical psychiatry 20010301

• [A patient with nodal tachycardia after general anesthesia during medication with a selective serotonin reuptake inhibitor].

  Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 20010301

• Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors.

  Acta paediatrica (Oslo, Norway : 1992) 20010301

• Lack of interaction between flibanserin and antidepressants in inducing serotonergic syndrome in rats.

  The international journal of neuropsychopharmacology 20010301

• Reactivity of serotonin in whole blood: relationship with drug response in obsessive-compulsive disorder.

  Biological psychiatry 20010215

• Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats.

  Life sciences 20010209

• Highly diastereoselective and enantioselective carbon-carbon bond formations in conjugate additions of lithiated N-Boc allylamines to nitroalkenes: enantioselective synthesis of 3,4- and 3,4,5-substituted piperidines including (-)-paroxetine.

  Journal of the American Chemical Society 20010207

• Female sexual dysfunction and antidepressant use.

  The American journal of psychiatry 20010201

• Citalopram-induced bruxism.

  The British journal of psychiatry : the journal of mental science 20010201

• 5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex.

  Journal of neurochemistry 20010201

• The toxicity profile of a single dose of paroxetine: an alternative approach to acute toxicity testing in the rat.

  Pharmacology & toxicology 20010201

• Psychopharmacologic treatment of adolescent depression.

  Archives of psychiatric nursing 20010201

• By the way, doctor. I've been taking Paxil for depression for about six months. Although it's helped my symptoms of depression, I've lost interest in sex. Aside from stopping the medication, is there any way to regain my sexual function?

  Harvard women's health watch 20010201

• Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study.

  Journal of clinical psychopharmacology 20010201

• Cost-effective treatment of depression with selective serotonin reuptake inhibitors.

  The American journal of managed care 20010201

• Galactorrhea induced by paroxetine.

  Canadian journal of psychiatry. Revue canadienne de psychiatrie 20010201

• Disinhibition of libido: an adverse effect of SSRI?

  Journal of affective disorders 20010201

• Drug induced akathisia, suicidal ideation and its treatment in the elderly.

  International journal of geriatric psychiatry 20010201

• Antidepressant treatment and global tests of coagulation and fibrinolysis.

  The Journal of clinical psychiatry 20010201

• Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures.

  Clinical therapeutics 20010201

• Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation.

  International journal of impotence research 20010201

• New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.

  Journal of medicinal chemistry 20010201

• [The transfer of selective serotonin reuptake inhibitors to human milk].

  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20010120

• Nicotine exposure during pregnancy is a factor which influences serotonin transporter density in the rat brain.

  European journal of pharmacology 20010112

• The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study.

  The American journal of psychiatry 20010101

• Paroxetine in breast milk.

  The American journal of psychiatry 20010101

• A proposed pathological model in the hippocampus of subjects with schizophrenia.

  Clinical and experimental pharmacology & physiology 20010101

• Social support and treatment response in older depressed primary care patients.

  The journals of gerontology. Series B, Psychological sciences and social sciences 20010101

• The effects of antidepressants on obstructed and unobstructed gait in healthy elderly people.

  The journals of gerontology. Series A, Biological sciences and medical sciences 20010101

• Paxil and self-scratching.

  Journal of the American Academy of Child and Adolescent Psychiatry 20010101

• Withdrawal reactions of a premature neonate after maternal use of paroxetine.

  Archives of disease in childhood. Fetal and neonatal edition 20010101

• Treatment of social phobia with antidepressants.

  The Journal of clinical psychiatry 20010101

• Pharmacological treatment of depression: the role of paroxetine.

  Hospital medicine (London, England : 1998) 20010101

• Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.

  Drugs 20010101

• Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.

  The Journal of clinical psychiatry 20010101

• An ideal trial to test differential onset of antidepressant effect.

  The Journal of clinical psychiatry 20010101

• Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly.

  Depression and anxiety 20010101

• [Depressive disorders in neurologic rehabilitation: therapy with paroxetine].

  Psychiatrische Praxis 20010101

• 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze.

  Psychopharmacology 20010101

• Salmon calcitonin potentiates the analgesia induced by antidepressants.

  Pharmacology, biochemistry, and behavior 20010101

• No correlation between aggression and platelet (3)H-paroxetine binding in obsessive-compulsive disorder patients.

  Neuropsychobiology 20010101

• First experiences in combination therapy using olanzapine with SSRIs (citalopram, paroxetine) in delusional depression.

  Neuropsychobiology 20010101

• [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].

  L'Encephale 20010101

• Influence of exercise on serotonergic neuromodulation in the brain.

  Amino acids 20010101

• [Bleeding from selective serotonin reuptake inhibitors: a case report].

  Therapie 20010101

• Hyponatraemia associated with the use of a selective serotonin-reuptake inhibitor in an older patient.

  Age and ageing 20010101

• Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters.

  Journal of child and adolescent psychopharmacology 20010101

• [Changes in intake pattern in obese patients treated with paroxetine].

  Nutricion hospitalaria 20010101

• Selective serotonin reuptake inhibitors for late-life depression: a comparative review.

  Drugs & aging 20010101

• Pharmacotherapy of generalized anxiety disorder.

  The Journal of clinical psychiatry 20010101

• Paroxetine: a review.

  CNS drug reviews 20010101

• Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies.

  The Journal of clinical psychiatry 20010101

• Paroxetine in child and adolescent outpatients with panic disorder.

  Journal of child and adolescent psychopharmacology 20010101

• Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents.

  Journal of child and adolescent psychopharmacology 20010101

• [Cutaneous adverse effects during selective serotonin reuptake inhibitors therapy: 2 cases].

  Annales de dermatologie et de venereologie 20010101

• Tianeptine: a review of its use in depressive disorders.

  CNS drugs 20010101

• The economics of selective serotonin reuptake inhibitors in depression: a critical review.

  CNS drugs 20010101

• [Pseudoneurotic schizophrenia: a case report].

  Actas espanolas de psiquiatria 20010101

• Chronic depression in the elderly: approaches for prevention.

  Drugs & aging 20010101

• Pharmacological characterization of the serotonin transporter in young and elderly subjects.

  Neuropsychobiology 20010101

• Determination of moclobemide, paroxetine, and fluvoxamine in tablets by HPLC.

  Acta poloniae pharmaceutica 20010101

• Venlafaxine extended-release: a review of its use in the management of major depression.

  CNS drugs 20010101

• Characteristics of geriatric patients seeking medication treatment for pathologic gambling disorder.

  Journal of geriatric psychiatry and neurology 20010101

• A review of the pharmacological and clinical profile of mirtazapine.

  CNS drug reviews 20010101

• Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study.

  Cerebrovascular diseases (Basel, Switzerland) 20010101

• [A case of a rare side effects of paxil therapy in a male patient with irritable colon syndrome].

  Klinicheskaia meditsina 20010101

• Olanzapine-induced retarded ejaculation: role of paroxetine comedication? A case report.

  Therapie 20010101

• SSRI-induced bleeding: two case reports.

  Therapie 20010101

• [Alpha-interferon and mental disorders].

  L'Encephale 20010101

• The neuropharmacology of upper airway motor control in the awake and asleep states: implications for obstructive sleep apnoea.

  Respiratory research 20010101

• New use for Paxil approved.

  FDA consumer 20010101

• Interpersonal psychotherapy for late-life depression: past, present, and future.

  The Journal of psychotherapy practice and research 20010101

• Long-term costs of treatment for depression: impact of drug selection and guideline adherence.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20010101

• Status of minor depression or dysthymia in primary care following a randomized controlled treatment.

  General hospital psychiatry 20010101

• A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20010101

• Quality of life in geriatric depression: a comparison of remitters, partial responders, and nonresponders.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20010101

• Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers.

  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20010101

• Serotonin syndrome preceding pseudoseizures in an adolescent.

  Psychosomatics 20010101

• Paroxetine for social anxiety and alcohol use in dual-diagnosed patients.

  Depression and anxiety 20010101

• Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.

  Pharmacoepidemiology and drug safety 20010101

• Interactions between herbal medicines and prescribed drugs: a systematic review.

  Drugs 20010101

• Sertralilne, paroxetine and venlafaxine in refugee post traumatic stress disorder with depression symptoms.

  Medicinski arhiv 20010101

• SB-236057-A: a selective 5-HT1B receptor inverse agonist.

  CNS drug reviews 20010101

• [Psychiatric and psychological aspects of premenstrual syndrome].

  L'Encephale 20010101

• Enantiomeric enrichment of (+)-(3R,4S)-4-(4-fluorophenyl)-3-hydroxymethyl-1-methylpiperidine by crystallization.

  Enantiomer 20010101

• Depression and anxiety in oncology: the psychiatrist's perspective.

  The Journal of clinical psychiatry 20010101

• Reports of SSRI-associated bruxism in the family physician's office.

  Journal of orofacial pain 20010101

• National Patterns of Medication Treatment for Depression, 1987 to 2001.

  Primary care companion to the Journal of clinical psychiatry 20010101

• Serotonergic antidepressants and urinary incontinence.

  International urogynecology journal and pelvic floor dysfunction 20001201

• Antidepressant-induced regulation of 5-HT(1b) mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation.

  Journal of neuroscience research 20000701

• Exacerbation of psychosis by phenylpropanolamine.

  The American journal of psychiatry 20000601

• Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine.

  The Journal of clinical psychiatry 20000501

• [Tourette's syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine].

  Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 20000501

• Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment.

  Journal of clinical psychopharmacology 20000401

• Unilateral facial numbness and visual blurring associated with paroxetine discontinuation.

  Journal of clinical psychopharmacology 20000401

• Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia.

  International journal of antimicrobial agents 20000401

• Cocaine-associated stroke: three cases and rehabilitation considerations.

  Brain injury 20000401

• Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.

  The Journal of clinical psychiatry 20000401

• Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.

  The Journal of clinical psychiatry 20000301

• Rifampin-induced selective serotonin reuptake inhibitor withdrawal syndrome in a patient treated with sertraline.

  Journal of clinical psychopharmacology 20000201

• Antidepressant drugs appear to enhance cocaine-induced toxicity.

  Experimental and clinical psychopharmacology 20000201

• Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder.

  Depression and anxiety 20000101

• An open trial of paroxetine in the treatment of children and adolescents diagnosed with dysthymia.

  Journal of child and adolescent psychopharmacology 20000101

• Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 19991201

• Neurological recovery after prolonged verapamil-induced cardiac arrest.

  Anaesthesia and intensive care 19991201

• [3H]Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine.

  International journal of immunopharmacology 19991001

• Syndrome of inappropriate secretion of antidiuretic hormone induced by paroxetine.

  Archives of internal medicine 19990927

• Effects of paroxetine on heart period variability in patients with panic disorder: a study of holter ECG records.

  Neuropsychobiology 19990901

• [Serotonin syndrome associated to the use of paroxetine. Case report].

  Arquivos de neuro-psiquiatria 19990901

• Stopping the pills.

  Lancet (London, England) 19990814

• Hyponatremia in an older patient.

  Journal of the American Geriatrics Society 19990801

• Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group.

  The British journal of psychiatry : the journal of mental science 19990801

• A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder.

  Journal of affective disorders 19990701

• Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors.

  Journal of clinical psychopharmacology 19990601

• Citalopram and sexual side effects of selective serotonin reuptake inhibitors.

  The American journal of psychiatry 19990501

• Sildenafil treatment of paroxetine-induced anorgasmia in a woman.

  The American journal of psychiatry 19990501

• Relief of SSRI-induced sexual dysfunction with mirtazapine treatment.

  The Journal of clinical psychiatry 19990401

• Atrium and paroxetine-related severe hepatitis.

  Journal of clinical gastroenterology 19990101

• Cognitive effects of paroxetine in older depressed patients.

  The Journal of clinical psychiatry 19990101

• A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 19981201

• [Interaction between paroxetine and clomipramine as a possible reason for admission to a department of internal medicine].

  Ugeskrift for laeger 19980921

• Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.

  Journal of clinical psychopharmacology 19980801

• Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline.

  The American journal of psychiatry 19980801

• Depressive symptomatology during clozapine treatment: two case reports.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 19980801

• [ECG changes after paroxetine. 3 case reports].

  Der Nervenarzt 19980701

• Serotonin syndrome following the administration of tramadol with paroxetine.

  International journal of geriatric psychiatry 19980501

• Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.

  Bioorganic & medicinal chemistry letters 19980303

• Indan analogs of fenfluramine and norfenfluramine have reduced neurotoxic potential.

  Pharmacology, biochemistry, and behavior 19980301

• Postural hypotension induced by paroxetine.

  BMJ (Clinical research ed.) 19980214

• Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.

  The American journal of psychiatry 19980101

• Sexual dysfunction induced by serotonin reuptake antidepressants.

  Journal of sex & marital therapy 19980101

• The serotonin syndrome scale: first results on validity.

  European archives of psychiatry and clinical neuroscience 19980101

• Pharmacological profile of antidepressants and related compounds at human monoamine transporters.

  European journal of pharmacology 19971211

• How long should pindolol be associated with paroxetine to improve the antidepressant response?

  Journal of clinical psychopharmacology 19971201

• Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction.

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 19971201

• Dose-dependent pharmacokinetic interaction of clozapine and paroxetine in an extensive metabolizer.

  Pharmacopsychiatry 19971101

• Paroxetine-induced mania.

  Journal of the American Academy of Child and Adolescent Psychiatry 19970601

• Syndrome of inappropriate ADH secretion attributed to the serotonin re-uptake inhibitors, venlafaxine and paroxetine.

  The Netherlands journal of medicine 19970601

• Two cases of deep vein thrombosis associated with a combined paroxetine and zotepine therapy.

  Pharmacopsychiatry 19970501

• Delirium associated with paroxetine and benztropine combination.

  The American journal of psychiatry 19970401

• SSRI-induced mania.

  Journal of the American Academy of Child and Adolescent Psychiatry 19970401

• A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.

  The Journal of clinical psychiatry 19970401

• Transient, paroxysmal, shock-like paresthesias associated with paroxetine initiation.

  The Journal of clinical psychiatry 19970401

• [Severe hepatitis attributed to paroxetine (Seroxat)].

  Nederlands tijdschrift voor geneeskunde 19970315

• A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.

  The Journal of clinical psychiatry 19970301

• Withdrawal hypomania associated with paroxetine.

  Journal of clinical psychopharmacology 19970201

• Serotonin syndrome associated with nefazodone and paroxetine.

  Annals of emergency medicine 19970201

• Paroxetine-induced chorea.

  The British journal of psychiatry : the journal of mental science 19970201

• SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

  Journal of sex & marital therapy 19970101

• SIADH caused by paroxetine.

  The Annals of pharmacotherapy 19961201

• Restless legs syndrome and paroxetine.

  Acta psychiatrica Scandinavica 19961201

• [Adverse effects of selective serotonin uptake inhibitors. Hyponatremia caused by Schwartz-Bartter syndrome].

  Ugeskrift for laeger 19961125

• Bupropion plasma levels and CYP2D6 phenotype.

  Therapeutic drug monitoring 19961001

• Serotonin reuptake inhibitor withdrawal.

  Journal of clinical psychopharmacology 19961001

• Lhermitte's sign in paroxetine withdrawal.

  Journal of clinical psychopharmacology 19961001

• Paroxetine-induced angioedema and tongue swelling.

  The Journal of clinical psychiatry 19961001

• Pharmacological characterization of BNMPA (alpha-benzyl-N-methylphenethylamine), an impurity of illicit methamphetamine synthesis.

  European journal of pharmacology 19960912

• Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 19960901

• [Bradycardia after beginning therapy with metoprolol and paroxetine].

  Psychiatrische Praxis 19960901

• Serotonin syndrome complicating migraine pharmacotherapy.

  Cephalalgia : an international journal of headache 19960801

• Paroxetine as a treatment for premenstrual dysphoric disorder.

  Journal of clinical psychopharmacology 19960201

• Recurrent hyponatremia associated with fluoxetine and paroxetine.

  The American journal of psychiatry 19960101

• Depression following smoking cessation in women.

  Journal of substance abuse 19960101

• Nightmares and hallucinations after long-term intake of tramadol combined with antidepressants.

  Acta clinica Belgica 19960101

• [Sexual dysfunction secondary to SSRIs. A comparative analysis in 308 patients].

  Actas luso-espanolas de neurologia, psiquiatria y ciencias afines 19960101

• Rapid cycling triggered by pindolol augmentation of paroxetine, but not with desipramine.

  Depression 19960101

• Possible paroxetine-zolpidem interaction.

  The American journal of psychiatry 19951101

• Paroxetine-induced SIADH.

  The Medical journal of Australia 19951002

• Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday.

  The American journal of psychiatry 19951001

• Paroxetine-induced psychotic mania.

  The American journal of psychiatry 19950901

• Exacerbation of extrapyramidal symptoms with paroxetine.

  The Australian and New Zealand journal of psychiatry 19950901

• Physical symptoms associated with paroxetine withdrawal.

  The American journal of psychiatry 19950801

• Severe psychiatric symptoms associated with paroxetine withdrawal.

  Lancet (London, England) 19950701

• Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients.

  Psychopharmacology 19950601

• Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors.

  The American journal of psychiatry 19950501

• A possible paroxetine withdrawal syndrome.

  The American journal of psychiatry 19950401

• Spontaneous seizure after concurrent use of methohexital anesthesia for electroconvulsive therapy and paroxetine: a case report.

  The Journal of nervous and mental disease 19950201

• Paroxetine-molindone interaction.

  The Journal of clinical psychiatry 19950201

• Paroxetine withdrawal syndrome.

  The American journal of psychiatry 19950101

• Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients.

  International journal of psychiatry in medicine 19950101

• Adverse events after the abrupt discontinuation of paroxetine.

  Pharmacotherapy 19950101

• Anisocoria associated with selective serotonin reuptake inhibitors.

  BMJ (Clinical research ed.) 19941217

• The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease.

  The American journal of emergency medicine 19941101

• Medication withdrawal symptoms in obsessive-compulsive disorder patients treated with paroxetine.

  Journal of clinical psychopharmacology 19940601

• Psychomotor retardation and semistuporous state with paroxetine.

  BMJ (Clinical research ed.) 19930501

• Extra pyramidal side effects associated with paroxetine.

  West of England medical journal 19921201

• The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms.

  Pain 19900801

• Laminar distributions of muscarinic acetylcholine, serotonin, GABA and opioid receptors in human posterior cingulate cortex.

  Neuroscience 19900101

• [Behavioral pharmacological properties of the novel antidepressant paroxetine, a selective 5-HT uptake inhibitor].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 19890901

• Comparison of some effects of paroxetine with amitriptyline on the cardiovascular system in animals.

  Arzneimittel-Forschung 19860301

• p,p'-DDT-induced myoclonus in mice: the effect of enhanced 5-HT neurotransmission.

  Acta pharmacologica et toxicologica 19850201